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Background: Although the Indonesian Government supports the role of pharmacists 
in patient care with relevant government policies, the role of pharmacists to ensure 
the safe use of medication is limited in Indonesian practice. Communication failure is 
one of the root causes of medication errors. Lack of communication may result from 
poor understanding of the role of other healthcare professionals. Meanwhile, studies 
showed that Interprofessional Education (IPE) may provide an opportunity for 
healthcare professionals to improve understanding of the role of other healthcare 
professionals. D’Amour and Oandasan in their framework for Interprofessional 
Education for Collaborative Patient-Centred Practice (IECPCP) stated that IPE and 
Interprofessional Practice (IPP) are closely linked and influenced by factors at the 
Micro (learners, teachers, practitioners and patients), Meso (institutional) and Macro 
(political, socio-economical, and cultural systems) levels. They further recommended 
that research to document the links of the Micro, Meso and Macro factors is 
required for adopting collaborative patient centred practice. This is the first study to 
investigate the feasibility of implementing IPE to assist in expanding the role of 
pharmacists in patient care to ensure the safe use of medication in the Indonesian 
context. 
 
Aims: This study had three aims: (1) to assess the feasibility of expanding the role of 
pharmacists in patient care in ensuring medication safety; (2) to examine the 
feasibility of the implementation of IPE in a public university; and (3) to examine the 
feasibility of the implementation of IPP in an Indonesian teaching hospital.  
 
Research Methods: The present study had five phases. The First Phase 
(development, validation, and translation) involved the development, translation and 
validation of questionnaires. All questionnaires were translated into Bahasa 
Indonesian. Validity and reliability of the questionnaires were obtained through 
review by an independent lecturer and from piloting the questionnaires to 
representative sample groups. The Second Phase (administration of questionnaires) 
involved administration of questionnaires employed at the present study. The 
Readiness for Interprofessional Learning Scale (RIPLS) questionnaire was 
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administered to Year 1, 2, 3, and 4 healthcare students (medical, nursing and 
pharmacy students) in Survey Year 2012 and the Year 1, 2, and 3 Cohorts in Survey 
Year 2013. The academics at the study university and practitioners in the study 
hospital responded to the RIPLS questionnaire and the medication errors case 
vignettes. The medication errors case vignettes were developed to reflect common 
cases seen in the local practice setting. The participants were selected using a 
random number generator available online. Pharmacy graduates of the study 
university responded to the graduates’ questionnaire of attributes as care providers 
to assess their preparedness to deliver patient care. The Third Phase (clinical 
pharmacy services) was conducted in a geriatric ward in the study hospital to 
determine whether the pharmacist could detect errors in the medication delivery 
process, and hence provide evidence for the pharmacist role in medication safety. 
The primary investigator (a Master of Clinical Pharmacy graduate) provided the 
clinical services including medication reconciliation, clinical review, and patient 
discharge counselling for 20 weeks in the study hospital. Data were reported as 
proportions of medication errors identified in the medication delivery process. The 
Fourth Phase (interprofessional learning-IPL workshop) involved a two day IPL 
workshop on medication safety involving final year medical, nursing, and pharmacy 
students from the study university. To identify whether the IPL workshop influenced 
healthcare students’ attitudes towards IPE, the students’ responses to the pre- and 
post- workshop RIPLS questionnaires were compared. The Fifth Phase (interviews 
and focus group discussions-FGDs) involved pharmacy graduates and healthcare 
professionals to determine facilitators, barriers, and the level of support for the 
implementation of IPE and IPP, as well as participants’ perceptions as to the role of 
pharmacists in patient care to ensure medication safety. Transcripts of the interviews 
and FGDs were thematically analysed.  
 
Results and Discussion:  
The First Phase Confirmatory factor analysis (CFA) confirmed the RIPLS questionnaire 
for healthcare students had two sub-scales (i.e. Shared Learning and Teamwork-SLT 
and Professional Identity-PI) in the study population. Similarly, CFA of the RIPLS 
questionnaire for healthcare professionals identified two sub-scales (Shared Learning 




The Second Phase A total of 488 students participated out of 550 RIPLS 
questionnaires administered in Survey Year 2012 and 346 students participated out 
of the 412 RIPLS questionnaires administered in Survey Year 2013. These gave a 
response rate of 88.7% and 83.9%, respectively. Overall, medical students had less 
positive attitudes towards IPE than their counterparts in nursing and pharmacy, and 
this was associated with a stronger sense of professional identity in both survey 
years. A strong sense of professional identity was also notable in the Year 2 Cohort 
medical students (p=0.03). This stronger sense of professional identity compared 
with other healthcare students was considered as a barrier to the implementation of 
IPE at the educational setting. The trend analysis indicated that Year 1 healthcare 
student’s attitudes towards shared learning and teamwork (SLT sub-scale) 
diminished as they progressed through their study. This suggests IPE should be 
initiated early in the healthcare students’ learning in the study university.  
 
A total of 310 healthcare professionals responded to the 550 questionnaires 
administered which gave a 56.4% response rate. Healthcare professionals regardless 
of their place of work had positive attitudes towards IPP and had no variation of their 
attitudes towards any RIPLS sub-scales. However, the Physician Groups had more 
positive attitudes towards Statement 19 (The function of nurses and therapists is 
mainly to provide support for doctors) compared to the Nurse and Pharmacist 
Groups (p=0.001). This indicated physicians had a stronger sense of professional 
identity than nurses and pharmacists which may be a barrier in the clinical practice, 
as it may diminish team work. Nurses at the study hospital had significantly more 
positive attitudes towards Statement 19 than nursing academics (p=0.001). This may 
be influenced by the informal learning at their place of work and may reflect the 
hierarchical model of healthcare service delivery at the study hospital. Interestingly, 
the healthcare academics had more positive attitudes than practising healthcare 
professionals towards Statement 19 (p=0.001). These findings were considered as 
barriers to the implementation of IPE at the education setting. This indicated the 
need for faculty development if IPE was to be implemented in the study university. 
The results from medication errors case vignettes study showed that the pharmacists 
who participated in the study were more likely to provide the expected answers for 
medication errors. The case vignettes aimed to examine healthcare professionals’ 
understanding of medication errors and the professionals responsible for the errors. 
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Only a small proportion of participants responded that communication failure was a 
contributor to the medication errors provided in the vignettes. 
 
Owing to a poor response rate of 15.4% of registered pharmacists that graduated 
from the study university, 40 of 45 pharmacy interns were recruited for the study 
and gave a response rate of 88.9%. A higher proportion of male than female 
pharmacy interns perceived to have the leadership potential attribute (p=0.004). 
Both male and female registered pharmacists and pharmacy interns showed no 
significant difference in the desirability to have the attributes for patient care, 
however, the pharmacy graduates felt that they had acquired few of the attributes 
required to provide patient care. The breadth of the pharmacy course content and 
short clinical placements were suggested as two potential reasons for the low 
acquisition. These findings indicated that pharmacy graduates from the study 
university lacked preparedness as care providers. 
 
The Third Phase A 20 week clinical pharmacy service activity was conducted in a 
geriatric ward at the study hospital. Ninety two of 121 geriatric patients who met the 
inclusion criteria consented to participate in the study. There were 770 medication 
orders for the 92 inpatients that participated in the study, i.e. 8.4 ±3.3 medications 
per patient. The total number of doses charted was 7,662, i.e 83 ± 81 doses per 
patient. A total of 1,563 medication errors were identified through the clinical 
pharmacy services provided by the investigator, which represented an error rate of 
20.4% (1,563/7,662). Administration errors were the most frequent medication 
errors identified (59.3%), followed by transcription errors (14.7%), dispensing errors 
(14.4%), and prescribing errors (6.5%). The pharmacist conducting clinical review 
activities on the study ward intercepted eight near miss events during the 
administration stage and 24 near miss events at the dispensing stage. A low 
acceptance rate of pharmacist interventions during the activity indicated a lack of 
familiarity with the pharmacy service, a lack of relationship with other healthcare 
professionals and the level of clinical experience of the investigator.  
 
The Fourth Phase Ten medical, 10 nursing and 15 pharmacy students responded to 
the RIPLS pre- and post- workshop RIPLS questionnaires. Healthcare students had 
significantly more positive attitudes towards some statements in the SLT sub-scale 
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after attending the workshop. The Fisher Exact test value indicated that healthcare 
students had varied responses to Statement 4 (Team working skills are essential for 
all healthcare students to learn) before and after the workshop (p=0.011). Medical 
students had less agreement; pharmacy had more agreement, while nursing 
students had no significant difference of agreement towards this statement after 
attending the workshop. The results from the open-ended questionnaire suggest 
that the healthcare students admitted of gaining experience of teamwork and 
communication skills and obtaining the respect and trust of other healthcare 
professionals. They also believed in the need to improve their understanding of the 
role and of the responsibility of other healthcare professionals.  
 
The Fifth Phase Although support for the implementation of IPE at the education and 
practice settings, and support for expanding the role of pharmacists were obvious 
from the interviews and FGDs activities, some barriers were also identified. The 
major barriers identified were pharmacists’ internal factors (i.e. lack of knowledge 
and experience, lack of confidence, lack of pharmacist workforce and pharmacists’ 
mind set) in the expansion of the role of pharmacists in patient care. The 
pharmacists’ external barriers were varying understanding of the role of pharmacist, 
no fee for service, and poor recruitment procedures. At the study university, barriers 
to the implementation of IPE were differences in curriculum between the healthcare 
courses, differences in opinions on when and how to start IPE as well as differences 
in opinions on the level of support from the university. The major barrier to the 
implementation of IPP at the study hospital identified by participants was the lack of 
competencies of IPP which was mainly due to the lack of understanding of the role of 
healthcare professionals. Other significant barriers to the implementation of IPP 
identified at the study hospital were the strong sense of superiority, no legislation 
from the government on teamwork and limited staff.  
 
Conclusion: This study found despite a number of barriers being identified to the 
implementation of IPE and IPP, the expanding role of pharmacists in patient care 
through the implementation of IPE and IPP was feasible for the following reasons. 
Firstly, the support from the Indonesian Government via a joint accreditation is 
considered as a significant driving force for the implementation of IPE in Indonesian 
health education. Secondly, participants in the qualitative study supported the role 
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of pharmacists for the perceived benefits of pharmacists’ involvement in patient 
care. Thirdly, a pharmacist providing clinical pharmacy services was able to identify 
and intercept medication errors during the medication delivery process. Findings of 
this study should provide data to support the expansion of the role of pharmacists in 
medication safety. It also provides evidence to facilitate the implementation of IPE 
and IPP as both are necessary and feasible with the support from the health system, 
health education, and pharmacy organisations. 
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CHAPTER 1 INTRODUCTION 
 
1.1 BACKGROUND 
Medication safety, as part of patient safety, is an issue world-wide. In Australia, a 
recent review in medication safety identified that 2-3% of hospital admissions were 
associated with medication,1 which gave an annual cost of $1.2 billion.1 In the United 
States of the estimated 98,000 deaths annually attributed to medical errors, 
medication errors contributed to approximately 10% to 20% of the fatality.2, 3 The 
Indonesian Government has recognised this issue by adopting the Joint Commission 
International (JCI) accreditation in seven public hospitals in the country.4 One of the 
standards of the accreditation is medication management use which aims to ensure 
the safe use of medication.5 Medication safety is an important issue for every 
healthcare service. The involvement of different healthcare professionals in the 
medication delivery process, who have various skills, knowledge and training, means 
each has a role in ensuring medication safety.  
 
There are different definitions of medication safety reported in the literature. Yu et 
al. in a systematic review found that adverse events, near misses, errors and adverse 
reactions were terms commonly used to study medication safety by organisations.6 
Other studies conceptualised medication safety as drug related problems (DRPs), 
medication misadventures, adverse drug events, and medication errors.7-11 Bates et 
al. who studied adverse drug events and the association with medication errors10 
stated that errors are common and preventable adverse drug events. Based on their 
findings, the American Society of Health-System Pharmacists (ASHP) recognised 
medication safety as medication misadventure which involved adverse drug 
reactions (ADRs) and medication errors.12 Manasse and Thompson stated that 
medication misadventure was a costly, preventable and common event which 
occurred during drug treatment.11 
 
The term medication errors had broad classifications in the literature. The error may 
be classified based on sources, outcomes, and stages during the process of 
medication delivery.12-14 Lisby et al. in a systematic review found inconsistency of the 
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term medication errors used in 45 studies. Medication errors were defined in 26 
different wordings from the studies.15 The authors found that less than 50% of the 
studies defined medication errors as generic or stage specific terms. Most studies in 
the literature used medication errors definitions from the National Coordinating 
Council for Medication Error Reporting and Prevention (NCCMERP). This Council 
defines medication errors as “any preventable event that may cause or lead to 
inappropriate medication use or patient harm while the medication is in the control 
of the health care professional, patient, or consumer. Such events may be related to 
professional practice, health care products, procedures, and systems, including 
prescribing, order communication, product labelling, packaging, and nomenclature, 
compounding, dispensing, distribution, administration, education, monitoring, and 
use.” 13  
 
Aronson stated that although the majority of preventable events may not lead to 
injuries, some minor errors may result in long-term major outcomes.16 The ASHP 
classified medication errors in terms of prescribing, dispensing, administration and 
patient compliance.12 The ASHP suggested the medication delivery process of the 
organisation should be designed to minimise errors. Lisby et al. studied medication 
errors based on stages of the medication delivery process.15 Identification of where 
the errors occurred is important because clear recommendations can be made 
related to improving the process of medication delivery.17, 18 
 
Many factors lead to unsafe care. Reason’s Swiss Cheese Model shows no single 
cause of medication errors.2 Root cause analysis (RCA) is a method to identify 
contributing factors which may result in unexpected outcomes including sentinel 
events.19 RCA is used retrospectively to identify problems which have occurred 19 and 
to develop actions for system improvement.20, 21 Vincent has classified contributing 
factors to medication errors.22 One of the root causes of medication errors is poor 
communication. 23,24 As mentioned previously, various skilled and trained healthcare 
professionals are involved in the medication delivery process. Communication and 
information transfer amongst those healthcare professionals is essential. The lack of 
communication among healthcare professionals may lead to unsafe healthcare 
service delivery. A safe healthcare service requires a comprehensive approach which 
involves healthcare professionals, patients, and health systems.25, 26  This means 
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healthcare professionals involved in the process of medication delivery need to work 
interprofessionally to ensure medication safety.  
 
Pharmacists are healthcare professionals who involved in the medication delivery 
process. Although the Agency for Research and Healthcare Quality (AHRQ) reported 
that evidence provided in the literature on the role of pharmacists in medication 
safety has weak methodology design and lack of comparability, the agency 
supported the role of pharmacists in reducing preventable adverse drug events (i.e. 
medication errors).27 A number of professional organisations also support the role of 
pharmacists in medication safety.28-31 The International Pharmaceutical Federation 
(FIP),28 the ASHP29 and the Society of Hospital Pharmacists of Australia (SHPA)31 have 
stated that pharmacists play an important role in ensuring the safe use of medication 
by optimising medication therapy and providing interventions in the medication 
delivery process. In this role, collaboration between pharmacists and other 
healthcare professionals is essential. The FIP emphasised that the role of pharmacists 
in medication safety was well-established.30 They strongly suggested that although 
pharmacy practices vary widely across different countries, pharmacists are the 
healthcare professionals who obtain the most extensive medication education.  
 
Clinical review and medication reconciliation are two pharmacists’ activities directed 
at ensuring the safe use of medication. Australia has national guidelines on 
medication safety which includes clinical review and medication reconciliation.32 
Clinical review is defined as “the review of patient-specific clinical information 
including patient parameters to evaluate their response to medication therapies and 
to detect and manage potential or actual medicines-related problems.”33 In this 
activity, the pharmacist reviews the patients’ current medication to identify 
medication related problems and to assess their medication related needs. 
Pharmacists need to work in collaboration with physicians and nurses in providing 
clinical review services.34, 35  
 
Medication use review as part of clinical review has been reported to improve 
patient care and professional integration in New Zealand and the United Kingdom.36, 
37 Carpenter highlighted that in a developing country, a shared and structured chart 
review would be an important approach to improve patient safety.38 Qualitative 
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research involving family physicians reported that physicians were believed to gain 
benefits after working in collaboration with pharmacists in the Integrating Family 
Medicine and Pharmacy to Advance Primary Care Therapeutics (IMPACT) Project in 
Canada.39 In the project, the pharmacists provided patients’ medication assessments 
and drug information to assist them achieve optimum drug therapy. The physicians 
perceived to gain benefits from obtaining reliable drug information and gaining a 
sense of teamwork.  
 
The SHPA defines medication reconciliation as “the standardised process of obtaining 
a patient’s best possible medication history and comparing it to presentation, 
transfer or discharge medication orders in the context of the patient’s medication 
management plan.” 40 In Australia, the activity is mandatory and includes identifying 
discrepancies between the patients’ medication history and the current medication 
as well as solving the discrepancies. The activity aims to reduce errors and to obtain 
the most accurate medication profile in optimising drug therapy. The ASHP 41 states 
pharmacists have a role in medication reconciliation because pharmacists have the 
appropriate knowledge, skills and abilities and such services could be implemented 
based on resources available in the healthcare services.  
 
Evidence shows that pharmacists may contribute to safe medication use in a wide 
range of settings such as in ambulatory, inpatient and in primary care, and in 
different patient groups such as psychiatric, elderly and paediatric patients.2, 34, 42-50 In 
Indonesia, the government created a policy on the role of pharmacists in patient care 
with the Indonesian Government Policy Number 51 in 2009. The policy highlights 
that pharmacists have the capacity to provide direct patient care to optimise 
patients’ health outcomes – a role which had never previously been acknowledged.51 
In terms of the role of pharmacists in patient care in the hospital setting, the 
Indonesian Directorate General of Pharmacy and Medical Supplies developed a 
guideline on ward visits.52 The guideline sets out the role and responsibility of ward 
pharmacists. One of the roles is working in a team with other healthcare 
professionals in ensuring patients received safe, quality and cost effective drug 
therapy. The other support was from the Indonesian Ministry of Health which comes 
from the release of a guideline in 2008 on the pharmacists’ role in ensuring patient 
safety.53 The guideline emphasised that pharmacists may play their role in 
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medication safety by working collaboratively with prescribers and patients; however, 
activities involved were not clearly defined in the guideline. These policies show that 
the government recognises and supports the role of pharmacists in patient care to 
ensure medication safety, whilst acknowledging barriers of lack of communication 
amongst healthcare professionals. Although the Indonesian Government supports 
the role of pharmacists, how this will be translated into practice is unclear. To date, 
there is limited data on the roles of pharmacists in patient care to ensure medication 
safety in Indonesian practice. In 2009, the United States Agency for International 
Development (USAID) reported that in Indonesia, the minimal role of pharmacists 
occurred both in the hospital and the community settings.54 A random check by the 
USAID team to assess the level of pharmacy practices in West Java, Indonesia 
showed that an antibiotic was sold without a prescription and without pharmacists’ 
attendance. This illustrated that the role of pharmacists is very limited in the country.  
 
Studies show that pharmacists’ internal and external factors may influence the 
expansion of the role of pharmacists in patient care.55-58 The internal factors may 
result from lack of staff, lack of communication skills and knowledge as well as lack of 
training. The external factors may be associated with a lack of a clear role for 
pharmacists, lack of fees for service, and unclear practice standards for pharmacists. 
Nimmo and Holland recommended that in order to improve the role of pharmacists 
in medication safety, it requires a clear, comprehensive, systematic and effective 
system, namely a Practice-Change System (PCS).59 The system involves a suitable 
practice environment, motivational strategies, and availability of learning resources 
which are critical for change. The PCS identifies strategies needed to address those 
who are involved in the clinical practice and those who are affected by the change 
such as the society, health system and the practice environment. The PCS also 
identifies motivational strategies and learning resources in ensuring medication 
safety. The motivational strategies emphasised internally driven factors of 
pharmacists to provide quality and safe patient care. Learning strategies involved 
supporting facilities for the activities for the role of pharmacists in medication 





Interprofessional collaboration between healthcare professionals is the key to safe 
and quality healthcare.60 Chrisholm-Burns suggested that to improve the safe use of 
medication, pharmacists should be involved in and work with other healthcare 
professionals in the process of medication delivery.61 In fact, a number of authors 
have suggested that collaboration between pharmacists and physicians is crucial to 
ensure medication safety.1, 8, 50, 62 Studies support the model of pharmacist and 
physician collaboration to ensure quality use of medicines.47, 50, 63-65 Strand and 
Hepler recommended that pharmacists should work interprofessionally with other 
healthcare professionals regardless of their settings.8 They suggested that 
collaboration develops through good interpersonal relationships amongst physicians 
and pharmacists.  
 
Evidence shows that collaboration or Interprofessional Practice (IPP) may develop 
awareness of the role of other healthcare professionals,66 build communication 
between healthcare professionals,67 and enhance abilities in resolving conflicts.68, 69 
Freeth et al70 described IPP as “two or more professions working together as a team 
with a common purpose, commitment and mutual respect.” In an effective IPP, 
respect, trust and understanding of each other’s role are the basis of effective 
communication.66, 71-76 When misconception of the role of other healthcare 
professionals is minimised, healthcare professionals should have a better 
understanding of the role of others. A Canadian study suggested that 
Interprofessional Learning (IPL) enhanced the recognition of other healthcare 
professionals of the nursing profession.76 This means working with other healthcare 
professionals may not only ensure the safe use of medication but also enhance the 
awareness towards the role of others. 
 
As outlined in the literature, IPP and interprofessional education (IPE) are inter-
related in fostering competent healthcare professionals.77-81 Frenk et al. suggested 
that to strengthen the health system, health education should be redesigned to 
prepare the competencies of future healthcare professionals.81 Barr et al. suggested 
that there are three foci of IPE.82 These are individual preparation, collaborative 
group/teamwork, and improving service. The first focus relates to knowledge, skills, 
and attitudes of individual learners. The second focus involves support from 
healthcare professionals, community, professional organisations and patients. The 
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third focus concerns quality service improvement which depends on support from 
policy-makers and management in the implementation of IPE. Hammick et al.80 who 
employed the 3P model (i.e. Presage, Process, and Product) in analysing IPE stated 
that teacher and learner characteristics as well as context are the presage 
components of the implementation of IPE. This suggests that support from the 
government, health policy and management, as well as those involved in IPE is 
essential.  
 
D’Amour and Oandasan created a framework for Interprofessional Education for 
Collaborative Patient-Centred Practice (IECPCP). The framework highlighted that IPE 
and IPP were interconnected and influenced by factors at the Micro, Meso, and 
Macro levels.79 IPE refers to “occasions when students from two or more professions 
in health learn together during all or part of their professional training with the 
object of cultivating collaborative practice for providing patient- or person- centred 
health care.”83 In the educational setting, the Micro level involves interaction 
between teaching factors (i.e. learning context and faculty development). The 
Collaboration at the Meso level depends on institutional factors (i.e. leadership and 
administrative processes), while at the Macro level it is influenced by the education 
system (i.e. accreditation and institutional structured). Within the practice setting, 
the Micro level is determined by interactional factors (i.e. sharing goals and the 
sense of belonging). The Meso level is related to organisation factors (i.e. governance 
and structuring clinical care). While the Macro level is influenced by the professional 
system (i.e. regulatory bodies and liability). Further, D’Amour and Oandasan 
identified that government policies (from local to national policies) and social and 
cultural values (at the Micro and Macro levels) were systemic factors for the 
implementation of IPE and IPP.  
 
In parallel, the WHO has highlighted the importance of IPE and IPP to improve 
healthcare outcomes with the Framework for Action on Interprofessional Education 
for Collaborative Practice (IPE-CP).84 The aims of the framework are to provide ideas 
and approaches for health policy makers, educators and health workers to manage 
their local health systems in order to improve healthcare outcomes. It is illustrated in 
the framework that if healthcare students learn together and understand each 
other’s role, they will be ready to practice interprofessionally in the future because 
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IPE may facilitate the development of competencies required in IPP in ensuring safe 
patient care.60, 85 A report60 of an Expert Panel in the United States identified that 
there are four core competencies of IPP, namely values/ethics for interprofessional 
practice, roles/responsibilities, interprofessional communication, and team and 
teamwork. They further recommended that the healthcare students should learn 
about being part of the healthcare team to foster those competencies.  
 
Although some studies have shown the benefits of IPE,72, 86, 87 barriers may be 
encountered in the implementation of IPE. These barriers may be associated with 
threats to professional identity, ineffective team dynamics, differences in philosophy 
of patient care, and a lack of financial support from the health system.62, 88, 89 
However, if healthcare students learn in an effective IPE environment, they will gain 
experience of collaboration (teamwork) which may facilitate the development of 
competencies of IPP.63, 85, 90 In the team training, students learn about the team 
process and its structure to enhance their learning outcomes91, 92 93 Accordingly, 
Thistlewaite and Moran85 recommended that the six main learning outcomes of IPE 
(i.e. teamwork, roles/responsibilities, communication, learning/reflection, the 
patient, and ethics/attitudes) may be obtained through working together in formal 
education and during practical experiences. The outcomes are similar to the 
competencies in IPP as mentioned previously. 
 
In order to expand the role of pharmacists in patient care, particularly in ensuring the 
safe use of medication through IPE and IPP, identifying facilitators for and barriers to 
the expansion of the role of pharmacists in patient care as well as the 
implementation of IPE and IPP is important. Thus, in the present study, mixed 
methods of qualitative and quantitative methodologies were employed. Data were 
collected from healthcare students, healthcare professionals, as well as key 
stakeholders in one university and hospital in Bali, Indonesia to investigate the 




1.2 MEDICATION SAFETY 
Medication safety as part of patient safety is an issue world-wide in healthcare 
service delivery. This issue of patient safety has been widely discussed since the 1995 
United States Institute of Medicine’s report titled “To Err is Human.” 94 In many 
countries, this issue has raised concerns with the development of agencies to ensure 
safe healthcare services. In Australia, there are national and state organisations to 
ensure the safe use of medication.95 In Indonesia, the Ministry of Health committed 
to adopt the United States Joint Commission International (JCI) Accreditation in 
order to ensure patient safety in healthcare practice.4 One of the accreditation 
standards is medication management use which ensures medication safety in the 
hospitals.96  
 
The extent of medication safety issues is reported differently in the literature. For 
instance, the problem has been reported as the percentage of incidence of adverse 
drug events, rate of medication errors, mortality rate, and even the cost of 
treatment and hospitalisation. Bates et al. found the rate of adverse drug events in 
medical and surgical units was 6.5 per 100 admissions in 1995.10 In the United States, 
it was estimated that annually, around 98,000 deaths resulted from medical errors 
and the medication errors contributed to 10-20% of the fatality estimation.3 In 
Australia, a review in medication safety reported that 2-3% of hospital admissions 
were due to the use of medication which contributed to an annual cost of $1.2 
billion.1 Medication errors were reported to result in direct hospital costs of £ 200-
400 million per year in 2004 in the UK.97 The United Kingdom Health Department 
emphasised that medication errors caused burden to the patients, family, and social 
community. 
 
Medication safety, is defined as drug related problems, medication misadventures, 
adverse drug events, and medication errors.6, 7, 9, 12, 98 Ackroyd-Stolarz et al. stated 
that several definitions employed by medication safety organisations have 
implications for clinical, policy and research practices.7 These implications allow the 
medication safety organisations to identify priorities and strategies to ensure 
medication safety. Ackroyd-Stolarz et al. presented a relationship of the types of 
problems associated with the use of medication based on whether or not the 
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problems caused injury (Figure 1.1). As seen from Figure 1.1, medication safety may 













(Reprinted from Research in Social Administrative Pharmacy, Ackroyd-Stolarz S, Hartnell N, MacKinnon 
NJ, Demystifying medication safety: Making sense of the terminology, Pages 280-9., Copyright (2006), 
with permission from Elsevier) 
 
Figure 1.1 Relationship between types of problems associated with medication use 7  
 
Debate remains on the most appropriate terms to use in the study of medication 
safety. According to the NCCMERP an ADE is defined as an injury which results from 
a medical intervention related to the use of a drug. ADRs are a type of ADE which 
relate to any unintended response during the use of a medication within the normal 
dose range for prophylaxis or therapy. Meanwhile, medication errors are another 
type of ADE which are preventable events which may cause or lead to inappropriate 
use of medication while the medication is under the control of healthcare 
professionals.13  Nebeker et al.99 argued that focusing mainly on medication errors in 
medication safety might overlook ADRs which might be preventable but not related 
to errors. However, Otero and Schmitt100 stated that the association of ADRs with 
medication errors was inappropriate considering ADRs were related to the intrinsic 
properties of the drugs and cannot be prevented, while, medication errors are 
preventable events.26 
 
With the undecided definition of medication safety, in 2013, Bürkle et al. argued that 
the Ackroyd-Stolarz et al.’s definition of medication errors’ was vague, because 
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medication errors emerged in both supersets of injury and non-injury.101 Thus, Bürkle 
et al. defined medication errors as errors occurring during a medication pathway 
which includes all activities in the process of medical decision-making and action 
taken in treating patients. Adverse drug events (ADEs) and ADRs referred to as 
clinical symptoms and events observed during patients’ treatment. These definitions 
are similar to Hepler and Strand’s definition who stated that ADEs and ADRs are 
outcomes of the use of medication.8 Bürkle et al. generated a model of the 
relationship between MEs (Medication Errors - medical decisions and actions), 
clinical symptoms and events (ADEs and ADRs). The model is used to identify, classify 
and count drug related events and take into consideration diseases associated with 
the events (Figure 1.2). The model illustrates all decisions and actions in the process 
of medication delivery related to medication errors which may lead to drug effects. 
The drug effect may cause clinical symptoms and events which may cause ADEs. The 
ADEs may be associated with one drug and/or one ME or more. Bürkle et al. also 
created a medication pathway to show all decisions and actions made in a drug dose 
(Figure 1.3). Any errors occurring in the medication pathway (which is shown as 
Medication errors 1 to 4 in Figure 1.3) are considered as medication errors. However, 
Bürkle et al.’s classification of omission errors leading to an event (OEE) as clinical 
symptoms and other events may be inappropriate. These may be better classified as 
errors in actions. This is because error in omission is no action taken or no drug given 
during the medication process. The omission may or may not lead to ineffective 



















(A new approach to identify, classify and count drug-related events, Bürkle T, Müller F, Patapovas A, 
Sonst A, Pfistermeister B, Plank-Kiegele B, Dormann H, Maas R, British Journal of Clinical Pharmacology, 
76: S1.Copyright © 2013 The British Pharmacological Society) 
 
Figure1.2 Proposed set theory diagrams for clinical symptoms and medical decisions in drug 











(A new approach to identify, classify and count drug-related events, Bürkle T, Müller F, Patapovas A, 
Sonst A, Pfistermeister B, Plank-Kiegele B, Dormann H, Maas R, British Journal of Clinical Pharmacology, 
76: S1.Copyright © 2013 The British Pharmacological Society) 
 
Figure 1.3 Level of medication pathway for one single dose101  
 
The importance of medication safety reported in the literature, led to medication 
errors being chosen as the focus of the present study. Medication errors are 
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preventable events in the process of medication delivery. Thus, it is important to 
understand the failures during the process17, 102 because different approaches are 
required to overcome the errors.17,102 If the causes and potential outcomes of the 
errors are identified, recommendations may be made to ensure a safe healthcare 
service. 
 
Every healthcare professional involved in the medication delivery process is 
responsible for the quality and safety of healthcare service. However, the healthcare 
professionals (i.e. physicians, nurses and pharmacists) involved in the process may 
have different skills and training. Communication failure is one of the root causes of 
medication errors.23, 24, 103, 104 Communication failure in the provision of a healthcare 
service may result from the complex problem of role ambiguity, interpersonal power, 
and conflict.103 Routledge indicated that communication and collaboration amongst 
healthcare professionals are required to avoid harm to the patients.105 Thus, study 
on medication errors and collaboration amongst healthcare professionals is 
warranted. 
 
1.2.1 MEDICATION ERRORS 
1.2.1.1 Definition 
Similar to medication safety conceptualisation, medication errors have also been 
hypothesised in many ways. A medication error has been stated as the only 
preventable event in medication safety.106,107 Medication errors are defined as errors 
occurring in the medication delivery process (i.e. prescribing, transcribing, dispensing 
and administration) which may or may not result in clinical consequences.12, 106, 108 
Ferner and Aronson defined medication errors as “a failure in the treatment process 
that lead to, or has the potential to lead to, or harm the patient”.108 Although their 
definition has been amended by The Australian Council for Safety and Quality in 
Health Care with the addition of the phrase “and includes an act of omission or 
commission,” Aronso and Ferner stated the phrase has little impact on their 
definition and claimed their definition is applicable in any error scenario.108  
 
Lisby et al. in a systematic review of 45 studies identified that there were 26 different 
types of wording in the literature to describe medication errors.15 They found that 
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less than 50% of the studies featured in the systematic review defined medication 
errors as generic or stage specific terms. This shows the inconsistency of the 
definition of medication errors used in the literature. They found that the majority of 
definitions used in the literature employed the National Coordinating Council for 
Medication Error Reporting and Prevention (NCCMERP) definition.13 The NCCMERP 
recommended researchers and institutions use the following definition in identifying 
errors:13  
 
"A medication error is any preventable event that may cause or lead to 
inappropriate medication use or patient harm while the medication is in the 
control of the health care professional, patient, or consumer. Such events may 
be related to professional practice, health care products, procedures, and 
systems, including prescribing; order communication; product labelling, 
packaging, and nomenclature; compounding; dispensing; distribution; 
administration; education; monitoring; and use."  
 
Based on the NCCMERP definition, medication errors are not only related to human 
errors but also system errors. This definition also includes errors which are 
associated with the medication process, from prescribing, dispensing, labelling, 
administration, monitoring and communication processes.  
 
1.2.1.2 Causes of medication errors  
Leape et al. employed systems analysis to identify causes of ADEs which may result 
from medication errors.23 In general, they classified the causes of errors into human 
and system sources. Human-related errors ranged from physiological, psychological 
to knowledge factors, while the system errors included lack of training, limited 
access to patient’s information, and lack of standard operational procedures. The 
Californian Healthcare Foundation claimed that insufficient knowledge of the patient 
and their medication, as well as poor understanding of the current guidelines and 
policy, may result in medication errors.109 Leape et al. described the causes of errors 
as being less complex than that of the Reason’s or Vincent’s framework of the 
sources of errors. The Reason’s Swiss Cheese Model is the commonest model used to 
explain the causes of medication errors (Figure 1.4).2  The model demonstrates that 
no single error leads to medication errors. According to the Swiss Cheese model, 
errors maybe caused by latent and unsatisfactory working conditions, as well as 

















(Reprinted from The Lancet, Vol 359, Dean B, Schachter M, Vincent C, Barber N, Causes of prescribing errors in 
hospital inpatients: a prospective study, Pages 1373-8., Copyright (2002), with permission from Elsevier) 
 
Figure 1.4 Reason's Framework on causes of errors 110 
 
In parallel to the Reason’s Framework, Vincent classified and explained the sources 
and contributing factors of medication errors (See Table 1.1).22 As seen in Table 1.1, 
medication errors may result from the institution, management, the system, 
healthcare professionals, and even from the patients. Cohen defined the system of 
medication errors as being influenced by the interconnection between how 
information management is handled, how the environment is structured, and how 
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Table 1.1 Vincent's Framework of sources and contributing factors of medication errors 22 
 
Framework Contributory Factors Example of problems that contribute 
to errors 
Institutional Regulatory context 
Medico legal environment 
Insufficient priority given by regulators 
to safety issues; legal pressures 
against open discussion; preventing 





Financing resources and 
constraints Policy standards and 
goals 
Safety culture and priorities 
Lack of awareness of safety issues on 
the part of senior management; 




Staffing levels and mix of skills 
Patterns in workload and shifts 
Design, availability, and 
maintenance of equipment 
Administrative and managerial 
support 
Heavy workload; leading to fatigue; 
limited access to essential equipment; 
inadequate administrative support; 
leading to reduced time with patients 
Team Verbal communication 
Written communication 
Supervision and willingness to 
seek help 
Team leadership 
Poor supervision of junior staff; poor 
communication among different 
professions; unwillingness of junior 
staff to seek assistance 
Individual staff 
member 
Knowledge and skills 
Motivation and attitudes 
Physical and mental health 
Lack of knowledge or experience; long-
term fatigue and stress 
Task Availability and use of protocols 
Availability and accuracy of test 
results 
Unavailability of test result or delay in 
obtaining them; lack of protocols and 
guidelines 
Patient Complexity and seriousness of 
illness 
Language and communication 
Personality and social factors 
Distress; language barriers between 
patients and caregivers 
[(Reproduced with permission from Vincent), Copyright Massachusetts Medical Society] 
 
Failure Mode Effects Analysis (FMEA) and Root Cause Analysis (RCA) are two 
methods to study the causes of an event.19 FMEA is a proactive approach to prevent 
an event from occurring and to explore what could happen if a particular event 
occurred in a process. FMEA is a quality improvement process in evaluating a new 
program or service or product to decide points where failure might occur and 
consequences of the failure.111, 112 RCA is a retrospective approach to analysis after 
an event has occurred or nearly occurred. RCA aims to answer the questions on what 
happened, why an event occurred, and what can be done to prevent a similar event 
from occurring?19, 113 FMEA and RCA are similar in involving team activity and in 




The Office of Safety and Quality in Healthcare Western Australia defines RCA as the 
following: 114 
 
“Root Cause Analysis (RCA) is a comprehensive and systematic methodology to 
identify gaps in hospital systems and the processes of healthcare that may not be 
immediately apparent and which may have contributed to the occurrence of an 
event.”  
 
RCA focuses on systems and processes of healthcare, and it does not emphasise 
blame for the individual.114 It is undertaken in a comprehensive and systematic way 
to reveal the contributing factors of an event. The analysis involves an 
interdisciplinary team which consists of 3-5 people who are familiar with the 
event.114 Although RCA aims to create recommendations to reduce sentinel 
events,113 it may also be applicable to less harmful events.19 The RCA needs to be 
thorough and credible.115 Thorough means it determines the primary causes and 
secondary causes of the events by asking why questions. The RCA determines the 
potential improvement in the process to minimise the risk of re-occurring. Credible 
means the RCA should involve the leader in the organisation, is consistent and 
supported by evidence. The Joint Commission suggested having 12 minimum scopes 
of the root cause analysis in medication errors which may result in sentinel events.19 
The scopes are patient identification process, staffing level, orientation and training 
of staff, competency assessment, supervision of staff, communication among staff 
members, availability of information, adequate technology support, equipment 
management/maintenance, physical environment, control of medications: (storage 
and access), and labelling of medication. 
 
1.2.1.3 Methods to identify medication errors 
Direct observation, unannounced control visits, pharmacist and nurse interventions, 
chart reviews, administrative data, and voluntary error reports are some of the 
methods to detect medication errors.18, 23, 116-118 Although direct observation is the 
least commonly employed method and the most costly, it is accurate in detecting 
medication errors119 and can identify the highest number of drug related 
problems.120 In spite of the Hawthorn effect on an observational study, Dean and 
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Barber in 2001 reported that the observation methods used to study administration 
errors were reliable and valid.118  
 
Chart review conducted by healthcare professionals has also been used widely to 
identify medication errors and ADEs.10, 98 Chart review has been employed to study 
medication safety in adults and paediatric populations.18, 120 Bates et al. found that 
nurses and pharmacists medication chart reviews could detect medication errors 
which may result in ADEs.98 Flynn et al. also suggested that chart review was less 
expensive than direct observation studies in detecting medication errors.117 They 
also stated that this review could identify prescribing errors. Meyer-Masseti et al.120 
found that chart review could identify potential drug related problems more 
frequently than incident reports.  
 
Other studies recommended employing a triangulation method to identify 
medication errors.18, 23, 50, 116, 120 This is because each method has its weaknesses and 
strengths.120 This triangulation approach may involve more than one method for 
instance chart reviews, pharmacist interventions, and voluntary error reports. Lisby 
et al. identified the frequency, type and potential clinical consequences of 
medication errors during the process of medication delivery by adopting direct 
observational, unannounced control visits, and chart review methods.116 Mangino in 
2004 stated “combining incident reports with practitioner interventions into a single 
reporting system has the potential for building a powerful database for analysing 
faulty processes.”50 The involvement of healthcare professionals to clarify drug 
orders could be a useful step to detect and prevent errors before reaching the 
patient. Because none of the reported methods appear better than the others, in the 
present study, chart review and direct observation were employed to detect 
medication errors.  
1.2.1.4 Strategies to prevent medication errors  
Several strategies have been outlined in the literature to prevent medication errors. 
These strategies involve a sustainable system which may include formulary 
management, targeted medication interventions, clinical pathways, clinical 
pharmacy programs, operational improvement and the support of technology during 
the prescribing stage.18, 50 Miller et al. recommended some strategies to reduce 
medication errors in the paediatric population based on a review of the literature 
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(Table 1.2).18 They identified 26 recommendations from a range of medication safety 
organisations. The recommendations ranged from technical and administrative 
aspects in the medication delivery process to training to up skill healthcare 
professionals. The technical aspects included adopting computerised-physician order 
entry (CPOE), automatic dispensing devices, unit dose dispensing, and clear and 
accurate documentation of drug administration. The strategies to improve the skills 
of healthcare professionals may consist of adequate training and continuing 
professional development for healthcare professionals in the process of medication 
delivery.  
 
From the prescriber’s point of view, medication errors could be prevented by both 
education and practice initiatives.16 The education initiatives may include 
undertaking continuing education and assessment on safe prescribing. Whilst, 
practice initiatives may involve implementing a standardised national guideline and 
computerised system of safe prescribing in hospitals, from the organisational point 
of view, the American Society of Health-System Pharmacists (ASHP) recommended a 
well-designed medication delivery process covering prescribing, dispensing, and 
administration to reduce medication errors.12 A non-blame culture is considered as a 
fair and accountable way to improve safety in the health system.121 The culture 
should facilitate healthcare professionals’ involvement in identifying the errors and 




Table 1. 2 Recommendations to reduce medication errors in paediatrics 18  
 
Recommendation  
Computerised provider order entry 
Automatic dispensing devices 
Paediatric presence with formulary management 
Appropriate and competent pharmacy personal and environment 
Pharmacist available “on call” when pharmacy is closed 
Policies on verbal orders 
Clear and accurate labelling of medications 
Quality improvement efforts with drug use evaluation and medication error reporting and 
review 
Healthcare workers have access to current information and references 
Emergency medication dosage calculation tools 
Accurate documentation of medication administration 
Medication standardisation and appropriate storage 
Standardise equipment (pumps, weight scale) 
Patient education on drugs 
Direct participation of pharmacists in clinical care 
Computerised detection/alert system for adverse drug events 
Standardise measurement systems (kilograms) 
Standardise order sheets to include areas for weight and allergies 
Reducing adverse drug events related to anticoagulants 
Unit dose drug distribution systems 
Special procedures and written protocols for high alert drugs 
Use pharmaceutical software 
Pharmacy-based IV admixture systems 
Use of bar coding for medication administration 
Training of all healthcare professionals in appropriate medication prescribing, labelling, 
dispensing, monitoring and administration 
 
(Adapted by permission from BMJ Publishing Group Limited. [Medication errors in paediatric care: a 
systematic review of epidemiology and an evaluation of evidence supporting reduction strategy 
recommendations. Miller MR, Robinson KA, Lubomski LH, Rinke ML, Pronovost PJ. 16; 116-26., 
Copyright 2015]). 
1.2.1.5 Medication error classifications 
Medication errors have been classified based on the sources of errors, the outcomes, 
and the process of medication delivery.13-15 The ASHP12 stated that their classification 
of medication errors was not exclusive considering multiple factors may lead to 
medication errors (See Table 1.5). Although Ferner and Aronson108 classified 
medication errors based on a psychological approach, they claimed that this 
classification could explain and prevent errors. However, their classification may lead 
to the notion that errors only result from human factors. Other errors such as failure 





The NCCMERP classified medication errors based on the outcomes. The classification 
ranged from no error (Category A), no harm (Category B, C, D), error with harm 
(Category E, F, G) and fatality (Category I). In 2007, Forrey et al.122 conducted a study 
to validate the NCCMERP categories. They found that NCCMERP categories were 
valid when tested using 27 case scenarios amongst three groups of respondents who 
used the index alone, or, a paper based or computer based algorithm. However, this 
classification is focused on the outcomes not the process of medication delivery.  
 
Lisby et al. who classified medication errors during the process of medication 
delivery116 (See Table 1.3) also defined the potential outcomes of medication errors 
(See Table 1.4). This error classification is important because healthcare 
professionals involved in the process may have different knowledge and skills. 
Communication amongst healthcare professionals is essential. Therefore, it is not 
surprising that studies have shown that communication failure amongst healthcare 
professionals is one of the root causes of medication errors.23, 24, 103 Thus, in the 
present study, medication errors were studied in the context of the process of 
medication delivery, because understanding how errors occur in the process should 





Table 1.3 Medication errors classification based on stages in the medication process 116 
Stage Definition Errors Types 
Ordering Unambiguous prescription Omission of: drug name, drug 
formulation, route, dose, dosing 
regimen, date, signature, treatment 
time for antibiotics  
Transcription An identical copy of 
prescription in medical record 
Discrepancy in: drug name, drug 
formulation, route, dose, dosing 
regimen, omission of drug; 
unordered drug 
Dispensing Dispensed medication is 
concordant with prescribed 
drug in nurse medication chart 
Unordered drug (wrong drug), 
unordered dose, omission of dose, 
wrong dose, wrong formulation 
Administration The right medication to the 
right patient in the right way 
and at the right time 
Wrong: administration technique 
(injection), route, time (±60mins), 
delivery (dose not delivered directly 
to the patient); unordered drug, 
unordered dose, omission of dose, 
lack of identity control 
Discharge 
summaries 
Eligible prescriptions in medical 
record are identical to 
prescriptions in discharged 
summaries 
Discrepancy in: drug name, drug 
formulation, route, dose, regime, 
omission of drug, unordered drug 
(Lisby M, Nielsen LP, Mainz J. Errors in the medication process: frequency, type, and potential clinical 
consequences. International Journal for Quality and Health Care, 2005; 17: 15-22, by permission of 
Oxford University Press) 
 
Table 1. 4 Definitions of potential clinical consequences 116 
Category Definition Definition of keywords 
Potentially 
fatal 
Medication errors judged to 
imply a potential clinical risk for 
causing the death of the patient 
Fatal refers to medication errors that 
could lead to the death of the patient 
Potentially 
serious 
Medication errors judged to 
imply a potential clinical risk of 
injuring the patient 
Injury includes medication errors that 
would require active treatment to 
restore the health of the patient. A 
potentially serious error would lead to 




Medication errors judged to 
imply a potential clinical risk of 
being inconvenience for the 
patient-without causing any 
harm or injury 
Inconvenience refers to unpleasant 
consequences of wrong dose/drug or 
omission of dose/drug that could lead 
to pain, dizziness. It also refers to any 
monitoring of the patient such as extra 




Medication errors judged to be 
without any potential clinical risk 
for the patient 
Without clinical risk refers to 
medication errors that did not lead to 
any injury or inconvenience for the 
patient 
(Lisby M, Nielsen LP, Mainz J. Errors in the medication process: frequency, type, and potential clinical 
consequences. International Journal for Quality and Health Care, 2005; 17: 15-22, by permission of 






Prescribing errors can be defined as errors occurring during the process of 
prescribing which may result from errors in the selection of the medication (i.e. the 
drug, dose and dosage form) and the action of writing the prescription.106 In the 
present healthcare service in Indonesia, physicians have the role to prescribe 
medication. Wrong selection may include wrong drug, wrong dose, wrong quantity, 
wrong indication, wrong or contraindicated drug, and prescribing a drug which has 
clinically significant drug interactions (i.e. drug-disease interactions).107 Dean et al.123 
stated that prescribing errors may be errors in decision making and errors in the 
writing of the prescription. They carried out research employing two Delphi 
techniques which proposed the definition of prescribing errors as failure to 
communicate the important information of the patient and failure to select the 
appropriate drug and the dose through not considering the patient’s circumstances. 
They also suggested prescribing errors involved errors during writing the prescription 
which may include the physician failing to prescribe the patient’s regular medications 
at the time of hospitalisation. Dean et al. also stated that drugs written outside the 
hospital formulary and guidelines were excluded as prescribing errors. 123 
 
The rate of errors may be described in a number of ways, such as errors per 
medication order, errors per 100 admissions, and error per 1000 patient days.124 
Dean reported more than 50% of prescribing errors was errors in decision making 
and 42% in medication order writing.125 Some studies reported the rate of 
prescribing errors was around 50% for hospital admissions124, 126 and most occurred 
on the first day of hospitalisation.127 Although 25% of prescribing errors were 
reported clinically significant,110 most of the errors were not serious or life-
threatening.124, 126  
 
Some causes of prescribing errors reported in the literature may be influenced by 
personal, environmental, and organisational factors. Personal factors included lack of 
knowledge, lack of patient information during prescribing, poor handwriting, 
inaccurate medication history taking, uncertainty of the name of drugs, 
inappropriate use of decimal points, using abbreviations, in-sufficient 
communication with team members and using verbal orders.106, 107 124, 128 
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Environmental factors include high workload and a distractive working 
environment.124 Organisational factors may involve hierarchy in the medical team, 
and a lack of physicians’ awareness to their contribution to errors.124 Some studies 
recommended training on rational prescribing for junior physicians. The training may 
be on deciding the appropriate medication and its dosage to minimise the frequency 
of prescription errors.16, 124 The World Health Organisation (WHO) created a guide to 
good prescribing which is primarily designed for undergraduate medical students 
before entering clinical internship.129 It is anticipated the guide will be used as a 
resource for rational prescribing by medical students. However, the guide could also 
be employed by medical postgraduates as a resource to improve their prescribing. 
CPOE systems have been recommended to be adopted as a means to reduce 
prescribing errors.16, 26, 50 However, the effectiveness of such systems on patient 
outcomes is still under investigation.  
 
Dispensing errors 
Dispensing errors can be defined as discrepancies between interpretable written 
prescriptions and dispensed medications130, 131 They may occur in the process of 
dispensing of medication from the pharmacy for the ward prior to the medication 
being given to the patient.106 Pharmacists have the role of dispensing medication in 
the process of medication delivery. The rate of dispensing errors has been reported 
to range between 1 to 24% predominantly due the supply of the wrong dose and 
wrong drug due to look alike and sound alike medications. 106 Beso et al. reported 
that dispensing errors occurred in 2% of all dispensed items, and were made up of 
content, labelling and documentation errors.131  
 
James et al. reviewed 60 studies in hospital and community pharmacy settings to 
determine the incidence, type, and causes of dispensing errors.132 They found 
different definitions of dispensing errors because of different settings and methods 
reported in the literature. They defined dispensing errors into prevented and un-
prevented dispensing errors, and filling errors. A prevented dispensing error was 
defined as an error which occurred during the process of dispensing which was 
detected in the pharmacy (near-miss). An un-prevented dispensing error was 
identified as an error detected after the medication has left the pharmacy. A filling 
error occurred when the pharmacist identified an error while dispensing the 
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medication. James et al. reported prevented errors occurred more frequently than 
un-prevented errors.132 Thus, as outlined in the literature106, 132 dispensing errors can 
be classified as drug omission, near miss, wrong drug, wrong dose, wrong dosage 
form, wrong quantity of drug and labelling errors.  
 
Factors contributing to dispensing errors found in the literature were workload, 
interruption or distraction from the environment, skills and knowledge, 
communication, reliance on others in identifying errors, drug packaging and 
protocols in labelling and storage in the dispensing area.131, 132 Dispensing errors may 
be minimised by ensuring drug distribution and dispensing procedures occur in a 
systematic, safe environment with minimum distraction. In addition, clearly defined 
processes to deal with look and sound alike medication and improved awareness of 
high alert medication (such as potassium chloride and cytotoxic agents) should be 
employed to prevent dispensing errors.  
 
Transcription errors 
There is very little discussion in the literature on transcription errors. Dean et al. 
classified transcription errors as part of prescribing errors.123 They stated that errors 
of transcription may include unintentional omissions of patients’ regular medication 
prior to admission, transcribing wrong medication orders, and transcribing wrong 
medication on the discharge summary. The Californian Healthcare Foundation stated 
transcription errors may occur during transcription of prescriptions from physicians 
to pharmacists or to nurses.109 In the process of medication delivery, communication 
may be in writing, verbally, or electronically which may potentially result in errors 
during transcription. Transcription errors may result from illegible handwriting, 
inaccurate spelling, inappropriate use of abbreviations, and lack of communication 
skills. The Situation, Background, Assessment, and Recommendation (SBAR) method 
is recommended in minimising communication failure between healthcare 
professionals.133 If verbal orders are unavoidable, the order should be read back by 
the nurse who received the order, written verbatim on the medication chart, and 
signed by the physician as soon as possible. Other ways to reduce transcription 
errors include use of standard abbreviations, computerised records and enforcement 






Nurses have the role to administer medication to patients. In the literature, 
administration errors were reported as the second most frequent medication error 
occurring after prescribing errors.102 An administration error occurs when there is a 
discrepancy between the intended prescribed medication and the actual medication 
administered to patients.106, 109 The classification of ASHP (Table 1.5) has been used 
widely in studies on administration errors.102, 134-136 Studies employing this 
classification revealed that the wrong route of administration, wrong dose and 
wrong time were the commonest errors identified in the administration process.134-
136 Kelly and Wright134 found that in some circumstances, medication administration 
had been recorded although the medication had not been given. The authors 
suggested that this may lead to loss of control of patients’ diseases. Berdot et al.102 
found 66 publications on administration errors in the literature. The publications had 
different study designs and reported error rates either as doses observed (i.e. total 
number of doses observed in the process of medication administration)137 or total 
opportunity of errors (i.e. the sum of the doses given plus the number of omission 
errors). The reported average rate of administration errors based on doses observed 
was 19.7% from 12 studies and the rate was 10.5% according to the total opportunity 




Table 1.5 Types of medication errors by the ASHP 12 
Types of Medication Errors Definition 
Prescribing errors Incorrect drug selection (based on indications, 
contraindications, known allergies, existing drug therapy 
and other factors), dose, dosage form, quantity, route, 
concentration, rate of administration, or instructions for 
use of a drug product ordered or authorised by physician 
(or other legitimate prescriber), eligible prescriptions or 
medication orders that lead to errors that reach the 
patient. 
Omission errors The failure to administer an ordered dose to a patient 
before the next scheduled dose, if any. 
Wrong time errors Administration of medication outside a predefined time 
interval from its scheduled administration time (this 
interval should be established by each individual health 
care facility). 
Unauthorised drug error Administration to the patient of medication not 
authorised by a legitimate prescriber for the patient. 
Improper dose error Administration to the patient of a dose that is greater 
than or less than the amount ordered by the prescriber or 
administration of duplicate doses to the patient, i.e. one 
or more dosage in addition to those that were ordered. 
Wrong dosage-form error Administration to the patient of a drug product in a 
different dosage form than ordered by the prescriber. 




Inappropriate procedure or improper technique in the 
administration of a drug. 
Deteriorated drug error Administration of a drug that has expired or for which the 
physical or chemical dosage form integrity has been 
compromised. 
Monitoring error Failure to review a prescribed regimen for 
appropriateness and detection of problems, or failure to 
use appropriate clinical or laboratory data for adequate 
assessment of patient response to prescribed therapy. 
Compliance error Inappropriate patient behaviour regarding adherence to a 
prescribed medication regimen. 
Other medication error Any medication error that does not fall into one of above 
predefined categories. 
(Originally published in American Society of Hospital Pharmacists. ASHP guidelines on preventing 
medication errors in hospitals. Am J Hosp Pharm. 1993; 50:305-14 © 1993, American Society of Health 
System Pharmacists, Inc. All right reserved. Reprinted with permission) 
 
Factors contributing to administration errors may include personal factors (feeling 
tired and lack of support in the work place); environment factors (noisy and busy 
working environment); 138 insufficient knowledge of patient’s condition and their 
medication; and non-adherence to policy and procedures at the workplace.106, 109 
Convenient working environment, accurate patients’ identification, and double 
checking of medication by other healthcare professionals are required in order to 




Facing the fact that medication errors may occur in every stage of medication 
delivery and that different healthcare professionals are responsible in those stages, it 
is essential that healthcare professionals work interprofessionally in order to 
minimise the errors from occurring.  
 
1.2.2 THE ROLE OF PHARMACISTS IN MEDICATION SAFETY 
Although the role of pharmacists in ensuring the safe use of medicine is significant, 
44, 61 disagreement on their role remains.44, 139, 140 Some researchers claim that the 
role of pharmacists in patient care has not provided enough positive evidence on 
their influence on mortality, morbidity and the patients’ quality of life.34, 44, 46, 141 
Chisholm-Burns et al.61 suggested that the lack of evidence to support the impact of 
pharmacists on patients’ quality of life may be because of limited time of interaction 
between pharmacists and patients. Sanghera46 claimed that pharmacists’ activities 
reduced medication errors because pharmacists provided services in a range of 
settings which reduced the risk of medication errors. A meta-analysis from the 
United States reported that the rate of ADEs detected through medication chart 
reviews was higher when pharmacists conducted the reviews compared to other 
healthcare professionals.142  
 
The significant role of pharmacists in ensuring the safe use of medication has been 
recorded in different settings such as in ambulatory, elderly, paediatrics and 
psychiatric patients.34, 46, 47, 143, 144 Studies have shown that pharmacists’ involvement 
in a team with other healthcare professionals improved patient safety by reducing 
medication errors, polypharmacy, suboptimal prescribing in frail elderly as well as 
minimising medication related diseases in diabetic and hypertensive patients.61 47, 64, 
145, 146 Dean et al. 125 found that pharmacists detected and resolved prescribing errors 
in 1.5% of medication orders. Leape et al.47 identified that pharmacist participations 
in ward rounds with physicians as part of a medical team reduced prescribing errors 
by 66%. In that study, the pharmacist made more than 300 recommendations and 
99% of them were accepted by the physician. An Ethiopian study reported that 
68.4% of the pharmacists’ interventions were accepted by the physicians. The 
majority of the interventions in that study related to changes of drug dosage and 




Bond et al.148 evaluated the association between clinical pharmacy services in 
reductions in medication errors in several hospitals in the United States. They found 
that pharmacists’ activities reduced medication error rates from between 13% to 
51%. The pharmacists’ activities which were associated with a reduction in 
medication errors were: participation in ward rounds, participation in ADEs 
management, provision of drug information services, undertaking drug use 
evaluations and taking of admission medication histories. The level of pharmacist 
staffing per occupied bed was also a strong predictor of reduced medication errors, 
providing strong evidence for the need for adequate pharmacist numbers.52, 148 
Further, Bond and Raehl149 identified seven clinical pharmacy services that were 
associated with reduction of mortality rate delivered in hospitals in the United 
States, and confirmed that the incidence of medication errors was inversely 
proportional to the number of pharmacists (administrative and clinical). The 
International Pharmaceutical Federation (FIP) as the international pharmacist 
association strongly recommends that the role of pharmacists in medication safety is 
essential because of their expertise in medication.30 The FIP indicated that 
pharmacists’ involvement in the healthcare team is crucial because pharmacists have 
a greater knowledge of medication and drug formulations compared to other 
healthcare professionals.  
 
This study was focused on the role of pharmacists in medication safety within 
hospital settings. Medication reconciliation and clinical review are two pharmacists’ 
activities related to ensuring the safe use of medication at hospital settings.27, 33, 40, 41, 
150, 151 The Joint Commission152 stated that medication reconciliation should be done 
in all transition care regardless of the setting, the type of service provided, and the 
level of care. The Society of Hospital Pharmacists of Australia (SHPA)40 defined 
medication reconciliation (MR) as “the standardised process of obtaining a patient’s 
best possible medication history and comparing it to presentation, transfer or 
discharge medication orders in the context of the patient’s medication management 
plan (MMP).” The aim of MR is to ensure the patient receives the optimum drug 
therapy by reducing errors in the medication history. The SHPA recommends that 
MR should be standardised in health institutions (i.e. hospitals) and it should be 
conducted as soon as the patient is admitted to the hospital. The confirmed list of 
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the patient’s medication should be provided to the doctor before ordering 
medication begins if possible.  
 
The SHPA40 states there are four steps of MR, namely: 1) obtaining and documenting 
the best possible medication history; 2) confirming the accuracy of the medication 
history; 3) comparing the medication history with the prescribed medicine and 
follow-up discrepancies; and 4) supplying verified information for ongoing care. 
Vogelsmeier et al.153 in a qualitative study found that healthcare professionals had 
different opinions on the professionals who were responsible for MR, but those who 
participated in the study agreed that pharmacists have a critical role in MR. 
 
Another pharmacist activity which contributes to medication safety is clinical review. 
The SHPA defines clinical review as “the review of patient-specific clinical information 
including patient parameters to evaluate their response to medication therapies and 
to detect and manage potential or actual medicines-related problems.”33 The clinical 
review activity involves:  
1. Obtaining information of the patient’s medication history from MR, assessing the 
patient’s needs for medication based on their clinical signs, symptoms and 
laboratory results, 
2. Documenting medication information which is not included in the formal 
documentation of medication administration, 
3. Making interpretation and evaluation based on the patient’s medication history, 
significant laboratory results, pathophysiology of the disease, and management 
plans, 
4. Identifying actual and potential drug related problems based on the risk and 
urgency,  
5. Having a discussion on the problems with the physician and documenting the 
resolved issues in the patients’ medication record.  
As discussed previously (See Section 1.2.1.3), clinical review by healthcare 
professionals is one of activities which may allow them to detect medication errors.  
 
The above evidence shows that pharmacists have a significant role in patient care to 
ensure the safe use of medication by conducting MR and clinical review within 




1.2.3 INTERPROFESSIONAL PRACTICE (IPP) IN MEDICATION 
SAFETY  
As recommended in the literature, IPP is warranted to improve healthcare service 
and patient safety.8, 12, 26, 85, 154-156 Studies have shown that pharmacists’ involvement 
in healthcare teams offer positive benefits to health outcomes.47, 61, 157 Teamwork in 
healthcare will only occur when the health system supports the implementation of 
teamwork in the provision of healthcare service.155, 158 The support from the health 
system includes support from the professionals’ organisations, regulatory bodies, 
health education institutions, and accreditation organisations.  
 
Despite the fact that support from the health system is required in IPP, several 
agencies have also highlighted the significance of team training in medication safety 
in the provision of healthcare service.30, 159, 160 A report on the emergence of a global 
patient safety network from the WHO recommended that research to improve the 
skills and knowledge of healthcare professionals in developing countries is one of the 
priorities.161 In parallel, Baker et al reported for the Agency for Healthcare and 
Research Quality (AHRQ) highlighting the three main competencies (knowledge, skills 
and attitudes) are required in effective team training in patient safety.160 Knowledge 
competencies include knowledge of the role of other team members, as well as the 
knowledge of the team mission and objectives. Skills competencies include 
communication skills, teamwork, leadership, and mutual monitoring to ensure the 
task has been completed. Attitudes competencies consist of team orientation 
morale, shared vision, mutual trust, and the importance of teamwork. In 2011, the 
Interprofessional Education Collaborative Expert Panel released a report on core 
competencies for interprofessional collaborative practice which fell into four 
domains.60 The domains were values/ethics for IPP, roles/responsibility, 
interprofessional communication and teams/teamwork. The panel indicated that 
healthcare professionals should acquire the competencies required in IPP to ensure 




1.3 THE ROLE OF PHARMACISTS IN PATIENT CARE  
The expansion of the role of pharmacists in patient care has been well accepted with 
the concept of pharmaceutical care from Hepler and Strand.8 They defined 
pharmaceutical care as “The responsible provision of drug therapy for the purpose of 
achieving definite outcomes that improve a patient’s quality of life” in 1990. The 
definition of pharmaceutical care was updated by Cipole162 in 2007 as “a patient-
centred practice in which the practitioner assumes responsibility for a patient’s drug 
related needs and is held accountable for this commitment”. However, Blackburn et 
al.163 stated that those definitions did not provide clear guidance on how to practice 
pharmaceutical care. Thus, they recommended the process of care should be 
focused consistently on the patients with the highest priority.  
 
1.3.1 FACTORS INFLUENCING THE EXPANSION IN THE ROLE 
OF PHARMACISTS IN PATIENT CARE 
The role of pharmacists in patient care in the present study is focused on medication 
safety in hospital setting. The review of the role of pharmacists in medication safety 
is discussed in Section 1.2.2. Few studies were found in the literature to identify 
factors which influenced the expansion of the role of pharmacists in medication 
safety.164 Although this study is focused on the role of pharmacists in hospital 
settings, review of factors influencing the role of pharmacists in patient care from 
both hospital and community settings can be classified into pharmacists’ internal and 
external factors. Table 1.6 lists the factors summarised from studies and reviews 

















Surveys - Lack of time  
- Lack of knowledge 
- Lack of clinical problem 
solving 
 
- Absent reimbursement 
system 
- Finance 
- Appropriate space 
- Patient demand 
- Access to patient medical 
records 





Surveys  - Lack of staff 
- Lack of communication 
- Lack of teamwork 
- Lack of relationship with 
physician 
- Lack of remuneration 
- Pharmacy layout 
- Patient expectation 
- External support/assistance 




al and primary care 
clinic pharmacists 
(Argentina) 
Surveys  - Lack of time 
- Lack of training 
- Lack of communication 
skills  
NA 






Surveys  - The humanistic factors of 
pharmacists (lack of 
motivation, narrow and 
inward focus on current 
role, negativity towards 
current healthcare 
environment, silo 
thinking, personal factors)  
 
- No integrated system of 
care and teamwork 
- Funder relationships and 
remuneration factors 
- Lack of research support 
- Lack of a united voice in 
pharmacy organisations  
- Lack of promotion  
- Lack of appreciation of the 







Qualitative  - The willingness and 
commitment of 
pharmacists  
- Lack of knowledge 
(competencies) 
- Lack of communication 
with physician 







Surveys  - The preparedness of 
pharmacists and their 
knowledge 
- Lack of facilities (internet, 
computers) 
- Lack of support from 
institution  
- Lack of support from other 
healthcare professionals 
- Lack of budget 




(The United States) 
Review  
 
- The shortage of 
pharmacists  
- Structural and process  
Martin-Calero, 
et al., 200458 
(Spain) Review  - Lack of education  
- Lack of communication 
with physician 
- Lack of time  
- Lack of skills 





- Absent of acknowledgment 
and economic compensation 
from healthcare authorities 
- No practice standard in 
implementing 
pharmaceutical care 
- Lack of documentation 
- Lack of reimbursement 




Review  - The shortage of 
pharmacists 
- The pharmacists focused 
on management service 
- Lack of recognition of 
pharmacists from health 
system which led to lack of 














Review  - The workload of 
pharmacists  






Review  - Lack of education and 
training 







Review - Lack of role clarity 
- Pharmacists do not 
understand the role of 
other healthcare 
professionals in teamwork 
- Lack of pharmacists’ 
assertiveness 
- Inadequate pharmacists’ 
support 
- Lack of space 
- Inadequate pharmacists’ 
training 
- Other healthcare 
professionals have unclear 
expectation of the role of 
pharmacists in the team 
- Patient had no 








Review  - Inadequate skills 
pharmaceutical care 
- Lack of training  
- Lack of supportive 
technology 




- Lack of financial or fee for 
service 
Rubio-Valera 
et al., 2014173 
Mental Health Care 
(Australia)  
Review - Lack of interactions with 
other healthcare 
professionals 
- The stigma of pharmacists  
- Lack of time  
 
- Limited direct access to 
patients’ clinical data 
- Other healthcare 
professionals’ stigma 
- Lack of privacy 
- Inadequate remuneration 
Notes: NA = Not available 
 
Pharmacists’ internal factors 
As seen in Table 1.6, the pharmacists’ internal factors ranged from the pharmacists’ 
lack of time, knowledge, skills, and training to a lack of staff and interactions with 
physicians. There were two studies conducted in Indonesia which described barriers 
to the role of pharmacists in patient care in the community and hospital settings.56, 
174 Both studies found that lack of knowledge was one of the pharmacists’ internal 
factors. The studies indicated that the lack of knowledge may result from inadequate 
training during undergraduate education or lack of ongoing profession development. 
Thus, Nasution et al. highlighted the importance of continuing professional 
development for registered pharmacists.56 Lack of time was also mentioned as 
another pharmacist internal factor. The lack of time may relate to the lack of 
pharmacists’ workforce. This may lead to high workloads which were also identified 
in other studies.57, 164 Yuniar and Herman proposed to recruit more pharmacists and 
to empower pharmacy technicians as a means to overcome the lack of a pharmacist 
workforce in Indonesia.174 Another internal factor in the community setting in 
Table 1.6 continued 
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Indonesian practice was a lack of communication with the physician. This lack of 
communication may result in a lack of rapport between pharmacists and physicians.  
 
Pharmacists’ external factors 
The pharmacists’ external factors as outlined in the literature included no practice 
standards, no support from the health system, lack of recognition from other 
healthcare professionals, and inadequate remuneration. As opposed to the lack of 
support from the Pakistani Government,169 the Indonesian Government has 
supported the role of pharmacists in patient care through the introduction of the 
Indonesian Government Regulation No 51 in 2009.56 In the hospital setting, the 
Directorate General of Pharmacy and Supply Medicine established a guideline for 
ward visits.52 This suggests that the role of pharmacists in Indonesia should be viable 
with the support from the government. There was only one study which discussed 
the pharmacists’ external factors as barriers to the expansion of the role of 
pharmacists in Indonesia. Nasution et al.56 indicated that the pharmacists’ external 
factors in the Indonesian hospital setting included the lack of facilities (internet and 
computers), lack of support from the hospital, lack of support from other healthcare 
professionals and lack of funding in providing patient care. The lack of financial 
support identified within the Indonesian setting was also similar to the lack of 
remuneration identified in other countries.58, 165, 166, 168, 172, 173 The lack of recognition 
from other healthcare professionals found in Indonesia may result from the fact the 
pharmacists did not play their role as expected as a profession.175 The lack of 
understanding of the role of pharmacists amongst healthcare professionals is also 
similar to that found in Spain58 and Pakistan.169 The lack of acknowledgement of the 
role of pharmacist may lead to lack of interaction with other healthcare 
professionals, which has also been previously identified.58, 166, 173  
 
1.3.2 MODELS IN THE EXPANSION OF THE ROLE OF 
PHARMACISTS IN MEDICATION SAFETY 
There are a number of possible models discussed in the literature for the 
implementation of new initiatives in healthcare services. One of the models is the 
sustainability model for implementing new initiatives proposed by the National 
Health System (NHS).176 This model was developed by experts in the UK to determine 
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the strength and to ensure the sustainability of the new initiative. It aims to identify 
key barriers to sustainability and to overcome the barriers of implementation of the 
initiative. The model is made up of 10 sustainability dimensions which are covered 
under three factors (i.e. process, staff, and organisation). The Process factor includes 
the dimensions: benefits beyond helping patients, credibility of the benefits, 
adaptability of improved processes, and effectiveness of the system to monitor 
processes. The Staff factor consists of the dimensions of staff involvement and 
training to sustain the process; staff behaviours towards sustaining the change; as 
well as support and engagement of senior and clinical leaders. Organisation factor 
involves the new initiative fit with the organisation’s strategic aims, culture and 
infrastructure for sustainability.  
 
Another model is the Holland-Nimmo Practice Change System (PCS). This model is 
particularly applicable for innovation in the role of pharmacists in medication safety. 
The model provides guidance for leaders to link the current practice and the desired 
change of practice. The leaders should clearly address not only those who are 
involved, but also those who are affected by the change.59 This model can be 
adapted by leaders in the organisation to justify whether the innovative role of 
pharmacists in medication safety is feasible. This model aims to identify barriers and 
to offer strategies to overcome these if pharmacists are to engage in expanding their 










(Reprinted with permission from Holland RW, Nimmo CM. Transitions in pharmacy practice, part 3: 
effecting change-the three-ring circus. Am J Health Syst Pharm. 1999; 56:2236) 
 
Figure 1.5 The Holland-Nimmo Practice Change System 59, 177 
 
Practice 







Figure 1.5 shows that there are three components of the PCS, i.e. practice 
environment, motivational strategies, and learning resources. 
 
Practice environment 
The practice environment covers three levels of changes (i.e. society, health system 
and practice site) to support the role of pharmacists in medication safety. The society 
level needs to address factors in the form of regulation from the federal, state, and 
local authorities. This level also takes into consideration the acceptance of patients 
and other healthcare professionals in the practice changes at the national level. The 
health system level involves factors derived from the availability of resources, 
support from the health administrator, infrastructure (e.g. internet and computers) 
and access to information. The practice site level is related to how things are done, 
interpersonal relationships, and communication patterns. The practice site level 
consists of training for pharmacists, a clear job description for pharmacists, and 
differences in values and expectations of the present state of practice to the desired 
state of practice.  
 
Motivational strategies 
This component addresses different values of pharmacists, as well as those of other 
healthcare professionals. The strategies have two components such as the mind-set 
of the pharmacists and the systematic motivation to drive the changes of practice. 
Nimmo and Holland59 emphasise that professional socialisation provides strong 
motivation for participants to learn and to engage in the new practice. This is 
important because those who have less motivation will gain less. Nimmo and Holland 
stated “creating motivational strategy entails persuading practitioners to acquire any 
knowledge and skills required for competence in the changed practice and to desire 
to make that mode of practice their own.” Thus, the leaders should create strategies 
to motivate the pharmacists to be practice ready as care providers.  
 
Learning resources 
The third component of the PCS model is the learning resources needed for the 
pharmacists in their role in medication safety. The resources consist of learning 
program materials (i.e. materials directly linked to the desired outcome), awareness 
(i.e. the learning program should meet the criteria for the specific training needed), 
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accessibility (i.e. the learning program should be accessible), affordability (i.e. the 
learning program should be affordable within the institution budget), and time (i.e. 
the training should be adjusted to the pharmacist’s regular work time). Nimmo and 
Holland59 recommended that these learning principles should apply to all practice. 
They indicated that all components of the PCS model should be addressed in 
expanding the role of pharmacists in medication safety.  
1.4 INTERPROFESSIONAL EDUCATION (IPE) AND 
INTERPROFESSIONAL PRACTICE 
1.4.1 WHAT IS IPE AND IPP? 
Meads et al. suggested that in order to be professional, education needs to be 
interprofessional.178 Interprofessionalism is required in the provision of healthcare 
services because no single healthcare profession can manage all the problems of 
patients. The word “Interprofessional” is commonly associated with collaboration, 
multidisciplinary or teamwork. However, Barr82 argues that teamwork, collaboration 
and multidisciplinary are different from interprofessional. Collaboration has a wider 
view which involves not only healthcare professionals as team members but also 
organisations or health systems. Multidisciplinary is also different from 
interprofessional. In multidisciplinary, members of the team consist of different 
professions who are responsible for their own role. According to the American 
College of Clinical Pharmacy (ACCP), the different healthcare professionals involved 
should share mutual goals, responsibilities, and resources in the interprofessional 
activities.179 Thus, in the present study, the term interprofessional was used because 
it has the notion that healthcare professionals involved in the collaboration should 
share the same goals and responsibilities in the healthcare service delivery.   
 
Thistlethwaite et al.85 stated that Interprofessional Education (IPE) is associated with 
education, while Interprofessional Learning (IPL) is associated with the learning 
experience of the participants in the collaboration. They suggest that IPL and IPE are 
used interchangeably. IPP is used to describe interprofessional activity involving 
healthcare professionals. The most frequently used definition of IPE in the literature 
is the definition of the Centre for the Advancement of Interprofessional Education 
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(CAIPE). The centre uses the term of IPE for learning processes from the academic 
through to the practice level. The CAIPE defines IPE as the following:180  
 
"Interprofessional Education occurs when two or more professions learn with, 
from and about each other to improve collaboration and the quality of care". 
 
Freeth et al. have defined IPL (and its relationship to IPE) as follows: 70  
 
“Interprofessional learning (IPL): Learning arising from interaction between 
members (or students) of two or more professions. This may be a product of 
interprofessional education or happen spontaneously in the workplace or in 
education settings. Interprofessional practice (IPP): Two or more professions 
working together as a team with a common purpose, commitment and mutual 
respect. “ 
 
In the present study, IPE is used when the discussion involves healthcare students 
and IPP when it refers to the healthcare professionals. In support of the argument of 
Freeth et al., Adam et al. point out the relationship of IPE, IPL, IPP and theoretical 
interdependent concepts which may influence IPE.181 They suggested that to put IPE 
in to practice, it requires informal, integrated, and situated learning.181 The informal 
learning helps the learners to gather interprofessional socialisation. The learners 
acquire the informal learning from their peers, students from other professions, their 
practice educators and their patients. From this learning, students gain 
interprofessional values of informal and social working. Integrated learning assists 
students to learn not only about each profession, but also interconnection between 
professions. In this type of learning the students learns about other profession roles 
and communication skills (‘proportional knowledge’), problem solving and decision 
making (‘tacit knowledge’), as well as learning and working experience in the 
community practice (‘personal knowledge’). Situated learning reinforces the need of 
learning to the interdisciplinary practice environment and to learn from other health 
professionals. The most important process of the situated learning is learners have 
the chance to experience, share, discuss and learn from one another in the 
interprofessional collaboration as part of the culture of interprofessional practice in 




CAIPE reinforces that an effective IPE:82 
- Works to improve the quality of care 
- Focuses on the needs of service users and carers 
- Involves service users and carers 
- Promotes interprofessional collaboration 
- Encourage professions to learn with, from and about one another 
- Enhances practice within the professions 
- Respects the integrity and contribution of each profession 
- Increases professional satisfaction 
In support of the CAIPE statement on requirements of IPE, Sargeant et al.182 
identified that understanding and respecting the role of other team members and 
communication were the two essential requirements. They also emphasised that an 
effective interprofessional practitioner needs the appropriate skills, knowledge and 
attitudes. These competencies were also discussed as requirements for healthcare 
professionals in IPP ensuring medication safety (See Section 1.2.3). Communication 
skills are considered essential for healthcare professionals in IPP. Knowledge 
competency is not only knowledge of one’s own discipline, but also knowledge of the 
roles of other health professionals which may be acquired through IPE. Respect of 
other healthcare professionals can also be gained through effective IPE.  
 
The outcomes of IPE  
No studies have provided solid evidence on the benefits of IPE.155 Research on IPE 
has mostly been on the attitudinal changes towards IPE after attending IPL.72, 87, 183 
Reeves et al.184 stated that in the last decade much research has been conducted on 
IPE and they recommended employing qualitative and quantitative data to support 
the implementation of IPE.184 A Cochrane review in 2009 suggested that further 
evidence is required to justify the effectiveness of IPE in health outcomes.185 The 
review authors also believed that the recent studies on IPP only showed promising 
results because no evidence was provided from well-designed randomised control 
studies. The WHO found that both developed and developing countries almost 
equally perceived the benefits of IPE.186 The benefits were similar as those reported 
by Hammick et al.80 They found that benefits were usually discussed in terms of 
three main outcomes (i.e. for learners, for healthcare service delivery and for 




Table 1.7 Classification of outcomes of IPE82 
Level 1 – Reaction Learners’ view on the learning experience and its 
interprofessional nature 
Level 2a – Modification of 
attitudes/perceptions 
Change in reciprocal attitudes or perceptions between 
participant groups. Change in perception or attitudes 
towards the value and/ or use of team approaches to 
caring for a specific client group 
Level 2b – Acquisition of 
knowledge/skills 
Including knowledge and skills linked to interprofessional 
collaboration 
Level 3 – Behavioural change Identifies individuals’ transfer of interprofessional 
learning to their practice setting and their changed 
professional practice 
Level 4a – Change in 
organisational practice 
Wider changes in the organisation and delivery of care 
Level 4b – Benefits to 
patients/clients 
Improvement in health or well-being of patients/clients 
(Permission granted from John Willey &Sons Ltd) 
 
Thistlethwaite and Moran85 argued that although Kirkpatrick’s model  used by Barr et 
al. (See Table 1.7) may be useful to assess the level of evidence of an IPE initiative, it 
was too broad. Thus, Thistlethwaite and Moran85 conducted a comprehensive 
literature review and categorised the outcomes of IPE into six themes; teamwork, 
role/responsibility, communications, learning/reflection, the patient, and 
ethics/attitudes. They found that teamwork, role and responsibility were the most 
frequent outcomes discussed in the literature. They suggested that learners will 
obtain these outcomes if the learners gain experience to be involved actively in a 
group. They recommended assessing several methods to measure the learning 
outcomes of IPE. They suggested that these learning outcomes may be obtained 
from formal education or from the real-world working environment.  
 
IPE theoretical frameworks  
Debates on theories to articulate IPE currently remain. Reeves and Hean argue that 
healthcare professionals believed that the theories belong to academia.187 However, 
theories are required for better understanding of IPE in practice for learners, 
educators, practitioners, and policy makers.188 187, 189 Theories outlined in the 
literature are built in a wide range of disciplines such as sociology, psychology, 
education and management.187, 189-191 The theories are developed in accordance to 
the aims of understanding IPE. Hammick et al.80 suggested that the 3P Model 
(Presage, Process and Product) was able to accommodate key messages to the 
adoption of IPE into practice. The presage encompassed socio-political context and 
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characteristics of learners, academics and administrators. Process involved methods 
employed in the learning and teaching, meanwhile Product referred to the outcomes 
of IPE. Hammick et al. argued that the model should reveal factors which may 
influence the process and product of IPE.80  
 
Hean et al. proposed several dimensions to consider in the adoption of the 
theoretical framework of IPE. The dimensions covered how, which, when, why and 
what to study which were described in a guide of the Association for Medical 
Education in Europe (AMEE).188 They used the term tool box to describe the 
dimensions. The tool box is selected based on the context of the understanding of 
IPE. They also argued adopting only one theory may be inappropriate knowing IPE 
involves complex interactions between participants from different courses of studies. 
They suggested that the theories of IPE are important as a reflection to the current 
practice and the tool box is viewed as a second reflection on the more objective 
understanding of IPE. According to the AMEE, the tool box (i.e. level tool boxes) may 
be employed in order to gain the understanding of factors of IPE at the Micro, Meso 
and Macro levels. The Micro level studies the interaction between teaching factors 
(i.e. learning context of how, what, where and when to teach IPE and faculty 
development in terms of recognition of ones professional beliefs and attitudes 
towards collaboration). Meso level explores the understanding of IPE as institutional 
factors (i.e. education institution and/or academic hospital environment) which may 
be influenced by leadership, resources and administration processes. The Macro 
level intends to gain an understanding of IPE at the systemic level of health and 
politics. Government policies, professional policies, and institution accreditation are 
crucial factors at the Macro level.  
 
D’Amour and Oandasan recommend a concept of interprofessionality in this level 
dimension.79 They suggested that the concept links IPE and collaborative practice to 
patient-centredness outcomes. Collaborations at Micro, Meso and Macro levels are 
essential to achieve interprofessionalism in patient-centred care. They named the 
framework the Interprofessional Education for Collaborative Patient-Centred 
Practice (IECPCP) which emphasises the association between patients, healthcare 
professionals, healthcare students, health academics, stakeholders at the institution 
and the policy makers to achieve patient-centred care. In the present study, the 
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IECPCP framework was adopted because it met the aims of the present study to 
understand the feasibility of implementing IPE and IPP which are aimed at enhancing 
patient care. The interconnection between IPE and collaborative practice in patient 




(Reproduced with permission of Informa Healthcare, [Interprofessionality as the field of 
interprofessional practice and interprofessional education: An emerging concept], [2005; Supplement 
1:8-20], Copyright © [2005], Informa Healthcare]). 
 
Figure 1.6 The Framework of Interprofessional Education for Collaborative Patient-Centred 
Practice (IECPCP)79 
 
When to initiate IPE? 
Barr192 put forward the introduction of IPE at the professional level. This was because 
the students already have their sense of professional identity and a better 
understanding of their role before learning from and about other professions. 
However, recent evidence recommends IPE should be introduced as early as the first 
year of undergraduate education and continuously learned until post 
qualification.193-195, 196 These suggestions were to reduce the pre-existing stereotyped 
views197 and to anticipate the different motivations198 amongst healthcare students 
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which may influence the effectiveness of the implementation of IPE. Saxel et al. 
supported the introduction of IPE at undergraduate level.195 They found medical, 
nursing and midwifery students learning during undergraduate improved their 
understanding towards the role of other healthcare professionals and allowed them 
to gain teamwork skills. Further, Ruebling et al.199 confirmed that early introduction 
of IPE into healthcare students’ learning, not only maintained the positive attitudes 
towards IPE but also improved them. Horsburg et al.86 found that first year nursing, 
pharmacy and medical students had positive attitudes towards shared learning. 
These positive attitudes towards IPE were also shown in third year healthcare 
students.200 Pollard et al.201 conducted a three year longitudinal study of a pre-
qualified interprofessional curriculum involving health and social care students. They 
concluded that the students had positive attitudes towards IPE but lacked confidence 
in their communication and teamwork skills in the second year of their courses. On 
balance the evidence indicated that IPE should be started early and delivered 
continuously during healthcare students’ education.  
 
IPE learning methods 
Adoptions of learning strategies are dependent upon the learning needs of the 
students because none of the learning strategies is better than others. Key to the 
learning process, learners must gain valuable experience in learning from, with and 
about each other. Some IPE learning strategies are summarised below. 
1. E-learning and blended learning: E-learning uses technology such as online 
seminars or workshop. Blended learning involves a mixed method of learning 
such as online seminars and face to face discussion. Authentic multimedia 
resources on medication safety in medical, nursing and pharmacy students were 
studied in the Australian setting. The study showed that such resources provided 
opportunities for students to engage interactively using a virtual experience of IPE 
in a clinical practice situation related to medication safety.202  
2. Exchange (seminars or workshop discussions): Each participant shares their 
experience, perspective and feelings while working in a group. Participants from 
different healthcare professionals have interactive discussions. Studies have 
shown that an IPL workshop activities improved healthcare students’ knowledge 
on the topic, enhanced their communication skills and improved students’ 
awareness towards other healthcare professionals roles.93, 203  
45 
 
3. Observation (work shadowing/site visits): In this method participants from 
different healthcare professionals view the role of others in practice. A study in 
Canada suggested that chiropractors who had interprofessional shadowing 
enhanced the experience of IPE.204 This may bring about benefits for future 
collaboration in patient care.  
4. Practice learning (student placement): This method provides students with a 
real-world practical experience where healthcare professionals work 
collaboratively. Khalili et al. reported that a clinical simulation practice as an 
addition to clinical placements in a Bachelor of Nursing and Practical Nursing 
course bridged the gap between theory and practice by enhancing competencies, 
confidence and real collaborative practice.205  
5. Problem-focused (problem-solving activities): This method is useful both at the 
pre- and post- qualification level. Hughes and Lucas206 reported that healthcare 
students were inspired to learn independently, had improved communication 
skills, and respected each other’s role better in problem based learning within a 
multiprofessional education curriculum. Barr et al. highlighted that problem-
based learning is important because it stimulates critical evaluation of a problem 
amongst participants.82  
6. Received (lectures/presentations): Although this method is considered 
inappropriate in IPE, this method remains important to provide background 
information and to allow participants to raise questions in IPE activities. However, 
there is little evidence in the literature to support lectures as one of learning 
methods in IPE.  
7. Simulation (role play): This method uses simulated patients and healthcare 
students from different professions who are involved in providing care for the 
patient. The simulation method is recommended by a number of researchers 
because it offers a meaningful learning experience for the learners.207, 208 Baker et 
al. found that the simulation learning method enhanced medical and nursing 




1.4.2 THE WORLD HEALTH ORGANISATION (WHO) 
FRAMEWORK  
IPE has developed globally, yet, there is a discrepancy between developed and 
developing countries. In the former countries, the preparation of IPP (i.e. practice of 
IPE) is concentrated on individuals and families, whereas, in developing countries, 
the practice moves toward community and public work.178 The WHO supported the 
development of IPE worldwide with the release of “A Framework for Action on 
Interprofessional Education and Collaborative Practice (IPE-CP) in 2008. The goal of 
the framework is to provide an instrument which can be implemented by local 
governments based on their local needs by adopting or changing their system to 
achieve or improve health outcomes in their countries.  
 
(Source: © World Health Organisation, Framework for Action on Inter-professional Education and 
Collaborative Practice, 2010). 
 
Figure 1.7 The WHO Framework for Action on IPE (IPE-CP) 
 
Figure 1.7 shows that healthcare professionals need to be provided with the 
opportunity to learn interprofessionally through both their education and health 
systems. Barriers such as fragmentation in health and/or education systems might 
restrict the implementation of IPE. Consequently, health and education systems 
need to change prior to the adoption of IPE into practice. If the learning experience 
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of healthcare students in working with other healthcare professionals is maintained 
after graduating, the future professionals are ready to practice in a culture of 
interprofessionalism. This then will strengthen the health system as well as 
potentially improve health outcomes. Frenk et al. recommended that in the present 
century, reformation of health education is required to strengthen the future health 
system.81 They further emphasised the importance of IPE to change the behaviours 
of healthcare professionals in the complex healthcare service.81 In 2010, Barr 
criticised the WHO framework as only a ‘blueprint’ for the international and national 
policy makers to support the WHO global health goals.210 Barr recommended that 
the framework should be viewed as a worldwide long term agreement of IPE. He also 
remarked that IPE remains a task for international organisations to establish 
multidisciplinary approaches in healthcare.  
 
Research on the global clarification of IPE in 2010 reported that there was no 
significant difference between developed and developing countries in terms of the 
perceived benefits of IPE for teaching and learning as well as for practice and 
policy.186 Some of the benefits mentioned were improvement of workplace practice 
and better health outcomes for the patients. However, Mickan et al. identified some 
barriers and facilitators from case studies in different settings in developed and 
developing countries (Table 1.8).63 Although some similarities were found in terms of 
support from the government and legislation as well as financial incentives in both 
developed and developing countries, some differences are illustrated in Table 1.8. In 
developed countries, the governance model may facilitate a shared model of 
responsibility amongst healthcare professionals, meanwhile, in the developing 
countries, the traditional hierarchical model of healthcare service delivery is 
considered as one of the barriers. Mickan et al. stated that the lack of access to 
medical records for healthcare professionals in developing countries may restrict 
IPP.63 This may relate to the culture and infrastructure of the health system. Thus, 





Table 1.8 Facilitators and barriers of collaborative practice in developed and developing countries 
63, 84 
Countries Facilitators Barriers 
Developed (Canada, 
Denmark, Japan, the 
United Kingdom) 
Remuneration models, a 




committed leadership, joint 
discussion of patients by 
general practitioners and 
staff, supportive legislation, 
structured protocols, team 
conferences; regular face to 
face meetings; respect for 
other professions 
Lack of electronic health 
record, interpersonal conflict, 
lack of structured protocols, 
unsuitable office and 
administrative space for all 
task, unclear division of 
responsibility and competency 
between different staff 
groups, discord between 
teams, time constraints, and 
lack of managerial support 
Developing (India, Nepal, 
Oman, Thailand) 
Approachability and 
adaptability of team member, 
evidence, government policy, 
commitment from high-level 
policy maker, ongoing staff 
training, clear guidelines, spirit 
of teamwork, supportive 
policies from universities, 
agencies, common goals, 
regulatory bodies, financial 
support, trusting relationships 
Miscommunication, time 
constraints, traditional care 
delivery models, managing 
difficult personalities, staff 
turnover, lack of time and 
resources 
 
1.4.3 FACTORS INFLUENCING THE IMPLEMENTATION OF 
IPE AND IPP 
Several factors may influence the implementation of IPE. These factors may include 
poor communication among healthcare professionals,103 ineffective team 
dynamics,89 sub-specialisation in professions, lack of awareness of teamwork, 
professionals’ traits,211 and competition amongst healthcare professionals. Hall 
highlighted professional cultures as a major barrier in working with other healthcare 
professionals.211 Professional cultures such as the power and hierarchy of physicians 
in team processes, lack of understanding of the role of other healthcare 
professionals, and professionals’ stereotypes are seem to inhibit IPP. However, Ateah 
et al. stated that not all of those stereotypes are negative.76 They described that 
nurses are known for their traits for being caring and trustworthy which brings a 
positive notion to the nurse as professional. Table 1.9 summarises factors affecting 
the implementation of IPE and IPP at the Micro, Meso and Macro levels from studies 
found in the literature. The factors at those levels were summarised based on the 
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IECPCP framework (Figure 1.6). Factors identified at these levels were analysed in 
assessing the feasibility of the implementation IPE and IPP in Indonesia as part of the 
present study. 
Table 1.9 Factors at Micro, Meso and Macro levels affecting to the implementation of IPE/IPP 
Sources Setting Micro level Meso level Macro level 
IECPCP framework 
from D’Amour and 
Oandasan79 
Education Teaching factors: 
learning context 
(how, what, where, 
and when) and 
faculty development 
(how to facilitate IPE 
and recognise own 
beliefs and 
attitudes); Social and 











Social and cultural values 





and sense of 









(regulatory bodies, liability); 
Government Policies (Federal, 
provincial/regional/territorial); 
Social and cultural values; 
structural and financial 
segregation of healthcare 
professionals training  
Hammick et al., 
200780(Review) 
Education Barriers: learners’ 
characteristics; 
approaching to 






Drivers: government policy, 
professional and public needs 
Barriers: regulatory 
framework; relationship with 
other stakeholders 
Nisbet et al., 
2011212 (Review) 
Education Different expectation 
of each profession; 
the fear of loss of 
status; students have 
different ability and 
interest; lack of 
resources for 
program coordination 
and facilitation; lack 




(i.e. curriculum and 
timetable difference); 




and intraprofessional rivalries  
























no staff who 
prepared to facilitate 
for IPE 
Ego of school; 
funding; structural 
barriers (i.e. no rule 
of IPE; no facilities; 
curriculum 
differences  
No legal law for collaboration; 
issues within the professions; 
the public perception of the 
role of healthcare 
professionals; different level 
of educations between health 

















NA Varying levels of qualifications 
and status; payment and 
rewards; differences in 
accountability, hierarchy; 
concerns regarding clinical 
responsibility; fears of dilutes 
professional identity; 
differences in language and 
jargon; difference in schedule 
and professional routines; 
historical interprofessional 
and intraprofessional rivalries; 
differences in requirements, 















Government policies; training 
of staff; support from 
regulatory bodies; traditional 
model of healthcare delivery; 
financial support 
Légaré et al., 
2008216 (Review) 
Practice Barriers: Time 
constraint; lack of 







impact on the clinical 
process; and patient 
outcomes 
NA NA 
Mickan et al., 
201063 (Review) 
















Government policy; training of 
staff; remuneration; financial; 
payment scheme for all 
healthcare professionals; 
support from regulatory 
bodies; professional prejudice 
and attitudes 
Notes: NA = Not available 
 
 1.4.4 MODEL OF COLLABORATION 
The FIP30 established a pyramid to illustrate the degree of collaboration pharmacists 
have with other healthcare professionals namely Collaborative Pharmacy Practice 
(CPP). The CPP has five levels of collaboration based on the level of interaction of 
pharmacists with other healthcare professionals and their responsibility in managing 
patients’ medications (Figure 1.8).  
  


















(Adapted from International Pharmaceutical Federation (FIP), FIP reference paper collaborative 
practice, 2009). 
Figure 1.8 Level of Collaborative of Pharmacy Practice (CPP) 
 
At Level 1, pharmacists have minimum contact with other healthcare professionals 
as well as with patients. The pharmacist works by themselves and has limited 
interaction with the physician. Interactions may occur while clarifying prescriptions. 
At Level 2, pharmacists give pharmacy only medication to patients. The National and 
Local Authorities regulate “the pharmacists only” and “the pharmacy only” 
medication. At this level, pharmacists have the authority to provide the medication 
to the patients in person based on their knowledge and skills. The interaction 
between the pharmacists and other healthcare professionals is built on personal 
relationships at Level 3. At this level, the pharmacists examine the prescribed 
medication and provide recommendations. The number of recommendations 
accepted is influenced by the level of rapport between physician and pharmacist. 
The level of interaction may occur in the hospital setting where ward pharmacists are 
present. At this level in the wards the activities of the pharmacists is limited to 
offering reactive advice.  
 
At Level 4, the pharmacist is considered as part of a healthcare team. The pharmacist 
provides proactive advice which may influence the decision related to patients’ 
medications. At this level, other healthcare professionals refer pharmacists to 
examine the rationale of the medication regimens of patients with multiple 
 
Degree of 







Minimal contact between pharmacists and other healthcare 
professionals 
System wide authority to supply medicines 
Prospective advice  
and/or 
Referral by other healthcare professionals 
CPP 
 




medications. The physicians may accept or reject the recommendations of 
pharmacists based on the level of trust in the competencies of the pharmacists.  
 
At Level 5 pharmacists have the authority to decide the medication of the patients. 
At this level, the pharmacists act as part of the healthcare team who share the 
responsibility of the decision of the medication. Pharmacists have the authority to 
change or initiate medication therapy based on agreements with the team. 
Pharmacists may visit patients in person or with other healthcare professionals, but 
they work as part of the team. The FIP30 also highlights that the level of collaboration 
of pharmacists with other healthcare professionals is highly influenced by support 
from the national and local health system.  
 
Another model of collaboration was from D’Amour et al. who created a model to 
promote patient care which takes into consideration the relationship and the 
interaction of 10 indicators at the level of the individual and organisational settings 
(Figure 1.9).217 The individual level consisted of Shared Goals and Visions and 
Internalisation dimensions which contained four indicators (See Figure 1.9 in italics). 
The organisation level comprised Governance and Formalisation dimensions which 
had six indicators (See Figure 1.9 in italics). Table 1.10 displays definitions of the 
indicators in the model of collaboration. D’Amour et al. further described the 
typology of collaboration based on the level of achievement of indicators (Table 
1.11). In the present study, this model was employed because it takes into 















(with permission from Creative Commons Attribution Licence) 
 




- Support for innovation 
- Connectivity 
Formalisation 
- Formalisation tools 
- Information exchange 
Shared Goals and Vision 
- Goals 
- Client-centred orientation vs 
other allegiances 
Internalisation 





Table 1.10 Description of indicators of collaboration by dimension 217 
Dimension Indicators Description 
SHARED GOALS AND VISION Goals The indicator is related to professional values in the form of common 
goals, with particular reference to the consensual and 
comprehensive nature of the goals. Identifying and sharing common 
goals is an essential point of departure for a collaborative 
undertaking. The data suggest that the goal most likely to rally 
stakeholders is that of promoting patient-centred care. Providing a 
response to clients’ needs thus becomes a central objective on which 
everyone can agree. The problem is that this goal entails a radical 
transformation of values and practices; its achievement would truly 
be an innovation 
 Client-centred orientation vs other allegiances There generally exists a complex structure of interests involving a 
variety of different types of allegiance: to the clientele, to the 
profession, to the organisation, to private interest, etc. The result is 
thus an asymmetry of interests among partners or a partial 
convergence of interests. Mutual adjustments are required, making 
the need to negotiate all the more important. In some cases, 
negotiation is possible. In others, interests are left largely 
unexpressed, and there is no negotiating process. When shared goals 
are not negotiated, the risk is that private interests will emerge, 
resulting in opportunistic behaviour and a concomitant loss of focus 
on client-centred collaboration. 
INTERNALISATION Mutual acquaintanceship The data show that professional must know each other personally 
and professionally if they are to develop a sense of belonging to a 
group and succeed in setting common objectives. Knowing each 
other personally means knowing each other’s values and level of 
competence. Knowing each other professionally means knowing 
each other’s disciplinary frame of reference, approach to care and 
scope of practice. The familiarisation process occurs at social 
occasions, training activities and formal and informal information-
exchange events. It is necessary to create the social conditions that 
will foster collaboration, particularly through social interaction. 
 Trust According to the professionals, collaboration is possible only when 
they have trust in each other’s competencies and ability to assume 
responsibilities (that is, when goodwill exists). Trust reduces 
uncertainty. Professionals acknowledge that they do not know each 
other well, and so must constantly gauge risks and allow them to be 
placed in a vulnerable position. When there is  too much uncertainty, 




Dimension Indicators Description 
clients as long as possible to avoid collaborating. Such actions run 
counter to the goal of constructing networks. Professionals use the 
results of collaboration to evaluate each other and build trust. 
GOVERNANCE Centrality Centrality refers to the existence of clear and explicit direction that is 
meant to guide action, in this care, towards collaboration. The data 
reveal the importance of the involvement of some central authorities 
in providing clear direction and playing a strategic and political role 
to further the implementation of collaborative processes and 
structures. Senior managers can exert significant influence on 
interorganisational collaboration; particularly through agreements 
they reach with the managers of other facilities to make the 
collaboration official. 
 Leadership Local leadership is necessary for the development of 
interprofessional and inter-organisational collaboration. Leadership 
may take a variety of forms and can be collaboration; leadership can 
be categorised as either emergent or as related to a position. With 
respect to collaboration, leadership can be exercised either by 
managers who have been mandated to do so or by professionals 
who take the initiative themselves. In the latter case, leadership is 
shared by the different partners and is subject to wide agreement. 
When leadership is related to a position, power should not be 
concentrated in the hands of single partner, all partners must be able 
to have their opinions heard and to participate in decision making.  
 Support for innovation Because collaboration leads to new activities or because it involves 
dividing responsibilities differently between professionals and 
between institutions, it necessarily entails changes in clinical 
practices and in the sharing of responsibilities between partners. 
These changes represent real innovations that must be developed 
and implemented. Collaboration cannot take hold without a 
complementary learning process and without the organisation 
involved drawing on internal or external expertise to support this 
learning process. 
 Connectivity Connectivity refers to the fact that individuals and organisations are 
interconnected, that there are places for discussion and for 
constricting bonds between them. Connectivity is the opposite of 
being cut off, isolated, separate. It solves coordination problems and 
makes it possible to make adjustments to practices. Connectivity 
allows for rapid and continuous adjustments in response to problems 
of coordination. It takes the form of information and feedback 




Dimension Indicators Description 
 
FORMALISATION Formalisation tools Formalisation is an important means of clarifying the various 
partner’s responsibilities and negotiating how responsibilities are 
shared. There are many types of formalised tools; inter-
organisational agreements, protocols, information systems, etc. For 
professionals, it is important to know what is expected of them and 
what they can expect of others. Earlier findings suggest that 
collaboration is influenced less by the degree of formalisation than 
by the consensus that emerges around formalisation mechanism and 
the specific rules that are implemented 
 Information exchange The exchange of information refers to the existence and appropriate 
use of an information infrastructure to allow for rapid and complete 
exchanges of information between professionals. The findings 
suggest that professionals use information systems to reduce 
uncertainty in their relationships with partners they do not know 
well. Feedback provides professionals with the information they 
need to follow up with patients as well as to evaluate their partners 
on the basis of the quality of the written exchanges and feedback. 
This is an important aspect of establishing relationships of trust.  
(with permission from Creative Commons Attribution Licence) 
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Table 1.11 Indicators of collaboration according to the typology 217 
Indicators Active Collaboration 
LEVEL 3 
Developing 
Collaboration LEVEL 2 
Potential or Latent 
Collaboration LEVEL 1 
Goals Consensual, 
comprehensive goals 
Some shared ad hoc 
goals 
Conflicting goals or 











Tendency to let 






meet, regular joint 
activities 
Few opportunities to 
meet, few joint 
activities 
No opportunities to 
meet, no joint 
activities 
Trust Grounded trust Trust is conditional, is 
taking shape 
Lack of trust 
Centrality Strong and active 
central body that 
fosters consensus 
Central body with an 
ill-defined role, 
ambiguous political 
and strategic role 
Absence of a central 
body, quasi-absence 
of a political role 

















Little or no expertise 
available to support 
collaboration and 
innovation 
Connectivity Many venues  for 
discussion and 
participation 
Ad hoc discussion 










agreements, do not 
reflect practices or are 
in the process of being 
negotiated or 
constructed 
No agreement or 
agreement not 












not meet needs or is 
used inappropriately 











1.5 THE CURRENT STATUS IN INDONESIA  
1.5.1 HEALTH WORKFORCE  
Data on the size of the health workforce was reported by the Ministry of Health in 
Indonesia218 in 2014, with healthcare professionals totalling 891,897 out of a 
population of 253,609,643.219 The distribution of healthcare professionals and the 
ratio per 1000 of the population can be seen in Table 1.12. The table shows that the 
ratio of nurses per 1000 population was the highest compared to other healthcare 
professionals. They were followed by the pharmacists, general practitioners and 
medical specialists. Data from the World Bank in 2008 from other South East Asia 
countries suggested that the ratio of physicians (0.4 per 1000 population) were 
higher than that in Indonesia in 2014.220 An update from the World Bank in 2014 on 
the education and distribution of healthcare professionals in Indonesia showed that 
more qualified healthcare professionals are required and that the healthcare 
professionals need to be distributed equally in the country.221 This suggests that 
reformation in health education and health policy are required.  
 
Table 1.12 Number and ratio of healthcare professionals218 
Healthcare professionals The number of healthcare 
professionals in 2014 
The ratio per 1000 
population 
Medical specialists 38,866 0.15 
General practitioners 42,265 0.17 
Nurses 295,508 1.17 
Pharmacists 46,336 0.18 
Others 422,975 1.67 
 
1.5.2 NATIONAL HEALTH SYSTEM 
The Indonesian health system employs decentralisation on financial support 
between the Central and the Local Governments. 222 The Central Government 
provides rules and guidance to conduct the service. The WHO recommended that a 
strong National Health Information System is required in the decentralisation 
system. 222 The information exchange between Local and Central Government needs 
to be accountable and up to date. Otherwise the system will fail to maintain a 
sustainable quality healthcare service to the community.  
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The decentralisation system influences the level of responsibility of the Local and 
Central Government in the healthcare service. The Local Government is responsible 
to manage their own issues within the provinces, districts, and sub-districts. Each 
sub-district in Indonesia has at least one physician who is responsible for a 
community healthcare service. The sub-district is also supported by sub-centres 
which are led by nurses. Decentralisation may also bring about an impact on human 
resources recruitment (in this instance, healthcare professionals) where the Local 
Government may employ their own district civil servants. The organisational 
structure of the health system in Indonesia from the Local to Central level (from 
bottom to top) can be seen in Figure 1.10. The figure also shows the referral system 
(in brackets) from the Primary Health Centre at the Village level to National Referral 
Hospital at the Central level.  
 
Figure 1.10 The structure of referral, government, and health systems223  
 
A report from the U.S Agency for International Development (USAID) found that the 
private sector play a significant role in the Indonesian healthcare service54 This was 
because the number of private hospitals was higher than public hospitals224 in 
Indonesia and almost half of the Indonesian community visited pharmacies and drug 
stores for self-medication. However, the pharmacies were rarely acknowledged as 
healthcare facilities.54 Data from the USAID showed that the Indonesian community 
has easy access to competitively priced medicine including prescribed medicines, but 
issues of counterfeit medications remain. Anyone can buy medication in pharmacies 
Ministry of Health (Central level - 
National Referral Hospital) 
Provincial health office (Provincial 
level- Provincial Hospital) 
Distric Level Health Office (District 
level - District/Municipal Hospital) 
Sub-district level health centre (Village 
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Sub-Health Centre/Village midwife 












or drug stores without the attendance of pharmacists. Although the Indonesian 
Pharmacy Association (IAI) has had an initiative “no pharmacist no service for 
medication” since 2009, its implementation may take many years. This may result 
from the fact that the IAI has no power in the Indonesian health system. As such, 
there are no penalties if the pharmacies disobeyed this regulation. The USAID data 
indicated that the irrational use of medication in Indonesian practice was largely 
driven by low fees for services to healthcare professionals.54 These facts showed that 
the safe use of medication is an issue in the Indonesian health system.  
 
1.5.3 HEALTH FINANCING SYSTEM  
Data from the World Bank demonstrated that although the Indonesian population 
has little expenditure on medication, it still has a higher proportion of the population 
with out of pocket health expenditure.225, 226 In comparison to other Asian countries, 
Indonesia has the highest proportion of out of pocket expenses for health 
expenditure after the Philippines. This high proportion may due to the fact that the 
World Bank collected the data in 2010 when health insurance was not well 
implemented in Indonesia. Recent changes in this area may however mean that the 
out of pocket health expenditure by the Indonesian population may change in the 
future. Jaminan Kesehatan Masyarakat (Jaskesmas), Jaminan Kesehatan Daerah 
(Jamkesda), Asuransi Kesehatan (Askes), Tabungan dan Asuransi Pensiun (Taspen), 
Jaminan Sosial Tenaga Kerja (Jamsostek) and private health insurers are existing 
health insurances available in Indonesia.227 The Indonesian Government has initiated 
the adaptation of the National Social Security System (SJSN- Sistem Jaminan 
Kesehatan Nasional). The system is mandatory to all Indonesian citizens and it is 
managed by the Social Security Administration Agency (Badan Penyelenggara 
Jaminan Sosial Kesehatan-BPJS Kesehatan) since 1 January 2014. All Indonesian 
citizens are expected to be covered by the insurance through a continuing program 
and partnership with the existing health insurers by 2019.  
 
1.5.4 THE JOINT ACCREDITATION IN INDONESIAN HEALTH 
EDUCATION 
The Indonesian Accreditation Agency for Higher Education in Health (IAAHEH) was 
established in 2014 as a commitment of the Indonesian Government to improve the 
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quality of health education in the country.228 The IAAHEH is an independent 
accreditation agency which aims to ensure the quality of education and that 
healthcare graduates meet the national standard for higher education (Standar 
Nasional Pendidikan Tinggi). The vision and mission of the agency are to ensure a 
trustworthy and sustainable standard of quality of health education.  
 
This joint accreditation consists of seven health education institutions and their 
professional organisations including those of physicians (AIPKI- Asosiasi Institusi 
Pendidikan Kedokteran Indonesia and IDI-Ikatan Dokter Indonesia), nurses (AIPNI- 
Asosiasi Institusi Pendidikan Ners Indonesia and PPNI- Persatuan Perawat Nasional 
Indonesia), midwifes (AIPKI- Asosiasi Pendidikan Kebidanan Indonesia and IBI- Ikatan 
Bidan Indonesia), pharmacists (APTFI- Asosiasi Pendidikan Farmasi Indonesia and IAI-
Ikatan Apoteker Indonesia), dentists (AFDOKGI- Asosiasi Fakultas Kedokteran Gigi 
Indonesia and PDGI- Persatuan Dokter Gigi Indonesia), public health (AIPTKMI- 
Asosiasi Institusi Pendidikan Tinggi Kesehatan Masyarakat Indonesia and IAKMI- 
Ikatan Ahli Kesehatan Masyarakat), and nutritionists (AIPGI- Asosiasi Institusi 
Pendidikan Gizi Indonesia and PERSAGI- Persatuan Ahli Gizi Indonesia). The role of 
IAAHEH is to facilitate the standard criteria and the standard assessment of 
interprofessionalism within healthcare professions and to facilitate integration of 
interprofessionalism in accreditation. At the time of writing of this thesis, the 
accreditation was under development and being piloted in a number of universities 
in Indonesia.  
 
1.5.5 THE ROLE OF PHARMACISTS IN PATIENT CARE IN 
INDONESIA  
Generally speaking, the role of pharmacists in patient care in Indonesia is very similar 
to that in other developing countries, which can be best described as unclear. The 
lack of a defined role for pharmacists in patient care in developing countries is 
reflected in the fact that the majority of pharmacists are business oriented. This 
often results in pharmacists being seen as people who sell products, rather than 
healthcare professionals who provide patient care. It is this recognition that 
pharmacists contribute to patient care which is essential to allow pharmacists to take 




As opposed to Pakistan,169 the Indonesian Government has supported the role of 
pharmacists in patient care in hospital and community settings through 
regulations229, 230 and policy.51 The Ministry of Health Decree No 889 in 2011 
regulates administrative requirements of the role of pharmacists as care providers.231 
Consequently, all Indonesian pharmacists who work in the community, hospital and 
industry must have a license as a pharmacist to ensure the best quality of pharmacy 
services is provided. In the hospital setting, the Directorate General of Pharmacy and 
Supply Medicine created guidelines for pharmacists’ ward visits.52 The guidelines 
provide the standard of practice of joint and independent pharmacist’s visits to the 
ward. In particular to the role of pharmacist in medication safety, the Indonesian 
Health Department232 released guidelines for pharmacists on the responsibility and 
activities involved in ensuring the safe use of medication in the hospital setting. The 
Ministry of Health Decree No 58 in 2014 on the standard of pharmaceutical care in 
the hospital setting regulates the ratio of pharmacists and patients should be 1 to 30 
for inpatients and 1 to 50 for outpatients.230 This ratio should allow pharmacists to 
provide pharmaceutical care within the hospital setting. Those regulations indicate 
that Indonesian Government supports the expansion of the role of pharmacists as 
healthcare providers particularly in ensuring the safe use of medication. 
 
Despite the fact the Indonesian Government supports the role of pharmacists, there 
are limited data on the role of pharmacists in patient care in Indonesian practice.55, 
175 Tan and Aslam reported that the role of pharmacists in 2000 was similar to that in 
England in the 1960s.233 They also found that the resistance to the role of the 
pharmacist in patient care came not only from other healthcare professionals but 
also from pharmacists. Tan and Aslam suggested that the Indonesian Pharmacists 
Association (IAI-Ikatan Apoteker Indonesia) does not have significant authority with 
the Indonesian Government as does the Royal Pharmaceutical Society of the Great 
Britain. The powers of the IAI are limited and depend upon the policy in each 
province. As discussed in Section 1.3.1, the pharmacists’ internal and external factors 
were reported to influence the role of pharmacist in patient care in Indonesian 
practice.55, 56  
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1.6 REVIEW OF STUDY METHODS  
1.6.1 MIXED METHODS 
The present study adopted mixed methods which have been used widely in the last 
decades234 to answer similar types of questions as set out in the aims. Other 
researchers prefer to use integrated design instead of mixed methods design. The 
integration is not only at the final outcomes but also during the process of research 
and the sources used. 235 One of objections to the use of combined research methods 
is the different epistemology of qualitative and quantitative approaches, and the 
validity of the mixed method approach.236 However, if both approaches have similar 
aims in understanding of the object under investigation then mixed methods 
approach is applicable.236 Although validity of mixed methods approach remains 
controversial, Creswell and Clark contended that validity of mixed method study 
could be acquired by improving the strategies during data collection, data analysis 
and interpretation of the data.234 They suggested that the investigator must take into 
consideration factors which might impede the validity of research activities. Errors 
during data collection might result from inappropriate sized samples and wrong 
sample selection, and techniques during data collection. Biased methods of analysis 
and different interpretation of themes in the qualitative approach may cause flaws in 
the data analysis process. Interpretation errors may occur when the investigator fails 
to relate the results to the research questions and inability to relate one result to 
others.  
 
Mixed methods approach is employed for a number of reasons.234, 235 Firstly, one 
data source is insufficient to answer the research questions. This is because each 
quantitative and qualitative data set has its own limitations. Quantitative data 
retrieves information from big numbers of participants, while qualitative data 
explores information intensively from individuals. Contradictive results may come up 
with both qualitative and quantitative approaches. This contradiction might not be 
captured if only one method of design is employed. Secondly, the mixed method 
approach is adopted for exploratory purposes. Qualitative studies may need to be 
implemented before a quantitative study. For instance, the investigator needs to find 
out the topics revealed from qualitative research before using a quantitative study 
for further exploration to understand the issues. Thirdly, the investigator might 
adopt a mixed method approach to comprehend complex problems using different 
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study designs. The design can be conducted sequentially or concurrently to answer 
the research questions. The investigator needs to use different strategies to improve 
validity of methods being used and to discuss any limitations of the study designs.234, 
236 If the investigator continuously adopts this in their research, combining these two 
methods remains acceptable. Mixed methods approach was employed in the present 
study because various study designs were required to answer the research questions 
posed. 
 
1.6.2 REVIEW OF QUALITATIVE METHODS 
The trend of data gathering and analysis in health sciences has shifted to qualitative 
study. In a positivisms’ point of views, qualitative studies have a lack of reliability and 
validity because the nature of the study is to understand human experience.237 The 
experiences tend to be subjective in themselves. However, Guba and Shenton 
proposed trustworthiness of qualitative studies may be acquired from credibility, 
transferability, dependability, and conformability.238,237 Patton239 stated that the 
credibility of qualitative study can be improved by understanding the philosophy of 
qualitative study which is naturalistic inquiry, inductive analysis, purposeful sampling 
and holistic thinking. Shenton suggested credibility is equal to internal validity in 
quantitative research.198 Some techniques to ensure credibility of qualitative studies 
consist of having the results of the interview checked by the interviewee (member 
check), describing the phenomena under study thoroughly, regular debriefing 
sessions, and adopting triangulation in the research study. Transferability in 
qualitative study can be achieved by providing thick description of the study.237, 238 
Information such as the number of organisations who participated in the study; 
participants involved in the fieldwork, data collection design, the length and the time 
of the study undertaken should be reported. This allows readers who have similar 
settings to relate the results of the study to their current settings. Dependability is 
equal to reliability in the quantitative study. The investigator should report the 
process of the study in detail. The process details include research design and its 
implementation, step by step detail of the study and evaluation of the process of 
data collection, so that others who aim to conduct similar studies could obtain 




Despite the fact a qualitative approach is costly, time consuming, and requires a 
complex analysis in the process of data analysis, interviews have several advantages 
compared to questionnaires.240 By nature, a one on one interview allows the 
interviewer to ask many open-ended questions, improve response rate, and the 
interviewer has more time to comprehend the interviewee’s opinion on the topic 
discussed. In contrast, questionnaires have limited space to obtain the participant’s 
opinion. In comparison to interviews, focus group discussions (FGDs) allow the 
investigator to explore the opinion from a small number of participants.241 Further, 
the investigator may capture responses from a group of participants at once and 
report the group interaction in the discussion.241, 242 In the present study, both 
interviews and FGDs were employed to capture data from different sources.  
 
1.6.2.1 Questions in interviews  
Patton pointed out that there are four types of interviews.239 The interviews can be i) 
informal, ii) guided (semi-structured), iii) standardised open-ended and iv) 
standardised close-ended. In the present study, the interviews were designed using a 
semi-structured approach because in this type of interview, topics can be outlined in 
advance and the interviewer can decide the sequence during interviews. Although 
the flexibility of the sequence and wording may result in different responses from 
different participants, it allows systematic, conversational and situational approaches 
with the different interviewees. Open-ended questions were used to provide more 
vigorous responses. The question asked during the interview may include 
experience/behaviour, opinion/values, feelings, knowledge, senses, and 
background/demographic characteristics. These questions are very effective in 
obtaining comprehensiveness on the topic of the interviews. Singular and clear 
questions are essential to eliminate confusion amongst interviewees. 
 
1.6.2.2 Analysis of qualitative study  
Phenomenology and hermeneutic are two methodologies commonly employed in 
qualitative studies. Phenomenology was introduced by Husserl to purely understand 
the world through intentionality and essence of phenomena.243 Laverty argued that 
phenomenology does not take into consideration participants’ pre-understanding to 
the process of understanding the phenomena.243 Hermeneutics methodology refers 
66 
 
to interpretation of human being experience which is influenced by historical and 
cultural backgrounds.244 There is no absolute truth of interpretation because the aim 
of interpreting lived experience is to search for possible meaning of phenomena.245 
In this study, hermeneutics methodology was employed to interpret the meaning of 
participants’ opinion and experiences during interviews and discussions. 
 
Hermeneutics methodology uses ‘thick description’, ‘paradigm cases’, ‘exemplar’ and 
‘thematic analysis’ to understand the meaning of human experiences.246 Braun and 
Clarke247 recommended thematic analysis in qualitative study because it is flexible 
and accessible in the analysis of qualitative study. There are two approaches in 
thematic analysis, inductive (bottom up) and deductive (top down) approaches. The 
inductive approach is organised based on open coding and categories in the analysis, 
meanwhile, a deductive approach employs a categorisation matrix in the analysis 
based on categories extracted from theories or literature.248 Grounded theory is an 
example of a bottom up approach in which the analysis is data driven. While in top 
down approach, it is derived from researchers’ theoretical or analytical interest. In 
support of Braun and Clarke’s recommendations, Bazeley249 stated that in qualitative 
data analysis, thorough thematic analysis, continuous activities of describing, 
comparing and relating one theme to others is recommended to support deeper 
analysis of the data.  
 
Braun and Clarke described the six steps in thematic analysis247 as the following; the 
investigator gets used to the data; creating preliminary codes where one sentence 
may be classified into several codes to obtain the widest possible perspectives of the 
issue being studied; themes exploration which involves constructing several codes in 
to themes by finding similarities, differences or relationships in the themes; 
assessment of themes which involves reviewing themes and refining themes; state 
and label the themes; and reporting the results. Qualitative study is not free from 
pitfalls.247 Errors in data analysis, utilising the research questions as themes, 
unconvincing analysis, and no correlation between data or theory and the analysis 




1.6.3 REVIEW OF QUANTITATIVE METHODS 
1.6.3.1 Validity and reliability of case vignettes  
There are four types of validity (i.e. content, face, construct, and criterion validity).250, 
251 Content validity should be done to ensure the content meet the objectives of the 
study. Face validity reviews the appearance of the survey to determine whether the 
survey is reader friendly and asks the appropriate questions. Content and face 
validity can be obtained from expert panels. Criterion validity is used to predict the 
likelihood of future occurrence in a population. Construct validity is used to 
demonstrate the difference between participants (respondents) using convergent 
and discriminant validity.251  
 
Considine stated that the concept of reliability is related to consistency, stability, 
internal consistency and equivalency of the measurement.250 There are several 
factors which may violate reliability of case studies. These include item sampling, 
construction of the items, test administration, scoring objectivity, item difficulties 
and participant factors.252 Item sampling error can be minimised by using more items 
(questions). Errors in item construction might result from ambiguity of wording or 
tricky questions. Problems relating to the difficulty of tests may result from the 
questions being too easy or too hard for the participants.  
 
Case vignettes used in the present study were designed as multiple choice questions 
(MCQs) on medication errors to assess the understanding of healthcare professionals 
of the root cause of medication errors. Collin suggested that if items in the MCQs are 
answered correctly by 50-75% participants, it means that MCQs are of moderate 
difficulty.253 According to Wichman,113 to determine system-based causes of errors, 
root cause analysis may be employed to identify ‘what happened, why it happened, 
and what can be done to reduce the likelihood of a recurrence. Consequently, the 
MCQs of the medication errors case vignettes of the present study were created 
based on those questions. Oppenheim pointed out that the questionnaire should 
follow some basic rules: the length of questions should not be more than 20 words, 
avoid double barrelled questions, avoid proverbs, beware of leading questions, avoid 




1.6.3.2 Questionnaires translation and validity  
Translating a survey from English to a non-English language may raise concerns of 
validity of the translated version. In assessing the validity and reliability of translated 
questionnaires one needs to consider the epidemiological and cultural differences of 
the languages.254, 255 This is because in a translation survey, factors such as content, 
conceptual, semantic, and technical differences may influence the equivalence of the 
translated version compared to the English version. Hunt and Bhopal pointed out 
that conducting translation and back translation of the translated surveys may be 
necessary but it is not always sufficient256 and required extensive time and monetary 
funds.257 In order to ensure validity of the translated version, it is suggested the 
translated version is validated for its face, content, construct and criterion validity in 
the second language.254, 256, 257 Dale stated that piloting the translated survey to a 
group of potential participants to find out their understanding on the translated 
version is considered sufficient.254 Hunt and Bhopal also highlighted that emphasising 
the similarity of the concepts instead of items equivalence was one of approaches to 
ensure validity of the translation version.256   
 
1.6.3.3 Factor analysis  
DiStefano et al. stated that factor scores could be analysed using non-refined and 
refined analysis.258 The non-refined method involves all scores of each positive item 
being added while the negative responses were deducted from the total positive 
scores. Negative responses may also be reverse-coded to have the same agreement 
as that in positive responses and adding them to the total positive scores.259 The 
refined method was conducted by comparing the attitudes of participants towards 
sub-scales retrieved from the factor analysis. The scores of each sub-scale amongst 
groups were then compared based on its mean regression factor scores.  
 
Explanatory Factor Analysis (EFA) and Principle Component Analysis (PCA) may be 
employed in the factor analysis. PCA is a unique mathematical solution analysis to 
explore components of a survey, whereas EFA is not.242 Each item is scored based on 
their loading on its components and can be treated as a new variable (refined 
analysis) in PCA. This variable is standardised automatically in SPSS software based 




In the present study, to determine the best factor structure of the modified RIPLS 
survey in the study population, Principle Component Analysis (PCA) and 
Confirmatory Factor Analysis (CFA) were employed. These analyses were run in SPSS 
Windows and AMOS Version 22.0.260 PCA was conducted to determine the latent 
variables in the data set.258 CFA was conducted to determine if the current data 
fitted in the model of the RIPLS from an established questionnaire.66, 261 CFA is a 
sophisticated analysis because factors are selected based on theory or pre-existing 
knowledge. Correlations of factors were assessed based on the p-value of covariance 
in the estimates column. If the p-value was <0.05, there is a correlation between the 
factors. CFA relies upon several statistical tests to assess the adequacy of model fit to 
the data. The model fit in CFA was assessed using several indices which include the 
Chi-square (χ²) statistic, the Tucker Lewis index (TLI), the comparative fit index (CFI) 
and the root mean square error of approximation (RMSEA).262 Chi-square test shows 
the differences between expected and observed covariance matrices. If the value is 
close to zero, it shows little different when the probability is higher than 0.05. CFI 
indicates the discrepancy function adjusted for sample size. TLI gives resolution to 
negative bias of discrepancy between Chi-square values of the hypothesised model 
and the value of null model. CFI and TLI values higher than 0.9 shows acceptable 
model fit. RMSEA is related to residuals in the model. In this case a value less than 
0.06 shows better model fit.263  
1.7 SUMMARY OF REVIEW FINDINGS 
The present review provides discussion on the importance of IPP amongst healthcare 
professionals in the provision of healthcare services. Evidence shows that IPP as a 
means of improving medication safety which requires interprofessionalism and IPP 
can be developed through IPE. Medication errors may occur in every stage of the 
medication delivery process and all healthcare professionals may contribute to these 
errors. Pharmacists have a significant role to play in ensuring the safe use of 
medication during the medication delivery process. However, in Indonesia the role of 
pharmacists in patient care is yet to be established. As outlined in the literature, 
there are a number of factors which may influence the implementation of IPE and 
the expansion of the role of pharmacists in patient care. Thus, a study to assess the 
feasibility of the role of pharmacists to improve medication safety as well as the 
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feasibility of the implementation of IPE and IPP involving pharmacists in Indonesia is 




CHAPTER 2 RESEARCH QUESTIONS, AIMS, AND 
SIGNIFICANCE OF THE STUDY 
2.1 RESEARCH QUESTIONS AND AIMS  
This study sought to investigate the feasibility of expanding the role of pharmacists in 
patient care in an Indonesian setting to ensure the safe use of medication through 
the implementation of Interprofessional Education (IPE) and Interprofessional 
Practice (IPP). To do this the following three research questions and aims were 
addressed: 
 
1. Is it feasible to expand the role of pharmacists in patient care to ensure 
medication safety? 
In order to fully address this research question, the following topics were 
investigated: 
1.1 The preparedness of pharmacy graduates to deliver patient care,  
1.2 The appropriateness of clinical review conducted by a hospital pharmacist 
as a means of identifying medication errors in Indonesian hospitals, 
1.3 Stakeholders’, healthcare professionals’ and pharmacy graduates’ attitudes 
towards the role of pharmacists in patient care.  
 
2. Is the introduction of IPE feasible in an Indonesian university? 
In order to fully address this research question, the following topics were 
investigated: 
2.1 The attitudes of medical, nursing and pharmacy students towards IPE, 
2.2 The influence of interprofessional learning (IPL) activities on medical, 
nursing and pharmacy students’ attitudes toward IPE,  




3. Is the introduction of IPP focused on medication safety feasible within an 
Indonesian teaching hospital? 
In order to fully address this research question, the following topics were 
investigated: 
3.1 Healthcare professionals’ attitudes towards IPP, 
3.2 Healthcare professionals’ understanding of medication errors and the 
attitudes towards professionals responsible for and factors contributing to 
the errors,  
3.3 Stakeholders’ and healthcare professionals’ support towards the 
implementation of IPP.  
2.2 HYPOTHESES 
The following were hypotheses of the current study: 
1. Male and female pharmacy graduates have no significant difference in 
terms of perceived attainment of all the attributes required to deliver 
patient care 
2. Pharmacists conducting clinical review have no means of identifying 
medication errors in Indonesian hospitals  
3. Stakeholders’, healthcare professionals’ and pharmacy graduates would 
not be supportive towards the role of pharmacists in patient care 
4. Medical, nursing and pharmacy students have no significant difference in 
attitudes towards IPE and there will be no significant differences in 
attitudes towards IPE as they progressed through their degrees 
5. Interprofessional Learning (IPL) activities would not have an influence on 
medical, nursing and pharmacy students’ attitudes towards IPE 
6. Stakeholders would not be supportive towards IPE 
7. Healthcare professionals regardless of place of work and profession would 
have no significant difference in attitudes towards IPP 
8. Physicians, nurses and pharmacists would have no significant difference 
regarding their evaluation of the medication error case vignettes and no 
significant difference in respect to which healthcare professionals are 
responsible for and the factors that contributed to the medication errors 
9. Stakeholders’ and healthcare professionals’ would not support IPP 
implementation at the study hospital. 
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2.3 SIGNIFICANCE OF THE STUDY 
To ensure medication safety, healthcare professionals need to work in a 
collaborative environment. This includes understanding the role and contribution 
that each professional can provide to ensure their practice reduces errors. 
Medication errors may lead to significant morbidity and mortality, and they are 
costly to the health system. This study provides information that is crucial to 
determining whether IPE needs to be incorporated into the undergraduate 
curriculum to promote effective IPP in the future. Further, through a pharmacist 
conducting clinical pharmacy services evidence of the role of the pharmacist in 
patient care through detecting and intercepting medication errors in an Indonesian 
hospital practice setting. This study provides recommendations on how pharmacists 
should be involved in improving the safe use of medication in Indonesian hospital 
practice and how this may be facilitated through IPE. These recommendations 





CHAPTER 3 RESEARCH METHODS 
 
The current study was conducted at a university and a public hospital in Denpasar, 
Bali Indonesia. The research gained approval from the Curtin University HREC 
Approval Number HR175/2011 (Appendix 1) and from the study hospital and 
university Ethics Committee Approval Number 64/UN.14.2/Litbang/II/2012 
(Appendix 2) and Research and Development Department Approval Number 
LB.02.01/II.C5.D11/4008a/2012 (Appendix 3).  
 
There were five phases of data collection, which employed both qualitative and 
quantitative approaches. The phases are explained in Sections 3.1 to 3.5.  
3.1 PHASE 1 DEVELOPMENT, VALIDATION AND 
TRANSLATION OF QUESTIONNAIRES 
 
The first phase of the present study had four stages which are outlined in the 
following sections. This phase consisted of the development of case vignettes, and 
validation and translation of questionnaires used in the study. The case vignettes 
were developed based on common clinical problems seen in the Indonesian practice 
setting. Established questionnaires to determine readiness of healthcare students 
and healthcare professionals towards interprofessional education and 
interprofessional practice and pharmacy graduates’ preparedness as care providers 
were employed. The questionnaires were translated and validated prior to data 
collection.  
3.1.1 DEVELOPMENT OF CASE VIGNETTES  
Case vignettes were created on medication errors as the focus of medication safety 
in the present study. These case vignettes aimed to gain an understanding of 
healthcare professionals’ knowledge of medication errors and their perception 
towards professions who are responsible for the errors. The vignettes were created 
based on common cases in practice in Indonesia. The questions for each of the cases 
were generated based on root cause analysis as recommended by the Canadian 
Patient Safety Institute.20 The questions developed included: Why the error 
occurred?; How to prevent it from occurring again?; and The level of severity of the 
75 
 
error?. The other questions sought the opinion of healthcare professionals on the 
profession (s) who was responsible for the error and on the type of medication error 
presented in each case.  
 
The development of the case vignettes involved two iterations. The first series of six 
case vignettes were reviewed by five physicians, five nurses and five pharmacists. 
The results from the piloting of the case vignettes revealed that physicians felt that 
the cases were too specific. It was suggested that the cases might not be applicable 
to general practitioners, even though the cases were to be administered to 
physicians at the study hospital. They suggested cases should be on common 
diseases. Pharmacists who participated in pilot study also stated that they needed to 
read the cases twice or three times before they could answer the questions. Nurses 
who participated in the pilot found that the cases were too hard to understand and 
they needed to read them twice or three times to answer the questions. The 
participants of the pilot also identified that they did not understand medication 
errors. For this reason, the primary investigator created a one page information 
sheet on medication errors for the participants (Appendix 4d).  
 
Based on the above feedback the case vignettes were redesigned to include more 
common diseases which may be seen in practice (as a second series of case 
vignettes). The cases were modified to include common disorders such as gastritis, 
pain, and adverse reactions, so to be relevant to a wider population. The second 
series were then piloted. The content validity was achieved by designing questions 
which assessed the respondents’ knowledge of medication errors. Content and face 
validity of the case vignettes employed in the current study were validated by two 
clinical pharmacy academics at Curtin University. Construct validity of the case 
vignettes was assessed from item difficulty of the case vignettes. Collins suggested 
that 50-75% participants should provide the anticipated correct answers.253  
3.1.2 QUESTIONNAIRES TRANSLATION AND VALIDITY  
Established questionnaires used in the literature were employed in the present 
study. The questionnaires were the Readiness for Interprofessional Learning Scale 
(RIPLS) for healthcare students modified from Curtin University, Perth, Western 
Australia,264 the RIPLS for healthcare professionals,261 and the validated Pharmacy 
Graduate Questionnaire from the Faculty of Pharmacy, Nova Southeastern 
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University, Florida, USA to evaluate graduates’ self-perceived ability to provide 
patient care.265 The study was conducted in Indonesia, thus those questionnaires 
were translated into Bahasa Indonesian which is the delivery language in the 
country. The accuracy of translation of the translated version of questionnaires 
employed in the present study was obtained from an independent academic who 
speaks both English and Bahasa Indonesia (Appendix 6). Piloting the questionnaires 
to potential participants as suggested by Dale was also conducted to obtain 
contextual meaning of the translated questionnaire.254 The questionnaires were then 
adjusted based on feedback obtained from participants of the pilots. Translated 
questionnaires were not translated back to English due to time limitations.  
 
3.1.2.1 Piloting of the graduates questionnaire 
Piloting the translated graduates’ questionnaire as care providers (Appendix 11b) 
was conducted in 10 pharmacy graduates from the study university. Graduates were 
contacted by the primary investigator via their mobile phone or email. The graduates 
who participated in the pilot found that the questionnaire could be completed in 10 
minutes. The graduates also pointed out the attribute related to “motivation” 
required explanation. Thus, the primary investigator amended the attribute of 
motivation as “motivation in providing patient care” in the questionnaire.  
 
3.1.2.2 Piloting of the RIPLS questionnaire to healthcare 
students 
The RIPLS questionnaire was adopted in the present study because it has been 
widely used in evaluating attitudes towards IPE in different courses of studies across 
a range of healthcare students including medical, nursing and pharmacy students.266 
In addition, there had not been any IPE learning activity in the study university prior 
to this study being undertaken. Employing the RIPLS questionnaire was therefore 
appropriate. The RIPLS questionnaire employed in the present study had 17 
statements which were adopted from a validated RIPLS questionnaire used at Curtin 
University, Perth, Western Australia.264 These statements were selected because 
they were considered to be more relevant for medical, nursing and pharmacy 
students. Each statement was scored using a Likert scale from 1 (strongly agree) to 4 




3.1.2.3 Piloting of the RIPLS questionnaire and case 
vignettes to healthcare professionals 
The primary investigator piloted the RIPLS questionnaire with five pharmacy 
lecturers, five physicians, five nurses, and five hospital pharmacists. All of them were 
able to understand the statements in the survey and answer the survey in around 10 
minutes. During piloting of the questionnaire, two participants suggested to add the 
year of graduation in the participants’ demographic characteristics because some 
participants might not work as practitioners as soon as they graduated (See 
Appendix 9b). They also suggested for the RIPLS survey to provide options for 
background education apart from their current profession such as Masters/PhD, 
specialisation or sub-specialisation in a certain area of medicine.  
 
The second series of six medication error case vignettes were piloted to three 
physicians, four nurses and three pharmacists at the hospital and three pharmacy 
academics. The medication error case vignettes (Appendix 4b) were provided with a 
one page information sheet on medication errors (Appendix 4d). The participants’ 
responses to the case vignettes in the pilot test can be seen in Table 3.1. The table 
shows that Pharmacy respondents were the most accurate in answering the case 
vignettes questions. Reliability was unable to be gathered because of the nature of 





Table 3. 1 The percentage of anticipated correct answers for piloting of the second set of 
questions.  
 
3.1.3 FACTOR ANALYSIS OF RIPLS QUESTIONNAIRES 
The RIPLS questionnaires for healthcare students and healthcare professionals 
employed in the present study were analysed to determine whether the 
questionnaires had the same sub-scales as that of the established questionnaires.66, 
261 Principle Component Analysis (PCA) and Confirmatory Factor Analysis (CFA) were 
adopted to determine the sub-scales of the questionnaires. A review of PCA and CFA 
can be seen in Section 1.6.3.3 
3.2 PHASE 2 ADMINISTRATION OF QUESTIONNAIRES 
This phase consisted of administration of questionnaires to pharmacy graduates, 
healthcare students, and healthcare professionals. The pharmacy graduates from the 
study university were selected to determine their preparedness as care providers 
after completing their pharmacy education at the study university. Year 1 to Year 4 
medical, pharmacy and nurse students of the study university were surveyed to 
assess healthcare students’ readiness to participate in interprofessional education. 
Physicians, nurses and pharmacists of the study hospital and academics of medical, 
nursing, and pharmacy schools of the study university were recruited to determine 
their readiness to participate in  interprofessional practice.  
Participants (N = 13) Number of 
correct answers 
(N=30) 
% of anticipated 
correct answers 
Pharmacy academic 23 76.7 
Pharmacist at the hospital 22 73.3 
Pharmacy academic 20 66.7 
Pharmacy academic 20 66.7 
Physician 19 63.4 
Physician      17 56.7 
Pharmacist at the hospital 17 56.7 
Pharmacist at the hospital 16 53.3 
Nurse at the hospital 16 53.3 
Nurse at the hospital 16 53.3 
Nurse at the hospital 13 43.3 
Physician 12 40.0 
Nurse at the hospital 12 40.0 
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3.2.1 THE ADMINISTRATION OF GRADUATES 
QUESTIONNAIRE AS CARE PROVIDERS 
 
3.2.1.1 The administration of graduates questionnaire 
The primary investigator retrieved contact details of registered pharmacists (former 
pharmacy graduates) from the Pharmacy Department in the study university. The 
primary investigator sent the questionnaire package via email to the registered 
pharmacists. The package included graduates questionnaire (Appendix 11b), an 
invitation letter (Appendix 12b), and participant information sheet (Appendix 12d). 
This was sent to the 104 registered pharmacists. The primary investigator 
recommended that those who had participated in the pilot study should not return 
the questionnaire. After one week, the primary investigator sent a reminder to all 
the registered pharmacists. A second reminder was sent one week later. The 
registered pharmacists’ responses were classified as “registered pharmacist group” 
in the present study. 
 
Due to a poor response rate from the registered pharmacist group, the pharmacy 
interns were invited to participate in the study. The primary investigator attended a 
meeting with the interns two weeks prior to their final examination when the 
students had finished all their internship courses to become a pharmacist. The 
primary investigator invited the pharmacy interns in the meeting and administered 
the graduate questionnaire to the interns. These participants were classified as 
“pharmacy interns group” in the present study.  
3.2.1.2 Analysis of pharmacy graduate questionnaire 
The responses of the pharmacy graduates on attributes in delivering patient care and 
their desirability to have those attributes were analysed descriptively. The responses 
were compared based on gender. Data were analysed using SPSS Window version 
22.0. Open-ended questions of the questionnaire were analysed using an inductive 




3.2.2 THE ADMINISTRATION OF THE RIPLS QUESTIONNAIRE 
FOR HEALTHCARE STUDENTS 
The primary investigator piloted the RIPLS questionnaire English version (Appendix 
7a) to 10 International Medical students and the translated the RIPLS questionnaire 
(Appendix 7b) to 10 Pharmacy students, 10 Nursing students and 10 Regular Medical 
students. Around 20% of medical students at the study university were International 
students. The students who participated in the pilot found that they understood the 
questionnaire and were able to answer the questionnaire within less than 10 
minutes. Some students stated they were not sure of the question whether they had 
previous interprofessional education. The primary investigator explained whether 
the students have had any kind of training or workshops which were conducted with 
other healthcare students. They suggested adding explanatory information on 
workshops or training for the question. The questionnaire was adjusted accordingly. 
 
3.2.2.1 The administration of RIPLS questionnaire in Survey 
Year 2012 
The primary investigator contacted each schools’ administrator to obtain the names 
of the students from each year and to find out their timetable prior to administration 
of the questionnaire. Three hundred and thirty two nursing students, 270 pharmacy 
students and 870 medical students were enrolled in 2012. This gave a total of 1472 
healthcare students. In order to obtain an estimate of overall support for IPE with a 
precision within 5%, a sample size of at least 385 was needed. In order to mitigate an 
anticipated non-response of 30% a total sample size of 550 was used. A stratified 
sampling strategy was used to ensure representation in the sample across all years in 
all schools. Based on the number of students in each school, the sample sizes were 
306, 95 and 149 for Medicine, Pharmacy and Nursing respectively in order to obtain 
representative sample from each school. Further stratifying of students into four 
equal sized year groups within each school meant there were 77, 24, and 37 in each 
year of each school respectively. The primary investigator selected a random sample 
of the students using a random number generator available online. 
 
The primary investigator invited the selected healthcare students to participate in 
the survey by attending classes, and explaining the aims and nature of the research. 
The primary investigator also explained the information package to the selected 
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students. The package consisted of the RIPLS questionnaire (Appendix 7a/b), an 
invitation letter (Appendix 8a/b), and participant information sheet (Appendix 8c/d). 
Because the study was voluntary, students who were willing to participate were 
asked to complete and return the questionnaire within one week. These activities 
were conducted in every Year of Study for each health course. In some Years of 
Study, the primary investigator enlisted the Year of Study coordinators to collect the 
questionnaires; this was particularly the case for the nursing and medical students. 
The primary investigator administered and collected the questionnaire directly for 
Year 4 medical students because they were about to start their internship.  
3.2.2.2 The administration of RIPLS questionnaire in Survey 
Year 2013 
For this survey year, the primary investigator administered the RIPLS questionnaires 
to medical, pharmacy and nursing students using similar methods as in the Survey 
Year 2012. However, only Year 1, 2 and 3 Cohorts from 2012 were recruited because 
the 2012 Year 4 Cohort had graduated. The healthcare students in these cohorts 
were also randomly selected which meant the healthcare students who participated 
in Survey Year 2012 may or may not necessarily have participated in Survey Year 
2013. A total of 412 students were invited to participate in the survey, consisting of 
231 medical, 111 nursing and 72 pharmacy students.  
3.2.2.3 Analysis of the RIPLS questionnaire to healthcare 
students 
In the present study, non-refined and refined factor analyses as suggested by 
DiStefano et al were adopted.258 The attitudes of healthcare students towards IPE 
were determined based on their responses towards each RIPLS statement, the total 
score of RIPLS (non-refined method) as well as from the sub-scales of factor analysis 
(refined method). Descriptions of these analyses can be found in Section 5.1.3.   
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3.2.3 THE ADMINISTRATION OF THE RIPLS QUESTIONNAIRE 
FOR HEALTHCARE PROFESSIONALS AND CASE VIGNETTES 
 
3.2.3.1 The administration of the RIPLS questionnaire and case 
vignettes for healthcare professionals 
The sample was derived from 320 lecturers (273 medical lecturers, 30 pharmacy 
lecturers, 17 nursing lecturers) and 1107 healthcare professionals from the study 
hospital (206 physicians, 19 pharmacists, and 882 nurses). For the same reasons as 
those in the RIPLS healthcare student group (See Section 3.2.2), the RIPLS 
questionnaire and case vignettes were administered randomly to a total of 550 
participants. The primary investigator conducted stratified random sampling using a 
random number generator available online in order to get proportional 
representation of academics and healthcare professionals at the studied hospital. 
The primary investigator selected 77 medical lecturers, 67 physicians, and 340 nurses 
who worked at the hospital. Because the number of pharmacy academics, nursing 
academics and pharmacists at the hospital was very low, the primary investigator 
invited all 30 pharmacy lecturers, 17 nursing lecturers, and 19 hospital pharmacists.  
 
The primary investigator provided packages which consisted of an invitation letter 
(Appendix 8b); participation information sheet (Appendix 10b); the RIPLS 
questionnaire (Appendix 9b); medication error case vignettes (Appendix 4b); a 
medication error information sheet (Appendix 4d); and an envelope, and asked the 
selected participants to return the questionnaire and case vignettes via the internal 
courier. After one week, the primary investigator sent a reminder to the participants. 
After two months, the primary investigator followed up the participants who had not 
returned the questionnaire by sending them a second questionnaire (consisted of 
the RIPLS questionnaire and case vignettes) and personally collected the 
questionnaire from the participants.  
3.2.3.2  Analysis of health professionals’’ RIPLS questionnaire and 
case vignettes 
Similar analysis was conducted to that of the RIPLS questionnaire to healthcare 
students. Principle Component Analysis (PCA) was used to determine the number of 
factors represented in the questionnaire. SPSS Windows 22.0 was used to undertake 
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this analysis. Confirmatory Factor Analysis (CFA) was used to confirm the factors 
which constructed the questionnaire fitted the model derived from PCA or from the 
established questionnaire found in the literature. Analysis Moment Structures 
(AMOS) and SPSS Windows version 22.0 was employed in the CFA.267 The factors 
from Reid et al. and factors that emerged from PCA were modelled using AMOS to 
justify the fitness of the factors to the study population.  
 
The cases consisted of prescribing (Cases 1 and 2), dispensing (Cases 3 and 4) and 
administration errors (Cases 5 and 6). Each case had five standard multiple choice 
questions and one question seeking participants’ opinions on the profession(s) 
responsible for the error. Each question of the case vignettes had three options 
because three options were as effective as four alternatives to answer the questions. 
Collins suggested that more options results in a longer time to read the 
questionnaire.253 
 
Each of the six medication error case vignettes was viewed by each participant in the 
study, and they gave responses to a set of six questions relating to each one. These 
questions all required a True/False (binary) response. A Logistic regression model 
could be used to analyse each question for each case vignette separately, but the 
results of this large number of analyses may be difficult to interpret. The simpler 
approach was to analyse all the data in a single model, but the model needs to take 
into account the fact that many responses were provided by the same respondent. 
Because of the correlations between these responses, a General Estimating Equation 
(GEE) was used to analyse the data (in preference to a logistic regression model). In 
this model, some adjustment is made for the internal correlations in the dataset. In 
this context, the GEE may be thought of as a ‘repeated measures’ Logistic 
regression.268 
3.3 PHASE 3 CLINICAL PHARMACY SERVICES 
The clinical pharmacy services were conducted on a ward in a public teaching 
hospital in Bali Indonesia to provide evidence of the role of hospital pharmacists in 




3.3.1 STUDY DESIGN AND PATIENT POPULATION 
This was a prospective study conducted in a 13-bed geriatric ward of a public 
teaching hospital, in Bali, Indonesia. The patients recruited into the study were those 
aged > 60 years, who did not have a primary diagnosis of malignancy, were not 
undergoing surgery, or receiving chemotherapy, and who were willing to participate 
in the study. The patients signed a consent form of participation (Appendix 15d) and 
received a participation information sheet (Appendix 16b). The consent was signed 
by the family member if the patient was unable to sign. In the ward where the study 
was undertaken, the protocol for the medication delivery process was as follows: the 
physician was responsible for writing the medications administered in the patients’ 
progress notes, medication charts, and in drug order forms. However, in most 
instances, nurses would transcribe the medications ordered in the patient’s progress 
notes onto medication charts and drug order forms. The drug order form is the 
primary form used to order medication from the Central Pharmacy in the hospital. 
Additional medications required after the physician visits the ward were ordered by 
phone or on a temporary drug order form. The Central Pharmacy dispenses 
medication orders based on the drug order form. The pharmacist on the ward 
dispenses medications in unit dose packaging based on the medication chart. Nurses 
document the administration of oral dosages on the medication chart, and record 
injectable medications in a nurse’s log book. 
 
The present study was conducted over a period of 20 weeks from February through 
July 2013, during which time the primary investigator provided clinical pharmacy ser-
vices to the study ward. It should be noted that such services are not routinely 
provided within the study hospital. 
 
3.3.2 DATA COLLECTION AND MEDICATION ERRORS 
CLASSIFICATION 
The primary investigator undertook training in hospitals in Perth, Western Australia 
and in Jakarta, Indonesia prior to data collection to obtain a clear insight into the 
medication delivery process and the delivery of clinical pharmacy services. 
Medication errors were identified through the delivery of clinical pharmacy services 
(see next paragraph). The error classification system used in the study was modified 
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from a number found in the literature.12, 106, 109, 123, 130-132 The classification was 
adjusted in order to identify as many errors as possible during the medication 
delivery process. In order to justify the validity of the current study’s classification 
system for medication errors, two independent pharmacists checked the accuracy of 
each error identified. 
 
The primary investigator provided clinical pharmacy services including medication 
reconciliation, clinical review, and patient discharge counselling. The primary 
investigator identified prescribing and transcription errors by reviewing patients’ 
progress notes, their medication charts, and nurses’ log books. The primary 
investigator identified dispensing and administration errors by reviewing 
medications dispensed from the Central Pharmacy in the hospital, reviewing 
medication charts, and checking stock levels in patients’ medication drawers. The 
primary investigator also interviewed patients or their carers to identify prescribing 
errors (such as failure to complete patients’ medication histories during admission), 
and to identify administration errors (e.g. whether or not medications had been 
administered as prescribed). In the ward where the study was undertaken, the 
patients were attended by their family members or carer 24 hours a day. Thus, if a 
patient was unable to communicate, the primary investigator obtained informed 
consent and patients’ information on medication use from family members or carers. 
 
Prescribing errors were classified as failures to prescribe regular medications in the 
patient’s progress notes, incomplete patient medication history, and drug not 
prescribed although it was indicated (omission), unclear indication, wrong drug, 
wrong dose, wrong time, illegible hand-writing, medication duplication, unclear 
duration for antibiotic use, and contraindicated medication prescribed. In the study 
ward, the physician had to prescribe on three different documents as described 
previously in Section 3.3.1. This resulted in transcription errors which may or may 
not have resulted in further errors in later steps of the medication delivery process. 
Transcription errors were defined as discrepancies in the medication (drug name, 
dose, frequencies, and dosage form [tablets/capsules/syrups/injections]) written in a 
patient’s progress notes, medication chart or drug order form, or in the nurse’s log 
book. The nurse’s log book was used as the nurse’s record of administering injectable 
medications (including the route, the dose, and the time). 
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Dispensing errors were defined as wrong dose, wrong patient, wrong drug, 
duplication, labelling errors, wrong dosage form (whether capsules or tablets [oral], 
or injections [e.g. intravenous]), wrong quantity, drug omission, and drug dispensed 
although it was not charted on the drug order form. In all cases, dispensing errors 
were identified after the medication had arrived in the ward. Administration errors 
were classified as administering the wrong dose, wrong drug, wrong dosage form 
(tablet, syrup [oral] or injections [intravenous, intramuscular]), duplicated 
medications, following the wrong instructions for drug administration, drug 
omission, drug given not indicated, and documentation errors. Documentation errors 
were further subcategorized into two classifications. These classifications were 
created during the review process because it was found that some doses of 
medication had not been documented although they had been given, while others 
had not been given but were documented as given. 
 
Monitoring errors were identified when monitoring patients’ outcomes had not been 
conducted, or the results of investigations were not available prior to patients being 
discharged. System errors included 1) errors in drug distribution (e.g. three different 
pharmacies used to dispense medications based on patients’ health insurance 
coverage, or stock outages); 2) errors in the health insurance system (e.g. when a 
medication was needed by the patient but it was not covered by their insurance, or 
the number of medications needed exceeded the limit of the patient’s health 
insurance coverage); and 3) technical problems (phone and facilities malfunctions). 
 
The Anatomy and Therapeutic Chemical classification was used to classify the 
medications associated with medication errors.269 In addition, the World Health 
Organisation’s International Classification of Diseases Tenth Revision (ICD 10) 
diagnosis classification was employed to report patients’ diagnoses in this study. 
Potential outcomes of documentation errors were classified based on the study of 
Lisby et al (See Table 1.5).116 
3.3.3. STUDY OUTCOMES AND ANALYSIS 
The primary outcomes of this study were the nature and frequency of medication 
errors detected during the medication delivery process. Simple statistical analyses 
were employed in obtaining frequencies, means, and standard deviations. The 
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primary investigator coded and evaluated each error identified during the activity 
based on stages of the medication delivery process. 
3.4 PHASE 4 WORKSHOP OF INTERPROFESSIONAL 
LEARNING (IPL) ACTIVITY  
The IPL Workshop activity involving final year medical, nursing, and pharmacy 
students of the study university aimed to identify changes of the healthcare 
students’ attitudes towards IPE before and after attending the workshop.   
In July 2012, the primary investigator selected a total of 72 final year medical, 
pharmacy and nursing students from the study university to attend a workshop in 
September 2012 using a random number generator available online. The primary 
investigator attended the classes of final year nursing and pharmacy students at the 
study university and delivered an invitation letter (Appendix 14b) and participation 
information sheet (Appendix 14d) to selected students to take part in the workshop. 
The primary investigator invited the medical students through the Medical Students 
Guild as per the requirement of the Medical Department of the study university. 
Confirmation of students’ participation was obtained within 2 weeks. The primary 
investigator also recruited a coordinator from each school. Two weeks before the 
workshop, the investigator sent a reminder to the students. Further follow up was 
conducted one week before the workshop through the assigned school coordinators. 
The primary investigator invited five facilitators from lecturers at the three schools 
who showed an interest to take part in the project. The facilitators underwent a 
facilitator training in IPL activity using Curtin University’s IPE online module. The 
training of facilitators was conducted to ensure common perceptions of IPE and to 
obtain understanding of how to facilitate a discussion in an IPL activity. The IPL 
activity was selected because the activity allowed the participants to interact actively 
and share their experience while working in a small group.  
 
There were three speakers in the workshop who gave lectures on quality and safety 
in healthcare, root cause analysis, developing interventions, medication safety and 
errors versus violations. The workshop materials were adopted from that of Curtin 
University Interprofessional Learning Workshop module on Medication Safety 
(Appendix 14e). The medication errors case vignettes used in the small group 
discussion were the same as that of the medication error case vignettes 
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administered to healthcare professionals in the present study (Section 3.2.3). On the 
first day, before attending those lectures, the students filled in the pre- workshop 
questionnaire (Appendix 13b). On the second day, the students experienced an IPL 
activity involving small group work which involved students from the three schools. 
In their group, the students discussed a case involving a medication error and 
determined the root cause of the error and devised an intervention to prevent its 
recurrence. The facilitators ensured all students took part in the discussion and 
shared their opinion on dealing with the cases. At the end of the session, the 
students presented the cases to their peers for critiquing and feedback. Finally, the 
students completed the post- workshop questionnaire (Appendix 13d).  
3.4.1 ANALYSIS OF WORKSHOP ACTIVITIES 
The responses of the students in the pre- and post- RIPLS questionnaire were 
compared. A Wilcoxon test was used to analyse the overall attitudes of the 
healthcare students in the pre- and post- questionnaire. Fisher’s Exact Test was 
employed to identify changes of attitudes in the three courses. A statistically 
significant difference was determined to be a p-value of less than 0.05. Open-ended 
question responses from the post-workshop questionnaire were analysed using an 
inductive approach to determine the themes that emerged.  
3.5 PHASE 5 INTERVIEWS AND FOCUS GROUP 
DISCUSSIONS (FGDS) ACTIVITIES  
Qualitative analysis in this study used triangulation where data were collected from 
interviews and FGDs. Participants in the interviews were recruited by purposeful 
sampling. Interviewed participants were the Heads of Medical, Nursing and 
Pharmacy Departments in a public university in Bali, Indonesia and the Director of 
the Hospital and Head of Pharmacy Department at a public hospital in Bali, 
Indonesia. Meanwhile, participants in FGDs were physicians, nurses and pharmacists 
from a public hospital in Bali, Indonesia. In addition, pharmacy interns at a public 
university in Bali, Indonesia were also selected for FGDs. The pharmacy interns were 
invited to participate in the study to obtain their opinion on IPP in the current 
healthcare service and their preparedness to deliver patient care to ensure the safe 
use of medications. Questions asked during interviews and FGDs were developed in 
order to answer the aims of the current study i.e. the feasibility of expanding the role 
89 
 
of pharmacists in patient care in the study hospital; the feasibility of the 
implementation of IPE at the study university and the feasibility of the 
implementation of IPP at the study hospital. The semi structured questions delivered 
in these activities can be seen in Appendix 5. 
 
Interview activities can be seen in Section 3.5.1 and FGDs activities in Section 3.5.2. 
Interviews with Heads of Departments at the university and in the hospital were 
conducted by the primary investigator. FGDs were facilitated by an independent 
facilitator to minimise bias during discussions. Three research questions were used in 
the interviews and FGDs:  
1) Do pharmacists have roles in patient care to ensure the safe use of medication? 
2) Is IPE feasible in the study university? 
3) Is IPP feasible in the study hospital? 
 
Semi-structured questions were developed (Section 3.1.2) as a guide for the 
interviews and FGDs (Appendix 5). This was to ensure consistency in the manner in 
which the primary investigator and facilitator conducted the interviews and FGDs, 
while helping ensure that the interviews and FGDs stayed on topic.  
 
3.5.1 INTERVIEWING THE HEADS OF DEPARTMENT AT THE 
HOSPITAL AND UNIVERSITY 
The primary investigator sent a participation information sheet (Appendix 15b) to all 
participants of interviews. The interviews were conducted during May and June 2012 
and were between 30 to 60 minutes in duration. All participants signed a consent 
form (Appendix 15d).  
3.5.2 CONDUCTING FGDS ACTIVITIES 
Participants in the FGDs were recruited from healthcare professionals at the study 
hospital and pharmacy interns at the study university. There were between six to 
eight participants in each of the FGD. The discussions were conducted during May 
and June 2012, and each lasted between 45 to 80 minutes. All participants also 
signed a consent form (Appendix 15d). 
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3.5.3 ANALYSIS OF QUALITATIVE STUDY  
Data triangulation to reduce the bias of a single source of data collection was 
adopted giving information from a range of participants. All interviews were 
recorded to ensure accuracy during the translation and transcribing processes. The 
interviews were translated and transcribed directly from Bahasa into English by the 
primary investigator to have more understanding in data interpretation. The primary 
investigator found some difficulties at the beginning of the translation and the 
transcription processes because of language differences between Bahasa Indonesian 
and English. This was also experienced by Thoha who also conducted a study in 
Indonesia.270 She suggested using English as a hybrid language and utilising Bahasa 
Indonesia as the nuances of the translation. Therefore, this study adapted the same 
translation and transcription processes. 
 
The translation and transcription were conducted within 48 hours after the 
interviews and FGDs were completed to ensure that important notes taken during 
interviews were not lost. After the primary investigator finished the first draft of 
transcription, the recordings were reviewed again and the transcripts edited to 
ensure that the interviews/discussions were transcribed verbatim. The final step 
involved editing the transcription for grammatical or typographical errors. The 
transcriptions of the semi-structure interviews were provided to the interviewees for 
checking while transcriptions of the FGDs were evaluated by the facilitator to ensure 
reliability of the transcriptions. However, in the process of reporting the results it 
became obvious that some of the participants’ quotes were not easily understood 
when translated from Bahasa Indonesia to English due to differences in language 
structure, i.e. vocabulary and grammar. Thus, the primary investigator has provided 
interpretations to some of the quotes for clarification purposes. These 
interpretations, together with the original quotes are provided in the thesis where 
appropriate. The interpretations appear within a box directly below the original 
quote.  
 
Hermeneutics methodology was adopted in the interviews interpretation.245 The six 
steps of Braun and Clarke’s thematic analysis were implemented in determining the 
themes (Section 1.6.2.2).247 The primary investigator was familiar with the transcripts 
of interviews and FGDs because she translated and transcribed the interviews 
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herself. Coding of all sentences and phrases was conducted for each interview. 
Coding is a procedure where similar sentences and phrases are grouped together 
under similar headings or themes. NVIVO™ software was used in data management 
of themes.271 Assessing, exploring and determining the themes were then conducted 
to justify the themes that were identified from the interview and FGD transcripts. 
Initially, themes were analysed based on the questions asked during each 
interview.266 Then, the themes were sorted and compared across all interview 
transcripts as a whole. This was part of decontextualizing the meaning of the text.245 
Major themes that were identified from the interviews and discussions were sorted, 
compared and integrated with respect to the research questions.266 
 
Frequencies of themes arising from interviews and FGDs were also presented to 
obtain an understanding of the theme distributions and the level of their importance 
with respect to the research questions. The higher the frequency of a theme 






CHAPTER 4 RESULTS AND DISCUSSIONS: THE ROLE OF 
PHARMACISTS IN PATIENT CARE TO IMPROVE 
MEDICATION SAFETY 
 
This chapter consists of two sections. Section 4.1 illustrates the results on pharmacy 
graduates preparedness as care providers (the results of Phase 2 Section 3.2.1). 
Section 4.2 demonstrates the role of pharmacists in medication safety by conducting 
clinical pharmacy services (the results of Phase 3).  
4.1 PHARMACY GRADUATES PERCEPTIONS OF THEIR 
ATTRIBUTES AS CARE PROVIDERS 
4.1.1 DEMOGRAPHIC CHARACTERISTICS OF PHARMACY 
GRADUATES (REGISTERED PHARMACISTS AND PHARMACY 
INTERNS) 
One hundred and four registered pharmacist graduates from the study university 
were invited to participate in the study. However, there only 16 registered 
pharmacists responded. Thus, 45 pharmacy interns were also recruited of whom 40 
completed the survey. Nine of 16 (56.25%) registered pharmacists were female and 
the mean age of the respondents was 24.0 ± 1.0 years. The majority of the pharmacy 
interns (30/40; 75%) were also female; with the mean age of the pharmacy interns 
being 22.4 ± 3.7 years.  
4.1.2 QUANTITATIVE RESULTS 
Pharmacy graduates attributes and their desirability in delivering patient care was 
assessed by administering the validated Nova Southeastern University Pharmacy 
Graduate questionnaire.265 This questionnaire has also been used and validated in 
medical graduates.272  
 
In general, gender did not appear to influence pharmacy interns’ perceptions of their 
acquisition of certain attributes as care providers (Table 4.1). More than 60% of 
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female and male pharmacy interns believed that they had acquired the following 
three attributes required by care providers; namely the ability to listen, had a caring 
and compassionate nature, and had the motivation to provide patient care. In 
addition, a further four patient care attributes were reported to be partially acquired 
by more than 60% of both female and male pharmacy interns. Those attributes were 
the adaptability in a changing environment, capacity for independent learning for 
life, perseverance, and being satisfactory at interpersonal relationships in their 
professional life.  
 
In regards leadership potential, 50% of male pharmacy interns stated that they had 
fully acquired the required leadership potential for patient care compared to only 
6.7% of female pharmacy interns (p=0.004). The majority of female pharmacy interns 
(76.7%) believed they had only partially acquired leadership potential. Different 
proportions of female and male pharmacy interns reported having fully acquired the 
attributes of spirit of curiosity and ability to recognise their own limitation and 
strengths, with the majority of male pharmacy interns believing that they fully 
acquired those attributes. There were similar proportions of female and male 
pharmacy interns who reported that they had fully or partially acquired the open-
mindedness attribute.  
 
Table 4.1 also shows that there were no significant differences between male and 
female participants in terms of their assessment of the desirability of the attributes 
listed in order to deliver patient care. More than 90% of both males and females 
thought that 15 of 16 attributes were desirable to have. A higher proportion of male 
graduates (80%) thought tolerance of ambiguity was desirable compared to female 
graduates (50%, p = 0.001). Yet, the Fisher’s exact test indicated that there was a 
statistically significant difference in male and female pharmacy interns’ beliefs 
around the desirability of tolerance of ambiguity and uncertainty (p<0.001). This is 
interesting given the majority of pharmacy intern males and females perceived they 
had either fully or partially acquired this attribute.  
 
Despite the fact that the number of registered pharmacists who graduated from the 
study university was very small (n=16), data analysis was also conducted. There were 
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more than 60% of registered pharmacists (males and females) who perceived having 
the following 10 attributes required to provide patient care (Table 4.2): ability to 
recognise their own limitations and strengths; ability to listen; ability to work in a 
team; ability in having a caring and compassionate nature; excitement with the 
subject of pharmacy; motivation; open-mindedness; perseverance; satisfaction in 
interprofessional relationships in professional life, and a spirit of curiosity. Similar to 
pharmacy interns, male and female registered pharmacists had no significant 
differences in their perceptions regards the desirability of proposed attributes 
required to deliver patient care (Table 4.2). 
 
Further comparisons using Fisher’s exact test were also conducted on pharmacy 
interns and registered pharmacist’s responses. Table 4.3 shows p-values of perceived 
attainment and desirability of having the attributes amongst pharmacy interns and 
registered pharmacists. There were statistically significant differences found on 
having the attributes amongst both groups. As can be seen in Table 4.3 there were a 
number of attributes where registered pharmacists and pharmacy interns differed in 
their perceptions of having attained the attribute, namely the ability to inspire 
confidence in others, adaptability in changing environment, caring and 
compassionate nature, excitement with the subject of pharmacy, motivation to 
deliver patient care, open-mindedness, perseverance, and satisfactory in 
interprofessional relationships in professional life. These differences generally 
related to registered pharmacists being more confident that they had a particular 
attribute than their pharmacy interns counterparts. For instance, the majority of 
registered pharmacists were satisfied with their interprofessional relationship skills 
(Table 4.2). Meanwhile, most pharmacy interns only partially believed they had 
acquired this attribute (Table 4.1). However, there were not significant differences 
between pharmacy interns and registered pharmacists in regards the desirability of 






Table 4.1 Comparison amongst male (n=10) and female (n=30) pharmacy interns of personal 















Ability to recognise 
own limitations and 
strength  




80.0 20.0 - 100 
Ability to inspire 
confidence in others, 
i.e. patients 




40.0 50.0 10.0 100 
Ability to listen 
F 76.7 23.3 - 
0.653 
100 
M 90.0 10.0 - 100 
Ability to work in a 
team  
F 73.3 26.7 - 
0.136 
100 
M 50.0 40.0 10.0 100 
Adaptability in a 
changing environment 








F 16.7 73.3 10.0 
1.000 
89.3 
M 20.0 70.0 10.0 90.0 
Capacity for self-audit 
  
F 23.3 66.7 10.0 
0.334 
88.9 
M 50.0 50.0 - 100 
Caring and 
compassionate nature 
F 73.3 26.7 - 
0.315 
100 
M 70.0 20.0 10.0 100 
Excitement with the 
subject of pharmacy 
F 70.0 30.0 - 
0.278 
100 
M 50.0 50.0 - 100 
Leadership potential 
  
F 6.7 76.7 16.7 
0.004* 
100 
M 50.0 30.0 10.0 100 
Motivation 
  
F 70.0 26.7 3.3 
1.000 
100 
M 80.0 20.0 - 100 
Open-mindedness 
  
F 46.7 50.0 3.3 
0.794 
100 
M 40.0 60.0 - 100 
Perseverance 
  
F 30.0 60.0 10.0 
0.757 
100 
M 20.0 60.0 20.0 100 
Satisfactory at 
interpersonal 
relationships in your 
professional life 
F 




30.0 60.0 10.0 100 
Spirit of curiosity 
  
F 40.0 60.0 - 
0.148 
100 
M 70.0 30.0 - 100 
Tolerance of ambiguity 
and uncertainty, i.e. 
decision making with 
inadequate data  
F 




20.0 50.0 30.0 80.0 




Table 4.2 Comparison amongst male (n=7) and female registered pharmacists (n=9) of personal 
attributes as care providers and desirability to have the attributes 
  
PERSONAL 







Ability to recognise 
own limitations and 
strength  




85.7 14.3  85.7 
Ability to inspire 
confidence in others, 
i.e. patients 




71.4 14.3 14.3 100 
Ability to listen 
F 100 - - 
0.143 
100 
M 71.4 28.6 - 88.9 
Ability to work in a 
team  
F 100 - - 
0.400 
100 
M 71.4 28.6 - 88.9 
Adaptability in a 
changing environment  








F 55.6 44.4 - 
0.608 
100 
M 28.6 57.1 14.3 100 
Capacity for self-audit 
  
F 44.4 44.4 11.2 
0.776 
100 
M 28.6 71.4 - 100 
Caring and 
compassionate nature 
F 100 - - 
- 
100 
M 100 - - 100 
Excitement with the 
subject of pharmacy 
F 100 - - 
- 
100 
M 100 - - 100 
Leadership potential 
  
F 50 50 - 
- 
100 
M 42.9 42.9 14.3 100 
Motivation 
  
F 100 - - 
- 
100 
M 100 - - 100 
Open-mindedness 
  
F 77.8 22.2 - 
0.486 
100 
M 85.7 14.3 - 100 
Perseverance 
  
F 88.9 11.1 - 
1.000 
100 
M 71.4 28.6 - 100 
Satisfactory at 
interpersonal 
relationships in your 
professional life 
F 
66.7 33.3 - 0.604 100 
M 71.4 28.6 - 100 
Spirit of curiosity 
  
F 77.8 22.2 - 
1.000 
100 
M 71.4 28.6 - 83.3 
Tolerance of ambiguity 
and uncertainty, i.e. 
decision making with 
inadequate data   
F 




42.9 28.6 28.6 80.0 




Table 4.3 P-values of perception of having personal attributes and desirability amongst pharmacy 
interns (n=40) and registered pharmacists (n=16) 
 
 
Notes: † indicated the group had higher proportion of perceived believe of having the 
attribute; * showed significant difference 
  
PERSONAL ATTRIBUTES PHARMACY GRADUATES 
p-value 
PERCEPTION DESIRABILITY 
Ability to recognise own 





Ability to inspire confidence 




0.525 Registered†  




0.283 Registered  




- Registered  





- Registered†  
Capacity for independent 




0.568 Registered  





0.548 Registered  





- Registered†  





























- Registered†  
Satisfactory at interpersonal 












0.273 Registered  
Tolerance of ambiguity and 
uncertainty, i.e. decision 








The open-ended question included in the survey identified other attributes which 
were reported to be developed amongst pharmacy graduates. These attributes 
included communication skills; ability in helping patients with self-medication; being 
independent, patience, honest and hard-working; and gained ability in managerial 
and entrepreneurship skills (see quotes below).  
 
“Patience and solving own problems” (Graduate-07) 
 
“Ability in helping the patients to provide self-medication service” (Graduate-09) 
 
“Ability to manage a community pharmacy in terms of drug management as 





“Being independent, ability to understand own strength and limitation and 
ability to work with in a team” (Graduate -18) 
 
“Ability to communicate with the patients and other healthcare professionals”  
(Graduate-51) 
 
“Working under pressure” (Graduate -54) 
 
 
4.1.3 QUALITATIVE RESULTS 
Qualitative results were obtained from a focus group discussion involving pharmacy 
interns. The discussion was conducted after the questionnaire was delivered. 
Patience in dealing with patients, drug knowledge, communication skills, long life 
learning, and leadership or managerial skills were attributes identified in delivering 
patient care in the focus group discussion. Eight participants of the focus group 
discussion were also participants in the pharmacy graduates survey. Thus, during 
discussion with these students, further clarification was obtained from the 
participants regards the findings on the survey. It was revealed that although they 
agreed the attributes listed in the questionnaire were important in providing patient 
care to the patients, they mentioned that they were not confident enough to 
acknowledge that they had those attributes, although they were to graduate within 
two weeks after the discussion was undertaken. They claimed that the broad content 
of pharmacy subjects and short pharmacy placement exposure were potential 
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reasons for their lack of experience and knowledge during their pharmacy 
undergraduate degree. Comments reflecting this are provided below: 
 
Theme 1: Lack of knowledge 
I also agreed with the others, but most importantly I think it is knowledge 
about pharmacy, without this knowledge, would you think communication with 
patients and others will be effective? (P4-PS) 
 
“Pharmacists should also have the knowledge particularly when they 
communicate with physician with medical specialists” (P6-PS) 
 
“In my opinion, I think my knowledge on medication is very insufficient… 
Because during our learning in pharmacy at this university, the area of learning 
is very broad. It’s not specific. I think it would be better, if the knowledge on 
medication will be specific. In certain kind of medication…I will be more 
confident. Because the knowledge that we got at university is very very broad 
and so I think I am not confident with my knowledge…” (P1-PS) 
 
“...I think that was because we have lack of knowledge on pharmacology and 
drug names although we graduated from pharmacy undergraduate but we 
only know about medication and its brand names in internship level [which was 
only 6 months]….” (P4-PS) 
 
Theme 2: Limited experience 
“…we [as pharmacists] will directly involve in the community pharmacy in 
providing counselling where I think one of important attributes is our ability to 
communicate with community and also provide information regarding 
patients’ medication” (P2-PS) 
 
“Although we‘ve learned the theory on medication, but I don’t know what will 
it be in practice. I think we need to have more experiences on how medications 
used in practice…” (P4-PS) 
 
4.1.4 DISCUSSION OF PHARMACY GRADUATES ATTRIBUTES 
AS CARE PROVIDERS  
Pharmacy graduates (both registered pharmacists and pharmacy interns) from the 
study university either completely or partially perceived that they had the attributes 
to be care providers. In addition, the pharmacy graduates desired to have those 
attributes as pharmacists in delivering patient care. These results suggest that the 
pharmacy curriculum in the study university had fostered some of attributes 
required of pharmacists in delivering patient care. As opposed to pharmacy interns, 
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it was found that registered pharmacists who graduated from the university after 
one or two years perceived having more attributes to provide patient care. This may 
be related to registered pharmacists having been exposed to professional experience 
in their place of work. Thus, they thought that they had acquired more of the 
attributes than pharmacy interns. Further, the registered pharmacists may have the 
sense of responsibility being registered as pharmacists. This may explain the higher 
proportion of registered pharmacists who perceived having some of the attributes 
such as ability to inspire confidence in others and satisfactory at interpersonal 
relationships in their professional life compared to pharmacy interns. However, it 
should be noted that the proportion of registered pharmacists who participated in 
the current study was very small compared to pharmacy interns, thus these findings 
should be viewed with some caution. As opposed to the results of pharmacy 
graduates from Nova Southeastern University, Florida,265 the majority of graduates 
perceived they had acquired all attributes required as patient carer. Whereas, 
pharmacy graduates (pharmacy interns and registered pharmacist) from the study 
university perceived to have less acquisition of the attributes. The differences may 
be influenced by the different curricula and learning methods adopted in the two 
universities. Nova Southeastern University has a 6 year PharmD program with a large 
amount of experiential learning and a strong focus on pharmaceutical care.273 
Meanwhile, pharmacy students from the study university had minimal content to 
shape their knowledge and experience in delivering patient care with their 
curriculum having a strong focus on pharmaceutical sciences.  
 
Hasan et al found that clinical placements or practice experience was important in 
gaining patient care competencies amongst students.274 Thus, they recommended 
adoption of clinical placements in undergraduate pharmacy curricula. Meanwhile, 
pharmacy students at the study university had minimal exposure to pharmacy 
practice experience during their course of study. These students had approximately 6 
months (around 750 hours) of pharmacy practice experience which was obtained in 
community and hospital settings as well as in Government’s institutions [(i.e. Primary 
Healthcare Service – Puskesmas and the National Agency of Drug and Food Control – 




Through further discussion with pharmacy graduates about their perceptions of 
attainment of attributes to provide patient care; it was revealed that their lack of 
confidence in attaining the attributes was due to a self-reported lack of knowledge of 
medications because of the broad pharmacy curriculum. This finding was also 
described as one of characteristics of pharmacy education in Indonesia. Anderson 
stated that “Indonesian pharmacists tend to have a wide knowledge of all areas of 
pharmacy practice but insufficient experience of one branch practice.”275 This 
suggested that pharmacy graduates of the study university had little practical 
experience hence limited opportunities to interact with other healthcare 
professionals. This may impact on graduates’ ability to form interprofessional 
relationships. 
 
The finding that a higher proportion of male pharmacy interns perceived they had 
developed leadership potential compared to their female counterparts mirrored that 
of pharmacy graduates from Nova Southeastern University, Florida265 and medical 
graduates from King College’s London.272 This may suggest that the male pharmacy 
interns had more active roles as leaders than female pharmacy interns in the study 
university. A group which shares similar social characteristics (gender in this regards) 
may influence group socialisation amongst its members. This is one assumption of 
group socialisation theory.276 The higher proportion of male pharmacy interns who 
perceived of having the attributes may also have been influenced by Indonesian 
gender ideology which emphasises men as leaders.277 In addition, the leadership 
gender ideology is considered similar to that of Asian countries. Cheng et al. 
described this model of leadership in the countries as paternalistic leadership.278 
Additionally, the higher proportion of males perceived to have higher leadership 
roles may also be influenced by one of male’s characteristics as a risk taker. Ertac and 
Gurdal found that male leaders took more risks on behalf of the group than their 
female counterparts.279  
 
The results of this study identified that although the majority of pharmacy graduates 
desired to be long life learners, most pharmacy interns reported only partial 
attainment of this attribute. Pharmacy graduates should be long life learners 
because it is essential to ensure their ongoing competency to practice as 
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pharmacists.280 In addition, although pharmacy interns believed that they have the 
ability to work in a team, they were not totally satisfied with their interprofessional 
relationships in their professional life. This might result from the fact that there is 
limited experiential learning during their undergraduate course. Although the 
number of registered pharmacists in the current study was low (n=16), registered 
pharmacists were more confident in their interprofessional relationships in their 
professional life than pharmacy interns. This is likely to reflect the influence of 
professional practice in development of professional identity and the confidence to 
interact with other healthcare professionals.281 This suggests that the pharmacy 
curriculum needs to be amended to allow more pharmacy practice experience during 
the undergraduate course. This may improve pharmacy graduates confidence in 
having the attributes to provide patient care.  
 
Findings from this study indicated that the pharmacy curriculum at the study 
university needs to be redesigned to meet the requirements of pharmacy graduates 
to fulfil their role as a seven-star pharmacist. The concept of the seven-star 
pharmacist was introduced by the WHO in 2000.282 It is “contemporary and future 
pharmacists must possess specific knowledge, attitudes, skills, and behaviours in 
support of their roles.”280 The roles include care-giver, decision-maker, 
communicator, manager, long-life learner, teacher and leader. A report from the 
WHO experts group on preparing the roles of future pharmacists in the healthcare 
system highlighted that curriculum change and partnership amongst leaders in the 
university and pharmacy profession are essential to adopt the roles of pharmacist as 
in the seven stars.280 It was suggested that the curriculum should be designed to 
foster the seven-star requirements amongst pharmacy graduates.  
 
The concept of pharmacists providing patient care (“pharmaceutical care is the 
responsible provision of drug therapy for the purpose of achieving definite outcomes 
that improve a patient’s quality of life”) was introduced by Hepler and Strand in 
1989.8 In the same year, the American College of Clinical Pharmacy (ACCP) in the 
United States agreed to the Doctor of Pharmacy (PharmD) as entry level degree to 
prepare pharmacy graduates to meet the demand of patient care in the future.283 
Since then, pharmacy education in the United States has changed. However, Khan 
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suggested that the implementation of the concept of pharmaceutical care in 
pharmacy education should be critically adjusted to the needs of individual 
countries.284 This was because direct adoption of that in other countries may 
potentially lead to prolonged pharmaceutical care implementation as a result of lack 
of facilities, a lack of skilled and qualified clinical pharmacists to develop the 
curriculum, and lack of support from local institutions and health systems. Further, 
curriculum development should focus on producing skilled and knowledgeable 
pharmacists based on local needs.  
 
The curriculum in pharmacy in Indonesian universities was designed by an 
independent organisation (Indonesian Higher Degree in Pharmacy Education 
Association-APTFI) which provides a standard curriculum which should be met by all 
pharmacy education institutions in the country since 2000. Facing the fact that 
pharmacy graduates in the study university indicated a lack of preparedness in 
delivering patient care, it is recommended that the current pharmacy curriculum 
needs to be amended. Amendments should involve both the course content as well 
as practical experience. The curriculum redesign should focus on ensuring pharmacy 
graduates feel more prepared to deliver patient care.  
 
The curriculum could be adjusted by introducing more experiential learning; which 
commences early and continues throughout the course. Experiential learning 
facilitates pharmacy students to reflect on real practice experience, to conceptualise 
the theory, and finally to actively participate in practice.285, 286 For instance, pharmacy 
students may be exposed to experiential learning by conducting pharmacy practice 
simulations and shadowing pharmacists in practice. These activities should allow 
pharmacy students to learn how to engage with patients.  
 
Currently in Indonesia, pharmacists’ engagement in pharmaceutical care is very 
limited. Thus, support from pharmacy organisations (e.g. Indonesian Pharmacy 
Association -IAI) is essential. The organisations should provide a supportive 
environment to foster professional socialisation amongst pharmacy students. 
Organisations could facilitate students’ learning by encouraging their members to 
provide facilities and share experiences with the students to allow them to gain an 
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understanding of pharmacists’ roles in community and hospital pharmacy. Members 
of pharmacy organisations (i.e. pharmacists practitioners) could act as role models or 
mentors during students’ learning.287 In the current practice, pharmacy organisations 
are involved in graduates’ pharmacy registration. In addition, a supportive health 
system and environment is also required for pharmacy students’ engagement in 
hospital or community practice. This means that various supports from health 
systems, health education institutions as well as pharmacy organisations is essential 
in order to improve pharmacy graduates opportunities to engage in practice and 
hence become prepared to deliver patient care.  
 
A recent development of Indonesian health curriculum has occurred in early 2014. In 
order to ensure the quality of healthcare providers in Indonesia, a joint accreditation 
authority for seven health professions (physician, nurse, midwife, pharmacist, 
dentist, public health, and nutritionist) was established. This accreditation 
organisation was named Indonesian Accreditation Agency for Higher Education in 
Health (IAAHEH).228 One of the aims of this accreditation body is to facilitate the 
incorporation of interprofessionalism in Indonesian health education. This suggests 
that the Indonesian Government is seeking to improve interprofessional care 
through the advancement of interprofessionalism in Indonesian health education. 
Thus, according to WHO framework for action on IPE and collaborative practice (See 
Figure 1.7),84 if health education providers are required to have interprofessionalism 
in their curriculum, this will facilitate healthcare graduates (pharmacist, in this 
instance) to have more collaboration with other healthcare professionals in providing 
patient care. Thus, it should allow more pharmacists’ engagement in working 




4.2 THE ROLE OF PHARMACISTS IN PATIENT CARE TO 
ENSURE MEDICATION SAFETY  
 
4.2.1 DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS  
Ninety-two of 121 patients (76%) who met the inclusion criteria consented to 
participate during the 20 weeks of study. The participants consisted of 37 (40%) 
female and 55 (60%) male patients, with the majority in their 70s (mean age: 
71.4±7.5 years). 
 
Fourteen patients (15%) were admitted because of diseases of the nervous system 
such as non-haemorrhagic stroke, vertigo, and epilepsy. Eleven patients (12%) were 
admitted with cardiovascular diseases, and a further 11 patients (12%) with digestive 
tract diseases. Eight patients (8.7%) were admitted with both cardiovascular and 
renal disease. In addition, seven patients (7.6%) were admitted with respiratory 




4.2.2 MEDICATION ERRORS DURING MEDICATION DELIVERY 
PROCESS  
The 92 patients in the study were ordered a total of 770 medications, ie, 8.4±3.3 
medications per patient. The total number of doses charted was 7,662 ie, 83±81 
doses per patient. A total of 1,563 medication errors were identified through the in-
hospital clinical pharmacy services provided by the investigator, representing an 
error rate of 20.4% (1,563 errors/7,662 doses). As can be seen in Figure 4.1, 
administration errors were the most frequent medication errors identified (59.3%), 
followed by transcription errors (14.7%), dispensing errors (14.4%), prescribing 
errors (6.5%), system errors (5.0%), and monitoring errors (0.1%). System errors 
identified were related to drug distribution and health insurance issues. Errors in 
drug distribution included unclear procedures to obtain the medication when there 
was no stock in the Central Pharmacy. In addition, health insurance-related errors 
involved a different quantity of medication dispensed than ordered, in accordance 
with the insurance policy. Lists of frequency of medication errors identified in the 
present study can be seen in Appendix 17.  
 
 













MEDICATION ERRORS (N= 1563) 
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4.2.2.1 Administration errors 
The majority (64.0%) of the 927 total administration errors were associated with 
documentation, as shown in Figure 4.2. Drug omission was the second most common 
administration error identified (22.9%). Pharmacist interventions during the study 
period prevented eight near miss events during the administration stage. These near 
miss events included patients potentially receiving the wrong drug or wrong dose of 
the right medication. For example, Humulin® insulin (Eli Lilly and Company, 
Indianapolis, IN, USA) was prepared to be given at a dose of 100 units more than the 
prescribed dose; 1 g of ceftriaxone was to be given instead of 2 g, because the nurse 
assumed one vial contained 2 g instead of 1 g; also, a dose of pantoprazole was not 
prepared to be administered as it had been omitted from the patient’s drug regimen. 
 
 






















Administration Errors (N: 927) 
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4.2.2.2  Transcription errors 
The majority of the 230 total transcription errors (35.2%) involved drugs needed by 
patients not being transcribed either onto the medication chart or drug order form, 
or into the nurse’s log book (Figure 4.3). These transcription errors resulted in seven 
drug omissions in the administration stage and two medications being given late. 
Valsartan, simvastatin, lansoprazole, calcium carbonate, and paracetamol were some 
of the medications identified in transcription errors which led to drug omission. 
Other transcription errors involved cessation of medications in patients’ progress 
notes but this cessation not being reflected on their medication charts. Almost half 
(45%) of medications involved in this type of transcription error were administered 
to the patient. Medications identified in this type of error included cefixime, 
paracetamol, pramipexole, captopril, lactulose, and Laxadine® (Galenium Pharmasia 
Laboratories, Semarang, Indonesia). These results demonstrate the need for 
accuracy during the transcription process in order to avoid administration errors in 
the medication delivery process. 
 




4.2.2.3 Dispensing errors 
Eighty-nine (39.6%) of 225 total dispensing errors identified during the study period 
were associated with omissions during the dispensing stage (Figure 4.4). Of these, 57 
(64%) resulted in omissions at the drug administration stage and six (6.7%) resulted 
in drug administration delays. The second most common dispensing errors were 
labelling errors in which medications for patients were labelled incorrectly. Twenty-
four near misses from dispensing errors were intercepted. The wrong dose of 
medication dispensed from the pharmacy was one type of near miss event detected. 
An example was a patient who was dispensed 2.5 mg ramipril instead of the 5 mg 
ramipril prescribed. The dispensed medication was labelled “1 tab of 2.5 mg ramipril 
once daily”. 
 




4.2.2.4  Prescribing errors 
The most frequent prescribing errors (40.6%) were related to regular medications 
not documented in patients’ progress notes (Figure 4.5). This type of error was 
followed closely in frequency by wrong dose prescribed errors. For example, a 
patient was prescribed both 80 mg and 100 mg aspirin. A review of the above 
patient’s progress notes revealed that whilst the neurologist had prescribed 80 mg 
aspirin, also written in the patient’s progress notes was “aspirin 100 mg daily”. In 
another case, ranitidine 50 mg injection twice daily was prescribed instead of 50 mg 
three times daily as in the patient’s progress notes. The third most common 
prescribing error was incomplete drug histories. For instance, digoxin, 
spironolactone, and telmisartan were identified by the pharmacist (the primary 
investigator) as regular medications for a patient during medication reconciliation, 
but these did not appear in the patient’s progress notes. 
 




4.2.2.5  Documentation errors and potential outcomes 
The medications involved in documentation errors identified were classified based 
on the Anatomy and Therapeutic Chemical classification system269 (Table 4.4). 
Medications for the alimentary tract and metabolism, cardiovascular systems, and 
nervous system were the most common groups of medications that had been given 
but had not been documented as such on the patient’s medication chart. Similarly, 
the same classes of medications were also the most common groups of medications 
which had not been administered but were documented as given. 
Table 4.4 Number of documentation errors identified based on ATC classification of medications 




Documented as Given 





(n = 80) 
Alimentary tract and 
metabolism 
190 20 
Cardiovascular system 81 25 
Nervous systems 54 13 
Anti-infectives for systemic 
use 
48 11 
Respiratory system 40 2 
Blood and blood forming 
organs 
29 4 
Dermatologicals 23  - 
General nutrient 19 1 




Musculo-skeletal system 4  - 
Various 3 2 
 
Potential outcomes associated with documentation errors were further analysed 
based on Lisby et al.’s classification (Table 4.5).116 Errors involving the failure to 
document administered doses (n=513) were all classified as potentially non-
significant because the patient had in fact received the medication. Documentation 
errors associated with omission of doses were deemed to have a range of potential 




All drug omissions may potentially have adverse consequences; the magnitude of 
such consequences depends on both the clinical status of the patient and the drug 
involved. Omissions of regular antihypertensive drugs, antinauseants and 
antiemetics, and opioid analgesics were classified as potentially significant. This 
classification was applied because omission of these drugs may result in 
uncontrollable symptoms or disease deterioration.288 Drug omissions which involved 
antibacterial drugs were classified as potentially serious, because omission of 
antibiotic treatment may result in ineffective therapy and recurrent infection.288 
Omission of antiepileptic drugs (e.g., phenytoin) was also classified as potentially 
serious as such drugs should be administered on time to maintain effective blood 
levels269 to reduce the risk of further seizures. Similarly, omission of anticoagulants 
and antiplatelet agents may result in serious outcomes. Therefore, omissions of 
those medications were classified as having potentially serious outcomes. 
 
Although the evaluation of pharmacist interventions was not the primary focus of 
this study, interventions were initiated. Recommendations made in the light of in-
hospital clinical services provided included adjustments to the length of antibiotic 
use, cessation or initiation of medications, and medication dosage adjustment. 
Acceptance of these recommendations was lower than that reported from other 
studies240, 289 as indicated by an acceptance rate of 35%; this low acceptance rate 
may reflect the unfamiliarity of the medical staff with in-hospital clinical pharmacy 
services in general, a lack of an established relationship between the clinicians and 





Table 4.5 Potential clinical outcomes of documentation errors and medication classes involved 
Category Errors 
N (%) 
Group of Medication Identified 
Potentially fatal 0 Nil identified 
Potentially serious 14 (2.4%) Anti-infective for systemic use (quinolones, 
beta-lactams, aminoglycosides); nervous 
system (antiepileptic drugs); blood and 
blood forming organs (antiplatelet and 
anticoagulants ) 
Potentially significant 61 (10.3%) Cardiovascular system (antihypertensive 
drugs, lipid modifying agents); alimentary 
tract and metabolism (drugs for peptic 
ulcers, antinauseants and antiemetics, drug 
for constipation); nervous systems (opioid 
analgesic, drugs indicated for analgesics 
and antipyretics) 
Potentially non-significant 518 (87.4%) Vitamins and mineral supplements 
 
4.2.3 DISCUSSION ON PHARMACISTS’ ROLE IN PATIENT 
CARE TO IMPROVE MEDICATION SAFETY 
To the best of our knowledge, this is the first study to document the frequency and 
nature of medication errors during the medication delivery process in an Indonesian 
hospital. This study found that administration errors were the most frequent 
medication errors. This might be due to the fact that nurses have high workloads. 
Nurses often take on the responsibility for transcribing medications from the 
patient’s progress notes onto medication charts and drug order forms. They are the 
primary healthcare professional responsible for medication administration and its 
documentation on the ward. Furthermore, they are also required to complete 
patients’ paperwork on admission and on discharge. These high workloads may have 
contributed to the high frequency of administration and transcription errors 
detected. 
 
Documentation errors were the commonest type of administration error identified in 
this study. This is despite the fact that regulations require two nurses to check 
medications. According to Ferner and Aronson14 documentation errors related to 
drugs given but not documented are associated with memory lapses (memory-based 
errors). In addition, documentation errors where medications have not been given 
but are documented as given are rules-based errors. Medication administration 
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should only be documented after the medication has been given, not before or when 
it is planned to be given. Thus, these documentation errors relate to a failure to 
follow the correct procedures during the medication delivery process. Clear, 
accurate, complete, and timely documentation is important for several reasons. 
Accurate documentation ensures the quality of healthcare service delivered. 
Accurate and complete documentation can be used to defend healthcare 
professionals against malpractice.290 Clear and timely documentation is also 
important for the sake of researchers and health organisations, because it serves as 
reliable evidence to evaluate the quality of healthcare services provided.290 
 
Medications not being transcribed onto the medication charts or drug order forms 
were the most frequent transcription errors identified. These transcription errors 
were highly influenced by the hospital documentation system. In the current system, 
the physician has to write patients’ medications in three different documents (the 
patient’s progress notes, medication chart, and the drug order form). The 
investigator identified transcription errors when reconciling patients’ regular 
medications. In these cases, regular medications were charted but they were not 
prescribed on patients’ progress notes. In this type of error scenario, physicians 
mistakenly did not note patients’ regular medications in their progress notes. This 
lapse quite often resulted in other health professionals (nurses or pharmacists) 
having different assumptions regarding patients’ regular medications. This could be 
seen when the investigator found discrepancies between patients’ progress notes 
and medication charts, and subsequently queried the nurse in charge as to which 
document was correct. According to Dean et al.123 this type of error is associated 
with prescription writing processes. Similar to documentation errors discussed 
previously in this section, this error type is also related to rules-based mistakes 
according to Ferner and Aronson’s classification of medication errors.14 These 
findings demonstrate poor quality assurance in the studied institution’s healthcare 
service delivery. 
 
In the study hospital, three different pharmacies provided medication to the ward 
depending upon a patient’s health insurance coverage. This created major issues in 
medication administration, particularly when there was no stock in the Central 
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Pharmacy or when a medication prescribed was not covered by the patients’ health 
insurance. Systems issues related to drug distribution and health insurance systems 
contributed to 78 medication errors. Sometimes, these errors caused additional 
errors in the administration process. This demonstrates that poor procedures in the 
drug distribution system and/or a lack of communication between the Central 
Pharmacy and the ward contributed to medication errors. To minimise drug omission 
errors arising through the dispensing process, it is suggested that drug distribution 
should be streamlined, with the Central Pharmacy distributing medication to satellite 
pharmacies in wards, with the satellite pharmacies to take responsibility for all drugs 
supplied. 
 
This study demonstrated that medication errors may occur in every stage of the 
medication delivery process. Different healthcare professionals have different roles 
during this process and hence, they may commit different types of medication 
errors. In addition, failures such as those associated with drug distribution and health 
insurance, may also lead to errors. The main limitation of this study was that only 
one ward in one hospital was included; thus, the generalisability of the results may 
be limited. Further, the presence of the primary investigator on the ward may have 
affected the behaviour of the other healthcare professionals, particularly when 
questions were asked about discrepancies, and recommendations were made to 
address actual errors and near misses. Finally, the validity of some documentation 
errors reported in this study was highly dependent on the information retrieved from 
nurses and patients, because the investigator was unable to observe all functions of 
medication administration. 
 
Medication errors are preventable events; thus, understanding the nature of errors 
during the medication delivery process may potentially improve healthcare services 
through the implementation of strategies to prevent the same errors from occurring 
again. However, there is no simple solution to preventing medication errors during 
the medication delivery process. Based on the findings of the present study, 
simplification of the medications ordering process, with removal of the need for both 
medication charts and drug order forms, would appear to be a means of reducing the 
number of omissions and transcription errors. The implementation of a 
116 
 
comprehensive computerised medication orders system would provide a more 
comprehensive solution. In the late 1900s, research demonstrated that 
Computerised Physician Ordered Entry (CPOE) reduced medication errors.291 
However, recent evidence shows that CPOE potentially contributes to other technical 
errors.292 Furthermore, CPOE requires information and technology maintenance 
which is costly, and requires healthcare providers to have sufficient computer 
literacy skills to effectively utilise the system. Thus, implementing CPOE in the study 
hospital is likely not a viable solution. 
 
Errors in documentation and transcription could be minimised by involving 
pharmacists during the medication delivery process. Pharmacists potentially play an 
important role in reducing medication misadventures through the delivery of in-
hospital clinical pharmacy services including medication reconciliation,41 medication 
chart review, clinical review, staff education, and patient discharge counselling. 
Medication reconciliation is an activity that ensures the continuity of medications 
used during transfers between wards, or before and after hospitalisation. The Joint 
Commission152 defines medication reconciliation as “the process of comparing the 
medications a patient is taking with newly ordered medication”. Although 
methodological issues exist in assessing the impact of pharmacists’ interventions on 
medication safety, the Agency for Healthcare and Research Quality27 suggested that 
pharmacists’ involvement reduces adverse drug events, particularly preventable 
events (e.g. medication errors).  
 
Pharmacists’ involvement in ensuring medication safety requires support from the 
healthcare system, health administrators, and a good practice environment. 
Currently, the role of pharmacists in medication safety in hospitals in Indonesia is 
very limited, as pharmacists are generally involved in drug distribution and not in the 
provision of patient-related services. This study suggests that pharmacists, through 
the provision of in hospital clinical pharmacy services, could potentially play a 
significant role in detecting and preventing medication errors. 
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4.3 SUMMARY OF THE ROLE OF PHARMACISTS IN 
PATIENT CARE TO ENSURE MEDICATION SAFETY 
This chapter illustrates that pharmacy graduates (registered pharmacists and 
pharmacy interns) perceived they had have some but not all the attributes required 
of care providers. This indicates that the pharmacy graduates at the study university 
have a lack of confidence in providing patient care. The graduates self-reported that 
the lack of perceived attainment of the attributes may relate to broad content of 
pharmacy curriculum and limited practical experiences in providing patient care. This 
study also found that pharmacists have a role in patient care to ensure medication 
safety by providing clinical review service and conducting medication reconciliation. 
However, the investigator attended training prior to conducting the research 
activities to gain insight on conducting the clinical review and medication 
reconciliation services. This training also aimed to provide practical experience in 
identifying potential errors during medication delivery process. This study found that 
medication errors were identified in every stage of the medication delivery process, 
meanwhile, healthcare professionals with different skills and knowledge were 
involved in the process. This suggests that healthcare professionals involved in the 
medication delivery process shared the responsibility in ensuring the safe use of 
medication. Pharmacists are one of healthcare professionals involved in the 
medication delivery process. This study found that a pharmacist could identify and 
intercept medication errors in the medication delivery process demonstrating that 
pharmacists have a role in patient care to ensure medication safety. This study also 
identified that system errors contributed to the errors. Thus, system improvement in 




CHAPTER 5 RESULTS AND DISCUSSIONS: HEALTHCARE 
STUDENTS’ ATTITUDES TOWARDS INTERPROFESSIONAL 
EDUCATION (IPE) 
 
This chapter consists of two sections. Section 5.1 describes healthcare students’ 
attitudes towards IPE employing the RIPLS questionnaire for healthcare students in 
Survey Years 2012 and 2013. Section 5.2 portrays the influence of an 
interprofessional learning workshop on medication safety on healthcare students’ 
attitudes towards IPE. 
5.1 SURVEY ON HEALTHCARE STUDENTS’ ATTITUDES 
TOWARDS IPE  
5.1.1 DEMOGRAPHIC CHARACTERISTICS OF HEALTHCARE 
STUDENTS PARTICIPATION 
The RIPLS questionnaire was administered to Year 1, 2, 3, and 4 students in 2012 and 
Year 2, 3, and 4 students in 2013. Four hundred and eighty-eight out of 550 students 
surveyed returned the RIPLS questionnaire in 2012, while 346 out of 412 students 
completed the questionnaire in Survey Year 2013 (Table 5.1). This gave response 
rates of 88.7% and 83.9% in Survey Years 2012 and 2013, respectively. 

































Tables 5.2 and 5.3 show the demographic characteristics of students in Survey Years 
2012 and 2013, respectively. In both surveys, the majority of participants were 
female with median age of 20 years. Overall, the proportions of participants who had 
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health related experience (e.g. voluntary or paid working experiences while studying 
within the students’ course) in the Survey Year 2012 (39.1%) was higher compared to 
participants in Survey Year 2013 (26%). Less than 15% of participants in both surveys 
had previous health education background (e.g. pharmacy assistance at high school 
or nursing diploma prior to undertaking undergraduate course). Although 25% of the 
participants in Survey Year 2012 and 10% in Survey Year 2013 stated they had 
Interprofessional Learning (IPL) exposure, additional information provided in their 
responses to this question was not related to “learning with other healthcare 
students”. For this reason, previous IPL was excluded in data analysis. 
 
After data had been cleaned, Expectation Maximization (EM) analysis was employed 
for the missing data in the survey. The Kolmogorov-Smirnov test indicated that data 
in 2012 and 2013 were not normally distributed, p=0.001. However, in this study 
parametric analyses were employed because that approach was considered robust 
enough even when a normal distribution was violated.293  
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Table 5.2 Demographic characteristics of participants in Survey Year 2012 
GENDER 
 Medical Nursing Pharmacy Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Female 132 50.9 114 81.4 62 69.7 308 63.1 
Male 122 47.1 22 15.7 22 24.7 166 34 
Missing 5 1.9 4 2.9 5 5.6 14 2.9 
AGE 
 Medical Nursing Pharmacy Total 
Age range 17-26 17-22 18-22 17-26 
Median 20 20 20 20 
YEAR OF STUDY 
 Medical Nursing Pharmacy Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
1 58 22.4 35 25 20 22.5 113 23.2 
2 68 26.3 37 26.3 25 28.1 130 26.6 
3 68 26.3 35 25 21 23.6 124 25.4 
4 65 25.1 33 23.6 23 25.8 121 24.8 
PREVIOUS HEALTH WORK RELATED EXPERIENCE  
 Medical Nursing Pharmacy Total 
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Notes: †= excluded in data analysis  
 
 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Yes 103 39.8 67 47.9 21 23.6 191 39.1 
No 156 60.2 73 52.1 68 76.4 297 60.9 
PREVIOUS HEALTH EDUCATION BACKGROUND  
 Medical Nursing Pharmacy Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Yes 56 21.6 11 7.9 9 10.1 76 15.6 
No 203 78.4 129 92.1 80 89.9 412 84.4 
PREVIOUS INTERPROFESSIONAL LEARNING† 
 Medical Nursing Pharmacy Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Yes  79 30.5 25 17.9 12 13.5 116 23.8 
No 180 69.5 115 82.1 77 86.5 372 76.2 
Table. 5.2 continued 
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Table5.3 Demographic characteristics of participants in Survey Year 2013 
 
GENDER 
 Medical Nursing Pharmacy Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Female 97 51.9 71 71 44 74.6 212 61.3 
Male 90 48.1 21 21 15 25.4 126 36.4 
Missing 0 0 8 8 0 0 8 2.3 
AGE 
 Medical Nursing Pharmacy Total 
Age range 17-24 18-22 18-22 17-24 
Median 20 20 20 20 
YEAR OF STUDY 
 Medical Nursing Pharmacy Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
2 56 30.1 30 30.6 19 32.2 105 30.6 
3 67 36 37 37.8 21 35.6 125 36.4 
4 63 33.9 31 31.6 19 32.2 113 32.9 
PREVIOUS HEALTH WORK RELATED ACTIVITY 
 Medical Nursing Pharmacy Total 




Notes: †= excluded in data analysis  
Yes 43 23 43 43 4 6.8 90 26 
No 144 77 57 57 55 93.2 256 74 
PREVIOUS HEALTH EDUCATION BACKGROUND  
 Medical Nursing Pharmacy Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Yes 10 5.3 21 21 3 5 34 9.8 
No 177 94.7 79 79 56 95 312 90.2 
 
PREVIOUS INTERPROFESSIONAL LEARNING † 
 Medical Nursing Pharmacy Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Yes 8 4.3 22 22 6 10.2 36 10.4 
No 179 93.7 78 78 53 89.8 310 89.6 
Table. 5.3 continued 
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5.1.2 FACTOR ANALYSIS 
The RIPLS questionnaire has been used extensively in the literature and adopted into 
different languages.294, 295 The questionnaire used in some countries revealed 
different items which constructed the RIPLS sub-scales. Thus, in order to ensure 
validity of the best structure of the RIPLS in the current population, Confirmatory 
Factor Analysis (CFA) and Principle Component Analysis (PCA) were undertaken on 
the responses from students who participated in Survey Year 2012. The analyses 
indicated that the current data did not fit the model of Parsel and Bligh.66 This could 
be seen from indicators on goodness of fit which did not meet the desired values 
(Table 5.4). Figure 5.1 demonstrates a diagram path analysis using Analysis of 




Figure 5.1 Confirmatory factor analysis based on Parsel and Bligh model.  
Notes:  
 TWC  = Teamwork and Collaboration sub-scale 
 PI  = PI sub-scale 









χ²/df TLI CFI RMSEA 
Desired value296 <2 >0.9 >0.9 <0.06 
Parsel and Bligh 
Model 
2.99 0.87 0.91 0.065 
Notes: 
χ²  = Chi-square 
df  = degree of freedom 
TLI  = Tucker-Lewis Index 
CFI  = Comparative Fit Index 
RMSEA  = Root Mean Square Error of Approximation 
 
Schmitt suggested Explanatory Factor Analysis (EFA) could be employed when CFA 
did not fit the current data.263 PCA is one form of EFA which was adopted for the 
current data analysis because of its uniqueness to explore components of 
questionnaires.297 PCA is a unique mathematical solution analysis242 and it is used 
when the researcher needs to explore components of a questionnaire. In PCA, 
participants’ responses to each item are scored based on its components (sub-
scales). This score is standardised based on factor loading for each item, and the 
mean and standard deviation of each sub-scale.258 In SPSS, this factor score could be 
requested and saved as a variable using regression Bartlett, and Anderson-Rubin 
methods. A factor loading of 0.4 was selected as the cut-off point because it provides 
fair results.298, 299 The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 
0.864 and the Bartlett’s test of sphericity was statistically significant (<0.001) which 
showed the current data were appropriate for factor analysis (Table 5.5).  
 
The Pattern Matrix retrieved from Direct Oblimin Rotation showed items and their 
factor loadings in three sub-scales for the RIPLS questionnaire from the current data 
(Table 5.6). Table 5.7 shows RIPLS sub-scales, statements that construct the sub-




Table 5.5 KMO and Bartlett's Test of RIPLS students 
 
Kaiser-Meyer-Olkin Measure of Sampling Adequacy. .864 








1 2 3 
RIPLS10 .737     
RIPLS11 .731     
RIPLS1 .723     
RIPLS12 .717     
RIPLS3 .709     
RIPLS9 .692     
RIPLS6 .685     
RIPLS13 .633     
RIPLS7 .600     
RIPLS5 .588     
RIPLS4 .471     
RIPLS2       
RIPLS16   .933   
RIPLS17   .913   
RIPLS15     .779 
RIPLS8     .566 
RIPLS14     .430 
 
Table 5.7 Items that construct RIPLS sub-scales and its reliability 
 
Similar to that in Parsel and Bligh’s model, there were three sub-scales that emerged 
from the current data. However, the current data had different items which 
constructed each sub-scale. Sub-scale 1 consisted of Statements 1, 3, 4, 5, 6, 7, 9, 10, 
Sub-scales RIPLS Statements Reliability  
(Cronbach’s alpha) 
1. Shared Learning and 
Teamwork (SLT) 
1, 3, 4, 5, 6, 7, 9, 10, 11, 
12, and 13 
0.873 
2. Roles and Responsibility 
(RR) 
16, and 17 0.869 
3. Professional Identity (PI)  8, 14 and 15 0.341 
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11, 12 and 13. The theme that emerged was based on those statements embracing 
“Shared Learning and Teamwork-SLT.” Sub-scale 2 of the current survey consisted of 
RIPLS Statements 16 and 17 with a theme of “Roles and Responsibility-RR”. Sub-scale 
3 consisted of RIPLS Statements 8, 14, and 15 with a theme of “Professional Identity-
PI”. In this analysis, Statement 2 was excluded from any sub-scales because it had a 
very low factor loading in more than one factor. Table 5.7 shows that the SLT and RR 
sub-scales had good reliability scores (α >0.8) however, PI sub-scale had low score.  
 
Further CFA analysis was conducted based on items retrieved from factors on EFA to 
confirm the model derived from EFA has an appropriate goodness of fit. It was found 
that the model from EFA had low goodness of fit based on the indicators. Thus, 
modification of model based on estimation on modification indices was 
conducted.263 It was found that indicators on goodness of fit were improved 
afterward. Indicators on goodness of fit of the model can be seen in Table 5.8. Figure 
5.2 demonstrated the EFA modified model. Compared to the model of Parsel and 
Bligh,66 factor loadings and constituent statements of Sub-scales 1, 2 and 3 were 
slightly different. This might be because three statements were excluded from the 
present questionnaire. In addition, differences in learning systems and curricula 
might influence the different items that constructed sub-scales in the present study. 
However, the correlation amongst variances showed that RR sub-scale had no 
association with the SLT sub-scale (p=0.147) or with the PI sub-scale (p=0.080). Thus, 
RR sub-scale was excluded in the study analysis.   
 
Table 5.8 Goodness of fit based on items constructed on EFA modified model  
 
Notes:   
Χ2  = Chi-square 
df  = degree of freedom 
TLI  = Tucker-Lewis Index 
CFI  = Comparative Fit Index 




χ²/df TLI CFI RMSEA 
Desired value296 <2 >0.9 >0.9 <0.06 
EFA modified 
model  




Figure 5.2 Confirmatory factor analysis based on EFA modified model 
Notes:  
SLT = Shared Learning and Teamwork sub-scale 
RR = Roles and Responsibility sub-scale 





5.1.3 HEALTHCARE STUDENTS’ ATTITUDES TOWARDS IPE  
 
DiStefano et al. suggested that factor analysis could be undertaken using non-refined 
and refined methods.258 The non-refined analysis is simple and straight forward, 
while refined analysis is more sophisticated. Both methods have advantages and 
disadvantages, for this reason in the current study both analyses were adopted. The 
non-refined method involved adding items in each factor. Meanwhile, participants’ 
responses were analysed by saving the scores as variables using a regression method 
in SPSS in the refined method. In this study, data from Survey Year 2012 were used 
as a reference to calculate factor loadings, mean values and standard deviations of 
each sub-scale were used to adjust for students who may have participated in both 
surveys (i.e. 2012 and 2013). Then, participants’ responses to the RIPLS sub-scales 
were analysed by comparing students’ mean scores for the RIPLS sub-scales. 
 
Students’ attitudes towards IPE were assessed in four ways. Figure 5.3 shows a 
diagram outlining the analysis of students’ attitudes towards IPE. The first analysis 
adopted non-refined analysis, meanwhile the second, third and fourth analyses 
adopted refined analyses. Post-hoc Scheffe comparison was employed because it 
provides strong protection against Type I error.300  
  
1. Healthcare students’ attitudes towards IPE were determined based on data from 
the cross sectional study in Survey Year 2012 and were assessed in three ways. 
Firstly, medical, nursing and pharmacy students’ mean scores differences towards 
each RIPLS statement were analysed. Secondly, healthcare students’ responses 
were also assessed based on total RIPLS mean scores and its sub-scales. Total mean 
scores of the RIPLS sub-scales were analysed using ANOVA to determine whether 
healthcare students had different attitudes towards IPE between courses of study 
as well as across different years of study. For the purpose of this analysis only, 
negative statements (RIPLS Statements 8, 14, 15, 16 and 17) were reverse coded to 
calculate the total scores. Meanwhile, each statement which constructed the PI 
sub-scale was analysed separately because of the low Cronbach’s alpha. Healthcare 
students’ attitudes towards the RIPLS sub-scales were also compared from the 
total scores of statements that constructed each sub-scale. The third analysis 
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involved comparing healthcare students’ attitudes towards IPE according to year of 
study within their course of study.  
2. Repeated cross sectional analysis. Medical, nursing and pharmacy students in 
Survey Year 2012 were analysed based on their mean regression factor score in 
refined analysis towards the RIPLS sub-scales. Although Cronbach’s alpha showed 
low reliability on the PI sub-scale, this sub-scale was also considered in the refined 
analysis because factor loadings of Statement 8, 14, and 15 were reasonably fair 
(more than 0.4).299 The low reliability may be due to different directions of 
agreement as shown in Analysis 1. Similar analyses were also performed on data 
from Survey Year 2013. These analyses aimed to assess whether healthcare 
students’ attitudes from different courses of study were consistent in both years. 
ANOVA analysis was employed. 
3. Years 2, 3, and 4 healthcare students’ mean scores on RIPLS factors in Survey Year 
2012 and 2013 within their chosen course were compared (e.g. Year 2 medical 
students in Survey Year 2012 versus Year 2 medical students in Survey Year 2013). 
This analysis was conducted to assess whether medical, nursing, and pharmacy 
students within in the same year of the course had similar attitudes towards 
interprofessional learning independent of the survey year. T-test analysis was 
employed. 
4. A trend analysis of students’ attitudes towards IPE aimed to provide answers as to 
whether students’ attitudes changed towards IPE over time during their chosen 
course of study. In this analysis, longitudinal level was at the population unit not at 
the subject unit.301 Thus, participants were selected randomly in Survey Year 2012 
and 2013. This analysis was conducted by analysing students’ mean regression 
factor scores as they progressed through their chosen course (e.g. Year 1 medical 
students in Survey Year 2012 versus Year 2 medical students in Survey Year 2013). 






Figure 5.3 Diagram on analyses of students' attitudes towards IPE 
 
Analysis 1: Year 1 to 4 students’ attitudes towards IPE– Cross sectional study in Survey 
Year 2012 
 
Analysis 2: Repeated cross sectional study of Year 2 to 4 in Survey Year 2012 and 2013  
 
Analysis 3: Year of Study analysis 
   
          Analysis 4: Trend Study analysis 
 
5.1.3.1 Healthcare students’ attitudes towards IPE 
The first analysis was a cross sectional study in which healthcare students’ attitudes 
towards IPE were assessed from each item of the RIPLS statement from healthcare 
students who participated in Year 1 through 4 in Survey Year 2012. Table 5.9 shows 
medical, nursing and pharmacy students in Survey Year 2012 had positive attitudes 
towards IPE. This was shown from the low total mean score on RIPLS positive 
statements and high total mean scores of RIPLS negative statements which indicated 
positive attitudes towards IPE. However, there were statistically significant 
differences for RIPLS Statements 4, 14, 16 and 17. As can be seen in Table 5.9, the 
mean scores of RIPLS Statement 4 for medical students was significantly lower than 
nursing and pharmacy students. This means medical students had more positive 
attitudes towards the importance of learning team work skills compared to other 
healthcare students. 
 
Interestingly, for the RIPLS Statement 14 “The function of allied health professionals 
is mainly to provide support for doctors,” medical students had significantly more 
positive attitudes compared to nursing and pharmacy students. The mean scores of 
medical students were also significantly lower than for nursing and pharmacy 
students for statements on acquiring more knowledge and skills (RIPLS Statement 16 
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indicated that medical students had more positive attitudes towards acquiring more 
knowledge and skills than other healthcare students. These findings suggested that 
although medical students agreed that learning team work skills was essential for 
healthcare students to learn, they believed they had to acquire more knowledge and 
skills than other healthcare professionals, who they perceived as having a main role 




Table 5.9 Means, standard errors, and p-value of ANOVA on each RIPLS statement amongst course of study (†: negative statement) 
RIPLS statements 
Mean ± SE 
(n) 
Mean ± SE 
(n) p-value 
Medical Nursing Pharmacy Total 
1. Learning with other students will help me become a more effective member of a 
healthcare team 
1.57 ± 0.03 
(258) 
1.57 ± 0.04 
(139) 
1.48 ± 0.06 
(87) 
1.56 ± 0.02 
(484) 
0.369 
2. Patient would ultimately benefit if healthcare students worked together 1.59 ±0.04 
(258) 
1.54 ± 0.05 
(139) 
1.47 ± 0.06 
(87) 
1.55 ± 0.03 
(484) 
0.276 
3.Shared learning with other healthcare students will increase my ability to 
understand clinical problems 
1.64 ± 0.036 
(258) 
1.62 ± 0.05 
(138) 
1.48 ± 0.06 
(87) 
1.60 ± 0.03 
(483) 
0.083 
4. Team working skills are essential for all healthcare students to learn 1.33 ± 0.03 
(253) 
1.46 ± 0.05 
(136) 
1.49 ± 0.06 
(81) 
1.40 ± 0.02 
(470) 
0.014* 
5. Shared learning will help me understand my own professional limitations 1.85 ± 0.04 
(254) 
1.99 ± 0.05 
(135) 
1.89 ± 0.06 
(81) 
1.90 ± 0.03 
(470) 
0.084 
6. Learning between healthcare students before qualification would improve 
working relationships after qualification 
1.68 ± 0.04 
(254) 
1.58 ± 0.05 
(136) 
1.56 ± 0.07 
(81) 
1.63 ± 0.03 
(471) 
0.109 
7. Shared learning will help me think positively about other healthcare 
professionals 
1.79 ± 0.03 
(253) 
1.73 ± 0.05 
(136) 
1.70 ± 0.06 
(81) 
1.76 ± 0.03 
(470) 
0.350 
8. It is not necessary for undergraduate healthcare students to learn together† 3.41 ± 0.04 
(254) 
3.45 ± 0.05 
(136) 
3.44 ± 0.09 
(80) 
3.43 ± 0.03 
(470) 
0.834 
9. Shared learning with other healthcare students will help me communicate better 
with patients 
1.75 ± 0.04 
(253) 
1.83 ± 0.05 
(136) 
1.84 ± 0.07 
(81) 
1.79 ± 0.03 
(470) 
0.394 
10. Shared learning with other healthcare students will help me communicate 
better with other professionals 
1.60 ± 0.03 
(254) 
1.68 ± 0.04 
(136) 
1.68 ± 0.06 
(81) 





11. I would welcome the opportunity to work together with other healthcare 
students 
1.65 ± 0.03 
(254) 
1.71 ± 0.04 
(136) 
1.63 ± 0.06 
(80) 
1.66 ± 0.02 
(470) 
0.460 
12. Shared learning will help me clarify the nature of patient problems 1.76 ± 0.04 
(254) 
1.66 ± 0.04 
(136) 
1.81 ± 0.06 
(81) 
1.74 ± 0.03 
(471) 
0.118 
13. Shared learning before qualification will help me become a better team worker 1.69 ± 0.03 
(254) 
1.60 ± 0.04 
(135) 
1.69 ± 0.07 
(80) 
1.67 ± 0.02 
(469) 
0.217 
14. The function of allied health professionals is mainly to provide support for 
doctors† 
2.15 ± 0.05 
(253) 
3.99 ± 0.06 
(136) 
3.03 ± 0.08 
(79) 
2.66 ± 0.04 
(468) 
<0.001* 
15. I am not sure what my professional role will be† 3.45 ± 0.04 
(254) 
3.60 ± 0.05 
(136) 
3.43 ± 0.09 
(81) 
3.49 ± 0.03 
(471) 
0.063 
16. I have to acquire much more knowledge than other healthcare students† 1.98 ± 0.05 
(254) 
2.19 ± 0.07 
(135) 
2.33 ± 0.08 
(81) 
2.10 ± 0.04 
(470) 
<0.001* 
17. I have to acquire many more skills than other healthcare students† 1.94 ±  0.05 
(254) 
2.13 ± 0.07 
(136) 
2.33 ± 0.09 
(81) 
2.06 ± 0.04 
(471) 
<0.001* 




The second analysis involved healthcare students’ attitudes towards IPE which were 
assessed based on the total mean scores of the RIPLS and its sub-scales. Table 5.10 
shows total mean scores of the RIPLS and its sub-scales across course of study in 
students who participated in Survey Year 2012. 
 










n        257      138        79 
Shared Learning and 
Teamwork (SLT) 
(RIPLS statement 1, 3, 4, 
5, 6, 7, 9, 10, 11, 12, and 
13) 
18.31 ± 0.25 18.37 ± 0.35 18.17 ± 0.48 0.942 
Professional Identity (PI) 
(reversed of RIPLS 
statement 8, 14, and 15) 
5.97 ± 0.08 4.59 ± 0.11 5.09 ± 0.17 0.001* 
RIPLS 31.97 ± 0.29 30.08 ± 0.46 30.13 ± 0.61 0.001* 
Notes: * showed significant difference 
 
The possible total scores for the RIPLS survey ranged from 17 (strongly agree) to 68 
(strongly disagree). Overall, healthcare students’ attitudes towards IPE were positive 
with the mean values ranging from 30-31 (agree). As can be seen in Table 5.10, there 
were significant differences in overall healthcare students’ attitudes towards IPE 
based on course of study (p<0.001). Multivariate analysis indicated that students’ 
course of study (i.e. medicine vs nursing vs pharmacy) was the only variable 
significantly influencing students’ mean scores differences in the total RIPLS scores 
(F[2,449]= 7.532, p< 0.001). A post-hoc test demonstrated that the overall score for 
medical students was significantly different to those of nursing students (p< 0.001) 
and pharmacy students (p<0.01), but there was no significant difference amongst 
nursing and pharmacy students (p=0.997). These results indicated that medical 
students had statistically significantly less positive attitudes towards IPE compared to 
nursing and pharmacy students.  
 
In addition, Table 5.10 demonstrates that healthcare students in the current study 
had different mean scores towards the PI sub-scale. Because of the low Cronbach 
alpha score on PI sub-scale (as shown in Table 5.7), in this analysis, statements which 
constructed this sub-scale (Statement 8, 14, and 15) were analysed separately. As 
can be seen in Table 5.9, there were no significant mean scores differences on 
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Statement 8 “It is not necessary for undergraduate healthcare students to learn 
together.” Medical, nursing and pharmacy students had high mean scores towards 
this statement. These indicated that healthcare students had positive attitudes 
towards learning together with others. Similarly, there was no significant difference 
for RIPLS Statement 15 (“I am not sure what my professional role will be”) between 
healthcare students from the different courses of study. All healthcare students had 
high mean scores which indicated that medical, nursing and pharmacy students had 
positive attitudes towards their professional roles. Meanwhile, medical, nursing and 
pharmacy students had significant difference attitudes towards RIPLS Statement 14 
(Table 5.9). Post-hoc test analysis indicated that medical students had significantly 
lower mean scores than nursing and pharmacy students for Statement 14 (“The 
function of allied health professionals is mainly to provide support for doctors”). 
 
Table 5.11 P-values on RIPLS Statement 14 amongst students’ course of study in Survey Year 2012 
Course of study Nursing Pharmacy 
Medical 0.001* 0.001* 
Nursing  0.001* 
Notes: * showed significant difference 
 
Table 5.11 shows p-values for RIPLS Statement 14 amongst healthcare students’ 
course of study in Survey Year 2012. This indicated that medical students had 
stronger agreement towards negative statements of PI sub-scale which indicated 
that they believed their own profession had more importance than other healthcare 
professionals. Interestingly, pharmacy students had significantly lower mean scores 
than nursing students for this statement. This indicated that pharmacy students had 
a greater level of agreement than nursing students towards the roles of other 
healthcare professionals are mainly to support physicians. This may imply that 
pharmacy students had less positive attitudes towards their own professional roles.  
 
The third analysis involved students’ attitudes towards IPE which were analysed 
within their chosen course of study across Year of Study. Table 5.12 and Table 5.13 
show that there were no significant differences on RIPLS sub-scales and statements 
on Professional Identity (Statement 8, 14 and 15) across the Years of Study amongst 
medical and nursing students. However, Year 1 nursing students had significantly 
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higher reversed mean scores on RIPLS Statement 14 than Year 4 in the course. This 
means Year 1 nursing students had more positive attitudes than other years of study 
of nursing students towards the role of other healthcare providers as mainly to 
support doctors.  
 
Meanwhile, Table 5.14 shows that there were significant differences in the mean 
total RIPLS scores amongst Year of Study in the pharmacy students groups. As can be 
seen from the table, the total mean scores for Year 3 students were higher compared 
to students in the other years of study in the pharmacy course. Multivariate analysis 
showed none of the variables (i.e. age, gender, previous health education 
background, and health related activities) for pharmacy students influenced the 
difference. Non-parametric tests were also conducted because the number of 
pharmacy students was relatively low. Kruskal-Wallis analysis indicated similar 
results U (3,79)= 10.853, p= 0.013. This suggested that pharmacy students had 
significant differences for total RIPLS mean scores across Year of Study. These 
indicated that Year 3 pharmacy students had less positive attitudes towards IPE 
compared to the other Years of Study in pharmacy course. 
 
Table 5.12 Mean scores of medical students for the RIPLS and its sub-scales across Year of Study  
Sub-scales, Statement 
and RIPLS 











n 56 68 68 65 
Shared Learning and 
Teamwork (SLT) 
(RIPLS 1, 3, 4, 5, 6, 7, 9, 
10, 11, 12, and 13) 
18.05 ± 0.51 18.43 ± 0.44 19.00 ± 0.52 17.72 ± 0.50 0.278 
Professional Identity 
(PI) 
(reversed RIPLS 8, 14, 
and 15) 
5.86 ± 0.15 6.0 ± 0.16 5.89 ± 0.15 6.04 ± 0.17 0.780 
Reversed statement 8 1.48 ± 0.08 1.68 ± 0.08 1.57 ± 0.07 1.61 ± 0.08 0.352 
Reversed statement 14 2.85 ± 0.08 2.87 ± 0.09 2.77 ± 0.09 2.87 ± 0.09 0.827 
Reversed statement 15 1.46 ± 0.78 1.54 ± 0.08 1.59 ± 0.07 1.58 ± 0.08 0.655 





Table 5.13 Mean scores of nursing students for the RIPLS and its sub-scales across Year of Study 
Sub-scales, Statements 
and RIPLS 










n 33 37 35 33 
Shared Learning and 
Teamwork (SLT) 
(RIPLS 1, 3, 4, 5, 6, 7, 9, 
10, 11, 12, and 13) 
19.03 ± 0.61 19.22 ± 0.65 17.63 ± 0.75 17.55 ± 0.729 0.174 
Professional Identity (PI) 
(reversed RIPLS 8, 14, 
and 15) 
4.45±0.24 4.78 ± 0.24 4.29 ± 0.20 4.45 ± 0.18 0.232 
Reversed statement 8 1.45 ±0.09 1.56 ± 0.08 1.50 ± 0.09 1.69 ± 0.11 0.315 
Reversed statement 14 1.97 ±0.14 1.72 ± 0.11 1.42 ±0.09 1.32 ±0.08   0.001* 
Reversed statement 15 1.39 ±0.11 1.44 ± 0.11 1.35 ± 0.09 1.42 ± 0.09 0.436 
RIPLS 31.03 ±0.83 31.14 ±0.86 28.97 ±0.86 29.12 ±0.88 0.235 
Notes: * showed significant difference 
 
Table 5.14 Mean scores of pharmacy students for RIPLS and its sub-scales across Year of Study 
Sub-scales, Statements 
and RIPLS 










n 18 22 17 19 
Shared Learning and 
Teamwork (SLT) 
(RIPLS 1, 3, 4, 5, 6, 7, 9, 10, 
11, 12, and 13) 
17.66 ± 0.91 17.34 ± 0.70 20.38 ± 1.33 17.60 ± 0.86 0.105 
Professional Identity (PI) 
(reversed RIPLS 8, 14, and 
15) 
5.55 ± 0.39 4.82 ± 0.25 5.58 ± 0.35 4.59 ± 0.35 0.086 
Reversed statement 8 1.67 ± 0.198 1.43 ± 0.152 1.94 ± 0.16 1.32 ± 0.15 0.055 
Reversed statement 14 2.27 ± 0.16 2.00 ± 0.17 1.94 ± 0.14 1.72 ±0.18 0.143 
Reversed statement 15 1.61 ± 0.22 1.43 ± 0.15 1.72 ± 0.21 1.54 ± 0.13 0.696 
RIPLS 29.89 ± 1.15 29.09 ± 0.79 33.37 ± 1.64 28.90 ± 0.89   0.024* 





5.1.3.2  Students’ attitudes towards IPE based on Survey Year 2012 
and 2013 (Repeated cross sectional analysis) 
 
Repeated cross sectional analysis was conducted on Year 2, 3, and 4 students in both 
survey years. This was because there were no data for Year 1 students in Survey Year 
2013.  
Demographic characteristics of students’ participation 
Table 5.15 shows demographic characteristics of students who participated in Survey 
Years 2012 and 2013. There were some significant differences in the participants’ 
demographic characteristics between the two survey years. Participants in Survey 
Year 2012 had more health related experience (i.e. paid or voluntary working 
experience related to students’ chosen course of study) than those in Survey Year 
2013. 
 
Table 5.15 Demographic characteristics of participants in Survey Years 2012 and 2013 







Age in years (Mean ± SD)  20.21 ± 0.147 20.12 ± 0.059 0.585 
Gender (%Male/Female) 36%/64% 37.3%/62.7% 0.723 
% of students had previous health 
background  
13.1% 10.1% 0.271 
% of students had work health 
related experience 
38.9% 26.3% 0.001* 
Notes: * showed significant difference 
 
Table 5.16 shows demographic characteristics of participants in Survey Year 2012 
and 2013 based on Year of Study. There were a greater proportion of Year 2 students 
in Survey Year 2013 who had a previous health background compared to those in 
Survey Year 2012. In contrast, a greater proportion of Year 3 and Year 4 students in 
Survey Year 2012 had a previous health education background and health related 




Table 5.16 Demographic characteristics of participants based on Year of Study in Survey Years 
2012 and 2013 





Year 2    
Age (Mean ± SD)  19.4±1.89 18.8±1.90 0.071 
Gender (%Male/Female) (29%/69%) (39%56%) 0.267 
% of students had a 
previous health 
education background  
8.5% 23.4% 0.001* 
% of students had work 
health related experience 
33.1% 40.2% 0.257 
Year 3    
Age (Mean ± SD)  20.2±2.70 20.12±0.79 0.698 
Gender (%Male/Female) (37%/56.5%) (32.5%/61.6%) 0.271 
% of students who had a 
previous health 
education background  
10.5% 3.2% 0.023* 
% of students had work 
health related experience 
50.8% 19.2% 0.000* 
Year 4    
Age (Mean ± SD)  20.2±2.7 21.1±0.74 0.825 
Gender (%Male/Female) (38.8%/60.3%) (34.5%/65.5%) 0.477 
% of students who had a 
previous health 
education background  
20.7% 5.3% 0.001* 
% of students had work 
health related experience 
33.1 % 21.2% 0.043* 
Notes: * showed significant difference 
 
Table 5.17 shows healthcare students’ mean regression factor scores of the RIPLS 
sub-scales based on refined analysis on data from Survey Years 2012 and 2013. 
 
Table 5.17 Medical, nursing, and pharmacy students' mean regression factor scores on RIPLS sub-





Survey Year 2012 Survey Year 2013 





Medical 201 0.016 ± 0.070 176 0.194 ± 0.084 
Nursing 105 -0.036 ± 0.100 100 0.068 ± 0.115 
Pharmacy 63 0.007 ± 0.147 58 -0.175 ± 0.145 
Professional 
Identity (PI) 
Medical 201 -0.191 ± 0.068 174 -0.405 ± 0.075 
Nursing 105 0.628 ± 0.088 100 0.664 ± 0.106 
Pharmacy 63 0.258 ± 0.156 58 0.450 ± 0.125 
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Students’ attitudes towards IPE in Survey Year 2012 
 
Table 5.18 shows p-values calculated from ANOVA analysis of healthcare students 
(Year 2, 3 and 4) in Survey Year 2012. Multivariate analysis indicated the course of 
study variable influenced significantly the differences of mean regression factor 
scores on Professional Identity (F [2,347] =19.539, p<0.001) between students from 
different courses of study. Other variables (i.e. age, gender, previous health 
education background, and health related experience) showed no significant mean 
scores differences towards these factors. P-values of post-hoc Scheffe test on mean 
regression factor scores of the PI sub-scales (Table 5.19) showed statistically 
significant differences between medical students on this sub-scale compared to 
nursing and pharmacy students.  
 
Table 5.18 P- values of RIPLS sub-scales between medical, nursing and pharmacy students in 
Survey Year 2012  
 
RIPLS sub-scales p-value 
Shared Learning and Teamwork (SLT) 0.913 
Professional Identity (PI) 0.001* 
Notes: * showed significant difference 
 
Table 5.19 P-values on the PI sub-scale amongst medical, nursing and pharmacy students in 
Survey Year 2012 
 
Course of study Nursing Pharmacy 
Medical 0.001* 0.005* 
Nursing  0.086 
Notes: * showed significant difference 
 
Analysis on RIPLS Statements 8, 14, and 15 were also conducted because of the low 
Cronbach’s alpha values for the PI sub-scale. Table 5.20 shows healthcare students’ 
mean scores across course of study on those statements in both years of the survey. 
ANOVA testing indicated that the only significant differences for mean scores 
amongst courses of study was related to Statement 14 (p<0.001). Medical students 
had significantly lower mean scores compared to those of nursing and pharmacy 
students. Yet, their attitudes were not significantly different for Statements 8 and 15. 
This showed medical students had more positive attitudes towards statement on the 
143 
 
function of other healthcare professionals which was mainly to provide support to 
doctors. This also suggested that medical students had a stronger sense of their 
professional identity and importance than other healthcare students.  
 
Table 5.20 RIPLS Statements 8, 14, and 15 mean scores across course of study and p-values in 












Notes: * showed significant difference 
 
Students’ attitudes towards IPE in Survey Year 2013 
 
Table 5.21 shows p-values from ANOVA analysis of medical, nursing and pharmacy 
students’ attitudes on RIPLS sub-scales in Survey Year 2013. 
 
Table 5.21 P-values of RIPLS sub-scales amongst medical, nursing, and pharmacy students in 
Survey Year 2013 
RIPLS sub-scales p-value 
Shared Learning and Teamwork (SLT) 0.104 
Professional Identity (PI) 0.001* 
Notes: * showed significant difference 
 
Multivariate analysis also indicated that there were significant differences in the 
mean regression factor scores on PI sub-scale (F[2,314]= 33.198, p<0.001) between 
the different courses of study in Survey Year 2013. Multiple comparisons using a 
Scheffe test indicated that medical students had statistically significant differences 
RIPLS Statements Course of 
Study 
Survey Year 2012 
N Mean ± SE p-values 
RIPLS 8 Medical 201 3.39 ± 0.04 0.996 
Nursing 105 3.41 ±0.05 
Pharmacy 63 3.41 ±0.11 
RIPLS 14 Medical 201 2.18 ± 0.05 0.001* 
Nursing 105 3.50 ± 0.05 
Pharmacy 63 3.02 ± 0.12 
RIPLS 15 Medical 201 3.43 ± 0.04 0.155 
Nursing 105 3.58±0.06 
Pharmacy 63 3.44±0.09 
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for mean regression factor scores (i.e. more positive attitudes) for PI sub-scale 
compared to their counterparts in nursing and pharmacy (Table 5.22).  
 
 
Table 5.22 P-values of PI sub-scale amongst medical, nursing and pharmacy students in Survey 
Year 2013  
 
Course of study Nursing Pharmacy 
Medical 0.001* 0.001* 
Nursing  0.559 
Notes: * showed significant difference 
 
Table 5.23 RIPLS Statements 8, 14, and 15 mean scores across course of study in Survey Year 2013 
 
 
Notes: * showed significant difference 
 
Similar to Survey Year 2012, ANOVA analysis was also conducted in Survey Year 2013 
on healthcare students mean scores on RIPLS Statements 8, 14, and 15 which 
constructed the PI sub-scale. Table 5.23 shows that medical students had significant 
mean score differences (i.e. lower) towards those statements compared to nursing 
and pharmacy students. This indicated that medical students had stronger 
agreements towards statements constructed PI sub-scale.  
 
These findings suggested that medical students in both Survey Years 2012 and 2013 
had more agreement on statements of PI sub-scales compared to their counterparts 
RIPLS 
Statements 
Course of Study 
Survey Year 2013 
N Mean ± SE p-values 
RIPLS 8 Medical 176 3.30± 0.05 0.002* 
Nursing 100 3.52 ± 0.06 
Pharmacy 58 3.57± 0.07 
RIPLS 14 Medical 174 2.11 ± 0.06 0.001* 
Nursing 100 3.47 ± 0.06 
Pharmacy 58 2.91 ± 0.11 
RIPLS 15 Medical 174 3.31 ± 0.05 0.003* 
Nursing 100 3.55 ± 0.06 
Pharmacy 58 3.59 ± 0.07 
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in nursing and pharmacy. In contrast, there were no significant differences in the 
attitudes of nursing and pharmacy students on this sub-scale. The higher agreement 
on statements which constructed PI sub-scales indicated that medical students had a 
stronger professional identity than their counterparts in nursing and pharmacy. 
Statements 8 and 15 which constructed the PI sub-scale consisted of negative 
statements towards IPE. All healthcare students had disagreements on these 
negative statements which indicated they had positive attitudes towards IPE. 
However, medical students were significantly more positive towards the statement 
on the function of other healthcare professionals which was mainly to support 
doctors (Statement 14-which also constructed PI sub-scale). This result also indicated 
that medical students had more positive attitudes towards their professional 
identity. 
5.1.3.3 Students’ attitudes towards IPE based on Year of Study 
within health schools 
Demographic characteristics of participants based on Year of Study can be seen in 
Table 5.16. Table 5.24 shows the mean regression factor scores for the RIPLS sub-
scales and the p-values calculated from t-test analysis. As can be seen from the table, 
there were some significant differences found amongst the groups of participants. 
Multivariate analysis indicated that there were no variables (i.e. age, gender, 
previous health education background and health related activities) influencing Year 
3 pharmacy, Year 3 nursing and Year 4 medical students across the two survey years.  
 
However, age (F[6,129]= 2.866, p<0.012) and health related experience (F[1,129]= 
3.948, p<0.049) influenced Year 3 medical students’ attitudes on the PI sub-scale 
across the two survey years. Multivariate analysis indicated that there were no 
interactions amongst age and health related experience that influenced Year 3 
medical students’ attitudes on the PI sub-scale. Parameter estimates indicated that 
older Year 3 medical students had lower mean scores (i.e. more positive attitudes) 
towards the PI sub-scale than their younger colleagues. In addition, students who 
had no health related working experience had lower mean scores (i.e. more positive 
attitudes) towards PI sub-scale than those who had health related activities. Similar 
to previous analyses, more positive attitudes towards the PI sub-scale indicated that 





The mean scores differences for the RIPLS Statements 8, 14 and 15 were also 
calculated for these data. T-tests indicated that statistically significant mean score 
differences were only shown in Year 3 medical students on RIPLS Statements 8 and 
14 (Table 5.25). Year 3 medical students in 2012 had more positive attitudes towards 
learning with other healthcare students compared to those in Survey Year 2013. In 
addition, Year 3 medical students in 2012 had less support towards the role of other 
healthcare professionals as mainly to support doctors. These results indicated that 
Year 3 medical students in Survey Year 2012 had more positive attitudes towards IPE 





Table 5.24 Medical, nursing and pharmacy students' mean regression factor scores on RIPLS sub-scales based on Year of Study in Survey Years 2012 and 2013 
Course of 
Study 
RIPLS Sub-scales  Year of 
Survey 
Year of Study 
 n Year 2 Students  p-value n Year 3  
Students  
p-value n Year 4  
Students  
p-value 
Mean ± SE Mean ± SE  Mean ± SE 
Medical Shared Learning 
and Teamwork 
(SLT) 
2012 68 0.017 ± 0.111 0.911 68 0.166 ± 0.127 0.788 65 -0.142 ± 0.123 0.015* 
2013 52 0.036 ± 0.124 60 0.103 ± 0.135 61 0.410 ± 0.168 
Professional 
Identity (PI) 
2012 68 -0.218 ± 0.122 0.671 68 -0.141 ± 0.106 0.001* 65 -0.217 ± 0.123 0.680 
2013 52 -0.150 ± 0.101 61 -0.750 ± 0.137 61 -0.287 ± 0.129 
Nursing Shared Learning 
and Teamwork 
(SLT) 
2012 37 0.219 ± 0.159 0.983 35 -0.175 ± 0.182 0.912 33 -0.176 ± 0.177 0.172 
2013 30 0.215 ± 0.124 37 -0.203 ± 0.172 31 0.277 ± 0.275 
Professional 
Identity (PI) 
2012 37 0.466 ± 0.175 0.687 35 0.493 ± 0.146 0.871 33 0.634 ± 0.126 0.718 
2013 30 0.362 ± 0.187 37 0.824 ± 0.138 31 0.731 ± 0.233 
Pharmacy Shared Learning 
and Teamwork 
(SLT) 
2012 23 -0.263 ± 0.173 0.370 18 0.553 ± 0.361 0.052 22 -0.156 ± 0.214 0.779 
2013 19 -0.164 ± 0.287 20 -0.315 ± 0.228 19 0.052 ± 0.241 
Professional 
Identity (PI) 
2012 23 0.405 ± 0.209 0.794 18 -0.334 ± 0.353 0.036* 22 0.589 ± 0.232 0.664 
2013 19 0.327 ± 0.211 20 0.571 ± 0.210 19 0.445 ± 0.234 




Table 5.25 RIPLS Statements 8, and 14 mean scores in Year 3 medical students in Survey Year 2012 
and 2013 
Group Year of 
Survey 
RIPLS 8 
(Mean ± SE) 
p-value RIPLS 14 





2012 3.44±0.07 0.002* 2.25 ± 0.09 0.03* 
 2013 3.08±0.09 1.95 ± 0.10 
Notes: * showed significant difference 
5.1.3.4 Students’ attitudes towards IPE as they progress through 
their chosen course of study at health schools (Trend 
Analysis) 
Demographic characteristics of students’ participation 
Table 5.26 shows demographic characteristics of the students involved in the trend 
analysis in Survey Years 2012 and 2013. This study involved surveying a random 
sample of the Year 1, Year 2 and Year 3 students in 2012, and then repeating the 
same in 2013 using a random sample of the Year 2, Year 3 and Year 4 students. The 
intent of this study was to assess whether time spent within the students’ course of 
study influenced their attitudes towards IPE.  
 
There were no significant differences in the demographic characteristics of the Year 
1 Cohort when comparing students who participated in Survey Year 2012 and Survey 
Year 2013 (Table 5.26). However, in the Year 2 Cohort, students who participated in 
Survey Year 2012 were younger and had more health related experience than those 
from Survey Year 2013. Similarly, in the Year 3 Cohort, students who participated in 
Survey Year 2012 were younger; had a lower proportion of males; and had more 




Table 5.26 Demographic characteristics of participants in cohort Year 1, 2, and 3 in Survey Year 
2012 and 2013  






Year 1 Cohort    
Year of Study Year 1 Year 2  
Age (Mean±SD)  18.5±0.68 18.8±1.90 0.054 
Gender (%Male/Female) 31%/66% 39%56% 0.267 
Medical/Nursing/Pharmacy 
(N) 
57/33/18 52/30/19 0.927 
% of students had previous 
health background  
23.9% 23.4% 0.926 
% of students had health 
related experience 
39.8% 40.2% 0.956 
Year 2 Cohort    
Year of Study Year 2 Year 3  
Age (Mean±SD)  19.4±1.89 20.12±0.79 0.000* 
Gender (%Male/Female) 29%/69% 32.5%/61.6% 0.426 
Medical/Nursing/Pharmacy 
(N) 
68/37/23 61/37/20 0.879 
% of students had previous 
health background  
8.5% 3.2% 0.074 
% of students had health 
related experience 
33.1% 19.2% 0.012* 
Year 3 Cohort    
Year of Study Year 3 Year 4  
Age (Mean±SD)  20.2±2.7 21.1±0.74 0.010* 
Gender (%Male/Female) 32.5%/65.5% 34.5%/65.5% 0.017* 
Medical/Nursing/Pharmacy 
(N) 
68/35/18 62/31/19 0.989 
% of students had previous 
health background  
10.5% 5.3% 0.143 
% of students had health 
related experience 
50.8% 21.2% 0.000* 
Notes: * showed significant difference 
Students’ attitudes towards IPE as they progressed through their chosen 
course  
Participants in the current study were selected randomly for both survey years, thus, 
the participants were treated as an independent variable. Students’ attitudes 
towards RIPLS sub-scales were reported based on changes of students’ mean 
regression factor scores as they progressed through their courses. T-test was 
employed to analyse healthcare students’ attitudinal changes during their course of 
study for each cohort.  
 
Table 5.27 shows the RIPLS mean regression factor scores amongst students as they 
progressed through their course of study (e.g. Year 1 Cohort refers to Year 1 
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pharmacy students in Survey Year 2012 vs Year 2 pharmacy students in Survey Year 
2013). The table also displays p-values of t-test analyses to determine any significant 
changes in the students’ mean regression factor scores over time. As can be seen 
from Table 5.27, only Year 2 Cohort medical students showed significant differences 
in mean regression factor scores for the PI sub-scale (p=0.004) as they progressed 
through their course. The students’ mean regression factor scores on this sub-scale 
were significantly lower (i.e. more positive attitudes) as they progressed in their 
studies. Once again, similar to findings from other analyses, more positive attitudes 
towards the PI sub-scale suggested that this cohort of medical students had more 
positive attitudes towards their own professional identity. This indicated that the 
Year 2 Cohort medical students showed improvement in their attitudes towards the 
PI sub-scale from 2012 to 2013. More positive attitudes towards this sub-scale also 
suggested that Year 2 Cohort medical students had less positive attitudes towards 
IPE as they progressed through their study. Multivariate analysis indicated that age 
was the only significant contributor influencing Year 2 Cohort medical students’ 
attitudes changes towards the PI sub-scale (F[5,128]= 3.479, p= 0.006) sub-scale. 
Parameter estimates indicated that older Year 2 Cohort medical students had lower 
mean regression factor scores (i.e. more positive attitudes) for this sub-scale 





Table 5.27 Students' mean regression factor scores on RIPLS sub-scales as they progressed through in the course of study 
Course of Study RIPLS Sub-scales  Year of 
Survey 
Cohort 
Year 1  Year 2  Year 3  
n Mean ± SE p-value n Mean ± SE  p-value n Mean ± SE  p-value 
Medical Shared Learning and 
Teamwork (SLT) 
2012 57 -0.086 ± 0.125 0.493 68 0.017 ± 0.111 0.571 68 0.166 ± 0.128 0.320 
2013  52 0.036 ± 0.124 61 0.116 ± 0.135 62 0.375 ± 0.168 
Professional Identity 
(PI) 
2012 57 -0.089 ± 0.115 0.693 68 -0.218 ± 0.122 0.004* 68 -0.141 ± 0.106 0.369 
2013 52 -0.150 ± 0.101 61 -0.750 ± 0.138 62 -0.292 ± 0.129 
Nursing Shared Learning and 
Teamwork (SLT) 
2012 33 0.149 ± 0.153 0.745 37 0.219 ± 0.159 0.076 35 -0.176 ±  0.182 0.166 
2013  30 0.215 ± 0.124 3737 
37 37 
37 
-0.203 ± 0.176 31 0.277 ± 0.275 
Professional Identity 
(PI) 
2012 33 0.511 ± 0.170 0.558 37 0.466 ± 0.176 0.114 35 0.792 ± 0.147 0.822 
2013 30 0.363 ± 0.188 3737 
37 37 
37 
0.825 ± 0.139 31 0.731 ± 0.233 
Pharmacy Shared Learning and 
Teamwork (SLT) 
2012 18 -0.147 ± 0.228 0.611 23 -0.263 ± 0.173 0.854 18 0.533 ± 0.362 0.071 
2013  19 0.043 ± 0.287 20 -0.315 ± 0.228 19 -0.247 ± 0.241 
Professional Identity 
(PI) 
2012 18 0.001± 0.302 0.378 23 0.405 ± 0.209 0.579 18 -0.334 ± 0.353 0.072 
2013 19 0.327 ± 0.211 20 0.572 ± 0.210 19 0.445 ± 0.235 




Further, analysis of RIPLS Statements 8, 14 and 15 were also conducted for this data 
set. T-tests indicated that only RIPLS Statement 8 was significantly different amongst 
Year 2 Cohort medical students as they progressed through their course (Table 5.28). 
The table shows that Year 2 Cohort medical students as they progressed through 
their course had more positive attitudes towards Statement 8 “It is not necessary for 
undergraduate healthcare students to learn together”. This indicated that Year 2 
Cohort medical students had less positive attitudes towards learning with other 
healthcare students.  
 
Table 5.28 RIPLS Statements 8 mean scores and p-values in Cohort Year 2 medical students in 
Survey Year 2012 and 2013 
 
Group Year of Survey RIPLS 8 
(Mean ± SE) 
p-value 
Year 2 medical 
students 
2012 3.34±0.07 0.03* 
 2013 3.08±0.09 
Notes: * showed significant difference 
 
The changes of mean regression factor scores for Year 1, 2, and 3 Cohorts of medical, 
nursing and pharmacy students in Survey Year 2012 and 2013 are shown in Figures 
5.4; 5.5 and 5.6. Figure 5.4 shows all Year 1 Cohort healthcare students’ from the 
three courses moved towards less positive attitudes on SLT sub-scale as they moved 
along in their chosen course of study.  
 
Figure 5.5 displays Year 2 Cohort had different attitudes on the PI sub-scale in the 
different courses of study. Year 2 Cohort medical students had more positive 
attitudes towards the PI sub-scale as they progressed through their study. 
Meanwhile, the Year 2 Cohorts of nursing and pharmacy students moved towards 
less positive attitudes towards the sub-scale. Figure 5.6 shows Year 3 Cohort medical 
and nursing students moved towards more positive attitudes towards PI sub-scale, 
on the contrary, pharmacy students of the same cohort showed less positive 
attitudes on this sub-scale.  
 
Furthermore, all cohorts (as seen on Figures 5.4 to 5.6) of medical students 
consistently showed more positive attitudes on PI sub-scale as they moved along the 
course at medical school. Yet, they had less positive attitudes towards SLT sub-scale 
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in all cohorts. In contrast, all cohorts of pharmacy students had consistently less 
positive attitudes on PI sub-scale as they moved along their course in pharmacy. 
Meanwhile, Year 1 Cohort nursing students had more positive attitudes towards the 
PI sub-scale, while the Year 2 and 3 Cohorts had less positive attitudes towards this 
sub-scale.  
 
The findings of trend analysis showed that medical students had less positive 
attitudes towards learning with other healthcare students. These were shown from 
less positive attitudes towards the SLT sub-scale and more positive attitudes towards 
the PI sub-scale. The most significant difference of medical students’ attitudes 
towards PI sub-scale was seen in the Year 2 Cohort.   
 
 
Figure 5.4 Medical, nursing and pharmacy students’ Year 1 Cohort changes in mean regression 









Notes: * showed significant difference 
 
Figure 5.5 Medical, nursing and pharmacy students’ Year 2 Cohort changes in mean regression 











Figure 5.6 Medical, nursing and pharmacy students’ Year 3 Cohort changes in mean regression 









5.1.4 DISCUSSION ON HEALTHCARE STUDENTS’ ATTITUDES 
TOWARDS IPE 
This study employed the RIPLS questionnaire to identify healthcare students’ 
willingness to engage in IPE. This questionnaire previously validated and has been 
used extensively in the literature. 66, 294, 296 Macfadyen et al. suggested that the 
original questionnaire had unstable sub-scales, thus they recommended researchers 
should use the questionnaire with caution.296 A recent Indonesian study employing 
RIPLS questionnaire found three sub-scales constructed the questionnaire, namely 
Teamwork and Collaboration, Positive and Negative Professional Identity sub-scales 
using 16 items of RIPLS questionnaire.294 However, in the present study, although it 
was also conducted in Indonesia, it retrieved different sub-scales (Shared Learning 
and Teamwork and Professional Identity). EFA (Explanatory Factor Analysis) retrieved 
three sub-scales, CFA (Confirmatory Factor Analysis) test indicated that the Roles and 
Responsibility sub-scale had no correlation with the other two sub-scales, thus, the 
modified RIPLS questionnaire in the present study constructed two sub-scales. The 
different sub-scales constructed may result from items employed in both studies 
being slightly different. The present study used a RIPLS survey which had been 
modified at Curtin University,264 meanwhile the study which was conducted in 
another province in Indonesia used 16 of 19 items from the original RIPLS.  
 
Cross sectional results of this study found that medical, nursing and pharmacy 
students’ attitudes towards IPE were generally positive. These positive attitudes 
towards IPE existed despite the fact that no IPE activities had been conducted at the 
university where the study was undertaken. Thus, as a new initiative participants’ 
attitudes may be positive. Furthermore, the overall positive attitudes towards IPE 
may also be influenced by the high level of disagreement on negative statements 
(Statements 8 and 15) from some participants. Participants in a survey tend to 
disagree more with negative statements than to agree with positive statements,302 
which may influence the direction of participants’ responses in the survey.  
 
This study also found that medical students had less positive attitudes towards IPE 
than those of nursing and pharmacy students. This finding was similar to that found 
in the literature. Curran et al. identified that medical students had less positive 
attitudes compared to nursing, pharmacy and social work students towards IPE.259 
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Subsequently to the administration of the RIPLS questionnaire in the study university, 
an unpublished report of a national multi-centre study in Indonesia in 2012 identified 
similar results where the medical students had the least positive attitudes towards 
IPE compared to other healthcare students.303 Further analysis of the RIPLS sub-
scales in this study revealed medical students’ attitudes towards the PI sub-scale 
were significantly more positive than nursing and pharmacy. Statements constructing 
this sub-scale were negative statements (unfavourable) towards IPE. This also 
suggested that medical students had less positive attitudes towards IPE. 
 
Although the overall mean scores towards IPE for medical students were less positive 
than nursing and pharmacy students, medical students had more positive attitudes 
towards the importance of learning with other healthcare students (Statement 4). 
This positive attitude may result from a tendency of participants to present 
themselves in a favourable light which was influenced by culturally acceptable and 
appropriate behaviour.304 This is one of the common biases in a survey which is 
known as social desirability bias. This bias may hide the true relationship between 
variables in the study.  
 
There were different directions of healthcare students’ levels of agreement towards 
negative Statements 8, 14, and 15 (which constructed a PI sub-scale). Medical 
students’ attitudes towards RIPLS Statement 8 and 15 were not significantly different 
compared to nursing and pharmacy students. However, the medical students had 
significantly more positive attitudes towards RIPLS statement 14 (The function of 
allied health professionals is mainly to provide support for doctors) than nursing and 
pharmacy students. This suggested that medical students in this study had strong 
positive attitudes towards their professional identity. These different directions may 
explain the low Cronbach’s alpha score on the PI sub-scale. Although reversed coded 
the scores for Statements 14 were shown to have the same direction as those for 
Statements 8 and 15, with the Cronbach’s alpha remaining low for this sub-scale. As a 
consequence, healthcare students’ attitudes towards the statements which 
constructed the sub-scale (Statement 8, 14, and 15) were also employed in data 
analysis to examine the significant differences on statements which may influence 





Analysing healthcare students’ mean score differences based on their responses to 
statements which constructed the sub-scales may be invalid in repeated and trend 
analysis. This was because some students may have received the questionnaire in 
both Survey Years 2012 and 2013. Thus, to reduce method bias, students’ responses 
towards RIPLS sub-scales were analysed based on mean regression factor scores 
which had been standardised based on factor loading of the sub-scales, students’ 
means and standard deviations of sub-scales retrieved from factor analysis in Survey 
Year 2012. However, because results of a cross-sectional study (Section 5.1.3.2) 
indicated healthcare students’ attitudes towards the statements which constructed 
PI sub-scale had different directions of agreement, consequently, analysis of 
healthcare students’ attitudes towards Statement 8, 14 and 15 were also employed. 
 
Repeated cross sectional analysis in the current study also found that medical 
students had more positive attitudes towards the PI sub-scale but no significant 
differences in attitudes towards the SLT sub-scale compared to nursing and 
pharmacy student in both Survey Years 2012 and 2013. This suggested that the 
attitudes of students from the three health courses towards RIPLS sub-scales were 
consistent in both survey years. The medical students will be physicians in the future. 
The positive attitudes found in medical students towards PI sub-scale as a perceived 
belief in superiority towards their own profession compared to other professions 
may result from the fact that medicine is a mature profession which has long been 
known for its autonomy in decision making in healthcare.72 This autonomy in decision 
making may influence the culture of healthcare service delivery where physicians 
consider themselves as the leader in healthcare service. In addition, they may 
perceive the roles of other healthcare professionals mainly to support the physician. 
This was also reflected in the results of cross sectional study (Section 5.1.3.1 and 
5.1.3.2) where medical students had more positive attitudes towards Statement 14 
than their counterparts in nursing and pharmacy.  
 
Furthermore, trend analysis showed that all cohorts of medical students had more 
positive attitudes towards PI sub-scale but less positive attitudes on SLT sub-scale as 
they progressed through the course. Year 2 Cohort medical students’ attitudes on the 
PI sub-scale were also significantly more positive as they progressed through their 
courses from 2012 to 2013. Multivariate analysis indicated that these students’ 
attitudes were influenced by their age where older students had more positive 
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attitudes on this sub-scale than younger students. The PI sub-scale was constructed 
of negative statements towards IPE which indicated that Year 2 Cohort medical 
students had less positive attitudes (unfavourable) towards IPE as they progressed 
through their study. This result was also confirmed from further analysis of RIPLS 
Statement 8. It showed that Year 2 Cohort medical students had less positive 
attitudes towards learning with other healthcare students as they progressed 
through their course of study.  
 
The above findings indicated that medical students may have gained professional 
socialisation during their learning in the university. Year 2 medical students were 
taught important units (i.e. infection and infectious diseases; and immune systems 
and disorders). In addition, most of the lectures at the medical school were delivered 
by medical specialist practitioners from the local teaching hospitals. The learning 
tasks were designed to develop medical students’ knowledge, skills and attitudes as 
medical doctors. Being exposed to medical practitioners in their field of practice 
during their course may have improved their professional socialisation. Trede et al. in 
a review on higher education suggested that students need to learn from the 
lecturers who engaged in practice to obtain a clearer understanding on their 
professional identity.305  
 
Nursing students in the current university may also have been taught important units 
(i.e. cardiovascular and respiratory blocks) in Year 1. However, in comparison to 
stronger agreement towards PI sub-scale amongst medical students as they 
progressed through in their chosen course, the nursing students had no significant 
different attitudes towards this sub-scale. The difference in attitudes towards this 
sub-scale between medical and nursing students may result from the different extent 
of professional socialisation amongst the different courses of study.306 Wynd stated 
that different beliefs in public service, as well as less autonomy for nurses, 
contributed to the difference in nurse’s professional identity development.  
 
Meanwhile, pharmacy students’ curriculum in the present university course was 
focused on pharmaceutical sciences with little exposure to patient care. Less than 
10% of pharmacy students’ curriculum was on pharmacotherapy and patient care 
related topics. Further, the topic of clinical pharmacy and pharmacotherapy were 
optional units for pharmacy undergraduates. These two units are considered 
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essential in students’ engagement with patient care delivery. The lack of exposure to 
these units amongst pharmacy students may explain the trend of less positive 
attitudes towards the PI sub-scale in pharmacy students in the three cohorts. In 
addition, the result of the mean scores on RIPLS Statement 14 in the cross sectional 
study as well as in the repeated cross sectional study showed that pharmacy and 
nursing students had significantly different attitudes towards this statement 
compared to those of medical students. Yet, pharmacy students’ had more 
agreement than nursing students on Statement 14 (The function of allied healthcare 
professionals is mainly to provide support for doctors). This may suggest that 
pharmacy students had less sense of their professional identity than nursing 
students. This may reflect a lack of pharmacy students’ confidence in their 
professional identity and may also imply the lack of understanding of their role or 
professional responsibility.  
 
The less positive attitudes towards the PI sub-scale in nursing and pharmacy students 
may suggest that they may not have a clear understanding on their professions’ roles 
within the healthcare system due to lack of educational role model. This may be 
because of the roles of the nurse and pharmacist professions are less well defined in 
the current health system than that of the physician. Studies showed that role 
models are essential in professionalism formation.307-309 This could be seen in medical 
students where they had stronger sense towards professional identity because the 
physician’s role in the health system is clear. Physicians have the most hierarchical 
authority and autonomy in delivering their care.306 In contrast, nurses often have 
lower autonomy and tend to follow orders from physicians.  
 
In the literature, debate on professional identity of nurses and pharmacists 
remains.310-312 Lai and Lim argued that nurses’ professional socialisation is influenced 
by two sociological conditions (structural and cultural). Structural conditions involved 
hospital and job descriptions while cultural conditions included systems prevalent in 
the society as expressed in wards, symbols, and ceremonies.309 These may include 
nurses’ uniforms and medical tools attached to physicians. Further, they suggested 
professional socialisation in nursing is essential to foster nurses’ professional identity. 
It was suggested that professional identity development in nursing required moral 
maturity to reflect their professional and personal growth in caring.311 Partnerships 
amongst nurse academics and practitioners were also deemed to be essential in 
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nurses’ professional identity development,311, 313 so that nursing students could 
foresee their future career from nurses practitioners.  
 
Pharmacists’ professional identity is also less well defined in the literature. Noble 
concluded the ambiguity of pharmacist’s role may be influenced by the fact that 
pharmacy curricula had less engagement with patients.314 This fact was also current 
in the pharmacy curriculum of the study university. Furthermore, an Indonesian 
study found that pharmacists in the country had limited participation in professional 
activity.175 This may result in a further uncertainty of the role of pharmacists in 
healthcare delivery in the country. The lack of role models for nurses and 
pharmacists in the study university may explain the lesser sense of professional 
identity amongst nursing and pharmacy students in this study.  
 
Although the cross sectional study in Survey Year 2012 showed medical students had 
more positive attitudes towards the importance of learning with other healthcare 
students (Statement 4), trend analysis identified all cohorts of medical students had 
less positive attitudes towards SLT sub-scale. Khalili et al. suggested that strong uni-
professional identity may lead to strong cohesiveness to their own profession but 
less acceptance of working with other professions.315 Further, they stated that if 
those who have strong uni-professional identity learned together with those who 
have lack of uni-professional identity; there may be ineffective interprofessional 
learning. In support, Wackerhausen316 argued that strong professional identity may 
inhibit interprofessional learning.  
 
Professional identity is an outcome of professional socialisation.309 Professional 
identity portrays professional attributes, professional self-image and behaviour. 
Wackerhausen316 stated that professional identity could be presented at the micro 
and macro levels. Micro level included culture dimensions which may involve 
habitual ways of talking, explaining, perceiving, valuing, doing and assuming based on 
one’s profession. He considered these dimensions may be exhibited by a person in a 
profession. Meanwhile, the macro level of professional identity included public 
perception, privileges, duties, regulation and self-image promoted by profession’s 
leaders. Meanwhile, professional socialisation is a complex process and requires 
interaction within the profession and a reflective nature during the learning 
process.317, 318 This socialisation is influenced by beliefs and values promoted during 
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the learning process. In the learning process of becoming a professional, healthcare 
students observe, experience and evaluate being a professional.319 Studying longer at 
university, healthcare students not only learn knowledge, skills, and attitudes but 
also values, norms and subcultures of their own professions.317, 320  
 
To promote effective interprofessional learning amongst healthcare students, Khalili 
et al. proposed fostering interprofessional socialisation.315 As opposed to professional 
socialisation, in interprofessional socialisation, intergroup contact theory and social 
identity theory were adopted to foster dual identity (Uni-professional Identity and 
Inter-professional Identity). The adoption of this dual identity is suggested to 
maintain interprofessional learning which can lead to continuing interprofessional 
collaboration in the future. Thus, continuing interprofessional collaboration will be 
very beneficial for future healthcare providers to improve teamwork in healthcare 
delivery.  
 
In support to overcome strong professional identity, Wackerhausen316 suggested a 
second order reflection. This reflection involved being a stranger in one’s own 
profession. Although a second order reflection which may not be easy to implement, 
it is an essential transformation of professional education for collaboration to work. 
He argued that being a stranger to their own profession may endanger a stable 
profession because they could be seen as an attacker of their own profession. 
Wackerhausen also argued that the purpose of professional existence remains, he 
named this term raison d’eˆtre. Second order reflection could mean interprofessional 
reflection thus it could address barriers of interprofessionalism resulting from strong 
professional identity. This suggests that because medical students at the study 
university had strong professional identity, they need to have a second order 
reflection during their learning if IPE is implemented in their curricula. In addition, 
involving teachers other than doctors was considered to provide a profound benefit 
to medical students learning which may emphasise the importance of other 
healthcare professionals.200 Further, it was suggested that other healthcare 
professionals may also enhance medical students understanding of the impact of 
disease on the patient, which may be neglected when medical students are taught by 




The results from trend analysis demonstrated that Year 1 Cohort in medical, nursing 
and pharmacy students showed less agreement towards SLT sub-scale as they 
progressed through their chosen course. This suggested that IPE needs to be initiated 
early in healthcare students’ education so that interprofessional socialisation can be 
fostered early in students’ courses of study. This is to prevent negative stereotypes 
which may prevent effective IPE in practice.196 This study also found that a strong 
sense of professional identity in medical students may be one of the barriers to 
interprofessional learning at the current university. Therefore, besides fostering IPE 
early in healthcare students’ curriculum, continuous reflection of the learning 
process is essential to gain the utmost benefits of implementing IPE in the current 
university. Furthermore, in order to improve the sense of professional identity 
amongst nursing and pharmacy students, nurses and pharmacists who worked as 
practitioners should also be involved during their learning so that these students 
have proper professional socialisation from practitioners in their professions.  
 
There were some limitations to this study. Firstly, despite the fact that the power of 
analysis was anticipated at 0.8 with the sample size being stratified across the health 
courses and year of studies and the response rate being high (more than 80% from 
each courses and Survey Year); there were very little significant differences in the 
present study. This result may associate with the unequal sample size across the 
courses or may be related to the lack of relationship between the groups in the 
present study.321 Secondly, other studies suggested that Statements 17, 18 and 19 in 
Parsel and Bligh questionnaire were considered unstable to construct a RIPLS survey 
because of low reliability.294, 296 These statements were Statement 14, 15, 16 and 17 
of the current questionnaire. McFadyen et al. argued that studies had shown 
employing those statements in RIPLS questionnaire had low internal consistency, 
thus they suggested researchers should take careful consideration when using the 
RIPLS questionnaire.296 This fact may explain some anomalies found in students’ 
attitudes towards the PI sub-scale (which was also constructed from Statement 14 
and 15). Year 3 medical students without having health related experience (e.g. paid 
or voluntary activities related to their roles) had more positive attitudes towards this 
sub-scale than those who had such experience. In addition, Year 1 nursing students 
also had stronger agreement towards Statement 14 than their seniors. In addition, 
analysis on RIPLS Statements 8, 14, and 15 in Survey Year 2013 may be more 
accurate if it was corrected based on means and standard deviations from Survey 
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Year 2012 to adjust for students who may participate in both survey years. However, 
the aim of the analysis of these statements was to obtain confirmation on where the 
significant differences were found in the mean regression factor scores on the PI sub-
scale in repeated and trend analysis. Thus, analysing these statements towards their 
raw mean scores was deemed to be more practical than adjusting the mean scores 
based on that in Survey Year 2012. The other limitation was the longitudinal study 
should have been conducted at an individual level so that bias from individual factors 
could be eliminated. However, in this study, the changes of healthcare students’ 
attitudes were assessed based on the population to identify the trend of changes in 
the population.  
5.2 IPL WORKSHOP ON MEDICATION SAFETY 
5.2.1 DEMOGRAPHIC CHARACTERISTICS 
Twenty-one medical, 16 nursing and 22 pharmacy students attended the first day of 
the IPL workshop. While on the second day, 10 medical, 10 nursing and 15 pharmacy 
students completed the post-workshop questionnaire. These respondents were 
made up of 22 (63%) female and 13 (37%) male students.  
5.2.2 QUANTITATIVE ANALYSIS OF PRE- AND POST-
WORKSHOP QUESTIONNAIRES 
Wilcoxon’s test indicated that RIPLS statements 1, 3, 6, 10, 11, 12 and 13 were 
significantly different pre-post workshop, p<0.05 (Table 5.29). These statements 
were components of the Shared Learning and Teamwork (SLT) sub-scale of the 
modified RIPLS questionnaire in the current study. This showed that the 
interprofessional learning workshop had changed students’ attitudes towards 
agreement on the importance of shared learning and working in a team with other 
healthcare students. In addition, responses to the RIPLS Statement 8 (It is not 
necessary for undergraduate healthcare students to learn together) showed no 
significant differences between the RIPLS pre- and post- workshop questionnaire (p = 
0.617) which indicated that the healthcare students agreed to similar extents with 
this statement. 
  
Despite the fact that the students’ attitudes toward the SLT sub-scale moved toward 
agreement, students from the three schools showed significant differences toward 
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the importance of learning teamwork skills. This was shown from students’ responses 
to RIPLS statement 4 (Team working skills are essential for all healthcare students to 
learn). Fisher’s exact test value (p=0.011) for this statement was significantly 
different across the three cohorts of students before and after attending the 
workshop (Table 5.29). Medical students’ responses moved towards disagreement on 
this statement in the post-workshop questionnaire, whilst those of pharmacy 
students became more positive, and those of nursing students’ remained unchanged 
(Figure 5.7). This may suggest that medical students had less agreement on the 
necessity to learn teamwork skills after attending the workshop.  
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Table 5.29 Students' mean scores on RIPLS statements before and after attending IPL workshop 
 
RIPLS Statement Pre-Test 
(Mean ± SD) 
Post-Test 
(Mean ± SD) 
Wilcoxon 
p-value 





1. Learning with other students will help 
me become a more effective member of 
a healthcare team 
1.63 ± 0.490 1.26 ± 0.423 < 0. 01* 0.640 
2. Patient would ultimately benefit if 
healthcare students worked together 
1.46 ±0.505 1.31 ± 0.471 0.197 0.162 
3. Shared learning with other healthcare 
students will increase my ability to 
understand clinical problems 
1.63 ± 0.490 1.34 ± 0.482 < 0.05* 0.643 
4. Team working skills are essential for 
all healthcare students to learn 
1.40 ± 0.497 1.31 ± 0.471 0.439 0.011* 
5. Shared learning will help me 
understand my own professional 
limitations 
1.77 ± 0.598 1.71 ± 0.519 0.480 0.899 
6. Learning between healthcare 
students before qualification would 
improve working relationships after 
qualification 
1.60 ± 0.497 1.29 ± 0.458 < 0.01* 0.101 
7. Shared learning will help me think 
positively about other healthcare 
professionals 
1.63 ± 0.490 1.49 ± 0.507 0.225 0.052 
8. It is not necessary for undergraduate 
healthcare students to learn together 
3.46 ± 0.482 3.46 ± 0.701 0.617 0.103 
9. Shared learning with other healthcare 
students will help me communicate 
better with patients 
1.83 ± 0.453 1.66 ± 0.684 0.186 0.165 
10. Shared learning with other 
healthcare students will help me 
communicate better with other 
professionals 
1.74 ± 0.443 1.49 ± 0.562 < 0.05* 0.901 
11. I would welcome the opportunity to 
work together with other healthcare 
students 
1.71 ± 0.458 1.46 ± 0.505 < 0.01* 0.700 
12. Shared learning will help me clarify 
the nature of patient problems 
1.71 ± 0.458 1.40 ± 0.497 < 0.01* 1.000 
13. Shared learning before qualification 
will help me become a better team 
worker 
1.71 ± 0.458 1.31 ± 0.471 < 0.01* 0.319 
14. The function of allied health 
professionals is mainly to provide 
support for doctors 
3.00 ± 0.686 3.11 ± 0.676 0.248 0.265 
15. I am not sure what my professional 
role will be 
3.29 ± 0.710 3.40 ± 0.604 0.439 0.356 
16. I have to acquire much more 
knowledge than other healthcare 
students 
2.03 ± 0.568 2.17 ± 0.707 0.096 0.174 
17. I have to acquire many more skills 
than other healthcare students 
2.03 ± 0.568 2.23 ± 0.731 0.052 0.768 





Figure 5.7 Changes of mean scores in medical, nursing and pharmacy students’ towards RIPLS 
Statement 4 after attending IPL workshop on medication safety. 
 
5.2.2.1 Qualitative results 
An inductive approach was employed to analyse healthcare students’ responses to 
open-ended questions. Healthcare students’ responses on those questions were 
categorised into several themes in each question. Qualitative analysis showed that 
the workshop had changed healthcare students’ view on the importance of 
teamwork and on understanding the roles, responsibility and limitation of healthcare 
professionals. The students also believed that they perceived a gain in teamwork 
experience and communication skills after the workshop. Table 5.30 shows themes 





























Table 5.30 Themes identified in the open-ended post-workshop questionnaire 
 
Post Workshop Questions Themes  
How the workshop has changed your 
view of the roles of other healthcare 
providers? 
 Understanding roles and responsibility of other 
healthcare professionals 
 The importance of teamwork  
 The importance of communication among 
healthcare provider in patient care  
How the workshop has enhanced your 
ability to interact with other students? 
 Gain teamwork experience and its importance 
 Improve communication skills 
 Open-minded to the roles, responsibility and 
limitation of healthcare professionals 
 Improve confident, respect, and trust 
What is the best aspect of the 
workshop? 
 Discussion session with other healthcare 
students  
 Experience to share ideas and knowledge with 
other healthcare students in a team as a practice 
of real world  
 More understanding on other healthcare 
professional roles 
 Have more friends from different health 
background 
 
Understanding roles and responsibility of healthcare professionals and the 
importance of teamwork in healthcare were identified as major themes on how the 
workshop had changed healthcare students’ view of the roles of other healthcare 
providers (Table 5.30). They also gained understanding on the importance of 
communication in healthcare services in patient care.  
 
“The workshop has improved my understanding on the importance of other 
healthcare professionals and I gained experiences on how to communicate and to 
work in a team (P5- Medical student).”   
 
“I had more understanding on the roles of healthcare professional and on the 
importance of working with others to improve healthcare service after attending 
this workshop (P1- Pharmacy student)”  
 
“…I realised the importance of working in a team with other healthcare providers 
after attending this workshop…” (P21- Pharmacy student) 
 
The students believed that the workshop enhanced their teamwork and 
communication skills in working with other healthcare professionals. In addition, the 
students stated that the workshop improved understanding on the roles, 
responsibility and limitation of other healthcare professionals. Lastly, the healthcare 
students stated that the workshop had improved their confidence, respect, and trust 
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after interacting with other healthcare students. The following are some students’ 
responses. 
 
“….The workshop has helped me to learn on how to communicate effectively 
with other healthcare professional. This is very important for my future 
practice” (P3- Nursing student)  
 
“…In the workshop I could share my knowledge. I found a connection while 
working with other healthcare students” (P10- Nursing student) 
 
“ improve trust to other healthcare professionals” (P4- Medical student) 
 
“the workshop improve my confidence and respect for each other…” (P21- 
Pharmacy student) 
 
The healthcare students stated that the discussion session with other healthcare 
students was the best aspect of the workshop. Other themes that were identified 
from this question were opportunities to share ideas and knowledge during case 
discussion, gained knowledge and teamwork experience, became open- minded, had 
more friends from different health background and improved understanding on the 
roles of other healthcare professionals. The following extracts demonstrate some of 
students’ responses.  
 
“…discussion session with other healthcare students was the best experience I 
gained because it was a rare opportunity” (P13- Nursing student) 
 
“…small group discussion to discuss case with other healthcare students who 
have different perspective based on their professions. I thought this was very 
useful for the future.” (P22- Medical student) 
 
All healthcare students showed agreement that the workshop has improved their 
knowledge on medication safety, with 71.4% students strongly agreeing and 28.6% 
students agreeing with the statement that “understanding medication safety will be 
beneficial for their future roles as healthcare providers”. All healthcare students also 
strongly agreed on the importance of learning about medication safety at the 
undergraduate level. With regards to professionals who were responsible to ensure 
medication safety, the healthcare students agreed that all healthcare providers have 
the responsibility of ensuring the safe use of medication.  
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5.2.2.2  Discussion on IPL workshop 
This study indicated that an IPL workshop on medication safety involving medical, 
nursing and pharmacy students improved students’ attitudes towards RIPLS SLT sub-
scale. The change in attitudes after attending the workshop was at Level 2a 
outcomes of IPE (See Table 1.7). Participants also stated that they obtained an 
understanding of the roles, responsibility and limitations of other health professions, 
as well as gaining teamwork and communication experiences with other healthcare 
students during the activity. This study suggested an increased positivity towards 
shared learning, teamwork and communication after attending an IPL workshop. This 
meant that participants of the present study also acquired knowledge and skills of IPE 
which was at a Level 2b outcome of IPE (See Table 1.7). The finding that medical 
students’ perceptions towards the need to learn to work in a team was less 
important following the workshop may be related to the strong professional identity 
of medical students in general. This needs further investigation prior to implementing 
IPE in the study university.  
 
The present study adopted the IPL workshop on medication safety as an initiative for 
IPL undertaken at Curtin University in 2008.264 This study found that the IPL workshop 
improved students’ attitudes towards SLT sub-scale with other healthcare students. 
This can be seen from the significant differences in students’ response on Statements 
1, 3, 6, 10, 11, 12, and 13 which constructed the SLT sub-scale, before and after 
attending the workshop. These findings were similar to those achieved at Curtin 
University. However, participants of the IPL workshop at Curtin thought more 
positively towards RIPLS Statement 7 (Shared learning will help me think positively 
about other healthcare professionals) after attending the workshop, whereas, no 
significant difference on this statement was seen in the present study.  
 
The open ended questions in the post-workshop questionnaire revealed that 
healthcare students perceived to acquire teamwork experience after attending the 
workshop. The above facts showed that in spite of the difference amongst healthcare 
students from the three cohorts towards attitudes on the importance to learn 
teamwork skills during their undergraduate years, they agreed that the IPL 




The students also recognised that the workshop provided an opportunity to 
understand the roles of other healthcare providers and to interact with other 
healthcare students. In addition, some students claimed that respect and trust was 
built during the workshop. This result was consistent with findings in the literature on 
the outcomes of IPE activities such as respect, trust, teamwork, communication skills 
and understanding on the roles of other professions.85, 182, 322 Similarly, Pollard and 
Miers323 found that health and social care students in the United Kingdom who 
attended IPL during pre-qualification showed confidence in communication skills and 
had more positive attitudes towards their interprofessional interaction than those 
who learned within their own field of study. 
 
Findings from the present study showed that interactive learning could potentially be 
an effective approach to initiate IPE on medication safety. This could be seen from 
the positive healthcare students’ attitudes on the RIPLS pre- and post- workshop 
questionnaire, as well as from the results of the open-ended questions. In addition, 
students have the opportunity to interact and to share their knowledge with 
healthcare students from different background in this type of learning. This learning 
plays a significant role in fostering communication skills amongst healthcare 
professional students. Leape et al using a system approach analysis on adverse 
events have found that communication failure was one of main sources of adverse 
events.23 In support of Leape et al findings, Allard et al stated that poor 
communication was the most common source of errors in the medication delivery 
process.324 Communication skills are very important for healthcare professionals in 
ensuring the safe use of medication, thus, interactive learning with other healthcare 
professional should be fostered in education.  
 
However, there were some limitations to the study. Although the primary 
investigator recruited the students randomly, students’ participation was entirely 
voluntary. Due to the nature of voluntary participation, it is likely that those who 
participated in the study were supportive of IPE. The other limitation was lower than 
expected student participation rate. Although class coordinators had supported 
students’ participation in the workshop, less than 50% of randomly selected students 
actually attended the two-day workshop. Further, there was a significant drop in the 
number of students’ participating on the second day. The investigators were unable 
to explain the drop in student participation. In summary, an IPL workshop conducted 
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on medication safety involving Indonesian pharmacy, medical and nursing students 
improved students’ attitudes toward shared learning, teamwork and communication 
with other health professional students. This supports the use of this type of 
workshop as an instrument to increase students’ readiness for IPE which is seen as 
key facilitator for effective interprofessional practice in the future. 
5.3 SUMMARY OF RESULTS ON HEALTHCARE STUDENTS’ 
ATTITUDES TOWARDS IPE ON MEDICATION SAFETY 
 
The results of this study found that the healthcare students in the study university 
had positive attitudes towards IPE. However, medical students had less positive 
attitudes towards IPE compared to nursing and pharmacy students which was shown 
from the more positive attitudes towards the PI sub-scale. This was also supported 
from the results that Year 2 medical students moved towards more positive attitudes 
on the RIPLS PI sub-scale as they progressed through their studies. The trend analysis 
also indicated that Year 1 medical, nursing and pharmacy students had less positive 
attitudes towards the SLT sub-scale as they progressed through their course of study. 
Given the fact that the IPL workshop on medication safety changed the medical, 
nursing and pharmacy students’ attitudes towards the SLT sub-scale, it suggests that 
such workshops may be one of the IPE learning methods which could be introduced 







CHAPTER 6 RESULTS AND DISCUSSIONS: HEALTHCARE 
PROFESSIONALS’ ATTITUDES TOWARDS 
INTERPROFESSIONAL PRACTICE (IPP) AND MEDICATION 
SAFETY 
 
This chapter consists of two sections. Section 6.1 reports the results of healthcare 
professionals’ attitudes towards IPP from their responses to Readiness for 
Interprofessional Learning Scale (RIPLS) questionnaire for healthcare professionals. 
Section 6.2 presents the healthcare professionals responses to a series of medication 
error case vignettes.  
6.1 HEALTHCARE PROFESSIONAL ATTITUDES 
TOWARDS IPP 
6.1.1 DEMOGRAPHIC CHARACTERISTICS OF HEALTHCARE 
PROFESSIONALS  
The translated RIPLS questionnaire (Appendix 9b) of Reid et al.261 was administered 
to healthcare professionals in the study hospital and university. Three hundred and 
ten (56.4%) questionnaires were returned from the 550 RIPLS questionnaires 
administered. The investigator could not reach 66 potential participants due to staff 
being on maternity leave, staff relocation, and being on academic leave during data 
collection. Forty five participants returned the questionnaires uncompleted. Table 
6.1 shows demographic characteristics of participants in the current survey. Twenty 
three of 67 (34.3%) physicians, 202 of 340 (59.1%) nurses, 12 of 19 (63.2%) of 
pharmacists at the hospital returned the survey. The response rates amongst 
university academics were as follows: 46 of 77 (62.3%) medical academics, 10 of 17 
(58.8%) nursing academics, and 17 of 30 (56.7%) pharmacy academics. The total 
number of participants included in the study was 310 (69 physicians, 29 pharmacists, 
and 212 nurses). Females made up 66.7% of participants and male 33.3%. The 
majority of the participants (60%) were in their 20s and 30s, whilst over 15% 
participants were in their 50s and above. More than 75% of participants worked at 
the hospital and the majority of the participants were nurses. A small proportion of 
participants (3.6%) had previous experience working with other healthcare 
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professionals (IPP). More than 75% of participants stated that they did not have any 
postgraduate training. Of those who did, 11.1% of participants had a Masters degree 
and 0.7% participants had a PhD. The majority of the physicians (60.6%) who 
participated in this study held a medical specialty or subspecialty, while 3% of nurses 
had a Masters degree. Nearly half of the pharmacists had a Masters degree. In terms 
of work experience, almost 30% participants had working experience of less than 5 




Table 6.1 Demographic characteristics of healthcare professionals participated in the study  
GENDER 
 Physicians Nurses Pharmacists Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Female 23 31.8 161 77.0 20 69 204 66.7 
Male 45 68.2 48 23.0 9 31 102 33.3 
AGE 
 Physicians Nurses Pharmacists Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
20-29 5 7.8 72 35 11 37.9 88 29.4 
30-39 16 25 66 32.5 11 37.9 93 31.4 
40-49 14 21.9 52 25.6 2 6.9 68 23 
50-59 19 29.7 14 6.9 2 6.9 35 11.8 
>60 10 15.6 0 0 3 10.3 13 4.4 
WORKING PLACE 
 Physicians Nurses Pharmacists Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Academics 46 66.7 10 4.7 17 58.6 73 23.5 
Practitioners 23 33.3 202 95.3 12 41.4 237 76.5 
PREVIOUS INTERPROFESSIONAL PRACTICE 
 Physicians Nurses Pharmacists Total 
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 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
Yes 6 9 5 2.4 0 0 11 3.6 
No 61 91 207 97.6 29 100 295 96.4 
OTHER EDUCATION BACKGROUND 
 Physicians Nurses Pharmacists Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
None 13 19.4 205 96.7 14 48.3 230 75.2 
Master 12 17.9 7 3.3 15 51.7 34 11.1 




40 59.7 0 0 0 0 40 13 
YEARS OF WORKING EXPERIENCE 
 Physicians Nurses Pharmacists Total 
 n Percentage (%) n Percentage (%) n Percentage (%) n Percentage (%) 
<5 14 21.9 62 31.6 8 34.8 83 29.4 
6-10 6 9.4 31 15.9 6 26.1 43 15.2 
11-15 10 15.6 40 20.5 3 13 53 18.8 
16-20 8 12.5 27 13.8 2 8.7 37 13.1 
21-25 8 12.5 21 10.8 0 0 29 10.3 
>26 18 28.1 15 7.7 4 17.4 37 13.1 
Table. 6.1 continued 
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6.1.2 FACTOR ANALYSIS  
There was less than 5% of missing data for each RIPLS statement. Thus, missing data 
were excluded in the total scores of the RIPLS survey. However, in the CFA and EFA, 
an Expectation Maximization (EM) approach was employed for missing data. This 
approach is the most robust and has good statistical validity.325 Similar to the analysis 
of students’ attitudes towards IPE, Confirmatory Factor Analysis (CFA) was also 
conducted on the RIPLS survey data involving healthcare professionals. The three 
sub-scales (Teamwork and Collaboration, Patient Centredness and Professional 
Identity) from Reid et al.261 were modelled using Analysis Moment Structure (AMOS) 
in the study population (Figure 6.1). However, it was found that the current 
population did not fit with the sub-scales of Reid et al. Key indicators for fits indices 
did not meet the desired values (Table 6.2). Schmitt suggested that EFA (Exploratory 
Factor Analysis) could be employed when CFA did not fit the current data.263 Thus, 
Principle Component Analysis (PCA) which is one of EFA approaches was conducted 
to determine factors that constructed the RIPLS survey for healthcare professionals 
in the current population.  
 
Table 6.2 Goodness-of fit indicators for the current data to Reid et al.261 
 
 
 Index Fits 
χ²/df TLI CFI RMSEA 
Desired value
296





0.87 0.83 0.08 
 
Notes: 
Χ2  = Chi-square 
df  = degree of freedom 
TLI  = Tucker-Lewis Index 
CFI  = Comparative Fit Index 







Figure 6.1 Path diagram based on Reid et al. on RIPLS Healthcare Professional  
Notes:  
TWC  = Teamwork and Collaboration 
PC = Patient Centredness 




Table 6.3 KMO and Bartlett’s Test for the factor analysis of the health professional RIPLS 
questionnaire 
 
Kaiser-Meyer-Olkin Measure of Sampling Adequacy. .921 




Table 6.4 Pattern matrix of RIPLS questionnaire and Cronbach’s alpha of components in healthcare 
professionals 
 
The Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy was 0.921 and 
Bartlett’s test of sphericity was statistically significant (p<0.001) which showed the 
current data was appropriate for factor analysis (Table 6.3).  
 









RIPLS1 .620       
RIPLS2 .749       
RIPLS3 .749       
RIPLS4 .882       
RIPLS5 .826       
RIPLS6 .868       
RIPLS7 .765       
RIPLS8 .800       
RIPLS9         
RIPLS10     .553   
RIPLS11    .549   
RIPLS12     .817   
RIPLS13     .825   
RIPLS14     .793   
RIPLS15     .638   
RIPLS16     .672   
RIPLS17        
RIPLS18         
RIPLS19   .730     
RIPLS20   .809     
RIPLS21   .736     
RIPLS22   .546     




Direct Oblimin Rotation retrieved four sub-scales of the RIPLS questionnaires for 
healthcare professionals (Table 6.4). Initially, a cut-off point of 0.4 factor loading was 
employed, however, the number of sub-scales and items constructed the sub-scales 
were not significantly different compared to when the cut-off point was 0.55. Thus, 
this cut-off point was selected because according to Pett et al., items constructed 
factor loading more than 0.55 shares 30% of variance and shows good 
contribution.298  The first sub-scale “Shared Learning and Teamwork-SLT” consisted of 
RIPLS Statements 1 – 8 (Cronbach’s alpha= 0.924); the second sub-scale “Professional 
Identity-PI” consisted of RIPLS Statements 19-22 (Cronbach’s alpha = 0.674); and the 
third sub-scale “Patient Centredness- PC” consisted of RIPLS Statements 10 – 16 
(Cronbach’s alpha = 0.848). Meanwhile the fourth sub-scale had very low Cronbach’s 
alpha and it only consisted of one RIPLS statement (Statement 23). Measurement of 
sampling adequacy (MSA) should be >0.6,298 while the MSA of this statement was 
0.475. These results suggested that deletion of the statement was appropriate. As a 
result, sub-scale 4 was excluded from the current study as one of sub-scales of the 
RIPLS of healthcare professionals. Statements 9, 17, and 18 did not significantly 
contribute to any factors because they had loadings less than the cut off value for 
factor loading (0.55) in more than two factors; thus, they were also excluded as items 
that constructed the RIPLS factors.  
 
Further CFA analysis was conducted based on items retrieved from factors from EFA 
to confirm the model derived from EFA had a goodness of fit. It was found that the 
model from EFA had low goodness of fit based on the indicators. Thus, modifications 
based on estimation of modification indices were conducted. It was found that 
indicators on goodness of fit were improved afterward. Indicators on goodness of fit 
of the model can be seen in Table 6.5. Figure 6.2 shows the path diagram of the 
modified EFA model. The correlation amongst variances showed that the PI sub-scale 
had no association with the SLT sub-scale (p=0.222) or the PC sub-scale (p=0.090). 




Figure 6.2 Path diagram of the modified EFA model of RIPLS healthcare professionals 
Notes: 
SLT  = Shared Learning and Teamwork 
PC  = Patient Centredness 




Table 6.5 Goodness of fit based on items constructed on EFA modified model  
 
Index Fits 
χ²/df TLI CFI RMSEA 
Desired value296 <2 >0.9 >0.9 <0.06 
EFA modified model  2.18 0.935 0.945 0.062 
Notes: 
Χ2  = Chi-square 
Df  = degree of freedom 
TLI  = Tucker-Lewis Index 
CFI  = Comparative Fit Index 
RMSEA  = Root Mean Square Error of Approximation 
 
Similar to the RIPLS students’ analysis, although the Kolmogorov-Smirnoff test 
indicated a degree of non-normality, data were analysed using parametric methods. 
Even in the case of non-normality distributed data, parametric methods are 
considered in many cases to give results more stable than non-parametric 
methods.293  
 
6.1.3 ANALYSIS OF HEALTHCARE PROFESSIONAL 
ATTITUDES TOWARDS IPP 
Three analyses were conducted to determine healthcare professionals’ attitudes 
towards IPP.  
1. Healthcare professionals’ attitudes towards IPP. Firstly, healthcare 
professionals’ mean scores towards each of RIPLS statement were analysed. 
Then, healthcare professionals’ attitudes towards IPP were assessed by 
calculating and comparing total RIPLS scores across professions. The total 
scores were obtained by summing all participants’ responses towards each 
RIPLS statement. For the sake of this analysis only, negative statements 
(Statement 19, 20, 21 and 22) were reverse coded. Secondly, Healthcare 
professionals’ total mean scores towards each sub-scale (retrieved from factor 
analysis i.e. SLT and PC sub-scales) were also analysed using ANOVA by adding 
items which constructed the sub-scale retrieved from factor analysis. In 
addition, healthcare professionals’ mean regression factor scores towards IPP 
were also analysed. Further, the mean regression factor scores for each of the 




2. Academics and practitioners (healthcare professionals who worked at the 
study hospital) attitudes towards IPP. Participants’ mean regression factor 
scores for the RIPLS sub-scales were compared based on their practice settings 
(practitioners at hospital versus academic at university). Participants’ mean 
regression factor scores were compared between practice settings within the 
same professions (e.g. physicians at the hospital versus academics in the 
medical school). T-test analysis was adopted in these analyses. 
3. Healthcare professionals’ and healthcare students’ attitudes (from Chapter 4) 
within the same profession were also analysed with regards the statement on 
the role of healthcare professionals. This statement was Statement 14 in the 
RIPLS for students and Statement 19 in the RIPLS for health professionals’ 
questionnaires.  
 
Multivariate analysis was employed to determine mean regression factor score 
differences of the RIPLS sub-scales amongst healthcare professionals by considering 
independent variables such as age, gender, previous interprofessional practice, and 
duration of working which may potentially influence participants’ attitudes towards 
IPP. 
6.1.3.1 Healthcare professionals attitudes towards IPP 
Healthcare professionals’ attitudes towards IPP were initially assessed by comparing 
their responses to each RIPLS statement. Table 6.6 shows all healthcare professionals 
had positive attitudes towards IPP. However, there were significant mean differences 
for RIPLS Statements 17, 18, 19 and 21 amongst healthcare professionals.  
 
Post-hoc Scheffe test analysis indicated that physicians had significantly more positive attitudes 
towards RIPLS Statements 17 and 19 compared to nurses and pharmacists (Table 6.7). In 
addition, physicians had more positive attitudes towards Statements 18 and 21 
compared to nurses but these were not significantly different compared to pharmacists. 
Yet, nurses and pharmacists had no statistically significant differences in their attitudes 
towards any of the statements. Examination of the responses to Statements 17 and 18 
indicated that physicians had more positive attitudes around patient care than nurses 




Table 6.6 Means, standard errors, and p-values of ANOVA on each statement amongst physician, 
nurse, and pharmacist  
 
RIPLS Statements 




Physician Nurse Pharmacist 
1. Shared learning will help me to think 









2. Shared learning helps to clarify the nature 








3. Shared learning with other healthcare 
professional will help me to communicate 









4. Shared learning before qualification 
would help healthcare professionals 








5. Shared learning with other healthcare 
professionals will increase my ability to 








6. Shared learning will help me understand 








7. Learning with other healthcare 
professionals will help me to be a more 








8. Learning with healthcare students from 
other disciplines before qualification 









9. Communication skills should be learned 








10. I would welcome the opportunity to work 









11. Team-working skills are essential for all 








12. For small group learning to work, 
healthcare professionals need to trust 








13. Patients ultimately benefit if healthcare 
professionals work together to solve 








14. Establishing trust with my patients is 








15. In my profession one needs skills in 









16. Thinking about the patient as a person is 




























19. The function of nurses and therapists is 








20. Clinical problem-solving skills should only 









21. I have to acquire much more knowledge 









22. I would feel uncomfortable if another 
healthcare professionals knew about a 








23. There is little overlap between my role 











Table 6.7 Post-hoc analyses on RIPLS Statements 17, 18, 19 and 21 
 
RIPLS Statements Professions Nurse Pharmacist 
RIPLS 17 Physician 0.017* 0.03* 
 Nurse - 0.199 
RIPLS 18 Physician 0.01* 0.172 
 Nurse - 1.00 
RIPLS 19 Physician 0.001* 0.001* 
 Nurse - 0.600 
RIPLS 21 Physician 0.008* 0.073 
 Nurse - 0.600 
Notes: *showed significant difference; means and standard errors can be seen in Table 6.6 
 
In addition, in order to determine healthcare professionals’ attitudes towards IPP, 
the total mean scores of RIPLS statements were calculated. Possible scores ranged 
from 23 (strongly agree) to 94 (strongly disagree). Homogeneity of variance (Levene’s 
statistic) was not significantly different across the professions (2, 304) = 1.127, 
p=0.325. 
 
Table 6..8 shows that physicians’, nurses’ and pharmacists’ attitudes towards IPP 
were positive and were not different significantly (p=0.960) between groups. This 
was seen from the fact that the total mean scores of the three groups of participants 
Table 6.6 continued 
Notes: RIPLS score (1 strongly agree to 4 strongly disagree); †: negative statement 
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were between 38 and 39. Further, it was found that healthcare professionals had no 
significant differences in their attitudes amongst the RIPLS sub-scales. 




6.1.3.2 Academics and practitioners’ attitudes towards IPP 
Table 6.9 shows mean regression factor scores of RIPLS sub-scales amongst 
healthcare professionals and their place of work. The table also displays mean score 
of Statement 19 of those participants. Levene’s equality of variances was also 
conducted to detect homogeneity of variance in healthcare professionals’ mean 
regression factor scores for those who worked in university versus hospital settings. 
If variables met homogeneity of variance (p>0.05), t-test results on RIPLS sub-scales 
were reported based on equal variances assumed. Otherwise, it was reported based 
on equal variances not assumed. T-test analysis of healthcare professionals working 
at hospital and at university showed no significant differences in attitudes towards 
any of the RIPLS sub-scales (Table 6.10). However, there were significant differences 
in regards to Statement 19 (The function of nurses and therapists is mainly to provide 
support for doctors) amongst academics and practitioners. Table 6.9 demonstrates 
that the mean score of academics was lower (more positive attitudes) for this 
statement. This indicated that healthcare academics had more positive attitudes 
regarding the role of nurses and allied healthcare professionals are mainly to support 
the physician. Interestingly, nurse academics had significantly less positive attitudes 
(p=0.001) on this statement in comparison to their counterparts in hospital. 
  
Sub-scales Healthcare Professionals’ Mean Score ± SE (n) p-values 










6.73 ± 0.23 7.11 ± 0.14 7.42 ± 0.37 0.224 
Total RIPLS 
scores 
39.00 ± 1.00 38.76 ± 0.48 38.87 ± 1.31 0.960 
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Table 6.9 Mean regression factor scores (refined method) of RIPLS sub-scales and mean of 





















SE Mean SE 
Professions   
Physician 67 -0.047 0.124 -0.158 0.113 1.90 0.10 
Nurse 211 0.012 0.065 0.020 0.065 2.91 0.06 
Pharmacist 29 -0.032 0.149 0.143 0.159 2.71 0.14 
Place of Work   
Hospital 237 0.003 0.060 0.032 0.062 2.77 0.89 
University 73 -0.016 0.114 -0.119 0.104 2.36 1.00 
Professions and place of work   
Physician at 
hospital 
21 -0.208 0.199 -0.161 0.202 2.09 0.19 
Nurses at hospital 21
0 
0.012 0.067 0.031 0.068 2.86 0.63 
Pharmacists at 
hospital 
12 0.124 0.191 0.300 0.207 2.55 0.21 
Medical academics 46 0.025 0.156 -0.158 0.138 1.84 0.16 
Nursing academics 10 0.009 0.228 -0.192 0.164 3.80 0.13 
Pharmacy 
academics 




Table 6.10 T-test results on RIPLS sub-scales and Statement 19 based on working place and 
professions  
Notes: *showed significant difference 
 
6.1.3.3 Comparison of healthcare students’ and professionals’ 
attitudes towards the statement on the role of other 
healthcare professionals 
Healthcare students’ and healthcare professionals’ attitudes towards the statement 
“The function of allied health professionals is mainly to provide support for doctors”  
were compared within professions (i.e. medical students vs physicians; nursing 
students vs nurses; and pharmacy students vs pharmacists). This statement was 
Statement 14 in the RIPLS for students and Statement 19 in the RIPLS for healthcare 
professional questionnaires. This analysis aimed to determine whether healthcare 
professionals had different attitudes compared to healthcare students within their 















0.530 0.148 308 0.882 
Patient centredness 
(PC) 
0.339 1.206 308 0.229 
Statement 19 0.062 3.250 308 0.001* 
Physicians at the 














Statement 19 0.187 1.190 65 0.239 
Nurses at hospital 
(n=202) vs nursing 




0.037 0.015 209 0.989 
Patient centredness 
(PC) 
0.011 1.259 209 0.231 










0.058 0.882 27 0.385 
Patient centredness 
(PC) 
0.312 0.826 27 0.416 





Table 6.11 Healthcare students’ versus professionals’ attitudes towards the statement on the role 
of other healthcare professionals 
 




t df Sig (2-tailed) 
Medical students 
(n=253) 
2.15± 0.05 0.175 2.418 314 0.016* 
Physicians (n=63) 1.90±0.10 
Nursing students 
(n=136) 
3.39±0.06 0.192 5.411 338 0.001* 
Nurses (n=204) 2.91±0.06 
Pharmacy students 
(n=79) 
3.03±0.08 0.718 1.908 106 0.059 
Pharmacist (n=28) 2.71±0.14 
Notes: *showed significant difference 
 
Table 6.11 contains the t-test results for the comparison of the attitudes of health 
professionals and students within their professions. This testing showed that 
physicians and nurses means scores were statistically significantly lower than those 
of medical and nursing students, respectively. Physicians strongly agreed with the 
notion that other healthcare professionals’ role is mainly to support doctors. Nurses 
generally disagreed with (the mean was close to 3-disagree), however their scores 
were relatively lower than nursing students which was almost 4 (strongly disagree). 
Meanwhile, the response of pharmacy students was not significantly different 
compared to pharmacists.   
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6.1.4 DISCUSSION ON HEALTHCARE PROFESSIONALS’ 
ATTITUDES TOWARDS IPP  
This study employed the RIPLS from Reid et al. because this survey has been 
validated in post-graduates (i.e. healthcare professionals).261 Confirmatory Factor 
Analysis (CFA) indicated the study population’s responses did not fit the sub-scales 
proposed by Reid et al. Thus, Explanatory Factor Analysis (EFA) was conducted which 
then revealed three sub-scales (Shared Learning and Teamwork-SLT; Professional 
Identity-PI; and Patient Centredness-PC) of the RIPLS survey in the study population. 
However, further CFA of sub-scales retrieved from EFA confirmed only two sub-scales 
(SLT and PC). Thus, the PI sub-scale was excluded in the analysis. Overall, regardless 
of place of work, healthcare professionals (physicians, nurses and pharmacists) who 
participated in the current study showed positive attitudes towards IPP. In addition, 
their attitudes were not significantly different towards IPP. This study also found that 
the healthcare professionals had similar attitudes towards the RIPLS sub-scales. This 
indicated that healthcare professionals had positive attitudes toward working with 
other healthcare professionals (reflected from SLT sub-scale) and had the same vision 
on Patient centredness (identified from PC sub-scale). In this study, Statements 17 
and 18 did not construct any RIPLS-sub-scales because their factor loadings were less 
than 0.5, unlike those of Reid et al., where these two statements were items of the 
PC sub-scale. This difference may result from the differences in the practice of 
healthcare service delivery in the current study and that of in the UK. For the present 
study, physicians are deemed to be the primary healthcare professionals.  
 
This study found that healthcare professionals had significant differences on 
Statements 17, 18, 19 and 21. This study identified that the Physician Group had 
significantly stronger agreements towards Statement 17 (I like to understand the 
patient’s side of the problem) and Statement 19 (The function of nurses and 
therapists is mainly to provide support for doctors) compared to the Nurse and 
Pharmacist Groups. Yet, the Nurse and Pharmacist Groups had no significant 
differences on these statements. These results may indicate that despite the fact that 
physicians had stronger willingness to understand patients’ perspective of their 
problems; they believed that other healthcare professionals were mainly to support 
them. Compared to nurses, physicians had stronger agreement towards Statement 
18 (I try to communicate compassion to my patients) and Statement 21 (I have to 
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acquire much more knowledge and skills than other healthcare professionals). These 
suggested that physicians had higher sense of superiority compared to nurses and 
pharmacists in healthcare service delivery.  
 
Physicians stronger sense of superiority may result from the fact that medicine is a 
well-established profession.306 The physicians’ role has been well-accepted in the 
healthcare service. Furthermore, physicians have a strong professional socialisation 
during their learning. Physicians have intensive working experience to engage with 
patients while undergoing medical specialists’ qualification. Professional socialisation 
is a life-long learning process which develops through interaction and reflection 
between the individual and environment.309, 318 Hafferty and Frank stated that 
medical education had three forms of curricula (formal, informal, and hidden 
curricula).326 They suggested informal socialisation in clinical settings as a hidden 
curriculum is a stronger component of professional socialisation compared to formal 
medical education.  
 
Additionally, physicians have a high level of autonomy within healthcare services 
which allows them to make judgements about the services they provided.306, 327 In 
contrast, nurses have less autonomy to provide services compared to physicians. 
Further, in comparison to the physician’s stable role, nurses and pharmacists’ role as 
health professionals are currently under developed. This could be seen from various 
initiatives to develop nurses’ and pharmacists’ professional identity as reported in 
the literature.310-312 Öhlén and Segesten suggested nurse identity development is 
needed to improve nurses’ self-esteem.311 This development was considered vital for 
the nurses’ professional and personal growth. Öhlén and Segesten identified that 
nurses’ professional identity emerged as a self-conceptualisation based on personal 
and interpersonal interaction, growth and maturity.311 Wynd recommended that in 
order to foster strong professionalism in nursing, nurses’ involvement in nursing 
organisations is crucial to build a symbiotic relationship amongst members and the 
organisation.306 Thus, nurses professionalism will increase as they are more involved 
in professional organisations and with the support from its members, these 
professional organisations will continue to grow. 
 
Similarly, pharmacists’ professional identity is currently under development. Noble et 
al. suggested that the pharmacist’s role ambiguity and weak professional identity 
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may result from curricula exposure which focuses more on pharmaceutical science 
rather than engagement with patients.314 They recommended pharmacy students 
need a role model to observe, experience what it is like to be a pharmacist and to 
evaluate their role. The importance of role models is essential in pharmacists’ 
identity development to clarify role expectations and to decrease identity conflict 
amongst new graduates.309 Pharmacy professional organisation must facilitate the 
development of role models in pharmacy practice. This means that pharmacy 
professional organisations should play their role in the development of professional 
identity amongst pharmacy graduates.  
 
Interestingly, although overall healthcare professionals’ attitudes towards IPP were 
not different regardless of their place of work, academics had significantly lower 
scores (more positive attitudes) on Statement 19 (The function of nurses and 
therapists is mainly to provide support for doctors) than their counterparts in the 
hospital. This may indicate that academics (the majority of academics were medical 
academics) believed that other healthcare professionals were to support physicians. 
This fact could be a barrier in IPP implementation in the study university because the 
academic is the key factor in the development of IPE.80 
 
However, further comparisons in the Nurse and Pharmacist Groups based on their 
place of work revealed different results. Although, the mean score of nurses who 
worked at the hospital was in the proximity of disagreement on Statement 19 (mean 
score was near 3-disagreed), they had significantly lower score (more positive 
attitudes) on this statement compared to that of nurse academics. Nurses who 
worked in the hospital had more positive attitudes on Statement 19 than their 
counterparts in the university. These findings indicated nurses who worked at the 
hospital had more positive attitudes than that of academics on their role were mainly 
to support physicians. This demonstrated healthcare professionals who worked at 
the hospital have been exposed to learning at the workplace (the hospital) where 
physicians are at the top of the hierarchy in healthcare service delivery.  
 
Learning in the workplace includes experiential learning, informal learning, incidental 
learning, and situated learning from everyday work activity.328 Informal learning 
obtained in the place of work has been acknowledged as significantly improving skills 
and knowledge beyond formal education.329 Tacit knowledge which is one of the 
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outcomes of informal learning is defined as subjective knowledge which was 
acquired from non-conscious and unintentional socialisation in the workplace by 
repetitive observation.329, 330 Eraut stated the other outcomes of informal learning in 
the place of work include improved task performance, role performance, awareness 
and understanding, personal development, decision making and problem solving, 
academic knowledge and skills, teamwork, and judgment.331 Further, learning in the 
workplace is influenced by the work, relationships and personal traits as well as a 
supportive working environment.  
 
Healthcare professionals’ and students’ attitudes towards the Statement “The 
function of allied health professionals is mainly to provide support for doctors” were 
different. Physicians and nurses had more positive attitudes on this statement 
compared to medical and nursing students, respectively. Physicians who participated 
in the current study had positive attitudes on this statement which may result from 
strong professional socialisation. Professional socialisation amongst physicians may 
have strengthened their belief that physicians have a superior role in healthcare 
service delivery. Physicians as professionals have long been known to have autonomy 
in providing healthcare service.306 In contrast, nurses in the current study showed 
more agreement on this statement compared to nursing students although the 
absolute scores are in the proximity of disagreement. Nurses as they progressed 
further in their working environment may find themselves in an inferior position 
compared to physicians due to the hierarchy that exists within their practice setting. 
Nurses mostly received orders from physicians when providing their services. This 
suggested that professional socialisation after working as physicians and nurses may 
have influenced the different attitudes amongst medical and nursing students’ vs 
physicians and nurses. Further, only a small proportion of nurses who participated in 
the current study had postgraduate degrees. Meanwhile, the majority of physicians 
in the current study were medical specialists. These levels were considered as post-
graduate degrees. This may influence their attitudes towards the role of other 
healthcare professionals in healthcare services which were mainly to support 
physicians.  
 
Pharmacy students and pharmacists’ attitudes towards the statement “The function 
of allied health professionals is mainly to provide support for doctors,” showed they 
had no significantly different attitudes on this statement. Although pharmacists had 
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lower scores (i.e. indicated more positive attitudes towards this statement) than 
pharmacy students, both pharmacy students and pharmacists had disagreement 
towards this statement. This result may indicate that pharmacy students and 
pharmacists want to be part of the healthcare team and to be seen as an equal with 
doctors. This may also suggest that pharmacists may already have a strong 
understanding of their role. However, in the current practice setting, pharmacists 
have less contact with patients as well as with other healthcare professionals, 
particularly with physicians in providing their services. In comparison to many 
interactions between nurses and physicians in providing their services, pharmacists 
mostly work in isolation in the pharmacy department. This may also indicate that 
pharmacists have less exposure in their place of work to engage with other 
healthcare professionals compared to nurses. Thus, pharmacists’ attitudes towards 
this statement may not have been significantly different compared to that of 
pharmacy students for this reason.  
 
Indonesian nursing education has developed rapidly. In 1998, the nursing 
qualification was revised from high school graduates to diploma holders to improve 
the standard of formal training of nurses. A study conducted in Indonesia in 1999 
identified that 39% of nurses graduated from the diploma course and 60% graduated 
from high school.332 As a result of developments within the nursing profession, 
clinical practice has been incorporated into the training of nurses in Indonesia. 
Meanwhile, the role of the pharmacist in patient care through pharmaceutical care 
was introduced in 2000. However, the development of pharmaceutical care has been 
slow. This was confirmed in a study in Surabaya, Indonesia which found that 
pharmacists in the community spent limited time in delivering their professional 
activities in delivering patient care.175 The authors suggested that if pharmacists did 
not conduct their services appropriately this may result in de-professionalism of 
pharmacy.  
 
There are some limitations of the current study. Firstly, the low response rate of 
healthcare professionals. In the first month after the survey administration less than 
30% of healthcare professional had responded, although methods which have been 
proven to improve response rate had been employed (a cover letter and second 
reminder).333-335 Hochstim and Athanasopoulos suggested that personal follow up 
could be employed when repeated contact was unsuccessful.336 Thus, the 
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investigator followed up the survey herself to improve participation. The investigator 
met the participants in person particularly those in the Physician Group during follow 
up. The low response rate of physicians may have resulted from the limited time to 
respond to the mail survey.335 Another limitation was the participants in the present 
study may have worked together to answer the questionnaire, however, this was one 
of common forms of response bias in survey based research. The investigator was 
unable to control this during the survey.  
 
6.2 MEDICATION ERRORS CASE VIGNETTES  
There were 308 (56%) case vignettes returned from 550 sets of cases administered. 
Twenty three of 67 (34.3%) physicians, 202 of 340 (59.4%) nurses, 14 of 19 (73.7%) 
pharmacists at the hospital returned the survey. Forty six of 77 (61.0%) medical 
academics, 10 of 17 (58.8%) nursing academics, and 15 of 30 (50%) of pharmacy 
academics returned the survey. Based on participants’ profession, there were 69 
physicians (22.3%), 29 pharmacists (9.4%) and 212 (68.4%) nurses. The same 
demographic characteristics were reported as that in the RIPLS healthcare 
professionals (Table 6.1).  
 
6.2.1 ACCURACY IN ANSWERING MEDICATION ERRORS CASE 
VIGNETTES  
The General Estimating Equation (GEE) was used to estimate participants’ responses 
in answering anticipated correct options for the case vignettes. Six cases were 
administered to the participants. The cases consisted of prescribing (Case 1 and 2), 
dispensing (Case 3 and 4), and administration errors (Case 5 and 6). Each case had 
five standard multiple choice questions and one question which sought an 
agreement as to which of the profession(s) was responsible for each error. The GEE 
approach was conducted on the five multiple choice questions to identify accuracy of 
anticipated answers across all cases. Table 6.12 shows pharmacists at the hospital (p 
=0.0027) and pharmacist academics (p=0.0036) responses were significantly different 
compared to medical and nursing academics or their practitioners groups. 
Pharmacists at the hospital were more likely to provide the anticipated correct 
answer for the case vignettes (OR= 1.61; 95% CI 1.16 - 2.06), as were pharmacist 
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academics; OR = 1.68; 95% CI 1.19 - 2.38). In contrast, participants who were aged 
over 50 years were less likely to give the anticipated correct answer (OR=0.79; 95% 
CI= 0.66 - 0.95).  
 
Based on the GEE analysis the Pharmacist Groups showed higher levels of deemed 
correct answers. Further analysis was conducted to identify in which case vignettes 
and/or questions the difference between healthcare professionals groups arose. The 
Pharmacy Groups were used as the reference in this analysis. The data presented in 
Table 6.13 demonstrates that differences arose in Case 2 (prescribing error), Cases 3 
and 4 (dispensing errors) and Case 6 (administration error).  
Table 6.12 GEE Analysis on case vignettes for correct responses 
 




Pharmacists at Hospital (14) 1.61 1.16 to 2.06 0.0027* 
Pharmacists at University (15) 1.68 1.19 to 2.38 0.0036* 
Age over 50 (50) 0.79 0.66 to 0.95 0.0129* 
Notes: * showed significant difference 
 
In Case 1, which involved a prescribing error, there was no significant difference in 
any question across all three professions. In Case 2, another prescribing error, the 
Nurse Groups were less accurate than the Pharmacy Groups in answering why the 
error had occurred with an OR = 0.177 (95% CI 0.059 – 0.533). However, in 
determining the level of severity in Case 2, the Physician Groups were more accurate 
(OR=3.388; 95% CI 1.179 - 9.627) than the Pharmacist Groups. For the cases on 
dispensing errors (Case 3 and 4), both Physician and Nurse Groups were less accurate 
than the Pharmacy Groups. They answered the questions for these cases less 
accurately than the Pharmacy Groups in terms of determining the types of errors, 
why the errors had occurred, what can be done to prevent the errors from occurring 
again, and the level of severity of the errors. In the case of administration errors, the 
Pharmacy Groups were more accurate in determining the type of error in Case 6 
compared to the Nurse Groups (OR=0.340; 95% CI 0.121 - 0.958), and what can be 
done to prevent the administration error from occurring again in Case 5 compared to 
the Physician Groups (OR=0.201; 95% CI 0.057 - 0.709). Interestingly, the Physician 
Groups answered the question more accurately than Pharmacy Groups on what can 
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be done to prevent the administration error in Case 6 (OR=3.449; 95% CI 1.256 – 
9.470). Table 6.13 also shows that the professional groups showed some significant 
differences in answering questions on the types of errors (Question 2), why the error 
occurred (Question 3), what can be done to prevent it from re-occurring (Question 5) 
and the level of severity of the errors (Question 6). However, no significant 
differences in determining patients’ problems (Question 1) across all cases were 




Table 6.13 Odds Ratio and its 95% Confident Interval of Physician and Nurse Groups compared to Pharmacy Group across all cases and questions  
 
 
Phy: Physicians; Nur: Nurses; * showed significant difference  
 
 
 Case 1 [OR (95% CI)] Case 2 (OR) Case 3 (OR) Case 4 (OR) Case 5 (OR) Case 6 (OR) 
Question 1 Phy [0.889 (0.084-9.422)] 
Nur [0.421 (0.052-3.373)] 
Phy [1.161 (0.274-4.916)] 
Nur [0.790 (0.217-2.868)] 
Phy [0.404 (0.082-2.003)] 
Nur [0.679 (0.149-3.086)] 
Phy [1.388 (0.467-4.125)] 
Nur [1.840 (0.713-4.747)] 
Phy [0.994 (0.375-2.637)] 
Nur [0.717 (0.305-1.687) 
Phy [1.366 (0.244-7.645)] 
Nur [0.645 (0.138-3.021)] 
Question 2 Phy [1.045 (0.347-3.145)] 
Nur [0.677 (0.259-1.771)} 
Phy [1.022 (0.284-3.682)]  
Nur [0.411 (0.135-1.253)] 
Phy [0.324 (0.107-0.976)]* 
Nur [0.372 (0.135-1.027)] 
Phy [0.150 (0.054-0.416)]* 
Nur [0.199 (0.085-0.468)]* 
Phy [0.943 (0.367-2.420) 
Nur [1.189 (0.526-2.691)] 
Phy [0.738 (0.233-2.337)] 
Nur [0.340 (0.121-0.958)]* 
Question 3 Phy [1.458 (0.504-4.216)] 
Nur [1.540 (0.585-4.015)] 
Phy [0.573 (0.169-1.942) 
Nur [0.177 (0.059-0.533)]* 
Phy [0.229 (0.070-0.750)]* 
Nur [0.208 (0.069-0.628)]* 
Phy [0.193 (0.070-0.530)]* 
Nur [0.120 (0.049-0.289)]* 
Phy [0.970 (0.291-3.235)] 
Nur [0.935 (0.329-2.658)] 
Phy [1.821 (0.694-4.778) 
Nur [1.545 (0.672-3.552)] 
Question 5 Phy [2.318 (0.600-8.955)] 
Nur [1.989 (0.566-6.981)] 
Phy [1.399 (0.496-3.951)] 
Nur [0.501 (0.209-1.201) 
Phy [0.268 (0.082-0.879.])* 
Nur [0.229 (0.075-0.701)]* 
Phy [0.257 (0.089-0.738)]* 
Nur [0.268 (0.103-0.696)]* 
Phy [0.201 (0.057-0.709)]* 
Nur [0.505 (0.203-1.255)] 
Phy [3.449 (1.256-9.470)]* 
Nur [1.377 (0.579-3.277)] 
Question 6 Phy [0.998 (0.386-2.576)] 
Nur [1.317 (0.569-3.043)] 
Phy [3.388 (1.179-9.627)]* 
Nur [2.594 (0.995-6.762)] 
Phy [1.666 (0.424-6.545)] 
Nur [2.255 (0.644-7.894)] 
Phy [0.556 (0.218-1.465)] 
Nur [0.441 (0.191-1.020)]* 
Phy [0.501 (0.197-1.273)] 
Nur [0.782 (0.345-1.775)] 
Phy [0.510 (0.182-1.434)] 
Nur [0.657 (0.259-1.668)] 
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Question 4 of each case assessed the level of agreement amongst the health 
professionals regarding who they thought was responsible for the error. In general, 
participants agreed which healthcare professional was responsible for each error 
based on the professions who possess the role during the medication delivery 
process. Interestingly, participants who had the role in medication delivery did not 
totally agree that they were the only healthcare professionals who were responsible 
for the errors as illustrated in Figures 6.3-6.8.  
 
 
Figure 6.3 Participants' opinion on which professional was responsible for prescribing errors in 
Case 1 
 
Figure 6.3 demonstrates that the majority of participants agreed that the physician 
and pharmacist were responsible for the prescribing error in Case 1. This case 
involved a prescribing error where a physician did not inquire about the patient’s 
medication history. Meanwhile, there were similar proportions of physicians who 
thought that physician only and physician as well as pharmacist was responsible for 





Figure 6.4 Participants' opinion on which professional was responsible for prescribing errors in 
Case 2 
 
In Case 2, which was another case involving a prescribing error, most participants 
agreed that the physician was responsible for an error in a patient who experienced 
an allergic drug reaction. The majority of participants believed that the physician was 
responsible because they failed to elicit a complete drug allergy history (Figure 6.4).  
 
 





Case 3 included a dispensing error where the pharmacist mistakenly dispensed the 
wrong medication. Figure 6.5 shows that most health professionals agreed that 




Figure 6.6 Participants' opinion on which professional was responsible for dispensing errors in 
Case 4 
 
In Case 4, a patient experienced dizziness and hypotension after he was dispensed 10 
mg of amlodipine. The pharmacy staff dispensed 10 mg instead of 5mg of 
amlodipine. On the ward, the nurse administered 10 mg amlodipine to the patient 
which resulted in the patient experiencing an adverse event. The majority of health 
professionals agreed that the pharmacist and nurse were responsible in this case 
(Figure 6.6). There were only a small proportion of pharmacists and nurses who 
thought the pharmacist was solely responsible for the error. More than 70% of 
pharmacists believed that they were not the only profession who was responsible for 






Figure 6.7 Participants' opinion on which professional was responsible for administration errors in 
Case 5 
 
Case 5 was an administration error where the patient received ciprofloxacin and 
sucralfate at the same time. These medications should not be administered at the 
same time because sucralfate reduces the absorption of ciprofloxacin. This has led to 
ineffective antibiotic therapy. The majority of healthcare professionals agreed that all 
healthcare professionals were responsible for the error occurring. There were around 
33% of nurses who believed that all healthcare professionals were responsible for the 
error (Figure 6.7). Notably there was just over 20% of nurses who thought they were 







Figure 6.8 Participants' opinion on which professional was responsible for administration errors in 
Case 6 
 
Case 6 was another case involving an administration error where the nurse gave the 
wrong dose of antacid. The majority of participants agreed that the nurse was 
responsible for the error. In addition, there was almost the same proportion of 
nurses who believed that nurse only as well as nurse and pharmacist were 
responsible for the error (Figure 6.8). This also meant that approximately 50% of the 
nurses agreed that they were not the only professional who was responsible for the 
administration error in this case.   
 
The possible root cause for Case 1 was lack of communication between the physician, 
patient and pharmacist. The physician should have inquired about the patient’s 
medication history. Similarly, the pharmacist should have also asked about what 
other medications the patient was on prior to dispensing the medication. If the 
pharmacist had identified the patient’s other medications prior to dispensing, they 
could have identified the problem and contacted the prescriber. Interestingly, there 
was only small proportion of participants who believed this error resulted from lack 
of communication. This may reflect that only a small number of participants believed 
that communication amongst healthcare professional is important. This error may 
also have resulted from healthcare professionals believing that the patient’s 
medication history had been retrieved by another healthcare professional. This may 




In Case 2, the root case was likely a lack of access to the patients’ information. This 
lack of access could be due to a lack of patient’s information documented prior to 
prescribing, or the patient being exposed to the medication for the first time thus 
there was no record on the patient’s medical history. Case 1 and 2 were purely on 
prescribing errors which resulted from incomplete medical histories being retrieved 
by the physician. Although physicians agreed that they were responsible for the 
errors, they also agreed that other healthcare professionals were also responsible for 
the errors. In Case 1, 32% of physicians agreed that physician were responsible whilst 
35% of physicians agreed that physician and pharmacist were responsible in that 
case. Meanwhile, in Case 2, 44% of physicians agreed that they were responsible, 
whilst 22% of physicians agreed that both the pharmacist and physician were 
responsible.  
 
In Case 3 which involved a dispensing error associated with similar brand name 
words (sound-alike) medications, the majority of pharmacists (76%) agreed that they 
were responsible for the error. Meanwhile, in Case 4 which resulted from the 
pharmacist dispensing the wrong strength of amlodipine and the nurse failing to 
double check the dose of medication to be administered, 72% of pharmacists agreed 
that both pharmacist and nurse were responsible for the error. Cases 3 and 4 were 
dispensing errors which arose from drug storage techniques utilised in pharmacy 
department. In Case 3, the nurse identified the error prior to it reaching the patient, 
thus, this became a near miss event. Meanwhile, in Case 4, although the root cause 
was a deficiency in the technique of storing the medication; the nurse may have also 
contributed to the error because the patient received the wrong dose of medication. 
The nurse should have double checked the dose of medication before it was 
administered. This meant that both pharmacist and nurse shared the responsibility 
for the medication error.  
 
In Case 5 which involved a nurse administering two interacting medications, 33% of 
nurses agreed that the nurse, physician, and pharmacist were all responsible for the 
error. There was only 25% of nurses who agreed that only the nurse was responsible 
for the error. Similarly, in Case 6, another administration error scenario involving a 
nurse giving the wrong dose of antacid, there were 31% of nurses who agreed that 
the nurse and pharmacist were responsible for the error and 29% of nurses agreed 
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that the nurse was the main health professional responsible for the error. Case 5 may 
have been caused by lack of communication amongst healthcare professionals. The 
pharmacist should have identified the drug interaction and notify the prescriber and 
nurse of its existence. However, only a small proportion of participants suggested the 
root cause of this error was a lack of communication. Again, this may indicate that 
only a small proportion of participants considered that communication barriers may 
result in medication errors. In Case 6, the root cause may have been the nurse’s lack 
of knowledge on the dose of medication. Although another contributing factor was 
the failure of the pharmacist to double check the dose to be administered to the 
patient.  
 
6.2.2 DISCUSSION ON MEDICATION ERRORS CASE 
VIGNETTES  
Some of the case vignettes in the current study were designed to evaluate 
participants understanding of “lack of communication” as a root cause of medication 
errors. However, there were only a small proportion of participants who believed 
that communication barriers may result in the errors portrayed in the case vignettes. 
This may indicate that some healthcare professionals had a lack of understanding of 
the importance of communication in medication safety. The result of the present 
study indicates that there is a need to improve healthcare professionals’ 
understanding of the importance of communication amongst healthcare 
professionals to ensure the safe use of medication. This is because communication 
failure may be one of root causes of medication errors23 which may be associated 
with hierarchical and personality differences, conflicting roles, and role ambiguity.103  
 
These case vignettes also indicated that health professionals had various views on 
responsibility with respect to making and identifying errors. Different views on 
professional responsibly for medication errors may result from the perceived role of 
healthcare professionals. For instance, nurses did not double check the dose of 
medication prior administration; they may have perceived that the physician and 
pharmacist had ensured the dose of medication was accurate. Thus, they could have 
administered the medication without verifying the dose. This suggests that each 
healthcare professional should understand the role and expectations of other 




Generally, healthcare professionals in the present study afforded responsibility for 
medication errors to healthcare professionals who were responsible for a particular 
stage of the medication delivery process. However, they also believed that other 
healthcare professionals shared the responsibility for medication errors. Cohen 
stated the importance of shared responsibility in preventing medication errors.26 
Most root causes of medication errors resulted from system errors. He suggested 
that every healthcare provider involved in healthcare delivery must be aware of their 
shared contribution to medication errors. Healthcare professionals (i.e. physicians, 
nurses, and pharmacists) share the responsibility to prevent medication errors from 
occurring. However, a qualitative study involving 17 nurses in the United Kingdom 
found that nurses believed they were responsible for most medication errors. Yet, 
the nurses also blamed physicians and pharmacists if other healthcare professionals 
were also involved.337 This indicated that there was a perception of shared 
responsibility in the provision of healthcare. Shared responsibility may improve 
healthcare professionals’ awareness to their contribution to medication errors. 
Further, a non-punitive culture should be employed to increase error reporting and 
system improvement thus enhancing medication safety.338  
 
Although Pharmacist Groups were more likely to provide the anticipated correct 
answers, this may be influenced by the fact that the investigator and her supervisors 
were also pharmacists. It might have been better to use a panel comprised of 
doctors, nurses and pharmacists to develop and evaluate the case vignettes. 
However, the investigator was unable to identify such a panel. This fact led to one of 
the limitations of the case vignette scenarios. Due to the nature of the study setting, 
comprehensive justification of validity was unable to be performed. As a result, the 
vignettes were only validated based on face and content validity. Another limitation 
was minimum information given to allow further understanding on the cases. This 
was because one of the criteria of the questionnaire is to be brief and to the point31, 
thus, long and detailed scenarios were avoided in this study. Participants may have 
worked together in answering the questions particularly if participants worked in the 
same clinical setting. But, this was beyond the control of the investigator.  
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6.3 SUMMARY OF HEALTHCARE PROFESSIONALS 
ATTITUDES TOWARDS IPP AND MEDICATION SAFETY 
The present study showed that healthcare professionals regardless of their place of 
work and professions had positive attitudes towards IPP and similar attitudes 
towards PC sub-scale. However, Physician Groups in the present study portrayed 
stronger senses of professional identity than Nurse and Pharmacist Groups. 
Academics in the study university also had a stronger sense that the role of other 
healthcare professionals is mainly to support physicians. In addition, this stronger 
sense was also identified in the Physician and Nurse Groups compared to medical 
and nursing students. Interestingly, no significant difference in attitude amongst 
Pharmacist Group and pharmacy students towards the role of other healthcare 
professionals is mainly to support physician. The results on the medication errors 
case vignettes indicated that Pharmacist Groups had higher accuracy in providing the 
anticipated correct answers in the vignettes. There was only a small proportion of 
healthcare professionals who believed that communication failure was one of root 
causes of medication errors presented in the vignettes. Further, the healthcare 
professionals also had various views on professionals who were responsible for 
errors in the vignettes. The various views of professionals responsible for the errors 
and a strong sense on the statement of the function of other healthcare 
professionals as supporting the physicians may be influenced by the unclear role of 
healthcare professionals and the hierarchical model identified in the present 




CHAPTER 7 RESULTS AND DISCUSSIONS: QUALITATIVE 
FINDINGS 
 
This qualitative study used interviews and focus group discussions (FGDs) to answer 
the three research questions as described in Section 3.5. The results of this study, 
being the emergent themes as well as their distributions, are reported in this section. 
In order to ensure the anonymity of participants in this study, the following 
abbreviations are used: 
- Heads of Departments in the University = HU1- HU3 
- Heads of Department in the Hospital = HH1- HH2 
- Participants in the Physician Group – [(P1- P7) – MG] 
- Participants in the Nurse Group – [(P1- P6) – NG] 
- Participants in the Pharmacist Group – [P1- P8) – PG] 
- Participants in the Pharmacy Interns Group – [(P1-P8) – SG] 
7.1 RESEARCH QUESTION 1: DO PHARMACISTS HAVE A 
ROLE IN PATIENT CARE TO ENSURE MEDICATION SAFETY?  
This question was asked of the Heads of Departments in the university and hospital. 
In addition, the question was also put to groups of healthcare professionals 
(including physicians, nurses and pharmacists) who worked at the study hospital and 
pharmacy graduates of the study university. Overall, although the majority of 
participants suggested that the role of pharmacists varied, they believed that the role 
of pharmacists in patient care was to ensure the safe use of medication. Interviewed 
stakeholders believed that pharmacists’ engagement in patient care may take time 
but their support of pharmacists undertaking this role can be seen in the following 
extracts.  
 
“There must be pharmacists. I also want to have a team to control infectious 
diseases in general because pharmacists’ and microbiologists’ role, pharmacists 
were supporting healthcare professionals in the hospital but they are an 
integrated part in healthcare services. Without pharmacist, it is impossible. For 
this reason, I acknowledge that the role of pharmacists are important…” (HH1) 
 
“I think if it is something to do with medication, I think pharmacist as well as … 
pharmacologist which I think they should understand the medication better than 




“I think it takes time, but if it is based on urgency, it should be 9 [9 over 10 of 
level of agreement), for nurse’s sake. So, pharmacists should be there.” (HU2) 
 
There were four themes identified from this question, these were: 
- Benefits of the role of pharmacists,  
- Government support, 
- Pharmacists’ internal factors, 
- Pharmacists’ external factors. 
 
Table 7.1 shows the themes identified of the interviews and FGDs as facilitators for 
and barriers to the role of pharmacists in patient care to ensure medications safety. 
The themes on the facilitators are described in Section 7.1.1 and the barriers in 
Section 7.1.2. 




Themes HU1 HU2 HU3 HH1 HH2 MG NG PG SG 
Facilitators Benefits of the role 
of pharmacists 
+ + + + ++ + + + + 
Government 
support 
+ + + + + + + + + 
Barriers Pharmacists’ 
internal factors 
++ ++ +++ ++ +++ +++ +++ +++ +++ 
Pharmacists’ 
external factors  
+ + + + + + + + + 
Notes: 
 +++: themes identified more than 50 times  
++: themes identified 25-50 times 
+: themes identified less than 25 times 
 
7.1.1 FACILITATORS FOR THE ROLE OF PHARMACISTS  
Two themes were identified as facilitators for expanding the role of pharmacists, i.e. 
benefits and the support from the government.  
 
(i) Benefits of the role of pharmacists  
The first theme identified as a facilitator for the role of pharmacists in patient care 
was the participants’ perceived benefits for the role of pharmacists. The participants 
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indicated that the pharmacists may have a role in ensuring medication safety, 
educating patients, as well as providing drug information to other healthcare 
professionals. These were identified from the three sub-themes which emerged and 
are listed below.  
 
 Ensuring medication safety 
“…they [pharmacists] are very important...because geriatrics use multiple 
drugs. So, I think pharmacists are important. When a patient has a possibility 
of having many medications, pharmacists should be there….” (HU1) 
 
“…by providing information to physician on how the medication works. I 
mean, they provide recommendation to the physician or if there is certain 
medication which may potentially interact with others, this role [the role of 
pharmacists] is very important. In some cases, it has been implemented.” 
(P6-NG) 
 
 Educating the patients 
“Pharmacists are highly needed to educate patients on what medication the 
patients were on and what for. The pharmacist should explain to the 
patients, although physician has also explained. And certain divisions may 
plan one or two drugs which are contraindicated if they are given at the 
same time. For instance, patients with chronic pain, for patient with cancer, 
who has liver damage, the patient was given high dose of paracetamol to 
reduce pain…” (P6-NG)  
 
“Pharmacists should explain the medication, on how to take and where to 
store them. We also could help them, we are flexible. I think it is about their 
needs to communicate, to give information, and to educate them [the 
patients], based on their competency…” (P1-MG) 
 
 Providing drug information to other healthcare professionals 
“They [physicians] accepted it. They are happy about it and so about drug 
doses also just like what we had last time, on Vesicare®. The physician 
wrote 5 mg, it was supposed to be 2 mg. The dose written was twice a day 
half a tablet every day. So, we corrected and discussed this. And so we have 
the role to discuss the medication in a way so they won’t think that we know 
it better” (P5-PG) 
 
(ii) Government support 
The other theme which emerged from interviews and FGDs as a facilitator regarding 
the role of pharmacists in patient care was that of support from the government for 
the pharmacists to have a role. Participants of the present study suggested that 
pharmacists’ engagement in patient care occurred when the government 




 The government policy 
“The government policy which I mentioned just now, has given the opportunity in 
National Health Insurance [JKN- Jaminan Kesehatan Nasional]. It has also offered 
the possibility for pharmacists to provide health services. If pharmacists work 
together and they have the same voices, the rewards which will be based on fee 
for service not on the salary, things should be changed. The problem is on how to 
implement it or how to overcome it” (HH2)  
 
“Government Policy Number 51 in 2009 and The Ministry of Health decree Number 
889 in 2012 and other pharmaceutical guidelines which are available in the 
hospital and in the community” (HU3) 
 
 The government program 
“Some systems have supported this [the role of pharmacists], for example, there is 
a program on prevention of antibiotic resistance. Thus, it is regulated that a 
clinical pharmacist is needed…and so they [pharmacists] would be able to….” 
(HH2) 
 
“Yes, support from the government I think. Sometimes, I am confused, who we 
are. That is what I think. For instance, previously, we worked in a good working 
environment. Then we are transferred to another working station. If we are not 
respected, I do not think, we will be fine, right? And so, for a program like 
tuberculosis, there should be pharmacist who responsible. Then, there will be, I 
think the government role, in this case is Ministry of Health, there must be 
pharmacist, then, it will happen” (P1-PG) 
 
Interpretation of extract (P1-PG): 
 
Support for the role of pharmacists in healthcare service delivery will be possible 
if the government supports their role. For instance, the Ministry of Health 
regulated pharmacists’ involvement in tuberculosis program, thus pharmacists are 
involved in the program.  
 
7.1.2 BARRIERS TO THE ROLE OF PHARMACISTS  
Participants in this study suggested pharmacist-related internal and external factors 
were barriers to expand the role of pharmacists in patient care. As can be seen from 
Table 7.1, participants identified pharmacists’ internal factors as key themes, 
indicating these may be the major barrier to expand the role of pharmacists in 
patient care. 
 
(i)  Pharmacists’ internal factors  
There were four sub-themes that emerged on the pharmacists’ internal factors (i.e. 
lack of knowledge and experience; lack of confidence; lack of pharmacists; and 
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pharmacists’ mind-set). The lack of knowledge and experience were reported to have 
an impact on their confidence to communicate with other healthcare professionals. It 
was also suggested that a lack of confidence had a negative effect on the role of 
pharmacists in patient care. The lack of pharmacist numbers was identified by all 
participants as a barrier to pharmacists’ engagement in providing patient care. The 
insufficient numbers of pharmacists contributed to high workloads which limited the 
capacity of pharmacists to deliver patient care. As a result, the level of care provided 
was variable. The participants of the present study indicated that the human 
resource shortage (limited number of pharmacists) is a significant challenge in 
expanding pharmacists’ roles. Another pharmacists’ internal factor mentioned by 
participants of the present study was the pharmacists’ mind-set. They indicated if 
pharmacists intend to expand their role in patient care, they should change the mind-
set that they will not only work in community pharmacies or the Pharmacy 
Department in the hospital setting.  
 
 Lack of knowledge and experience 
“…I think my knowledge on medication is very insufficient…because in our 
education, the area of learning is very wide, it’s not specific…I think it would be 
better the knowledge on medication will be in specialties, in certain kind of 
medication. Automatically, I will be more confident….the knowledge that we got 
at university is very wide, and so I am not confident with my knowledge”  
(P1-SG) 
 
“…Yes, we have lack of practice, less experience. And so, we will be uncertain…”  
(P2-SG) 
 
 Lack of confidence  
“They [pharmacists] are not confident to have an argument that this medication 
should not be given to patient because it is not under formularies mostly like 
this” (P4-NG) 
 
“…when we call for instance, we call nurses or physicians, it will be different. Our 
preparation will be different. I do not know why, I just felt different. I think that is 
because I was not confident enough. I think I have lack of competencies, say if I 
want to change a prescribed medication, we have to have a good argument to 
talk with physicians, but it is different If we talk to nurses” (P5-PG) 
 
 Lack of pharmacists  
“The number of patients to be taken care will be different each day and so it will 
be enough assessment to each patient. For instance, M who assessed the 
patients’ very details and so the number of patients assessed will be little. We 
should have a strategy in only for certain patients. The first stage will be the 




“Yes, but we have limited number of pharmacists. The ideal scenario will be as it 
is in geriatric department, pharmacist is available everyday” (HH1) 
 
“I think, what he meant, in the hospital, there are limited pharmacists but a lot 
of patients. They [pharmacists] don’t have much time, because they have other 
responsibilities.” (P7-MG) 
 
 Pharmacists’ mind-set 
“…I think it can be started by setting pharmacists’ mind-set, they [pharmacists] 
will not only work at pharmacies” (HU2) 
 
“The problem was most likely from the pharmacists. For example, they are not 
ready mentally, not confident. For example, their level of knowledge is 
insufficient or communication barriers” (HH2) 
 
 
(ii) Pharmacists’ external factors 
There were three sub-themes identified as the pharmacists’ external factors (i.e. 
varying understanding of the role of pharmacists; no fees for service; and poor 
procedures of staff recruitment). The first sub-theme identified as an external factor, 
that is a barrier to expanding the role of pharmacists, was the varying understanding 
of what the pharmacists’ role is in patient care; particularly to ensure medication 
safety. Participants indicated that currently the role of pharmacists in patient care is 
unclear because their role is mainly known in drug management. However, the 
participants suggested that the role of pharmacists in patient care may involve 
providing education and counselling in community pharmacy but provided no 
insights into their role within hospitals. No fee for service was another pharmacist 
external factor identified. Participants agreed that a professional fee for service is 
required by healthcare providers as a reward for the service provided. Unclear rules 
of what is expected as a fee/reward for conducting particular services were also 
potential contributors to the service not being delivered effectively. Stakeholders in 
the hospital identified there was unclear selection criteria for staff recruitments 
which was identified as the third sub-theme of pharmacists’ external factor.  
 
 Varying understanding of the role of pharmacists.  
“The job description [of pharmacists] should be clear, and so if one asked, what 
is this medication for? We could say, please ask the pharmacist. We do not need 




 “At the moment, most the role of pharmacists are done by nurses, even at public 
health services, drug dispensing and handing of the medications to the patients.” 
(HU2) 
 
“To my understanding, in community pharmacy, when I worked in private health 
service, the pharmacist explained the medication to the patient. They explained, 
you should take this medication in the morning, before food, this one, only in the 
morning. This one is taken at night only... So the patients were given information 
on their medication….but in this hospital, mostly the medication was given by 
nurses.” (P2-MG) 
 
 No fee for service  
“They [pharmacists] do not feel challenge to perform better if they do not get 
much, right? …..It is our challenge because reward is needed.” (HH1) 
 
 “They [pharmacists] provide consultation on this. It is a burden for the patients. 
Because they [pharmacists] work as a profession, there should be fee involved. If 
we work on social based, they will be bored also. Who wants to work on social 
bases all the time?” (HU1) 
 
“Physicians got fee or rewards every time they visited patients, nurses’ rewards 
are only given on the basis of salary. The same thing is in pharmacist. This is a 
significant gap, there are no equal rewards” (HU3) 
 
 Poor procedures of recruitment 
“Recruiting staff, it’s not an easy job. Because we’re under government 
legislation, we’re public hospital. That’s the problem because (pausing) …the 
mechanism of staff recruitment, the needs and its formation are determined by 
the Ministry of Health” (HH1)  
 
“There is no standard procedure on recruitment of staff; sometimes dropping 
sometimes recruited from those who worked on contract bases.” (HH2) 
 
Interpretation of extract (HH2): 
There is no clear standard for staff recruitment. Sometimes, the staff was 
recruited by the Ministry of Health in Jakarta; sometimes they were recruited 




7.2 RESEARCH QUESTION 2: IS IPE FEASIBLE IN THE 
STUDY UNIVERSITY?  
This question was asked of Heads of Department in the university and in the hospital 
to assess the feasibility of the implementation of IPE at the study university. In 
general, the Heads in the hospital and university agreed the implementation of IPE in 
the study university was viable. This can be seen from the following extracts.  
 
“…I support IPE 100% from the bottom of my heart” (HU1) 
 
Investigator:” If I could rank your level of support to adopt IPE from 1 
disagree to 10 agree, where is your level of agreement?” 
HH2: “I would say, 10” 
 
 
From the interview data several themes emerged relating to this question such as; 
- the importance of IPE,  
- different learning methods and curriculum,  
- different opinions on when to start IPE in healthcare education, 
- level of support from the university for adopting IPE.  
 
Table 7.2 shows themes identified based on stakeholders’ opinions of the facilitators 
for and barriers to; the implementation of IPE at the study university. Section 7.2.1 
describes themes of facilitators for and Section 7.2.2 provides themes of barriers to 
the implementation of IPE.  
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Table 7.2 Themes identified of the feasibility of adopting IPE at the study university 
Facilitator/Barriers Themes HU1 HU2 HU3 HH1 HH2 
Facilitators Importance of IPE +++ ++ ++ + + 
Barriers Difference in 
curriculum between 
healthcare courses 
++ +++ ++ + + 
 Difference in 
opinions on when 
and how to start IPE 
+ + + + + 
 Difference in 
opinions on the level 
of support from 
university 
+ 0 + + + 
Notes: 
+++: themes identified more than 50 times 
++: themes identified 25 -50 times 
+: themes identified less than 25 times 
 
7.2.1 FACILITATORS FOR IPE  
There was only one theme identified as a major facilitator for the implementation of 
IPE in this study as can be seen from Table 7.2. 
 
(i) Importance of IPE 
All interviewed stakeholders believed that IPE was very important for healthcare 
students to experience during their study which can be seen from in the following 
extracts.  
 
 Improving healthcare students’ understanding of the role of healthcare 
professionals.  
“From the beginning, students have been introduced that they work in a 
hospital, they will work with A, B, C.” (HU2) 
 
“It should be introduced from the beginning, so professionalism…is at the 
very beginning. And so students would understand the relationship with 
other professions should be started from the beginning, so it will be formed 
better.” (HU1) 
 
 Fostering teamwork amongst healthcare students to reduce the hierarchy.  
“If the education is designed for IPE from the beginning, the students 
already realise that they learn with other healthcare students during their 
study. After they graduate, they will retain the concept that they work as a 





“I want to adopt the concept of Mayo Clinic, which they call collaborative 
medicine. Because Mayo Clinic is also a teaching hospital and so from 
education, it has been taught. It is taught at university on how the students 
need to collaborate with others. To collaborate to treat the patients and so 
physicians who graduated from Mayo they already have in their mind that 
they already thought, I have to collaborate with other health professionals. 
That’s why they’re called it collaborative medicine.” (HH1) 
 
“In my opinion, the earlier the better which means early IPE introduction 
during healthcare students learning is preferable. This is because firstly, 
after they work as professionals, it will not be awkward to work in a team, 
and everyone has understood their role, and so everyone knew. They will 
not be surprised that they work with other healthcare professionals. 
Secondly, maybe classical problems will not occur such as refusal of certain 
profession or arrogance of a profession can be prevented by introducing the 
role of other professions at the earliest stage. I think starting from early of 
healthcare students’ education.” (HH2) 
 
An interesting point identified during the interviews was the interviewed Heads of 
Departments in the university stated that there had been a meeting amongst Heads 
of the Medical, Nursing and Pharmacy Departments to discuss the possibility of 
including IPE in the curriculum.  
 
“Last time, we had a meeting with management of Department of 
Pharmacy in our university. I hope that they are also enthusiastic about this. 
It is true in the first meeting, there is nothing realistic yet, but I think we 
have an idea in adopting IPE.” (HU1) 
 
“We already had a discussion with management from Faculty of Medicine, 
where they have Medical and Nursing Departments. In terms of the 
possibility to have IPE, we arrived in an agreement that the education may 
be started as an extracurricular program or other learning activities.” (HU3) 
 
One of the stakeholders in the university also identified another interesting point 
with regards to the feasibility of implementing IPE, that the Indonesian Ministry of 
Education has supported the implementation of IPE through the Health Professional 
Education Quality (HPEQ) Project. This Project is aimed at improving the quality of 
health schools in Indonesia and was ongoing while the interviews were undertaken.  
 
“It can be concluded from the last HPEQ conference that it [IPE] is a must. 
All health education institutions should implement IPE. The real model on 
the pilot project is under development by HPEQ team to find out the ideal 




7.2.2 BARRIERS TO IPE 
Three themes relating to barriers to IPE were identified as shown in Table 7.2: 
- Different curriculum between healthcare courses 
- Different opinions on when and how to start of IPE in healthcare education 
- Different opinions on the level of support from the study university 
The sub-themes are illustrated in the following. 
 
(i)  Different curriculum between healthcare courses. 
The first theme to emerge identifying a barrier to IPE, during the interviews, was the 
different curriculum utilised between healthcare courses. Interviews with 
stakeholders identified that similar curricula of problem based learning at the 
Medical and Nursing Departments were mentioned as facilitators for the 
implementation of IPE. However, pharmacy students at the study university had little 
exposure to problem based learning. The different curricula may pose a significant 
barrier to the implementation of IPE at the study university involving medical, 
nursing and pharmacy students. An interesting point was raised in relation to the 
curriculum of the different healthcare courses and how these are influenced by 
different roles within the healthcare system. One of the Heads of Department in the 
university suggested that such differences may be a barrier to curriculum 
development at the study university. This is illustrated in the following extracts:  
 
“Nursing also adapts block systems, the same as in medicine” (HU2) 
 
“Faculty of medicine used block system, when the students finished one 
unit, let say the unit consist of one or two credits, they can finish the unit in 
one month. Meanwhile in pharmacy education, we use classical education 
system [teacher centred], in which 1 credit unit is equal to one meeting for 
one hour every week. This learning method is different significantly to 
implement IPE. As a result, we need to evaluate the curriculum, to evaluate 
how the curricula is implemented and adding more staffs which may need, 
we are on our way to that .” (HU3) 
 
“Say in the first competency on the students should have competencies on 
professional knowledge, procedural knowledge, cognitive and affective. But, 
when it will go to other competencies, from assessment, diagnosis, 
determining type of medical activities, evaluation, the methods are the 
same. But in ours mostly on nursing care, but in physician, it will be curative 
medicine. Mostly on prescribing medication, but nursing mostly on nursing 
care, from our blocks. Say for instance in musculoskeletal block, we need to 
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identify the competencies. What the students need to know, we have the 
same [learning methods], type of assessment also the same with medical” 
(HU2) 
 
Interpretation of extract (HU2): 
Healthcare students should have competencies in their own professional 
knowledge. The learning methods and assessments in nursing and medical 
educations are the same. However, medical education focuses on 
diagnosing the disease and prescribing medication. Meanwhile, nursing 
education emphasises nursing care.  
 
(ii) Different opinions on when and how to start of IPE in healthcare 
education 
All interviewees agreed there was a need for IPE in healthcare education. However, 
these stakeholders had different opinions on when to start IPE. Some leaders argued 
that IPE should be started as early as possible in healthcare students’ education, 
meaning that IPE should be started at undergraduate level and may also be 
introduced into students’ curriculum at internship level. However, initiation of IPE at 
internship level may bring about difficulties because of the different lengths and 
quality of internships between the professions. The Heads of Departments 
interviewed argued that a professionalism unit for all healthcare students could be 
incorporated as part of the curriculum which could help teach and implement IPE at 
the study university. Students could learn communication skills and ethics of 
healthcare professionals in this unit. The interviewed stakeholders also had different 
opinions on whether IPE should be integrated within the existing curriculum or as an 
addition to the curriculum within each course. These differences of opinion on how 
to incorporate IPE into healthcare students’ education may also be a barrier.  
 
 Different opinion on when to start 
“Internship for medical students is almost for 2 years, while for pharmacy 
students only 6 months. Theoretically, it needs adjustment. Internship in the 
hospital for pharmacist is very limited. The curriculum at pharmacy 
education will need adjustment, particularly for pharmacy students who 
preferred to work at hospital and community. This needs assessment. We 
expect in pharmacy education, the students could learn on how to work 
interprofessionally” (HU3) 
 
“To allow interaction amongst healthcare students to meet hospital’s needs 
when those students have internships in the hospital, the duration of time 
should be the same for students from different professions and so the 




 Different opinion on how to start 
“With regards to IPE, we could start from the same curricula say from 
professionalism [block] because all professions teach about it, about 
communication” (HU2) 
 
“The education may be started as an extracurricular program or other 
learning activities which involved lecturers from those three health schools”  
(HU3) 
 
“I think it [IPE] is very important. I strongly agree that it should be initiated 
in the curriculum, it should be in intra-curriculum” (HU1) 
 
(iii) Different opinions on the level of support from the study university 
Different opinions on the level of support from the study university for IPE were 
identified as one of the barriers to the implementation of IPE. It was suggested that 
support from the university had not been granted because IPE was a new concept in 
the Indonesian health curriculum. That is, no one had presented the concept to the 
university management. It was suggested that IPE is possible because the 
Departments of Medicine, Nursing and Pharmacy are all located at the study 
university. However, the Pharmacy Department is under the Faculty of Mathematics 
and Biological Sciences, meanwhile the Nursing and Medical Departments are under 
the Faculty of Medicine at the study university.  
 
“…and the most significant barrier is the location, Pharmacy is under Faculty 
of Mathematics and Biological, while Nursing and Medical Departments are 
under the same faculty [Faculty of Medicine].“ (HU3) 
 
“This [lack of support of facility and financial from university] become a 
barrier in our system. It will be hard for us. We have the willingness, we 
have the ability but the system restricted it. It’s from the policy [university 
policy].” (HU3) 
 
“I think that is because there is no one talk about it [IPE] just yet, it is only us 




7.3 RESEARCH QUESTION 3: IS IPP FOCUSED TO 
PROMOTE MEDICATION SAFETY FEASIBLE WITHIN THE 
CURRENT PRACTICE MODEL? 
The above question was asked of Heads of Department at the study university and 
hospital, as well as FGDs involving university and hospital healthcare professionals 
(i.e. physicians, nurses and pharmacists) and pharmacy graduates at the study 
university. The purpose of the question was to identify potential facilitators for and 
barriers to the implementation of IPP focused on medication safety within the 
current practice model.  
 
From the interviews and FGDs, the following themes were identified: 
- Benefits of IPP, 
- Expectation towards others’ role, 
- Interaction between healthcare professionals, 
- Support of IPP from stakeholders and the government, 
- Lack of competencies of IPP, 
- Lack of understanding of the role of healthcare professionals, 
- Superiority, 
- No legislation from the government on teamwork, 
- Limited staff. 
 
Table 7.3 shows the major themes identified based on facilitators and barriers to the 
implementation of IPP focused on medication safety in the current practice. 
Descriptions on themes of facilitators can be seen in Sections 7.3.1 and on themes of 
barriers in Section 7.3.2. In general, the Heads of Departments in the university and 
hospital as well as participants in FGDs, were supportive towards IPP. The Heads of 
Department support can be seen in the following extracts: 
“I definitely agree with it [IPP]. I would say 10 [10 of being the highest level of 
agreement]. If, I could share my life experience as physician, I think it is 
important. If we interact with people, the ego should be diminished.” (HU1) 
 
“I absolutely agree at level 10 [10 of being the highest level of agreement] 
because, we always think about the patients.” (HH2) 
 





Facilitator: “Do you agree to work with other profession to provide healthcare 
service?” All participants in Nurse Group said yes and laugh.  
 
Facilitator: “…how many will…agree to work with other profession to ensure the 
safe use of medication? “ All participants in Pharmacy Group raised their hands.  
P1-PG: “It should be everyone as long as we keep our knowledge updated.” 
 
Facilitator: “Do you agree to work in a team with other team members in 
providing patient care?”  
P1-MG: “Yes, we do. Happy about it, we like to communicate. We’d love to call 
them or text them (laughing).”  
 
Facilitator: “Are you ready to work or agree to work with other healthcare 
providers?” All pharmacy interns agreed.   
Facilitator: Why?  
P4-SG: “Because the aim of health service is to improve patient’s quality life.” 
 
Further, to explore the current practice of working together between healthcare 
professionals (i.e. physicians, nurses, and pharmacists) to promote safe use of 
medication, the themes identified were analysed based on D’Amour et al.’s model of 
collaboration.217 This model was considered to be the most appropriate in relation to 
collaboration because it takes into consideration individual and organisational 
dimensions in the collaboration. The level of collaboration at the study hospital was 
assessed based on dimensions and indicators of collaboration as shown in Table 1.10 




Table 7.3 Themes identified as facilitators for and barriers to the implementation of IPP in medication safety 
Facilitators/ 
Barriers 
Themes HU1 HU2 HU3 HH1 HH2 MG NG PG SG 
Facilitators Benefits of IPP ++ + + + ++ + + + + 
 Expectation towards the role of others + + + + + + + + 0 
 Interaction between healthcare professionals  + + + + + + ++ + + 
 Support of IPP from stakeholders and the 
government 
+ + ++ ++ + + + + + 
Barriers Lack of competencies of IPP ++ +++ +++ ++ +++ ++ ++ +++ +++ 
 Lack of understanding of the role of 
healthcare professional 
++ +++ + + ++ +++ +++ ++ +++ 
 Superiority + + + + + + + + + 
 No legislation from the government on 
teamwork 
+ + ++ ++ + + + + + 
 Limited staff  + + ++ ++ + + + + + 
Notes: 
+++: themes identified more than 50 times  
++: themes identified 25-50 times 
+: themes identified less than 25 times    
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7.3.1 FACILITATORS FOR IPP 
There were four themes related to facilitators for IPP at the study hospital. The 
themes included participants’ perceived benefits of IPP, expectations towards the 
roles of healthcare professionals, interaction between healthcare professionals, and 
support from the Indonesian Government and hospital policies. As can be seen in 
Table 7.3, the distribution of the themes of facilitators identified from interviews and 
FGDs was very similar.  
 
(i) Benefits of IPP 
Benefits of IPP were identified as one of the facilitating themes in assessing the 
feasibility of implementing IPP at the study hospital. Participants identified that IPP 
would be beneficial in reducing the blame placed on nurses when medication 
misadventure occurred during healthcare delivery. Participants also identified that 
potential risk of misuse of medication may result from unclear prescriptions. 
Communication amongst healthcare providers is essential particularly when there 
was an unclear prescription due to poor hand writing. Unclear prescriptions need to 
be rectified to minimise assumptions made by other healthcare professionals. This 
suggested that IPP may potentially improve the safe use of medications. The sub-
themes of benefits of IPP were seen as the following:  
 
 Reducing blame 
P5-NG: “Yes, all the blame will be ours [nurses].”  
P4-NG: “For instance, when there is error, it is almost certain nurses will be 
blamed. Say, the pharmacists take the wrong medication. We did not check the 
accuracy of medication dispensed, nurse will be blamed.”  
 
 Minimising the potential risk of medication misadventure.  
“I had several experiences, in VIP wards, there were nurses for different kind of 
cases, and so one patient was not only treated by different physicians but also by 
different divisions. The patient was given medication by more than one 
physician, sometimes, the names of drugs were different but they had the same 
indication.” (P6-NG) 
 
“For example, when the physician prescribed medication for a geriatric patient 
with higher dose than what it should be. The pharmacist may provide suggestion 
that according to Beer’s criteria or other guidelines, this should be done or by 
showing alertness on certain adverse effects of medication, it can help the 
physician. And when there was a team meeting, and there was a discussion, and 
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the pharmacist pointed out that there was a potential of drug related problems 
and they mentioned it.”(HH2)  
 
“Then, technically, the physician should be able to write a safe prescription. For 
example their hand writing, it should be a clear prescription.”(HH2)  
 
Since all participants in the study identified the benefits of IPP in ensuring medication 
safety, therefore, they had a shared goal of improving patient care. Hence, the 
present setting achieved a Level 2 (Developing Collaboration) for the dimension of 
Shared Goal and Vision according to indicators from D’Amour et al’s model of 
collaboration (Table 1.11).  
 
(ii) Expectation towards the role of healthcare providers 
 
The interviewed Heads in the hospital articulated certain expectations of the roles of 
healthcare professionals. They claimed that other healthcare professionals (e.g. 
nurses and physicians) thought the role of pharmacists on the wards was mainly 
about logistics (medicine supply) and in reducing the workload involved in drug 
distribution. The stakeholder’s expected the interaction between nurses and 
pharmacists on the wards was more focussed on medication advice. One also stated 
that pharmacists have roles beyond distribution to the wards in the hospital (see 
below).  
 
“…they [nurses] are confused on something. So, interprofessionalism will make 
them easier to do the thing. It is not because the job load has been minimised” 
(HH1) 
 
“There will be working partners who could be able to discuss about adverse drug 
reactions, choosing solvents etc. Pharmacist actually will help them [other 
healthcare professionals] to solve something. It is not because the work load has 
been reduced or taken over. That’s not what we want. But what I get now, the 
work load has been reduced. And so, actually there are lots of benefits. For 
instance, for patients under health insurance, what can be replaced with, that 
sort of working relationship I expected. But what I found, they [pharmacists] only 
help in drug logistics…” (HH2) 
 
According to indicators from D’Amour et al’s model of collaboration (Table 1.11), 
what can be expected of a certain healthcare professional and what to expect of 
others are indicators of formalisation tools under Formalisation dimension. According 
to the above extract, the role of pharmacists in the hospital was less than the 
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expectation of stakeholders at the study hospital, thus, the practice of collaboration 
on this indicator was at Level 1 (Potential Collaboration).  
 
(iii) Interaction between healthcare professionals  
From the theme of interaction between healthcare professionals emerged three sub-
themes (i.e. interaction between physicians and nurses; interaction between 
pharmacists and nurses; and interaction between physicians and pharmacists). 
Participants stated that there was limited interaction between healthcare providers. 
Participants identified that physicians mostly work with nurses but had very limited 
interaction with pharmacists. Interviewed pharmacists described most interaction 
with nurses and limited interaction with physicians. Discussion with the Pharmacist 
Group also revealed different opinions on the level of communication between 
pharmacists and physicians in the hospital. It appeared that the level of relationship 
was dependent upon the wards and place of work. Interviewed pharmacists 
indicated that the senior physicians who treated patients in VIP wards were difficult 
to have a discussion with and this was not a recent issue. The pharmacists claimed 
that they had most communication with junior physicians, such as physicians in 
charge of the Third Class wards where the patients are treated by residential 
physicians. It was also revealed that pharmacists in the Central Pharmacy suggested 
that they encountered difficulties communicating with physicians because they did 
not have information about the patients’ health status. In certain wards, however, 
pharmacists had access to patients’ status, and these pharmacists were contacted by 
the physicians about medication related matters.  
 
Although the level of communication amongst physicians and pharmacists was 
thought to be poor, potential communication may occur when the medication 
prescribed was outside the hospital formularies or the prescription order was unclear 
due to poor hand writing. The interviewed physicians also indicated that they 
accepted the fact that the medications prescribed may be changed by pharmacists as 
long as there was confirmation by the physician. In addition, physicians were pleased 
if pharmacists contacted them regarding clarification of poorly hand written 
medication. The interviewed physicians claimed that pharmacists in the hospital 
were mostly unreachable, thus the physicians had lack of communication with 
pharmacists in the hospital. The sub-themes which emerged on the interaction 
between healthcare professionals are illustrated in the following extracts. 
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 Interaction between physicians and nurses 
P2-MG: “To ensure patient safety, for instance, there is an event, as what I had 
last night, when I worked night shift. I never prescribed KSR for patient with end 
stage renal disease. Because theoretically these patients tended to be 
hyperkalaemia (pause) the Central Pharmacy sent KSR. Then, I read from the 
medication records, it was written KSR. I know that was not my hand writing 
because my writing is poor. But what was written was KSR with clear and neat 
hand writing. But I have written in the diagnoses that the patient suffered from 
end stage renal disease, and then the nurses luckily, the nurse pointed it out. I 
think the nurse understood that it is impossible for patients with end stage renal 
disease are on KSR. And so, she asked me why patient with CKD was given KSR. I 
thought I never wrote KSR, but in the drug order form, we use this form in the 
hospital. I saw, there is KSR but I never wrote it. Luckily the nurse reminded me. It 
will be very dangerous if the patient took KSR. I did not understand, where the 
source of errors. Was it from the drug order form? or was there someone write 
on the order form? or anything? or was pharmacist in the Central Pharmacy 
wrong to read to order? Or wrong to give the medication? I did not know I 
thought the nurse had really understood the disease, and so I did not give the 
medication…” 
P1-MG:  “It means that there was teamwork amongst nurses and physicians…” 
Facilitator: “As what I could see, it’s only amongst physicians and nurses, what 
about the pharmacist? 
P1-MG:”with pharmacists, I think because the time is very short, there should be 
a moment of we [physicians] have communication with them [pharmacists]. Lack 
of communication with pharmacists, I think.” 
 
“…say to delegate the job to nurses, on how to administer the medication, which 
route of administration. We [nurses] will do this, we need collaborative practice. 
It is not only dependent on physician. They will write on the patient’s medication 
record if we write in the patient’s medication records. If we do it wrongly, wrong 
route, the patient will be in danger.” (P1-NG) 
 
“So it may seem, strange, I think. Physicians in the current hospital were not 
familiar in working with other healthcare professionals. I think the physician who 
never gained working experiences in working with other healthcare 
professionals…the physician in the hospital [study hospital] may find it is 
strange.” (HU2)  
 
 Interaction between pharmacists and nurses 
“I think I have more discussions with nurses, yes, we have more interaction with 
nurses. We could contact physician, we could, but it starts from the nurses. Then 
they [nurses] will talk to physician.” (P6-PG) 
 
“There are antibiotics which should be taken after or before food, we are not 
very sure, especially for new drugs. We do not have the drug leaflets; we haven’t 
read it yet, not clear.” (P5-NG) 
 
“Actually, if the medication was not under formularies, it should be explained by 
pharmacist. How the medication worked and how the medication impacted the 
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patients. Otherwise, we will be confused because we did not have the same 
perception.” (P3-NG) 
 
 Interaction between physicians and pharmacists 
“The physicians in other hospitals in Indonesia already get used to working with 
pharmacists to consult or ask about medication, in particular on drug 
interactions which may occur.” (HH2)  
 
“The resident physicians and I, all of us are learning in my ward…For me, because 
I am in drug central of Ward A, when there was something wrong with the 
medications the physicians contacted me.” (P2-PG) 
 
“Then, sometimes the nurse said, pharmacists should talk to physicians directly, 
because nurses do not know how to explain to the physician. Okay, we 
[pharmacists] will talk to the physician. Then, the physician explained, this was 
the patient’s condition and because I was in the Central Pharmacy, I did not 
know the patient’s condition, when the physician mentioned about an additional 
diagnosis that was the hardest bargaining position, I was clueless.” (P5-PG) 
 
 P1-PG: “In my experience, sometimes the physician is hard to have a discussion 
with, once, it was long time ago, I think it is much better now. Maybe 5-6 years 
ago, it’s hard to communicate with physicians. Once, in a paediatric clinic, there 
was a patient who was a son of our staff. He was given antibiotics combination, 
of chloramphenicol and amoxicillin in powder. We know that chloramphenicol is 
very bitter, we wanted to counsel the physician to change it to syrup, and we 
haven’t said anything yet. They were angry, was it you who prescribed the 
medication or me?”  
P6-PG: “Yes, something like that, they used almost the same language.” 
Facilitator: “It means, it was not only happened 6 years ago?” 
P6-PG: “I meant, communicating with senior physicians, even now, they have the 
same comments. That is why we prefer to speak to junior physician who may 
accept our opinion. But it does not always happen, some are open to discussion, 
and some are not. For those who are not cooperative, as what has been 
mentioned just now, they will say who has the competency to write the 
prescription? Is it me or you?” 
 
“I did not know how, I did not know what to do. I could not reach the pharmacy. I 
did not understand either maybe I am never able to be in touch with them 
[pharmacists].” (P7-MG) 
 
The above findings illustrated that there was limited interaction amongst healthcare 
professionals and no information found regarding interaction between organisation 
(hospital) and individual (healthcare professionals) at the study hospital. Hence the 
indicator of connectivity (under Governance dimension) at the current setting was at 
Level 1 (Potential Collaboration) according to D’Amour et al’s model of collaboration 




(iv) Support of IPP  
Two sub-themes emerged of this theme (i.e. support from the stakeholders and 
support from the government). Participants in the interviews and FGDs suggested 
that support from the health system for the implementation of IPP is essential. The 
participants stated that if the government and the hospital management have a 
specific policy stating that teamwork is essential for patient service provision, then 
the healthcare professionals will work as a team. During the data collection period, 
the hospital was preparing for the Joint Commission International (JCI) accreditation 
as part of the Indonesian Government policy to ensure patient safety. Participants of 
the interviews identified that the accreditation had facilitated an improved 
awareness of activities in patient safety including medication safety. Participants 
pointed out that since preparation of the accreditation, integrated notes had allowed 
interaction amongst healthcare professionals because every healthcare professional 
was required to document their care in the notes. Participants mentioned that 
before the accreditation, documentation of patient’s information was scattered. But, 
after the hospital preparing for the accreditation, the documentation had gradually 
shifted towards integrated notes.  
 
 Support from the stakeholders 
“I think, it is very important in the future if we want to provide a holistic care. 
There will be comprehensive care. All this time, we only see the physician and the 
nurse who do the job.” (HU2) 
 
“Start from the person because it has been formed. It should be introduced from 
the beginning and so professionalism block is introduced at the very beginning. 
They will understand so the relationship with other professions should be started 
from the beginning. So, they will be formed better.” (HU1) 
 
This is the one at Mayo Clinic that I want to adopt which they call collaborative 
medicine…It is clearly mentioned at Mayo that our physician is not excellent. It is 
the same as other physicians in the world. But the difference is they have strong 
collaborative medicine and it has been prepared from their education.” (HH1) 
 
 Support from the government  
“One aspect of the JCI accreditation is documentation should not be fragmented, 
so health providers should write on the same paper.” (HU2) 
 





“So, JCI can be implemented soon. If JCI is implemented, interprofessional 
practice will work. This is because one of JCI indicators accommodates 
teamwork.” (HH2) 
 
This study found that stakeholders supported IPP between healthcare professionals 
which may be fostered through IPE. According to indicators from D’Amour et al’s 
model of collaboration, this was a leadership indicator under Governance dimension. 
Based on findings of this study, this leadership indicator was at Level 2 (Developing 
Collaboration).  
 
However, although the government policy has supported JCI accreditation which may 
allow interaction amongst healthcare professionals because all healthcare 
professional should document their care on the same notes, it was not clear whether 
information exchanged amongst healthcare professionals has occurred. Hence, 
according to indicators from D’Amour et al’s model of collaboration (Table 1.11), 
information exchange indicator (under Formalisation dimension) at the study 
hospital was at Level 1 (Potential Collaboration). 
 
7.3.2 BARRIERS TO IPP 
Table 7.3 shows that from the interviews and FGD data there were five barriers 
identified to the implementation of IPP in the study hospital: 
- lack of competencies for implementation of IPP 
- lack of understanding of the role of healthcare professionals 
- superiority 
- no legislation on teamwork from the government 
- limited staff.  
 
The most frequent theme identified as a barrier was the lack of competencies in IPP. 
The theme of competencies had three sub-themes, namely knowledge, skills and 
attitudes. The competency of knowledge not only involved knowledge within one’s 
own profession but also knowledge of the roles of other healthcare professionals. 
This study found that healthcare professionals lack of competency in IPP was 
identified from their lack of understanding of the role of healthcare professionals and 
was classified as a theme (Section 7.3.2.ii). This theme was discussed frequently by 
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participants of this study which indicated the theme was a significant barrier to IPP at 
the study hospital.  
 
(i) Lack of competencies of IPP  
Although participants agreed competencies of IPE are important, participants 
indicated that healthcare professionals lacked these competencies. Knowledge 
competency was not only within one’s own profession but also knowledge of the 
roles of other healthcare professionals. Understanding the philosophy of healthcare 
professionals as care providers was also regarded as knowledge competency. 
Communication and teamwork skills emerged as skills or competencies of IPP in the 
present study. These skills included what and how to deliver a message to other 
healthcare professionals. Failure of clear delivery of the message might cause 
ineffective communication. This indicated that a lack of interpersonal skills may 
hinder effective communication. Participants stated that teamwork is essential in 
working interprofessionally in healthcare service delivery. However, one of the Heads 
interviewed highlighted that currently there was a lack of role models amongst 
practitioners with good communication skills who worked with other healthcare 
professionals in practice.  
 
Trust and respect were identified as attitude sub-themes. Participants suggested that 
trust of other healthcare professionals and patients are essential in IPP. For example, 
if physicians doubted the pharmacists’ competency to dispense medication for 
paediatric patients, this may reduce the physicians’ trust in working with the 
pharmacists in a team. Respect was the most common attitude mentioned during 
interviews. Respect of other healthcare professionals is essential in teamwork. Lack 
of respect was identified during the discussion with the Physician Group where the 
physicians reported medications they prescribed were changed without discussion. 
Meanwhile, the Pharmacist Group pointed out that respect of the role of pharmacists 
will only occur when their involvement is regulated in the healthcare system because 
the pharmacists have a clear role with the regulation  
 
 Knowledge 
“If we talk about knowledge…nurses also have the same knowledge…They 





“They [healthcare professionals] already have the same vision. For instance, with 
JCI, it is about patient safety. Actually we have the same aims. We only need to 
work together.” (HU2) 
 




“…the skill on how to deliver a message is very important. Basic knowledge, good 
interpersonal skills which mainly based on communication, and team work 
skills.” (HU2) 
 
“…how they [healthcare professionals] should communicate with others; how 
they communicate with patients in relation to confidentiality; what issues they 
could share in front of the patients. What they should say to the physician and so 
the communication will not put one inferior towards another. But it should be 
constructive to work together.” (HU3) 
 
 “…when the patients come, how should we start to talk to the patients? How to 
greet them or introduce ourselves? How to start? We do not have a role model. 
Then we also give medication. And at the end, we would say, you need to be in 
hospital and so we need to talk to a nurse and that’s it. We’re never taught 




“…in my department I think, I have an experience in paediatrics. In dispensing 
parenteral dosage forms, the pharmacist could not do it.” (P7-MG) 
 
“We need to respect them [others healthcare professionals’ opinion] and also 
feedback from other healthcare providers also needs appreciation…so respect 
each other’s’ opinion or skills.” (P5-SG) 
 
“So, each profession should take care and respect to work collaboratively.” (HH2) 
 
“In the healthcare system, pharmacists, nurses and physicians have to work 
together. And I felt it too from the beginning. I think there was respect towards 
each other. I felt it, because, the system may be (pausing) must be from 
pharmacist, from previous pharmacists. Now, it feels that when there is no 
pharmacist, there is something missing.” (P7-PG) 
 
Interpretation of extract (P7-PG): 
In the healthcare service delivery, if pharmacists, nurses and physicians are 
designed to work in a team, respect of each other’s roles will be present. Thus, if 
there is no pharmacist, other healthcare professionals may find something is 
missing. 
 
Because of the lack of trust identified from participants of the present study, the 
level of collaboration on the trust indicator (under Internalisation dimension) 
according to D’Amour et al’s model of collaboration was at Level 1 (Potential 
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Collaboration) at the study hospital (Table 1.11).  
 
(ii) Lack of understanding of the role of healthcare professionals 
Two sub-themes were identified of this theme (i.e. lack of understanding of own role 
and of other healthcare professionals roles). Lack of understanding of own role was 
identified when nurses see themselves as servants of the physician. The belief of the 
role of other healthcare professionals as physicians’ helper was identified in the 
present study. This may reflect the culture of healthcare service delivery in Indonesia 
where the physician assumes highest position within the healthcare hierarchy. The 
lack of understanding of the roles of other healthcare professionals (in this case the 
pharmacist) might be due to the fact that the role of pharmacists is unclear in current 
practice (Section 7.1.2). Evidence of uncertainty regarding the roles of healthcare 
professionals is demonstrated in the following extracts: 
 
 Lack of understanding of own role.  
“During our shift if the senior physician has a patient and they 
recommended or called their physician’s chief in charged. If the chief could 
not do it, they asked us to do it, so we did it.” (P6-NG) 
 
 Lack of understanding of the role of other healthcare professionals  
“I think, we [physicians] do not know what their [pharmacists] role will be, 
and they [pharmacists] also do not know how our [physicians] role will be. 
And so, there might be a notion that I’ve delivered my responsibilities to 
others. Oh no this is the role of pharmacists…oh…no…this is the role of 
physicians.” (P6-MG) 
 
“We do not know what the role of pharmacists and they also do not know 
what our role.” (P1-MG) 
 
“The nurse is considered as physician’s helper that image remains in 
physicians.” (HU2) 
 
“Pharmacists know the aim is to help physician. For instance, if there is any 
problem they should contact the physician. It should be like this right?”  
(HU1) 
 
“Nurses are also important because they help the physician. At least they 
[nurses] do their role. In the past, they (nurses) were definitely physician’s 
helper. How about now? The attitudes remain like this. Nurses should take 
initiative to take care for the patients.” (HU1) 
 
Because participants of the present study had a lack of understanding of the roles of 
healthcare professionals, the level of mutual acquaintanceship (under Internalisation 
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dimension) was at Level 1 (Potential Collaboration) at the study hospital based on the 
indicators from D’Amour et al’s217 model of collaboration (Table 1.11).  
 
(iii) Superiority 
Another theme identified as a barrier to IPP was superiority. As per dictionary 
definitions, “ego” is defined as a person’s self-importance (in this case the 
importance of certain professions within the healthcare delivery). “Hierarchy” is 
defined as the level of arrangement based on the importance in an organisation. 
“Superior” relates to higher status or power (in this case in health service delivery). 
Based on these definitions, ego, hierarchy, and superiority were considered as one 
theme of superiority. The sense of superiority of certain healthcare professionals 
may result in communication gaps in healthcare service delivery. This is illustrated in 
the following extracts: 
 
“This will only occur when the three professions do realise the needs on it [IPP]. 
There is no super ego amongst profession. That they are the most important 
person, but everyone is important.” (HH2) 
 
“...but it does not happen everywhere, it must be. Or even so, some of them 
[physicians] will be cooperative. But for those who are not cooperative as what 
mentioned just now. They said who has the competency to write the 
prescription? Is it me or you? I referred to senior physicians, even up to now, they 
have comments like that.” (P6-PG) 
 
“The barrier to IPE was only from ego of each person because as I said, I hope 
with medical, we have many health courses like nurse, public health, I hope with 
this no one will feel superior towards each other. If one profession considered 
themselves as superior to another there will be a gap in communication” (HU1) 
 
Because of the sense of superiority identified in the present study, the indicator of 
client-centred orientation versus allegiances (under Shared Goals and Vision 
dimension) was considered at Level 1 (Potential Collaboration) according to the 
D’Amour et al’s217 model of collaboration (Table 1.11).  
 
(iv) No legislation on teamwork from the government 
Pharmacists in the hospital claimed that support from the government on teamwork 
is essential for teamwork to occur. However, stakeholders in the university suggested 




“Support from hospital management is highly needed, as what I felt. Particularly 
when there is a program from hospital, there are some programs….There was a 
policy from the management that a team in which professions need to be 
involved, pharmacists, nurses and other healthcare professionals in a team. The 
role of each profession must be explained in aseptic team” (P8-PG) 
 
“I think because in our country, there is no legal rule on this [working in a team]. 
As far as I known” (HU2) 
 
“Say for instance in a case of medication error, pharmacist had reminded us, the 
medication has been approved by pharmacists for its safety, because the patient 
has a lot of medications, which have been regulated under certain legal aspect, 
the physicians should be benefited, right? Why we need to work our own, this is 
what we hope for the future” (HU1) 
 
 “….there should be a legal shared responsibility of a task or job. In a modern 
society, failure in medication process is associated with malpractice. If there is a 
legal shared responsibility amongst health professions which involved put 
patient safety as their primary goals, for sure, the physician will be very happy. 
Because at the moment, the physician feels that all of those responsibilities are 
in physician’s hand. So they have an objection if others did not take legal 
responsibilities in doing such job” (HU3) 
 
Support from the health system (i.e. the Indonesian Government policies) and 
stakeholders in the hospital, as well as adoption of an international accreditation at 
the study hospital were taken as indicators of centrality (under the Governance 
dimension). At the study hospital, although the government support was obtained in 
certain wards or patient populations, there was no explicit legislation on teamwork 
(collaboration) amongst healthcare professionals. Thus, the centrality indicator 
according to D’Amour et al’s217 model of collaboration (Table 1.11) in this study 
hospital was at Level 1 (Potential Collaboration).  
 
(v) Limited staff  
 
Limited staff was also mentioned during interviews. All participants suggested that 
more staff would overcome healthcare professional shortages. The lack of numbers 
of healthcare professionals was mentioned as one cause of sub-optimal healthcare 
services which could be one of barriers to the implementation of IPP. The lack of 
numbers of healthcare professionals (in this regard pharmacists) had also been 
discussed as a barrier to the expansion of the role of pharmacists in patient care 
(Section 7.1.2.i). The present study indicated that the lack of numbers of healthcare 
professionals was an indicator of support for innovation (under Governance 
dimension) at Level 1 (Potential Collaboration) according to D’Amour et al’s model of 
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collaboration (Table 1.11). 
 
7.3.3 THE CURRENT PRACTICE OF INTERPROFESSIONALISM 
RELATED TO MEDICATION SAFETY BASED ON D’AMOUR ET 
AL’S MODEL OF COLLABORATION 
The levels of collaboration assessed in Section 7.3.1 and 7.3.2 were visualized 
according to indicators from D’Amour et al’s217 model of collaboration (Figure 7.1). 
The Governance dimension of D’Amour et al’s model of collaboration had four 
indicators (centrality, leadership, connectivity, and support for innovation). Of these 
indicators, leadership was the only indicator at Level 2 (Section 7.3.1.iv). Connectivity 
(Section 7.3.1.iii), centrality (Section 7.3.2.iv) and the level of support for innovation 
(Section 7.3.2.v) indicators were at Level 1 (Potential Collaboration). Thus, the level 
of collaboration based on the Governance dimension was at Level 1 (Potential 
Collaboration).  
 
Shared Goals and Vision dimension consisted of goals and client-centred orientation 
and allegiances. As discussed in Section 7.3.1.i, goals indicator was at Level 2. A 
conflicting finding towards client-centred orientation and allegiances indicator was 
identified. Section 7.3.1.i showed that this indicator was at Level 2 because of the 
fact that healthcare professionals supported IPP for the benefits to healthcare 
professionals. However, Section 7.3.2.iii showed superiority at the study hospital 
which indicated the client-centred orientation and allegiances indicator was at Level 
1. The sense of superiority was also frequently discussed by the participants in the 
interviews and FGDs. Thus, this indicator was regarded as Level 1 (Potential 
Collaboration). Consequently, the level of collaboration based on Shared Goals and 
Vision dimension in this hospital was also considered at Level 1 (Potential 
Collaboration). 
  
The Internalisation dimension had two indicators (mutual acquaintanceship and 
trust). This study found that healthcare professionals had lack of trust (Section 
7.3.2.i) and lack of understanding of the roles of other healthcare professionals 
(Section 7.3.2.ii). These indicated that Internalisation dimension was at Level 1 
(Potential Collaboration). The last dimension was the Formalisation dimension which 
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consisted of two indicators (formalisation tools and information exchange). Findings 
in Section 7.3.1.ii and Section 7.3.1.iv showed the two indicators were at Level 1 
(Potential Collaboration). Thus, according to these findings, the Formalisation 
dimension was at Level 1 (Potential Collaboration) in the study hospital.  
 
The highest level (Level 3) of each indicator on the spider-chart indicates optimal 
collaboration. Figure 7.1 shows that there was a wide discrepancy between the 
current situation and optimal collaboration. It can be concluded that based on the 
dimensions and indicators from D’Amour et al’s model of collaboration in ensuring 




Figure 7.1 Indicators of collaboration achieved at the study hospital based on D'Amour et al’s 

























Indicators of collaboration according to 
D'Amour et al's model of colaboration  
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7.4 DISCUSSION ON QUALITATIVE FINDINGS  
7.4.1 DISCUSSION ON THE ROLE OF PHARMACISTS IN 
PATIENT CARE  
This study aimed to determine facilitators for and barriers to the engagement of 
pharmacists in patient care particularly in ensuring the safe use of medication at the 
study hospital. The present study identified that the Indonesian Government has 
supported the role of pharmacists in patient care through the government policies 
and programs. However, barriers related to pharmacists’ external and internal 
factors were identified. Firstly, barriers from pharmacists’ internal factors were 
identified as the major barrier to pharmacists’ engagement in patient care. The lack 
of knowledge and confidence, lack of communication skills, limited numbers of 
pharmacists in the hospital and pharmacists’ mind set were identified as pharmacists’ 
internal factors. Lack of confidence may result from the lack of knowledge and the 
lack of communication amongst pharmacists. If healthcare professionals have a lack 
of communication skills, their engagement with patients as well as with other 
healthcare professionals is likely to be less intensive. Another barrier identified was 
the limited numbers of pharmacists in the hospital. At the time of the interviews, the 
hospital had 700 beds and 19 pharmacists, although the Indonesian Government has 
indicated that the optimal ratio of pharmacist to patients is 1:30.230 As a result the 
pharmacists at the study university had limited involvement in patient care (1:37). 
Mostly, their duties are concentrated in the Central Pharmacy with minimum 
involvement on the wards. Further, this study found that the pharmacists should 
change their mind set that they will not only work in Pharmacy Department in the 
hospital setting or community pharmacies, but will engage directly in patient 
activities.  
 
In comparison to the well-established role of pharmacists in Australia, in the present 
setting, there were no clear rules of pharmacists’ engagement in patient care. This 
was considered as one of the pharmacists’ external factors. This lack of rules may 
lead to no fee for services. No fee in delivering pharmacists’ services may cause 
devaluation of their profession. It was revealed from the interviews that the National 
Health Insurance (JKN- Jaminan Kesehatan Masyarakat) may provide a schedule of 
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fees for the pharmacists’ services. However, how these fees for service will be 
implemented in practice was uncertain from the interviews.  
 
Lack of understanding of the role of pharmacists was identified as another of 
pharmacists’ external barriers to role expansion in patient care. Most, participants 
believed that the role of pharmacists is mainly in drug management, with limited 
engagement with patients as well as other healthcare professionals. This indicated 
that the role of pharmacists is fairly unclear in practice. Lack of understanding of the 
role of pharmacists may lead to misperception of the role. Hermansyah et al175 
indicated that the lack of pharmacists’ engagement in patient care may potentially 
lead to de-professionalisation of the profession of pharmacists. Another of the 
pharmacists’ external factors was poor procedures of staff recruitment at the study 
hospital. These procedures may result in variation in the quality of service provided 
by pharmacists in particular and by healthcare professionals in general. Michie and 
West in their framework to understand the link between organisation performance, 
organisation culture and the people suggested that qualified healthcare professionals 
are an essential factor in providing patient care in healthcare services.339  
 
According to the NHS sustainability model,176 expanding the role of pharmacists in 
patient care can be examined for sustainability based on three factors (i.e. process, 
staff and organisation). Process is the first NHS sustainability factor. The process 
factor involves benefits beyond helping patients, credibility of the benefits, 
adaptability of the process, and effectiveness of the system to monitor the process. 
In this study, the new initiative is the role of pharmacists in patient care in ensuring 
the safe use of medication. The results of the present qualitative study indicated that 
healthcare professionals were motivated for pharmacists’ involvement in patient 
care as long as it brings benefits for them. This means that the benefits not only to 
the patients but also to healthcare professionals should be highlighted if pharmacists 
are to engage in patient care with other healthcare professionals. The other 
components of the process factor (credibility of the benefits, adaptability of 
improved process and the effectiveness of system to monitor the process) were not 
identified in this study.  
 
The second factor of the NHS sustainability model is the staff factor which consisted 
of staff training, staff behaviours, and support from senior leadership and clinical 
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leaders. This study found that the major barrier to expand pharmacists’ role was a 
pharmacist internal factor, i.e. lack of knowledge and experience. This indicated 
training of pharmacists in providing patient care is required. Thus, further exploration 
on the effective training for pharmacists to provide patient care, particularly in 
ensuring the safe use of medication, is required. The NHS model endorsed members 
of the new initiatives (in this regards the role of pharmacists in patient care) to 
identify any knowledge and skills gaps prior to its implementation. This study found 
that there was lack of understanding of the role of pharmacists and pharmacists 
were reported to have lack of knowledge and skills. These showed that in the present 
study there were skills and knowledge gaps in expanding the role of pharmacists in 
patient care. Senior leaders’ support (in this regards stakeholders) has been 
identified. However, support of a clinical leader of the role of pharmacists was not. 
The NHS model recommends that a clinical leader is prominent, to use their influence 
to break down the barriers. Such a leader was not identified in this study.  
 
The last factor in the NHS model is the organisational factor. Findings of this study 
suggested that expanding the role of pharmacists in patient care needs to fit with the 
organisational strategic aims and culture. The study hospital adopted the JCI 
accreditation which has a standard on medication management use. Pharmacists 
could play a significant role in this area. But there were limited numbers of 
pharmacists to provide patient care at the study hospital. According to NHS 
sustainability model, barriers identified at staff, process and organisation factors 
described above are required to be addressed if pharmacists are to expand their role 
in patient care.  
 
In particular to analyse the feasibility of the expansion of the role of pharmacists in 
medication safety, the Holland-Nimmo Practice Change System (PCS) could also be 
employed.59 There are three components of the PCS model. The first component is 
practice environment. At the study hospital, although the support from the 
government policies of the role of pharmacists in medication safety and support from 
the stakeholders were obtained, there were some significant barriers to the 
expansion of the role of pharmacists in medication safety. These barriers were lack of 
interprofessional relationships between pharmacists and other healthcare 
professionals, no clear role of pharmacists in patient care and different expectations 
of the current practice. The second component is the motivational strategies which 
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indicated that pharmacists must change their mind-set that they will not only work in 
the community pharmacies but also in hospital pharmacies if the pharmacists intend 
to become involved in medication safety. Another motivation strategy was the 
systematic motivation to drive for change in which professional socialisation plays a 
significant role. It was evident in the present study that there was limited 
professional socialisation in the pharmacy education. This could be seen in the 
extracts of the sub-theme of lack of knowledge and experience mentioned by the 
pharmacy interns (See Section 7.1.2.i). The third component of PCS model was the 
learning resources.59 The resources consisted of training for the pharmacists to 
expand their role in medication safety. It is suggested the training should meet 
pharmacists’ learning needs and be accessible, affordable and available in a timely 
manner. In the present study, this component was not identified. Thus, this kind of 
training requires further exploration in the future.  
 
This study found that in order to expand the role of pharmacists in medication safety, 
support from the government in terms of providing a greater pharmacist workforce 
and clear procedures for their recruitment is essential. In addition, training for 
pharmacists as care providers and creation of a schedule of fees for pharmacists 
providing services is required. Pharmacists in the hospital need to engage with other 
healthcare professionals and the patients particularly in ensuring the safe use of 
medication. This could then provide evidence of the role of pharmacists in patient 
care and medication safety. In doing so, getting a clinical leader to acknowledge the 
role of pharmacists and to act as a champion to reduce potential barriers of 
expanding the role of pharmacists in the future is needed. It was also indicated in the 
present study that adjustment of the pharmacy curriculum to allow more exposure 




7.4.2 DISCUSSION ON THE FEASIBILITY OF THE 
IMPLEMENTATION OF IPE AT THE STUDY UNIVERSITY 
The aims of interviewing stakeholders were to identify facilitators and barriers to the 
implementation of IPE at the study university. Interviews with stakeholders showed 
that there had been an initial meeting amongst the Heads of Medical, Nursing and 
Pharmacy Departments to discuss possible implementation of IPE within their 
courses. This indicated that the Heads of Department were giving consideration for 
the implementation of IPE. Their support as leaders in health education institutions is 
important. According to D’Amour and Oandasan framework of Interprofessional 
Education for Collaborative Patient-centred Practice (IECPCP),79 leadership was an 
institutional factor at the Meso level (See Figure 1.6). This indicated that support at 
the Meso level had been obtained at the study university. Stakeholders also 
identified the importance of IPE (i.e. to improve understanding of the roles of 
healthcare professionals and to initiate teamwork skills). These benefits were also 
one of outcomes of IPE discussed in the literature (See Section 1.4.1).82, 85  
 
However, support from stakeholders of the study university required further 
clarification if IPE was to be implemented. This was because the stakeholders had 
different opinions on when and how IPE should be initiated. They had different 
opinions whether the IPE should be introduced as an intra or extra curriculum activity 
and had different opinions on whether IPE should be initiated at the undergraduate 
or internship level. The stakeholders also had different opinions on the level of 
support from the university board. This may reflect the lack of communication from 
university to faculty members. Stakeholders also believed that other barriers 
(support from university board and different curriculum) may be encountered in the 
adoption of IPE at the study university. These findings were potential barriers in the 
implementation of IPE at the study university. The barriers identified at the study 
university were similar to potential barriers found in the literature.214, 340-342  
 
Hall211 suggested that different roles of caring amongst healthcare professions may 
be one of the barriers in the implementation of IPE. She further indicated that the 
different roles of healthcare professionals may lead to communication barriers. 
Hall211 argued that the main aim of the physician is to diagnose and treat disease and 
they rely on objective data in providing their services. Meanwhile, nurses listen to 
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subjective patient histories in providing their care. Thus, she recommended that the 
differences which are mostly invisible should be made visible if IPE is to be 
implemented. In the present study, the different roles were identified during 
discussion with one of stakeholders in the university. The stakeholder suggested that 
the physician aimed to cure the disease meanwhile nurses provide nursing care 
which focused on the patient’s everyday well-being. The different roles of healthcare 
professionals may have an impact on healthcare students’ training.  
 
Although the HPEQ Project was mentioned by only one stakeholder, it was also 
reported. This was because further review indicated that the HPEQ Project showed 
that the Indonesian Government has supported the importance of IPE in the 
development of IPP amongst healthcare professionals. This support was shown by 
the Indonesian Ministry of Education and the Directorate General of Higher 
Education (Direktorat Jenderal Pendidikan Tinggi) which established a joint 
accreditation body in early 2014 as one of outcomes of HPEQ Project. This joint 
accreditation body consists of higher health education and professional 
organisations. The accreditation body is named IAAHEH - Indonesian Accreditation 
Agency for Higher Education in Health (LamPTKes - Lembaga Akreditasi Mandiri 
Perguruan Tinggi Kesehatan).228 The establishment of the IAAHEH as a joint 
accreditation body indicates that the Indonesian Government supports IPE in 
healthcare education curricula.  
 
The establishment of the IAAHEH identified in the present study was one factor in 
the Macro level of D’Amour and Oandasan on IECPCP framework from education and 
from professional organisation system.79 The role of the professional organisations in 
the implementation of IPE has been highlighted in the literature.340 Professional 
organisations may create organisational climates and cultures. Organisation climates 
may be created by members’ behaviours, procedures, policies and routine in their 
practice. Further, cultures are rooted from beliefs and values of an organisation. The 
beliefs, values and behaviours of members of the organisation will influence how 
they interact and engage with others. Ginsburg and Tregunno suggested that in order 
to change an organisation’s climate, certain practices should be stopped and new 
practices should be commenced.340 This qualitative finding demonstrated that 
according to D’Amour and Oandasan’s on IECPCP framework (See Figure 1.6), 
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support at the Macro and Meso levels for IPE has been obtained at the study 
university.79 
 
7.4.3 DISCUSSION ON FEASIBILITY OF THE 
IMPLEMENTATION OF IPP IN THE STUDY HOSPITAL 
The present study aimed to identify facilitators for and barriers to the 
implementation of IPP at the study hospital from interviews and FGDs activities. This 
study identified that healthcare professionals realised the importance of IPP in 
ensuring medication safety at the study hospital. Participants in interviews as well as 
FGDs discussed the benefits not only to the patient but also to healthcare 
professionals. In this regards, the healthcare professionals had identified that IPP 
may bring about positive benefits to the staff. If staff perceived gaining advantages 
from IPP, this may also positively influence organisation performance in patient care. 
Ginsburg and Tregunno stated that organisational culture (i.e. values, beliefs, and 
attitudes) and climate (i.e. policies, procedures, and staff’s belief in their 
organisation) have a strong influence in the successfulness of organisational 
performance in patient care.340 Thus, staff’s positive behaviour is an important factor 
if IPP is to occur. The results of the present study indicated that healthcare 
professionals were supportive towards IPP. This showed that support at Micro level 
(healthcare professionals) of frameworks of IECPCP from D’Amour and Oandasan’s 
(See Figure 1.6) existed.  
 
This study identified knowledge, skills and attitudes were competencies required in 
IPP. These competencies were also outlined in the literature.159, 160 The knowledge 
competency included competency within one’s own profession, as well as 
understanding of the roles of other healthcare professionals. However, this study 
found that healthcare professionals had a lack of knowledge of the roles of other 
healthcare professionals. This was considered as one of barriers to the 
implementation of IPP. Skills competency involved ability to communicate effectively 
amongst healthcare professionals as well as with the patients. Meanwhile, attitudes 
related to respect towards others. Suter et al suggested that communication skills 
are an important competency of healthcare providers in IPP.343 The skills involved 
using the appropriate language and ability to negotiate with others. This means that 
healthcare professionals are required to learn dual identities (their own professional 
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identity as well as interprofessional identity).315 One of the outcomes of IPE is the 
improvement in these competences.85 According to the WHO Framework (See Figure 
1.7), if IPE is fostered during healthcare professionals’ education they will obtain 
competencies to be practice ready in working with other healthcare professionals.  
 
The model of collaboration from D’Amour et al was employed in the present study 
because it relates to individual and organisational factors to determine the level of 
collaboration in a practice setting. According to indicators of this model, finding of 
this qualitative study showed that the current practice of collaboration in the 
hospital at Level 1 (Potential Collaboration) which meant that collaboration on 
medication safety at the study hospital did not yet exist. Findings on the level of 
collaboration in the present study emphasised the importance of WHO framework 
for IPE-PC in ensuring the safe use of medication at the study hospital.  
 
This study found that the level of government support was not fully gained. Studies 
showed that support from the government is essential to the implementation of IPP 
into practice.63, 79, 82 The government needs to provide clear policy, support, and 
incentive to key players in fostering IPP in the organisation.340 If the health system 
imposes a policy on working in a team (centrality indicator) and provides sufficient 
numbers of healthcare professionals to work in the team (support for innovation), 
healthcare professionals will work collaboratively with others. This will improve 
interaction amongst healthcare professionals (connectivity indicator). The lack of 
understanding of other healthcare professionals’ roles and the lack of trust identified 
in this study may result from the nature of healthcare service delivery in Indonesia 
where the physician is considered as the primary healthcare professional to provide 
patient care. This study found the role of physicians is superior, nurse is inferior and 
pharmacist is unclear. Understanding the role of other healthcare professionals is 
one of major competencies in patient-care based healthcare services.343 The varying 
understanding of the roles of healthcare professionals needs to be addressed prior to 
the implementation of IPP. It is recommended the academics and practitioners may 
use constructive conflict to challenge underlying assumptions and to build shared 
mental models to enhance the ability to understand the role of other healthcare 




In relation to the Collaborative of Pharmacy Practice (CPP) initiative from the 
International Pharmaceutical Federation-FIP25, (See Figure 1.8), the level of CPP at 
the study hospital was at Level 1. This was identified from limited interaction 
between pharmacists and other healthcare professionals (See Section 7.3.1.iii). As 
discussed in Section 7.1.2, barriers related to pharmacists’ internal factors need to be 
addressed if the pharmacists aim to engage in patient care to ensure the safe use of 
medication in collaboration with other healthcare professionals is to be achieved.  
 
The qualitative findings of this study showed some relationships between themes in 
answering research questions. These relationships may result from the nature of 
interpretation in the qualitative study where one quote may be categorised into 
several themes. The first relationship was on the theme of understanding of the role 
of healthcare professionals. This theme was identified in all three questions of this 
qualitative study (See Section 7.2.1.i; Section 7.1.2.ii; and Section 7.3.2.ii). Varying 
understanding of the roles of healthcare professionals (in this case pharmacist) is a 
barrier to pharmacists’ expansion of their role in patient care and in their 
involvement in IPP. However, as discussed in Section 7.2.1.i, interviewed 
stakeholders believed that IPE may improve the understanding of the roles of other 
healthcare professionals. This suggests that IPE may develop understanding amongst 
other healthcare professionals of the role of pharmacists in patient care.  
 
Another relationship sub-theme, namely reducing unclear prescriptions through 
interaction between healthcare professionals (See Section 7.3.1.iii) was also 
identified as one of benefits of IPP (See Section 7.3.1.i). This indicated there was a 
possibility of interaction between healthcare professional in ensuring the safe use of 
medication because healthcare professionals have realised the benefits of IPP. The 
last relationship was on the theme of limited staff in answering the feasibility of 
pharmacists’ engagement in patient care (See Section 7.1.2.i.b) and IPP (See Section 
7.3.2.iv). This indicated that in order to include pharmacists in IPP, the lack of 
numbers of pharmacists needs to be addressed.  
 
Despite the fact that this study identified the feasibility of expanding the role of 
pharmacists and IPE and IPP, there were some potential biases in this qualitative 
study. The bias may result from participants as well as researchers.344 Bias from 
participants may be associated with their positive motivation to be involved in 
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research. This may influence positive participants’ responses towards the questions 
asked. This was beyond the control of investigator. Meanwhile, bias from interviewer 
may results from the data collection and analysis process. Potential bias from 
interviewer was minimised by using a triangulation data collection method in which 
similar data was collected from interviews and FGDs. 
7.5 SUMMARY OF QUALITATIVE FINDINGS 
In terms of determining the feasibility of expanding the role of pharmacists in patient 
care, barriers identified need to be addressed if pharmacists are to engage in patient 
care in ensuring the safe use of medication with other healthcare professionals. 
Although the level of collaboration at the study hospital based on D’Amour et al was 
at Level 1 (Potential Collaboration), this study found that implementing IPE at the 
study university and IPP at the study hospital was feasible if the barriers identified 
are addressed accordingly. This is because support at the education and practice 
settings has been identified based on the IECPCP framework from D’Amour and 
Oandasan’ (See Figure 1.6). At the education setting, support at the Macro level (the 
establishment of accreditation body- IAAHEH) and the Meso level (stakeholders at 
university) have been obtained. Support at the Micro level (healthcare students) has 
not been identified in this qualitative study. In the practice setting, although support 
from the Macro level (Health system) has not been fully obtained, some degree of 
support at the Meso level (stakeholders at hospital) and Micro level (healthcare 




CHAPTER 8 GENERAL DISCUSSION AND 
RECOMMENDATIONS 
8.1 INTRODUCTION  
The primary aim of this study was to determine the feasibility of expanding the role 
of pharmacists in medication safety through IPE and IPP. Three research questions 
were employed to identify the feasibility of pharmacists’ engagement in patient care 
to ensure medication safety, the feasibility of implementing IPE in the study 
university and IPP in the study hospital.  
 
This chapter outlines key findings on:  
 Role of pharmacists in patient care to ensure medication safety (Chapter 4) 
 Healthcare students’ attitudes towards IPE (Chapter 5) 
 Healthcare professionals’ attitudes towards IPP in medication safety (Chapter 6) 
 Qualitative findings on the feasibility of the role of pharmacists, the feasibility of 
the implementation of IPE and IPP in medication safety (Chapter 7)  
The relationship of each of these topics to the research questions of this study are 
illustrated in Figure 8.1. Medication Safety (MS) where the three circles intersect is 
the key subject of this study.  
 
Circle A represents research activities in the present study on the feasibility of 
expanding the role of pharmacists in patient care to ensure medication safety. The 
data consists of;  
 Pharmacy graduates perceived attainment of attributes as patient care providers 
(Section 4.1)  
 Pharmacist conducted clinical review activity as a means of identifying medication 
errors in an Indonesian hospital (Section 4.2)  
 Qualitative findings on the feasibility of expanding the role of pharmacists in 
patient care to ensure medication safety (Section 7.1).  
Circle B depicts research activities to identify the feasibility of the implementation of 
IPE in the study university. The information consists of;  
 Healthcare students’ responses from an RIPLS questionnaire on attitudes towards 
IPE (Section 5.1)  
 Findings from an IPL workshop on medication safety (Section 5.2)  
 Qualitative findings on the feasibility of the implementation of IPE (Section 7.2).  
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Circle C represents research activities into the feasibility of IPP implementation in the 
study hospital. This area includes;  
 Healthcare professionals’ responses from RIPLS questionnaire on attitudes 
towards IPE (Section 6.1) 
 Healthcare professionals’ understanding of professionals responsible for and 
factors contributing to medication errors depicted in case vignettes (Section 6.2) 

























Figure 8.1 Venn diagram depicting the association between sections of the present 
study 
 
A summary of the key findings of this study is shown in Table 8.1. The table lists 
research questions, aims and findings identified from both qualitative and 
quantitative results as applicable. 

















The role of pharmacists 
in patient care 








     
IPP (Sections 6.1 and 7.3) 
 
IPE (Sections 5.1 and 
7.2) 




 IPL Workshop on 
medication safety 
(Section 5.2) 
Medication errors case 
vignettes (Section 6.2) 
C 
MS 
The role of pharmacists 
in medication safety  
        (Section 4.2) 
Notes: A: Feasibility of the role of pharmacists in patient care; B: Feasibility 
of IPE; C: Feasibility of IPP; MS: Medication Safety 
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Table 8.1 A summary of key findings of this study 
Research Questions Aims Quantitative Findings Qualitative Findings 
Feasibility of expanding 
the role of pharmacists in 
patient care to ensure the 
safe use of medication 
Assess pharmacy graduates 
preparedness in patient care 
(Section 4.1) 
Pharmacy graduates questionnaire: 
 Pharmacy interns perceived they had attained less of attributes to 
provide patient care than registered pharmacists (**) 
 60% of pharmacy interns from the study university perceived they 
had developed three attributes of patient care fully and four 
attributes partially (**) 
 Amongst pharmacy interns, a higher proportion of males than 
females perceived they had leadership potential  
FGDs: 
 Lack of knowledge and limited 
experience are likely to influence 
graduates’ lack of preparedness in 
delivering patient care (**) 
 Assess the role of pharmacist 
in medication safety (Section 
4.2) 
 Pharmacist could identify where medication errors occurred in the 
medication delivery process and could intercept  medication errors 
in a geriatric ward (*) 
 35% acceptance rate of pharmacist’s interventions 
NA 
 Stakeholders’, pharmacy 
students’, and healthcare 
professionals’ attitudes 
towards the feasibility of 
expanding the role of 
pharmacists in patient care to 
ensure medication safety 
(Section 7.1)  
NA Interviews and FGDs: 
 Facilitators: (*) 
- Benefits of the role of pharmacists and 
support from the Indonesian 
government for the role of 
pharmacists  
    Barriers: (**) 
 internal (pharmacists’ mind set, 
lack of knowledge and confidence; 
low number of pharmacists) 
 external (varying understanding of 
the role of pharmacists; no fee for 
services; poor staff recruitment) 
Feasibility of IPE in the 
study university 
Assess healthcare students’ 
attitudes towards IPE  
(Section 5.1) 
RIPLS in healthcare students:  
Analysis 1 (Year 1 to 4 healthcare students’ attitudes towards IPE in 
Survey Year 2012) 
- Medical, nursing and pharmacy students were positive (*)  
- Medical students were less positive than nursing and pharmacy 
students(**) 




Research Questions Aims Quantitative Findings Qualitative Findings 
nursing and pharmacy students (**) 
Analysis 2 (Year 2 to 4 of healthcare students’ attitudes towards IPE in 
a repeated cross sectional study in Survey Years 2012 and 2013)  
- Medical students were more positive on the PI  sub-scale than 
nursing and pharmacy students in both survey years (**) 
- No significant difference on the PI sub-scale between nursing and 
pharmacy students in either survey year  
Analysis 3 (Year of Study analysis in Survey Years 2012 and 2013) 
- Year 3 medical students in 2013 who were older and had no health 
related activities had significantly more positive attitudes towards 
the PI sub-scale than in Year 3 medical students in 2012 (**) 
- Year 3 medical students in 2012 had more positive attitudes on 
Statement 8 but less positive attitudes on support Statement 14 
than in Year 3 medical students in 2013 (*). 
Analysis 4 (Trend Study Analysis):  
- Year 2 Cohort medical students moved towards more positive 
attitudes on the PI sub-scale and moved towards less positive 
attitudes towards Statement 8 as their study progressed (**) 
- All cohorts of medical students moved towards more positive 
attitudes towards the PI sub-scale but less positive attitudes 
towards the SLT sub-scale (**) 
- Year 1 Cohort students in medical, nursing and pharmacy moved 
towards less positive attitudes on the SLT sub-scale (**) 
 Assess healthcare students’ 
attitudes towards IPE after 
attending an IPL workshop on 
medication safety (Section 
5.2) 
IPL Workshop: 
 Learning with other healthcare students (medical, nursing and 
pharmacy students) improved the students’ attitudes towards the 
SLT sub-scale (*) 
 Medical students had less positive attitudes towards Statement 4 
than nursing and pharmacy students after the workshop (**) 
 
IPL Workshop (*): 
 Improved understanding of the 
role and responsibilities of 
healthcare professionals 
 Improved understanding of the 
importance of teamwork and 
communication skills in 
healthcare service delivery in 
medication safety 





Research Questions Aims Quantitative Findings Qualitative Findings 
 Stakeholders attitudes 
towards IPE (Section 7.2) 
NA Interview findings: 
 Facilitator: Importance of IPE (*) 
 Barriers:  
 Differences in school curriculum 
(**) 
 Differences in opinion on when 
to start IPE and on the level of 
support from the university (**) 
Feasibility of IPP in the 
study hospital 
Healthcare professional 
attitudes toward IPP (Section 
6.1) 
RIPLS in healthcare professionals  
Analysis 1 (Healthcare professional attitudes towards IPP):  
- Healthcare professionals regardless of their profession or place of 
work were positive (*) 
- Healthcare professionals had no significant difference in their 
attitudes towards the Patient Centredness and SLT sub-scales (*) 
- The Physician Group had more positive attitudes towards Statement 
17 and 19 than the Nurse and Pharmacist Groups, whilst there was 
no significant differences amongst Nurse and Pharmacist Groups 
(**) 
- The Physician Group had more positive attitudes towards 
Statements 18 and 21 than the Nursing Group but did not differ 
significantly from the Pharmacist Group (**) 
Analysis 2 (Comparison of healthcare professional practitioners’ and 
academics’ attitudes towards IPP) 
- Healthcare academics had more positive attitudes than 
practitioners towards Statement 19 (**) 
- Nurse practitioners had significantly more positive attitudes 
towards Statement 19 than nursing academics (**) 
Analysis 3 (Comparison of healthcare professionals’ and healthcare 
students’ responses to the idea that the function of other 
healthcare professionals is mainly to support doctors)  
- The Physician Group were more positive than the medical students 
(**) 







Research Questions Aims Quantitative Findings Qualitative Findings 
 Healthcare professionals 
understanding of medication 
errors and agreement on 
healthcare professionals 
responsible for errors 
(Section 6.2) 
Medication errors case vignettes  
 Pharmacist Group members showed higher accuracy but older 
participants (>50 years old) had less accuracy to provide anticipated 
correct answers for the case vignettes(*)  
 A small proportion of participants believed that communication 
barriers may result in medication errors (**) 
 Healthcare professionals had varying views on the professionals 
who were responsible for the various medication errors (**) 
NA 
 Stakeholders’, pharmacy 
students’, and healthcare 
professionals’ attitudes 
towards the feasibility of IPP 
implementation (Section 7.3) 
NA Interview findings  
 Facilitators: (*)  
 Benefits of IPP 
 Expectations regarding other 
healthcare professionals’ role 
 Potential interaction between 
healthcare professionals 
 Support from government and 
hospital policies  
 Barriers: (**) 
 Lack of understanding of the 
role of healthcare professionals 
 Sense of superiority 
 No government legislation on 
teamwork 
 Limited staffs numbers 
 Lack of competency in IPP  
Notes: NA: Not Available;  *: Facilitator ; **: Barrier 
PI: Professional Identity; SLT: Shared Learning and Teamwork; PC: Patient-centredness 
Statement 4 in RIPLS healthcare students: Team working skills are essential for all healthcare students to learn 
Statement 8 in RIPLS healthcare students: It is not necessary for undergraduate healthcare students to learn together 
Statement 14 in RIPLS healthcare students: The function of allied health professionals is mainly to provide support for doctors 
Statement 17 in RIPLS healthcare professionals: I like to understand the patient’s side of problem 
Statement 18 in RIPLS healthcare professionals: I try to communicate compassion to my patients 
Statement 19 in RIPLS healthcare professionals: The function of nurses and therapists is mainly to provide support for doctors 
Statement 21 in RIPLS healthcare professionals: I have to acquire much more knowledge and skills than other healthcare professionals
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8.2 DISCUSSION OF KEY FINDINGS 
Pharmacists in Indonesia currently have a limited role in patient care.54, 175 Although 
the Indonesian Government has supported their role in patient care51 in ensuring 
medication safety,345 little is known on how this has been implemented. This may be 
associated with pharmacists having limited engagement with patients and with other 
healthcare professionals. The theory, learning model, and the outcomes of IPE have 
been discussed extensively in the literature.74, 77, 213, 346, 347 One of the key outcomes of 
IPE is to improve communication and to develop understanding of the roles of other 
healthcare professionals.82, 85 In the present study, the Interprofessional education 
for Collaborative Patient-centred Practice (IECPCP) theoretical framework from 
D’Amour and Oandasan was employed because the framework suggests that health 
academics and healthcare professionals involvement are interdependent in patient 
care.79 They also recommended that the cross-link between factors of the health 
system and health education are required to create a supportive environment for 
collaborative practice to occur.79 D’Amour and Oandasan described factors in both 
education and practice settings at the Micro, Meso and Macro levels which were 
relevant to the aims of the present study. Table 8.2 shows the findings of the present 
study based on IECPCP framework.  
 
Table 8.2 Factors identified at Micro, Meso and Macro level in the study university 
and hospital settings according to IECPCP framework.79 
Setting Micro Meso Macro 
Education - Teaching factors: 
healthcare students 
and academics’ 
attitudes towards IPE 
Institutional 
factors: - support of 
leaders at the 
institutions  











and cultural values 
Organisation 
factors: - support of 
leaders at the 
hospital 
No policy on teamwork; 
limited staff; social and 
cultural values 
 
The WHO framework for action on Interprofessional Education and Collaborative 
Practice (IPE-CP) highlights the importance of IPE in improving health system and 
health outcomes.84 According to this framework, if healthcare students (i.e. medical, 
nursing and pharmacy students) study the topic of medication safety together, those 
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students are better prepared to work interprofessionally with other healthcare 
professionals to ensure the safe use of medication. The topic of medication safety 
was selected in the present study because healthcare professionals (i.e. physicians, 
nurses, and pharmacists) are responsible in the medication delivery process and they 
may all contribute to medication errors during healthcare service delivery. This topic 
is also one of the issues recommended for the implementation of IPE.348  
 
It is anticipated that understanding of the role of pharmacists in patient care to 
ensure the safe use of medication through IPE will allow the expansion of the role of 
pharmacists in medication safety. This study explored IPE in education and IPP in 
practice settings in an Indonesian context. The results of the present study should 
provide evidence for stakeholders and decision makers regarding the current practice 
of IPP in Indonesia. Changes to the health system, health education and health 
professional organisations may be required to foster healthcare professionals who 
are more practice ready to work in collaboration. The goal is to ensure patient safety 
in the Indonesian setting and to be consistent with the recommendations from the 
WHO framework for action on IPE-CP. This study also provides recommendations to 
prepare future pharmacists for engagement in patient care in collaboration with 
other healthcare professionals to ensure medication safety. The present study is the 
first study conducted in Indonesia to study the possible expansion of the role of 
pharmacists in medication safety through the introduction of IPE. 
 
8.2.1 ASSESSMENT OF THE FEASIBILITY OF THE ROLE OF 
PHARMACISTS IN PATIENT CARE TO ENSURE MEDICATION 
SAFETY  
During a clinical review activity conducted in a ward of the study hospital, the 
investigator (a pharmacist) detected and prevented medication errors in the 
medication delivery process. This shows that pharmacists have a role in medication 
safety by conducting clinical review activities and medication reconciliation which 
confirmed findings from studies outlined in the literature.27, 148, 150 The Geriatric 
Department in the study hospital was selected because this population has a higher 
risk of medication errors occurring.349 This study found that medication errors 
occurred in every stage of the medication delivery process. This indicated that 
healthcare professionals involved in the medication delivery process shared the 
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responsibility to ensure the safe use of medication. The majority of medication errors 
identified were during the administration stage. In the present healthcare service, 
nurses have the role to administer and document medication administration. The 
high administration errors identified in the present study may be related to the 
nurses’ high workload in the study ward or may be associated with a system issue 
identified during the study (i.e. the documentation of drug distribution and three 
pharmacies dispensing medication to the wards). Errors in the transcribing process 
indicated the need to improve the information management in the study hospital. 
This was also confirmed from the results of the qualitative findings (See Section 
7.3.2.iii) which illustrated that pharmacists at the Central Pharmacy found difficulties 
in communicating with the physicians because the pharmacists had no access to the 
patients’ health medical records. The finding of a lack of access to patients’ health 
status mirrored that of studies found in the literature.63, 212 This lack of access to 
patient data was considered as one of the practical barriers to the implementation of 
healthcare professional collaboration in developing countries. Cohen highlighted that 
interconnecting systems of information management, structured environment, and 
human resources highly influenced the process of medication delivery.26 Findings of 
the present study confirmed the study hospital needs to improve its information 
management system, to enhance the environment of safety culture in the 
medication delivery process, and to allocate sufficient numbers of healthcare 
professionals to ensure medication safety.  
 
The investigator identified a number of potential interventions through the clinical 
review activity. However, the rate of acceptance of the interventions were low 
(around 35%), when compared to the high acceptance rate (more than 60%) found in 
the literature.47, 147, 350 The low acceptance rate in this study may have been 
associated with a lack of acceptance of the role of pharmacists in patient care, a lack 
of rapport with doctors, and the investigator’s minimum level of clinical experience in 
the activity.  
 
A possible role for pharmacists in medication safety was also identified from the 
findings of medication error case vignettes (See Section 6.2) involving academics and 
practising healthcare professionals in the study university and hospital. It was found 
that pharmacists, both pharmacy academics (OR = 1.68; 95% CI 1.19 - 2.38) and 
hospital pharmacists (OR= 1.61; 95% CI 1.16 - 2.06) were more likely to provide the 
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predicted correct answers to the vignettes. The pharmacists were particularly better 
in answering cases related to dispensing errors in terms of determining the types of 
errors, why the errors had occurred, what can be done to prevent the errors from 
occurring again, and the level of severity of the errors. Participants of the interviews 
and FGDs were supportive towards the role of pharmacists in patient care to ensure 
medication safety (See Section 7.1). However, the participants identified a number of 
pharmacist internal and external factors as barriers to the expansion of the role 
pharmacists in medication safety.  
 
Pharmacists’ internal factors 
In the present study, pharmacists’ internal factors were the themes frequently 
discussed by the participants in interviews and FGDs. This indicated that the 
pharmacists’ internal factors were the major barriers to the expansion of the role of 
the pharmacist in patient care to ensure medication safety (i.e. pharmacists’ mind-
set, the lack of knowledge and confidence and the low number of pharmacists to 
engage in patient care). Pharmacists’ internal factors identified in the present study 
were similar to other Indonesian studies (See Section 1.2.1).55, 56 The lack of 
knowledge was also reflected in the findings from the pharmacy graduates 
questionnaire on attributes in patient care (See Section 4.1). In that survey the 
pharmacy graduates from the study university believed they had only partially 
attained the required attributes to deliver patient care. Pharmacy students have little 
practical experience and hence limited opportunities to interact with patients. 
Consequently, pharmacists may have a lack of confidence in engaging with patients. 
A similar finding was noted by Anderson275 who stated that “Indonesian pharmacists 
tend to have a wide knowledge of all areas of pharmacy practice but insufficient 
experience of one branch of practice.” Further, this study found that the number of 
pharmacists in the study hospital did not meet the specified ratio of pharmacists to 
patients in providing patient care. The Indonesian Ministry of Health regulates the 
ratio is 1:30,230 however, the study hospital has 19 pharmacists for 700 beds (which 
gave a ratio of 1 in 37). Additionally, the pharmacists in the study hospital are mostly 
involved in drug logistics with limited engagement in patient care. The lack of 
engagement may in part reflect an inadequate number of pharmacists to provide 




Pharmacists’ external factors 
The external barriers to the expansion of the role of pharmacists in patient care 
identified in the present study included: healthcare professionals varying in the 
understanding of the role of pharmacists, no fee for delivering patient care, and poor 
staff recruitment. These findings mirrored those of other studies found in the 
literature (See Section 1.2.1)56, 165, 166 Pharmacists in developing countries are mainly 
known for their dispensing and business roles.139 The varying understanding of the 
role of pharmacists identified in this study may be related to their ambiguous role in 
healthcare service delivery. Noble et al. suggested that pharmacy education is 
important in the development of the professional identity of pharmacists to minimise 
the role ambiguity of pharmacists.314 A lack of a fee for service for pharmacists for 
delivering patient care may also result from this ambiguity of role. Another barrier to 
the expansion of the role of pharmacists in patient care was poor staff recruitment. 
Michie and West339 highlighted that Human Resource Management (HRM) referred 
to “the management practices such as recruitment, selection, induction, training, 
appraisal, design and application of rewards systems which all aim to enhance 
organisational performance by improving the performance of individuals within the 
organisation.” This indicated that HRM as part of people management is essential in 
determining the organisational performance.  
 
The Holland-Nimmo Practice Change System (PCS) was employed to determine the 
feasibility of the role of pharmacists in medication safety. The three components of 
PCS (See Section 1.2.2) were used to assess factors to identify the feasibility in the 
present study.  
 
Practice environment 
The practice environment has three levels of change (i.e. society, health system and 
practice site). The results of the present study identified some factors at each of 
these levels. Firstly, the Indonesian Government provides guidelines52, 232 and 
policies51, 230 as to the role of pharmacists in patient care which showed support at 
the society level was granted. Secondly, the health administrators at the hospital also 
supported the role of the pharmacist which indicated support at the health system 
was achieved. However, barriers to the expansion of the role of pharmacists in 
medication safety at the health system and practice site were also identified. At the 
health system level, the pharmacists had no access to information (patients’ 
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information in this regard) and no supportive infrastructure such as computer or 
internet facilities to support the pharmacists’ activity at the hospital setting. At the 
practice site level, it was found that the pharmacists had no clear job description 
detailing their role in ensuring the safe use of medication; different expectations of 
the current role of pharmacists from the desired practice; and a lack of 
communication between pharmacists and other healthcare professionals in the study 
hospital. Barriers identified to the health system and the practice environment must 




The participants of the qualitative study supported the role of pharmacists for the 
perceived benefits of their role to ensure the safe use of medication, educating the 
patients and providing drug information to other healthcare professionals (Section 
7.1.1). This is one of motivational strategies in the Holland and Nimmo Practice 
Change System. As suggested by Holland and Nimmo, professional socialisation is 
necessary for the expansion of the role of pharmacists in medication safety. 
However, the present study found that there was limited exposure to facilitate 
socialisation in the pharmacy education. Pharmacy interns explained that they had 
little opportunity to engage with the patient as care providers during their learning. 
This suggests that the pharmacy educators need to redesign their curriculum to 
provide experiential learning where interns act as care providers. Hughes suggested 
that experiential learning includes continuing reflections of the learning activities 
which provide an illustration of the role of pharmacist in practice.351 The learning 
could range from simulation on campus to practical placement by observing 
pharmacist practitioners. The results from the present study indicated that the 
pharmacy education providers in collaboration with the Indonesian Pharmacists 
Association (IAI-Ikatan Apoteker Indonesia) should facilitate that pharmacy interns 
gain more experiential learning.  
 
In relation to the expansion of the role of pharmacists to ensure medication safety, 
Nimmo and Holland suggested a motivational strategy which focused on the 
pharmacists’ internal drivers to be involved medication safety in collaboration with 
other healthcare professionals need to be emphasised.59 As suggested by participants 
in the present study pharmacists need to change their mind-set such that they 
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believe that they do not only work in drug distribution but also provide patient care 
by working in collaboration with other healthcare professionals in ensuring the safe 
use of medication. This requires support from the pharmacists (as individuals), the IAI 
(as the professional organisation) and the health institution (as the health 
organisation). A fee for service or remuneration for the role may be an essential 
pharmacist external driver. Studies have shown that lack of remuneration for 
pharmacists is one of external factors which impact negatively on the role of 
pharmacists in patient care.56, 166, 168 The introduction of a fee for service needs 
support from the health institution management and the IAI, as well as from the 
government. The strong support and commitment of the management at the 
hospital is crucial. This was supported from a personal communication with a 
colleague in one hospital in Indonesia (Budiarti E, oral communication, 8th February 
2015). In that hospital, the pharmacists provide patient care in ensuring medication 
safety and receive a fee for the service they provide. The hospital management had 
set up a schedule fees for this service.  
 
Learning resources 
According to Holland and Nimmo, learning resources may be in the form of 
modification of the pre-existing procedure or new training which fits the initiative of 
the proposed practice change model. The learning resources are important because 
they consist of learning materials/programs required by the healthcare professionals 
in order to perform the tasks the professionals are expected to do (in this instance 
pharmacists’ delivered patient care to ensure medication safety). However, it was 
unclear whether learning resources to support the role of pharmacists in medication 
safety are available in the study hospital. Thus, future research is required to 
determine existence and adequacy of these resources. 
 
Therefore, in order to expand the role of pharmacists in medication safety, factors 
identified based on the PCS framework are required to be addressed. Conversations 
with pharmacists in hospitals in other provinces in Indonesia (Martini E and Budiarti 
E, oral communication, Feb 2015) revealed that the introduction of pharmacists into 
patient care in their hospitals has evolved from the pharmacists’ involvement in drug 
supply management and in the drug information centre. The pharmacists in the 
hospitals started to deliver patient care services after more than 10 years of 
engagement in those activities. In the two hospitals, pharmacists deliver patient 
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counselling, provide recommendations to physicians, and conduct monitoring and 
personal or joint visits with the physician on some wards. These personal 
communications suggest that the pharmacists’ engagement in patient care took time 
and required a strong commitment from the respective pharmacists as the role 
models (i.e. local champion) in the institution, as well as support from the health 
institutions’ management.  
 
8.2.2 THE FEASIBILITY OF THE IMPLEMENTATION OF IPE 
In evaluating the feasibility of the implementation of IPE in the study university the 
framework of IECPCP from D’Amour and Oandasan79 was used. Whilst, stakeholders 
of the present study were generally supportive towards IPE, some potential barriers 
were identified and these would need to be addressed if IPE is to be implemented in 
the study university.  
 
Micro level 
The first barrier identified at Micro level to the implementation of IPE in the study 
university was related to teaching. Stakeholders at the university suggested the 
implementation of IPE included practical issues such as differences in curricula, 
learning methods, and the length of clinical training in medical, nursing and 
pharmacy student courses (See Section 7.2.2). These barriers are similar to those 
reported in the literature.212, 214, 341 To overcome the Micro level barriers, reformation 
of health education system is required. This will be discussed in the Macro level 
section.  
 
Healthcare students’ attitudes towards IPE are also included at the Micro level of the 
IECPCP framework. In the present study, the healthcare students’ attitudes towards 
IPE were positive (See Section 5.1). However, the medical students had less positive 
attitudes towards IPE than nursing and pharmacy students in the study university. 
Medical students had significantly more positive attitudes towards the PI sub-scale 
and Year 2 medical students throughout their study had more positive attitudes 
towards the same sub-scale. This suggests that there was a strong sense of 
professional identity in medical students possibly resulting from the strong 
professional socialisation at the medical school. The strong sense of professional 
identity amongst medical students was considered a barrier at the Micro level to the 
implementation of IPE in the study university.  
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Weaver et al. found that professional inclusivity, social exclusivity, and a close 
relationship of the two generated a strong professional identity in medical 
students.352 Professional inclusivity developed during clinical placement while the 
social exclusivity derived from the shared sense of identity amongst medical students 
as being separated from non-medical students. This strong sense of professional 
identity may be a potential barrier to the implementation of IPE in the study 
university. This is because those with a strong sense of uni-identity may be less 
accepting of working with other healthcare professionals and thus this may inhibit 
interprofessional learning.315, 316  
 
The influence of academics on professional socialisation is also confirmed in the 
present study. The strong sense of professional identity amongst medical students 
may also be associated with the findings of attitudes amongst the medical academics 
in the study university. Medical academics responses to Statement 19 (The function 
of nurses and therapists is mainly to provide support for doctors) were more positive 
than any of other groups (See Section 6.3). The Year 2 Cohort medical students who 
displayed more positive attitudes towards the PI sub-scale as they progressed 
through their course of study may also be influenced by professional socialisation of 
medical academics. Medical students started to learn about their core units in Year 2. 
Mostly, medical practitioners teach these students. Weidman et al. stated that 
academics have primary control of the process of professional socialisation.353 
Medical academics therefore are likely to play a significant role in the professional 
socialisation of medical students. The strong sense of professional identity in medical 
academics was also considered as another barrier to the implementation of IPE at 
the Micro level in the study university. This finding further indicated the need for 
faculty development in the study university as suggested in the literature as one of 
the keys to the successful implementation of IPE.354, 355  
 
While all healthcare students were supportive of IPE, Year 1 healthcare students of 
all cohorts who participated in the study had less agreement on the SLT sub-scale. 
This result warrants the introduction of IPE at the beginning of healthcare students’ 
education. Coster et al. also recommended introducing IPE early in healthcare 
students’ learning to prevent negative stereotypes.196 Findings from an IPL workshop 
on medication safety (See Section 5.2) involving final year medical, nursing and 
pharmacy students from the study university, indicated that the workshop improved 
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the students’ attitudes towards the SLT sub-scale. This indicates that IPL workshops 
could be a means of starting IPE in the study university. Similar to a report in the 
literature,203 this study found that IPL improved students’ understanding of other 
healthcare professionals’ roles.  
 
According to the results of the present study, in terms of promoting IPE in the study 
university, healthcare education providers should design their curriculum to allow 
students to develop not only a strong uni-professional identify but also an 
interprofessional identity. Khalili et al.315 recommended adopting interprofessional 
socialisation (IPS), intergroup contact theory and social identify in healthcare 
students’ curriculum which allows the development of interprofessional values, 
beliefs, behaviours, knowledge and skills. In parallel, Wackerhausen316 suggested a 
second order reflection is required to overcome the strong professional identity 
which is potentially a significant barrier to IPE. He further suggested that although 
this reflection may be hard to have, it is an essential transformation in the 
implementation of IPE. 
 
Meso level 
Support from stakeholders for the importance of IPE was considered as a facilitator 
at the Meso level. However, how this support is implemented in practice requires 
further investigation. This was because interviews with stakeholders in the present 
study showed that there were differences in opinion between the stakeholders on 
when and on how to start IPE, and on the level of support from the university board. 
This may require further clarification if IPE is to be implemented in the study 
university because equal support and commitment from executive leaders of the 
various health courses is essential prior to the implementation of IPE.341 
 
Macro level 
Support at the Macro level (the Indonesian Government) was identified from one 
stakeholder of the interview. While only mentioned by one stakeholder, this was 
considered a facilitator because the literature on this point indicated that the 
Indonesian Government has supported IPE-CP implementation in the country.356 
Hammick et al. stated that support from the government was considered as the top 
down driver.80 They further concluded that the call from the government to improve 
collaboration may be seen as the adoption of IPE at the education and practice 
setting levels. In Indonesia, the Ministry of Health and Directorate General of Higher 
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Education have supported IPE to improve the quality of healthcare professionals in 
the country with the Health Professionals Education Quality (HPEQ) initiative. As a 
result, in early 2014, a joint accreditation body, namely the Indonesian Accreditation 
Agency for Higher Education in Health (IAAHEH) consisting of seven health education 
institutions and their professional organisation bodies, was established.228 The 
IAAHEH is intended to ensure healthcare graduates gain teamwork skills to assist 
them in working interprofessionally. This will consequently improve IPP in the future 
leading to better patient care. By means of the IAAHEH the Indonesian Government 
supports the importance of IPE to enhance patient care through collaborative 
practice. It is anticipated the adoption of IAAHEH may address barriers at the Micro 
level including differences in curriculum in healthcare courses in the study university 
which may impede IPE.  
 
Although Meads et al.178 claimed that the WHO framework influenced national policy 
in developed and developing countries differently, Rodger et al.186 found that the 
perception of benefits of IPE for education and for health policy in developed and 
developing countries were the same. The WHO355 highlighted that transformation 
and scaled up healthcare professionals’ education and training is required in 
improving the quantity, quality and relevance of healthcare professionals of a 
country and to empower the health system of a country. The WHO also 
recommended that the transformation of education and training institutions; 
accreditation and regulation; financing and sustainability; monitoring and evaluating; 
and governance and planning are essential for the implementation of IPE to 
strengthen the health system of the country.  
 
Barriers identified in the present study were congruent with those found in other 
developing countries. Sunguya et al.357 in a systematic review found that there were 
three barriers to the introduction of IPE in developing countries, namely; IPE 
curriculum, resource limitation and stereotypes. Sunguya et al.357 also suggested that 
apart from the three barriers, leadership, student diversity, IPE concept, teaching, 
enthusiasm, professionals’ jargon and accreditation were barriers of IPE 
implementation in developed countries. Facing the fact that the three barriers 
identified in developing countries were also found in developed countries, they 
recommended that the other barriers found in the developed countries should be 
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anticipated in the developing countries if the developing countries aimed to 
implement IPE.  
 
8.2.3 THE FEASIBILITY OF THE IMPLEMENTATION OF IPP 
As described in Table 8.2, the facilitators for and barriers to the implementation of 
IPP at Micro, Meso and Macro levels of the IECPCP framework of D’Amour and 
Oandasan were identified in the study hospital.  
 
Micro level 
The results from the quantitative study (i.e. the RIPLS questionnaire involving 
healthcare professionals) showed that although healthcare professionals had positive 
attitudes towards SLT and PC sub-scales, the Physician Group had a more positive 
attitude towards the statement “The function of nurses and therapists is mainly to 
provide support for doctors” than the Nurse and Pharmacist Groups. This suggests 
that physicians had a stronger sense of superiority towards other healthcare 
professionals. In addition, physicians had more positive attitudes than the medical 
students towards the RIPLS statement “The function of nurses and therapists is 
mainly to provide support for doctors.” Although nurses disagreed with this 
statement, they had statistically more positive attitudes towards the statement than 
did nursing students. In contrast, there was no significant difference in attitudes 
between pharmacists and pharmacy students on the statement. These results may 
be influenced by informal learning in the current healthcare service delivery model 
where physicians sit atop the hierarchy in the healthcare service. In the present 
study, nurses work closely with the physicians, whereas pharmacists have limited 
engagement with other healthcare professionals. The informal learning which occurs 
over time between healthcare professionals may lead to role transition.358 This 
indicates that the informal learning gained from the hierarchical model of healthcare 
service delivery in the present study may influence the role transition of healthcare 
professionals involved in the service delivery. 
 
In support of the quantitative findings, the qualitative results also indicated the sense 
of superiority in medical practitioners which may lead to the limited interaction 
between healthcare professionals. This superiority could be one of the barriers to the 
implementation of IPP at the Micro level at the hospital setting. The sense of 
superiority could be influenced by strong professional socialisation amongst 
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physicians. Much research in the literature has discussed the development of 
professional socialisation in physicians.326, 353 The socialisation may be developed in 
an informal curriculum. Hafferty and Frank stated that professional identity in 
physicians was developed in an informal curriculum namely, a hidden curriculum.326 
Similarly, Weidman et al. also described the informal stage as an important part of 
professional socialisation in graduates.353 Whitehead suggested that physicians’ 
involvement in professional collaboration should be designed in a model which 
provided evidence of improving patient outcomes.359  
 
The sense of superiority in healthcare service delivery found in the present study may 
result from a lack of understanding of the role of other healthcare professionals. This 
lack of understanding was identified as the major barrier in the qualitative results for 
the implementation of IPP. This was similar to findings from the medication safety 
case vignettes (See Section 6.2). The vignettes illustrated healthcare professionals 
had different views as to which professionals were responsible for the errors and 
only a small proportion of them believed communication barriers contributed to the 
medication errors. The findings of the present study should help healthcare 
professionals be aware of their contribution and help to prevent the occurrence of 
future errors. Healthcare professionals should be aware that communication barriers 
in healthcare service may jeopardise the safe use of medication. This is because 
communication failure has been identified as a significant contributor to medication 
errors.360, 361 The present study supported the importance of communication and 
teamwork between healthcare professionals in the study hospital as outlined in the 
literature to ensure medication safety.61, 362  
 
Meso level 
Stakeholders in the present study believed that IPP could potentially minimise the 
risk of medication misadventure. This represents support at the Meso level in the 
study hospital. This support is essential for the implementation of IPP.63, 84 However, 
there was no standard protocol at the hospital to work in a team with other 
healthcare professionals. Although the study hospital adopted an international 
accreditation which made communication amongst healthcare professionals 
inevitable with the introduction of integrated notes, it is unknown whether the 
integrated notes had facilitated information exchange amongst healthcare 
professionals in performing their duties. The lack of standard protocols and the lack 
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of facilities to work with other healthcare professionals were also discussed in the 
literature as barriers to the implementation of IPP (See Table 1.9).63, 84  
 
Macro level 
At the Macro level, the participants indicated that the Indonesian Government 
supported interprofessional collaboration amongst healthcare professionals in 
certain populations. However, participants felt that there was no clear legislation on 
teamwork in the provision of healthcare service in the present practice. Additionally, 
support from professional organisations towards IPP was not identified in the 
present study. Thus, further study may be required to identify support from the 
professional organisations. This is because support from the government and 
professional organisations is considered as significant drivers to the implementation 
of IPP.63,84 The present study also identified another barrier to the implementation of 
IPP namely limited pharmacist workforce to engage in the collaboration. The present 
study identified no fee for service as one of the pharmacists’ external factors as care 
providers (See Section 7.1.2.ii). One of the participants in the present study stated 
that lack of equal rewards received by the healthcare professionals may be a 
significant gap in the present healthcare service delivery. Review of the literature 
suggested that the different rewards earned by the healthcare professionals may be 
a barrier to the implementation of IPP.63, 215  
 
As described in Table 1.9, there are a number of barriers and facilitators to the 
implementation of IPP in developed and developing countries. The communication 
barriers, the model of healthcare delivery, and the lack of facilities on health 
information system (no centralisation in the information system) identified in the 
present study hospital mirrored barriers found in other developing countries.63, 84 
Similarly, support from the government and policy makers were also identified in the 
present study. However, as opposed to the report from the WHO,84 there were no 
clear guidelines of collaboration and financial support for the interprofessional 
collaboration amongst healthcare professionals in the present study hospital.  
 
Based on indicators of D’Amour et al.’s217 model of collaboration, the level of 
collaboration between healthcare professionals on medication safety in the study 
hospital was at Level 1 (Potential Collaboration). This indicates that collaboration in 
medication safety (hence IPP) in the study hospital does not yet exist. In this model, 
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indicators of collaboration were evaluated based on individual and organisational 
factors. The individual factors showed that healthcare professionals had a common 
goal in the healthcare service (i.e. patient care). This was also confirmed from the 
results of RIPLS questionnaire to healthcare professionals (See Section 6.1) which 
demonstrated they had no significant differences in attitudes on the Patient 
Centredness sub-scale. Yet, qualitative findings (See Section 7.3) showed that it was 
unclear whether these goals had been communicated amongst the healthcare 
professionals. Another individual factor identified in the present study was lack of 
understanding of the role of healthcare professionals which was a significant barrier 
to implementation of IPP. In regards to organisational factors (Governance 
dimension), it was found that there were limited staff numbers and no clear policy on 
teamwork in the study hospital. The results of the present study demonstrated that 
the barriers at the Micro, Meso and Macro levels must be addressed if IPP in 
medication safety is to be implemented in the study hospital 
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8.2.4 MODEL OF HEALTHCARE SERVICE  
According to the findings of the present study, the model of healthcare service in the study hospital 
in relation to medication safety was hierarchical. Physicians had the highest hierarchy in providing 
healthcare service to the patient, while nurses and pharmacists support the physicians. Thus, in the 
hierarchical model, physicians are the only professionals who are responsible for the patient’s well-
being. Hierarchy in healthcare service may lead to inevitable errors in the provision of healthcare 
service.363 Sutcliffe et al.361 highlighted that the hierarchical differences, conflicting role, role 
ambiguity, conflicts of interest, and interpersonal factors may lead to communication failure where 
errors are more likely to occur.  
 
Leatherman and Sutherland identified that organisational and healthcare delivery model changes are 
interventions to improve health quality.364 In the present study, it is proposed to change the model of 
the healthcare service delivery to one that is patient-centred by adopting a collaborative practice to 
ensure medication safety (Figure 8.2). In this model, physicians, pharmacists and nurses work in 
collaboration to ensure the patient’s safe use of medication, in doing so they share the responsibility 
for the patient’s health outcomes.  
 
However, changing the model of the provision of healthcare service from hierarchical to 
collaborative is not an easy task. Leatherman and Sutherland364 proposed a multi-tier method in 
order to change the health system. The method has four levels (i.e. national, regional, institutional, 
and individual). According to their method, improving medication safety through IPP requires 
legislation on collaboration (teamwork) at the national level which is translated to regional policy, at 
the institutional (hospital) level and to the individual level (healthcare professional). Studies indicated 
that support and strong commitment from the health system and health education providers is 
essential in the implementation of IPP.80, 84, 315 339, 340, 365 In the study university, the establishment of a 
joint accreditation body in the health education system involving professional organisations may 
support the change of model of healthcare service. However, it may require further clarification to 
identify support at the regional and institutional (hospital) levels in changing the model.  
 
Leape et al. identified five essential concepts to the transformation of a safe healthcare service.365 
The concepts were transparency, care integration, patient engagement, restoration of joy and 
meaning in work and reformation in medical education. The first three concepts focused on the 
patient-centredness in the provision of healthcare services in collaborative practice which is similar 
to IECPCP framework.79 Meanwhile, the restoration of joy and meaning in work is related to people 
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management in the organisational context.339 The last concept of reformation of medical education 
may be done through Interprofessional Professional Socialisation (IPS) proposed by Khalili et al.315 








Figure 8.2 Changes of healthcare service model (Ernawati, 2015) 
 
Ginsburg and Tregunno340 stated organisational context is influenced by the culture and climate of 
the organisation. The culture consists of hierarchy, job description, informal practice and norms. The 
organisational culture relates to the values, beliefs and attitudes of healthcare professionals in the 
organisation. The climate is dependent upon the procedures, policy of the organisation, and 
employees’ perception towards their organisation. The organisational context (i.e. the climate and 
culture) may significantly influence employees’ behaviour in people management. It may accelerate 
well-being and performance of healthcare professionals as individuals, as members of the group and 
as members of the organisation. The employees’ behaviour met one of the concepts (i.e. restoration 
of joy and meaning in work) from Leape et al. in transforming a safe healthcare service.365 Thus, this 
indicates the management leader should manage the people and practice of Human Resources 
Management (HRM) in hiring, selecting, and training workforce. Those are essential to achieve the 
desired climate and culture of an organisation delivering patient care. Thus, to change the model of 
the healthcare service, the culture and climate of the organisation needs to be changed.  
 
Other proponents of the change of organisational context to ensure patient-centred care in the 
provision of healthcare service are Michie and West, who stated that “people and their performance 
are key to organisation effectiveness”.339 The organisational effectiveness is referred to patient-
centred care service. They created a framework of the organisational context (consisting of 
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influence the performance of healthcare service delivery (Figure 8.3). The organisational context 
influences the people management which may impact psychological aspects of healthcare 
professionals and their behaviour in the organisation. Subsequently, all of these factors will 























[Managing people and performance: an evidence based framework applied to health service organisation. 
Michie S, West MA. International Journal of Management Reviews. 5/6. Copyright © [2004] Blackwell 
Publishing Ltd) 
 
Figure 8.3 Framework for understanding the links between organisation context, people 
management, and psychological consequences for employees, employee behaviour and 
organisational performance339 
 
To address reformation in medical education in the transformation to a safe healthcare environment 
as suggested by Leape et al.,365 Khalili et al.315 proposed an IPS framework to facilitate IECPCP. They 
suggested that the IPS framework is influenced by systemic factors (i.e. professional education 
programs, professional regulation, and the model of healthcare service) and personal factors (i.e. 
beliefs and behaviours towards IPE; individualistic and collectivistic orientation; and previous 
experience of IPE). This indicated that IPS amongst healthcare professionals is also influenced by the 
model of healthcare service delivery.  
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The IPS framework has three stages (i.e. breaking down barriers, interprofessional role learning, and 
dual identity development).315 The first stage may break down the misconception of the strong or 
unclear uni-professional identity. The second stage may facilitate the development of knowledge, 
skills and attitudes of the role of healthcare professionals in collaboration. Although some learning 
theories discuss in the literature in the development of interprofessional learning,80, 181, 331, 353 
informal and experiential learning are considered the most effective in improving positive attitudes 
towards IPE. This may be due to the influence of social factors in experiential learning.80, 181, 366 The 
last stage was the development of dual identity which may foster the sense of belonging to a 
profession and to a collaboration. Hammick et al. recommended that the key factor of socialisation is 
staff development.80 Socialisation requires role models from healthcare academics and practitioners 
to support the interconnections between health education and practice settings. The role models 
should portray the acknowledgement of the role of other healthcare professionals with respect and 
trust, as well as with good communication and teamwork skills. This would indicate that medical 
academics in the study university should be the role models for collaborative practice aimed at 
ensuring a safe healthcare service. This is because in the present study it was evident that the less 
positive attitudes of medical students towards IPE in the study university may be influenced by the 
strong agreement of medical academics towards the role of other healthcare professionals as a 
support for physicians. It is anticipated if the medical academics had more positive attitudes towards 
collaboration, it may lead to more positive attitudes towards IPE amongst medical students. Once 
again, this result indicated the need of faculty staff development if IPE is to be implemented in the 
study university.  
 
8.2.5 MEDICATION MANAGEMENT AND COMMUNICATION SYSTEM  
Ginsburg and Tregunno recommended that changing a process is more feasible than changing the 
culture of an organisation.340 For this reason, from the present study, changing the process of 
medication management and the communication system is also recommended. As discussed 
previously, support from the health system is required in order to change the process of medication 
management to ensure a safe healthcare service by preparing the human resources, supportive 
health information system and structural environment.1, 32, 367 Preparing the human resources has 
been discussed in the previous section (i.e. HRM in hiring, selecting and training of healthcare 
professionals). In terms of a supportive health information system, it was found that there was a lack 
of an information system in the study hospital. This was similar to a review from the Health Metrics 
Network which found that the overall health information system in Indonesia was present but it was 
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not adequate.368 Improving the health information system and technology may require further 
exploration in the study hospital. 
 
The Australian Pharmaceutical Advisory Council (APAC) indicated that there are two essential 
components to ensure safe and quality use of medicine (i.e. standard operating procedures of 
medication management and identification of the position or person who is responsible during the 
medication delivery process).367 The first component requires support from the leaders to ensure and 
endorse the procedure of medication management practised. The second component involves the 
leaders and healthcare professionals participating actively and responsibly in ensuring, sustaining 
and monitoring the medication delivery process. Active participation may be in the form of effective 
communication amongst healthcare professionals.  
 
To address the first component recommended by the APAC,368 in the present study hospital, a 
structured environment may be improved by adopting a medication management system. The APAC 
created a Medication Management Cycle which can be employed in any setting. The cycle has nine 
key components (See Figure 8.4) which covers system processes of medicine procurement; data 
collection; review of quality and safety; effective and accurate communication; as well as complete 
and comprehensive information. One cycle is an episode of care. Continuity of medication 
management occurs when accurate information is transferred between the episodes of care.  
 
                         [adapted from the Australian Pharmaceutical Advisory Council (APAC)] 
 
                                 Figure 8.4 Medication Management Cycle 368 
274 
 
To address the second component suggested by the APAC, adoption of a model of communication 
may be implemented. Communication in healthcare service can be formal and informal.369 Team 
meetings, emails, and communication logs are formal communication. Informal communication can 
be in verbal and face to face conversations. Several ways are offered in the literature to improve 
formal and informal communication, for instance the SBAR (Subjective, Background, Assessment and 
Recommendation) technique, improvement of health information technology and the adoption of a 
model of communication. 215, 370-372 
 
In terms of adoption of a model of communication, Liu et al.373 classified the model of 
communication used in medication safety into Causal and Exploratory models. The Causal model 
aims to identify the causes of communication failure (such as human and system errors). Exploratory 
models discuss the behaviours which occur in the process of medication management which included 
the APAC Partnership Model and Medication Communication Model. However, Kitson et al. 
recommended that the Circle of Care Modelling as the framework of medication communication 
across a continuum of care settings (See Figure 8.5).372 They stated that their framework was built 
upon a Medication Communication Model373 and Interdisciplinary Team Communication 
Framework371 to understand communication amongst healthcare professionals and across settings to 
ensure patient safety. There were six communication activities on medication in this model which 
include: determine the need of medication, prescribe, dispense, administer, monitor and coordinate 
the communication.  
 
 
                (with permission from Creative Commons Attribution Licence) 
 




Kitson et al.372 proposed an officer to arrange the coordination of the role between activities in this 
model. The role of coordination may include transferring information between healthcare 
professionals in the process of medication delivery. Rather than assigning a medical office assistance 
as a coordinator of communication in the process of medication delivery at the hospital setting, it is 
proposed to involve pharmacists as the coordinator knowing that pharmacists have a potential role 
in ensuring the safe use of medication. In fact, the activities in the Medication Communication 
Framework (i.e. determine the need of medication, dispense and monitor the medication 
administration) for parts of clinical pharmacy services.31 Thus, employing pharmacists as coordinators 
in the model should improve communication in the process of medication delivery to ensure 
medication safety and at the same time it may expand the role of pharmacists in patient care. 
8.3 RECOMMENDATIONS  
The present study demonstrated that pharmacists have a role in patient care in Indonesian hospitals 
to ensure medication safety. In order to expand the role of pharmacists in patient care to ensure the 
safe use of medication through the implementation of IPE and IPP in the Indonesian setting, a 
number of recommendations have been made at the education and practice levels.  
 
8.3.1 RECOMMENDATIONS AT THE EDUCATION LEVEL 
1. Pharmacy education providers need to redesign their curriculum. This recommendation is made to 
address barriers in the pharmacists’ internal factors. In terms of expanding the role of pharmacists 
in patient care, this study identified that pharmacy education providers need to redesign their 
curriculum because of the perceived partial attainment of attributes required to provide patient 
care amongst recent graduates. Khan suggested that pharmacy education is required to adjust to 
the needs of patient care delivery of a country.284 This present study found that pharmacy graduates 
self-reported a lack of knowledge and training during their education. The pharmacy graduates 
believed that their lack of knowledge may result from the broad pharmacy topics covered during 
their learning. The present study also identified that the graduates believed they had very short 
clinical placements to gain experience in engaging in patient care. This suggests that the pharmacy 
curriculum in the study university needs to be redesigned to allow pharmacy students to have more 
experience in delivering patient care. This also indicates that the pharmacists may require further 
postgraduate degree or placement courses to equip them and to improve their confidence in 
providing the services as care providers. In fact, such postgraduate courses are offered in many 
parts of the world. Hughes who studied the relevance of pharmacy curriculum to prepare the future 
graduates as care providers found that the pharmacists who participated in the study stated that 
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clinical pharmacy, pharmacology, pharmacy practice, pharmaceutics and dispensing as the five most 
relevant topics in the pharmacy curriculum. 351 In the present study university, some of these units 
are already included. However, clinical pharmacy, pharmacology and pharmacy practice need to be 
emphasised in the pharmacy education in the study university.   
 
Pharmacy curriculum redesign is essential to develop pharmacy graduates attributes as patient 
carers. This redesign may include more practical experience early in the pharmacy course. Studies 
have shown the importance of the clinical placement or practice experiences in providing patient 
care.274, 374 The curriculum may include integrated experiential learning with other healthcare 
students in IPE. Pharmacy students should engage with other healthcare students in units which 
require interaction and teamwork as part of IPE. Pearson et al.375 in their review suggested that 
despite the fact that curriculum integration needs commitment from the pharmacy education 
institutions in terms of time, resources, method of teaching and learning, and assessment 
strategies, the curricular integration and integrative learning are crucial in the pharmacy education 
to allow students to obtain the required knowledge, skills and attitudes to be care providers in 
complex environments.  
 
2. Involving members of the Indonesian pharmacy organisation (IAI) in the pharmacy intern training 
program. This is another recommendation to address the pharmacists’ internal factors. The IAI 
could facilitate clinical placements for pharmacy students to gain professional socialisation in 
providing patient care. The organisation may encourage its members (registered pharmacists) who 
may have practised patient care to facilitate pharmacy interns gaining the experiential learning. The 
registered pharmacists could be the role models as care providers for the pharmacy interns. At the 
moment, the IAI creates standard competencies for pharmacists and arranges registration for 
pharmacists with limited engagement in the learning process.  
 
3. Commencing IPE early and maintaining it continuously throughout healthcare students’ learning. 
This recommendation is made to address barriers of the strong positive attitudes towards PI sub-
scale in the medical students (Micro level). Early IPE exposure may minimise the effect of strong uni-
professional socialisation on the negative stereotyping.82 The initiation of IPE requires an interactive 
learning method to improve the understanding of each other’s role and thereby enhance 
collaboration.77, 203 An IPL workshop activity conducted as part of the present study improved 
healthcare students’ understanding of the role of other healthcare professionals. However, further 
investigation may be needed with regards to the appropriate learning method of IPE to be adopted 
given the different learning methods and curriculum employed in the Medical, Nursing and 
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Pharmacy Departments in the study university. Inserting one common module into the healthcare 
students’ curriculum may be one way to the implementation of IPE.191 In the study university, a 
topic to improve communication skills may be inserted in a professional unit within each curriculum. 
In case of working interprofessionally in patient safety, the WHO has created a multiprofessional 
patient safety curriculum guide for healthcare students.376 The guide may also be incorporated in 
the study university. The guide aims to assist health education institutions in preparing their 
graduates to promote patient safety in their future practice as healthcare professionals. The guide 
also assists academics in the implementation of the WHO patient safety curriculum into their own 
curriculum. Buring et al.348 suggested that the benefits of obtaining competent future healthcare 
professionals to work collaboratively should be highlighted in the IPE learning process.  
 
4. Training of academics as facilitators or mentors in IPE. This recommendation is to address the 
strong sense of professional identity in academics highlighted in the present study (Micro level). The 
training of academics is needed prior to implementation of IPE in the study university because staff 
development is the key to effective IPE.80 Faculty development is often associated with staff 
development.354 Steinert et al. suggested that the staff development should enhance teaching 
skills.354 This may improve students’ learning experience which may be beneficial for their learning 
outcomes. Facilitators (academics) are required to have experience of interprofessional activities as 
well as understanding group dynamics.77 These need support from the university board in terms of 
funding and resources. Ho et al. recommended that healthcare educators learn to work together 
prior to the implementation of IPE in order to better anticipate the hierarchy between medicine and 
nursing.377  
 
5. Reforming the medical education. This recommendation was also suggested by Leape et al. into the 
transformation of a safe healthcare service.365 As discussed in the previous recommendations, 
knowledge of patient safety may need to be incorporated into the medical curriculum.376 The 
knowledge may involve information management, the concept of human interaction, the theory of 
healthcare system and quality, teamwork and communication skills in ensuring patient safety is 
incorporated into the healthcare service. The IPS framework proposed by Khalili et al.315 may 
facilitate the development of the competencies of IPP. Further, Confield and Kelly recommended 
that medical academics should not only consist of medical practitioners, but also other healthcare 
professionals.200 They suggested that academics other than medical practitioners should be given an 
opportunity to emphasise the impact of disease on the patients. They claimed that this opportunity 
may be lacking if the academics are all medical practitioners. The academics should demonstrate 
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collaborative practice in terms of acknowledging the role of and showing respect and trust for other 
healthcare professionals. These academics could be then the role models of IPE.  
 
6. Obtaining firm support from the university board in terms of facilities, human resources and funds 
for the implementation of IPE. This is to address barriers identified at Meso level. The Indonesian 
Government, in this instance the health system as well as health education supports the 
implementation of IPE in the health education with the establishment of the IAAHEH accreditation 
body. However, the government also needs to support the implementation of IPE by providing 
policies and regulations on IPE at the institutional levels (university) of the health education. This 
should be in parallel with support from stakeholders at the university in the form of providing 
sufficient facilities, human resources and funds for the implementation of IPE. 
 
8.3.2 RECOMMENDATIONS AT THE PRACTICE LEVEL 
1. Changing the mindset of pharmacists from drug distributor to care provider. In the present study, 
it was evident that the pharmacists found difficulties in expanding their role in patient care in the 
hospital setting. The present study showed that the internal pharmacists’ barriers as the most 
important barriers identified by the participants. The mindset is developed from a mental model of 
an individual or group or organisation.378 The mental model can be used to enhance the 
understanding of why people behave in certain ways.379 Based on the results from the present 
study, in order to expand the role of pharmacists, it is recommended that changing the mindset of 
the pharmacists’ such that they accept that their role as care providers is essential. This may be 
done by initially introducing the role of pharmacists in ensuring the safe use of medication as part 
of the current drug management system. If the mental model of the pharmacists is changed 
towards a role which is more manageable (i.e. a safe drug management), this should allow more 
positive acceptance of their role as care providers. The change of mental model needs to be done 
at both individual and organisational levels. The positive impact of the drug management system as 
an approach to introduce the role of pharmacist in medication safety was revealed from a personal 
communication with a pharmacist in another province in Indonesia who stated that the role of 
pharmacists gained recognition after 10 years of pharmacists’ activity in drug management (Martini 
E, oral communication, 5th February 2015). This showed that expanding the role of pharmacists 





2. Enhancing the understanding of the role of healthcare professionals. This recommendation is 
made to counter barriers at the Micro level and the pharmacists’ external factors. This study 
identified the differences in the understanding of the role and expectations of healthcare 
professionals, superiority, and the lack of trust as barriers to IPP. IPP may clarify the different 
understanding and expectations towards the roles of healthcare professionals.85, 380 Boscche et 
al.381 indicated that team learning allows the development of shared mental models amongst 
healthcare professionals allowing them to work in teams. The shared mental model improves team 
performance of healthcare professionals because it allows healthcare professionals to share 
knowledge. One of the important pieces of knowledge which can be shared among members of 
healthcare team is the role of healthcare professionals. The findings in the present study support 
the importance of the implementation of IPP in the study hospital. This was because in an effective 
IPP, respect and trust are the basis of communication to learn from, with and about each other.71, 
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Baker et al. stated that the use of the theory of closure strategy could identify power relationships 
amongst healthcare professionals.382 They found that IPE created an opportunity to improve the 
understanding of the role of nurses and allied healthcare practitioners. Improved understanding of 
the role of pharmacists in patient care requires organisational changes and sustainability of those 
changes.383 The organisational changes should address barriers to and facilitators for the role of 
pharmacists in patient care. Westrick suggested that the leaders of the organisation (the IAI, in this 
instance) could adapt Lewin’s model and Force Field Analysis to the changes of the organisation.383 
He further recommended using Force Field Analysis because it is more specific to accomplish a 
specific goal. To achieve the goals, driving forces should be greater than restraining forces.  
 
In the present study, the government legislation of the role of pharmacists as well as perceived 
benefits of pharmacists’ involvement in patient care were the driving forces, while, pharmacists’ 
internal factors were the restraining forces. The sustainability of the change requires a champion 
who can modify, integrate and continuously evaluate the service of patient care within the 
organisation.383 In relation to findings of the present study, it is recommended that the restraining 
forces (i.e. pharmacists’ internal barriers) need to be addressed in the expansion of the role of 
pharmacists in patient care in Indonesian practice. Driving forces should be emphasised; in this 
regards the benefits of pharmacists’ engagement in patient care in collaboration with other 




3. Providing effective legislation on teamwork in the healthcare service delivery. This 
recommendation is made to accommodate barriers identified at the Macro level at the practice 
setting. This study found there was no clear legislation on the role of healthcare professionals 
within a collaborative practice model. This suggests that there is a need for the government to 
provide regulations on teamwork and clear roles for healthcare professionals in the teamwork. 
Health system regulation is essential in order to implement IPP in the study hospital. The regulation 
should also be supported by the healthcare professional organisations. These organisations should 
provide standards/guidelines for collaborative practice. The guidelines should be part of roles and 
responsibilities of healthcare professionals in delivering their service. The leaders of department 
should ensure that teamwork is established in the healthcare service delivery.  
 
4. Having role models of pharmacists in patient care and healthcare professionals in collaborative 
practice. The role models should portray ideal collaboration amongst healthcare professionals and 
should demonstrate positive attitudes towards the role of other healthcare professionals in 
practice. Further, the role models are also required in terms of expanding the role of pharmacists in 
patient care.383 As recommended earlier at the education level, pharmacist practitioners who may 
have delivered patient care may act as role models and mentors to other pharmacists and 
pharmacy interns. If the pharmacist role models could work in collaboration with other healthcare 
professionals, the professionals could provide evidence of the benefits of pharmacists’ engagement 
in patient care. The importance of role models was also indicated in personal communications with 
pharmacists in other provinces in Indonesia. Thus, future pharmacists could foresee their future 
role as care providers.  
 
5. Having a clinical leader who champions the benefits of pharmacists’ involvement in IPP. This 
recommendation is made to address the pharmacists’ external factor of the lack of understanding 
of the role of pharmacists. Support from a clinical leader is required to reinforce the importance of 
pharmacists and their involvement in IPP in the study hospital. The Head of Pharmacy Department 
in the hospital should consider how to establish a positive relationship between pharmacists and 
the clinical leaders. Further, D’Amour et al. suggested the leadership role may need to be explored 
in IPP.384 If clinical leaders gain benefits from pharmacists’ involvement in IPP, they will use their 
power to recommend pharmacists’ involvement. In this study, a clinical leader was not identified. 
Thus, further study may be required to identify a clinical leader who supports pharmacists’ 




6. Providing qualified and sufficient numbers of healthcare professionals (in this regards 
pharmacists) to be involved in IPP. This recommendation is made to address a barrier at the Macro 
level in the study hospital and the pharmacists’ external factor. The lack of pharmacists needs to be 
addressed to allow a sufficient workforce to engage in collaboration. A transparent staff 
recruitment process is required to improve organisational performance in regards to providing 
patient care.339 The issue of low numbers of pharmacists in patient care was identified as one of 
pharmacists’ external barriers. Although the Indonesian Ministry of Health has determined the 
number of pharmacists to provide service to inpatients to allow sufficient care (1:30),230 in the 
study hospital the ratio was higher (1:37). Further, pharmacists in the study hospital mostly do 
logistics role with little engagement in patient care. Support from the health system as well as from 
the hospital management is essential to recruit sufficient numbers of appropriately qualified 
healthcare professionals for the provision of healthcare services.  
 
7. Facilitating a supportive environment for pharmacists to gain skills in patient care by the IAI. This 
recommendation is made to accommodate a barrier identified amongst the pharmacists’ internal 
factors, namely lack of clinical experience. A supportive environment should also be accompanied by 
sufficient learning resources to support pharmacists in the expansion of their role in patient care. As 
discussed previously (See Section 8.2.1), learning resources are one of the components of Nimmo 
and Holland PCS framework which was not identified in the present study. Thus, future studies on 
the effective training for pharmacists in providing patient care are required. The IAI could improve 
pharmacists’ skills in patient care by conducting training related to the role of pharmacists in patient 
care, for instance training in counselling and communication skills with patients, as well as with other 
healthcare professionals. Additionally, pharmacists are also required to continuously improve their 
drug knowledge. Active members (pharmacist practitioners) who may have delivered patient care in 
their practice could be involved in the pharmacists’ professional socialisation.  
 
8. Developing a clear pharmacist job description prior to allocating fee for services provided by the 
pharmacists. This recommendation is made to address the pharmacists’ external factor of no fee for 
pharmacists’ services. The IAI needs to clearly define the role of pharmacists in patient care prior to 
the introduction of fees for their services. Jorgensen et al.171 in their review also recommended that 
if pharmacists are to work in teams with other healthcare professionals, then pharmacists need to 
develop a clear role as members of the team. The other team members also require to be educated 
about the role of the pharmacist. The fee for pharmacists’ services should be reasonable based on 
the benefit derived by the patient. Existence of such fees would also benefit the pharmacy profession 
and facilitate practice change. The IAI needs to create a schedule for fees for service. Support from 
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the health system, the pharmacy education institution and the IAI are all essential for the expansion 
of the role of pharmacists in patient care to ensure medication safety in the Indonesian context.  
 
9. Improvement of information management systems to ensure the safe use of medication. In the 
study hospital, in addition to pharmacists’ involvement in ensuring medication safety, it is suggested 
that communication of patient information amongst healthcare professionals may be enhanced by 
improving the health information system and technology.370 This is to address errors identified in the 
transcribing process and difficulties encountered due to a lack of patient information in the Central 
Pharmacy and on the wards. The use of information and technology may require financial support in 
terms of providing more facilities (i.e. computers, internet, and software program) and trained 
human resources. Littlejohns et al.385 recommended that assessment of the social and professional 
cultures of the healthcare organisation and the complexity of the healthcare processes may be 
required prior to the adoption of new information management systems.  
 
8.3.3 RECOMMENDATIONS FOR FUTURE RESEARCH 
In a recent review, Brandt et al. recommended focusing on the triple aims to the implementation of 
IPE-CP.386 The aims consist of the outcomes of patient care and safety, cost-effectiveness and 
experiences for the healthcare professionals and the patients. As mentioned earlier, support from 
clinical leaders and effective training for pharmacists in providing patient care are required for the 
expansion of the role of pharmacists in patient care to ensure medication safety. Further 
investigations into the impact of the implementation of IPP on patient outcomes, determining the 
level of support from clinical leaders and professional organisations, the effective training for 
pharmacists in delivering patient care and the adaptable health information system are 
recommended for future research. 
8.4 STUDY LIMITATIONS  
Limitation of methods employed in this study has been incorporated in the respected chapters. This 
section summarises the limitations identified. Firstly, this study was only conducted in one university 
and one hospital. Thus, generalisation to other settings in Indonesia should be made cautiously due 
to differences of healthcare students’ learning and differences of the model of healthcare service. 
Secondly, this study used translated established questionnaires found in the literature. There were 
some discussions in the literature on cross cultural research.254, 255, 387 Translation and back 
translation is considered one way to ensure validity and reliability of translated questionnaires.387 
However, validity of translated questionnaires may be obtained from an independent person who 
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reviewed the accuracy of translation and the questionnaires were piloted to representative 
participants. These steps were considered sufficient.255, 257 Another limitation was potential research 
method bias which may result from participants who tended to be agree to positive statements and 
disagreed to negative statements or participants tended to be more positive if they accepted the 
invitation to participate in a study, namely social desirability bias.304, 388 However, this was beyond 
the investigator’s control. The mixed methods design employed in the present study should minimise 
bias because the results of both quantitative and qualitative studies were the same. Finally, the 
present study did not investigate patients’ perception of the role of the pharmacist in ensuring safe 
medication use. Thus, a future study focused on the understanding of IPP from the patients’ 





CHAPTER 9 CONCLUSION 
 
This is the first study in the Indonesian context to explore the feasibility of the expansion of the role 
of pharmacists in patient care to ensure medication safety through the process of implementing 
Interprofessional Education (IPE) and Interprofessional Practice (IPP). The topic of medication safety 
was selected because of the range of healthcare professionals (i.e. physicians, nurses, and 
pharmacists) involved in the medication delivery process. Three research questions were employed: 
1) Is it feasible to expand the role of pharmacists in patient care to better ensure the safe use of 
medication?; 2) Is the introduction of IPE feasible in a public university in Indonesia?;and 3) Is the 
introduction of IPP feasible within a teaching hospital in Bali, Indonesia? There were five phases of 
the research employed in the present study involving both qualitative and quantitative approaches.  
 
This study sought to determine the feasibility of expanding the role of pharmacists in patient care in 
ensuring medication safety through the implementation of IPE and IPP based on conclusions drawn 
from testing the study’s nine hypotheses (See Page 71).  
 
Hypothesis 1: Male and female pharmacy graduates have no significant difference in terms of 
perceived attainment of all the attributes required to deliver patient care 
A higher proportion of male than female pharmacy interns believed they had the leadership 
potential attribute (p=0.004). Based on this finding, the hypothesis was not proven. More than half of 
pharmacy interns at the study university believed they had only three of 16 attributes required for 
patient care provision (i.e. the ability to listen, a caring and compassionate nature, and the 
motivation to provide patient care). Pharmacy interns perceived they had less attainment of the 
seven attributes of patient care than did registered pharmacists. The results of the focus group 
discussion (FGD) with the pharmacy interns indicated that the lack of attainment of attributes as care 
providers was associated with the lack of knowledge and limited experience in providing patient care 
during their education.  
 
Hypothesis 2: Pharmacists conducting clinical review have no means of identifying medication 
errors in Indonesian hospitals 
As a new initiative, it was found that a pharmacist providing clinical pharmacy services, including 
medication reconciliation, clinical review and patient counselling and education in a geriatric ward 
at the study hospital was able to identify and intercept medication errors that occurred during the 
medication delivery process, thus the hypothesis was not proven. The results demonstrated that 
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pharmacists had a role in patient care to ensure medication safety. However, there was a low rate of 
acceptance of the pharmacist’s interventions in comparison with literature reports which may have 
been associated with unfamiliarity of the pharmacy service amongst healthcare professionals, the 
lack of rapport with doctors and the minimum level of clinical experience of the investigator.  
 
Hypothesis 3: Stakeholders’, healthcare professionals’ and pharmacy graduates would not be 
supportive towards the role of pharmacists in patient care 
Stakeholders in interviews and FGDs supported the role of pharmacists in patient care because of 
the perceived benefits of pharmacists’ engagement in patient care through ensuring medication 
safety, educating the patient and providing drug information to other healthcare professionals. 
According to these findings, the hypothesis was not confirmed. However, pharmacists’ internal and 
external factors were found to be barriers to the expansion of their role. The present study 
confirmed pharmacists’ internal factors (i.e. lack of knowledge and experience, lack of confidence, 
lack of pharmacist workforce and pharmacists’ mind-set) as the major barriers. The pharmacists’ 
external factors highlighted in the present study were varying understanding by other healthcare 
professionals of the role of pharmacists, lack of fee for service, and poor recruitment procedures. All 
of these need to be addressed to enhance pharmacists’ impact on patient care. 
 
Hypothesis 4: Medical, nursing and pharmacy students have no significant difference in attitudes 
towards IPE and there will be no significant differences in attitudes towards IPE as they 
progressed through their degrees 
Despite the fact that medical, nursing, and pharmacy students who participated in the present study 
were supportive towards IPE, medical students had less positive attitudes towards IPE when 
compared to nursing and pharmacy students. The medical students less positive attitudes towards 
IPE were also reflected in more positive attitudes towards their own professional identity (as 
indicated by the RIPLS PI sub-scale) in the two survey years (2012 and 2013). The Year 2 Cohort 
medical students had strong positive attitudes to the PI sub-scale and to statement “It is not 
necessary for undergraduate healthcare students to learn together”. Year 1 Cohorts of medical, 
nursing and pharmacy students moved towards a less positive attitude to the Shared Learning and 
Teamwork (SLT) sub-scale as they progressed through their respective courses. These results 




Hypothesis 5: Interprofessional Learning (IPL) activities would not have an influence on medical, 
nursing and pharmacy students’ attitudes towards IPE 
IPL workshop on medication safety involving final year medical, nursing and pharmacy students 
improved the healthcare students’ attitudes towards the Shared learning and teamwork (SLT) sub-
scale. Participants of the workshop agreed it enhanced their understanding of the role and the 
responsibility of healthcare professionals; to gain respect, trust and confidence; and to experience 
teamwork as well as improve their communication skills. These findings therefore did not support 
hypothesis that no such change would occur. Given that the Year 1 Cohort of medical, nursing and 
pharmacy students moved to less positives attitude towards SLT sub-scale during their course of 
study, it may be that early exposure to IPL workshops may be appropriate if IPE is to be 
implemented at the study university.  
 
Hypothesis 6: Stakeholders would not be supportive towards IPE 
Although stakeholders at the study university and study hospital suggested curriculum differences 
may be encountered between the health courses, the stakeholders supported the implementation 
of IPE at the study university. Hence, the hypothesis was not confirmed. This was because of the 
perceived benefits of IPE such as improving the understanding of the role of healthcare 
professionals; fostering teamwork skills amongst healthcare students; and reducing hierarchy in the 
provision of healthcare service. Interviews with stakeholders at the study university also revealed 
that the Indonesian Government supports IPE in the Indonesian health curriculum with the Health 
Profession Education Quality (HPEQ) project. 
 
Hypothesis 7: Healthcare professionals regardless of place of work and profession would have no 
significant difference in attitudes towards IPP 
Healthcare professionals regardless of their profession or place of work had positive attitudes 
towards IPP and no significant differences of attitudes towards the RIPLS sub-scales. However, the 
Physician Groups had significantly more positive attitudes than the Nurse and Pharmacist Groups 
towards Statement 17 (I like to understand the patient’s side of problem) and Statement 19 (The 
function of nurses and therapists is mainly to provide support for doctors). The Physician Group also 
had significantly more positive attitudes than the Nurse Group towards Statement 18 (I try to 
communicate compassion to my patients) and Statement 21 (I have to acquire much more 
knowledge and skills than other healthcare professionals). This indicated that the Physician Group 
had a greater sense of professional identity than the Nurse and Pharmacist Groups. Thus, the 
hypothesis was rejected. Further, it was found that healthcare academics showed more positive 
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attitudes than practitioners towards Statement 19. The strong positive attitudes of medical 
academics found in the present study towards Statement 19 may explain the strong sense of 
professional identity seen amongst medical students. This indicates that the role of academics in 
development of professional socialisation in the healthcare education is significant. This also 
suggests the needs of faculty development if IPE is to be implemented in the study university. Nurse 
practitioners had significantly more positive attitudes towards Statement 19 than their nursing 
academic counterparts. This may be associated with informal learning in the place of work which 
reflects the hierarchical model of healthcare service delivery at the study hospital.  
 
Hypothesis 8: Physicians, nurses and pharmacists would have no significant difference regarding 
their evaluation of the medication error case vignettes and no significant difference in respect to 
which healthcare professionals are responsible for and the factors that contributed to the 
medication errors 
In comparison to other healthcare professionals who participated in the present study, pharmacy 
academics in the study university and pharmacists in the study hospital showed higher accuracy, 
while older participants (>50 years old) were less accurate in providing anticipated correct answers 
for the medication error case vignettes. This indicated that pharmacists may have had a better 
understanding of the medication errors provided in the study. In general, although healthcare 
professionals agreed on which professions were responsible for the medication errors in the case 
vignettes based on the profession’s role in the process of medication delivery, the healthcare 
professionals who had that role did not agree that they were the only professionals who were 
responsible for the errors. This may reflect the importance of shared responsibility in the provision 
of healthcare service. The present study also found that only a small proportion of participants 
believed that communication failure was a contributor to the errors. According to these findings, the 
hypothesis was not confirmed.  
 
Hypothesis 9: Stakeholders’ and healthcare professionals’ would not support IPP implementation 
at the study hospital 
Stakeholders in the interviews and FGDs supported the implementation of IPP at the study hospital 
because of the perceived benefits (i.e. reducing blame and minimising the risk of medication 
misadventure). These findings did not confirm the hypothesis. However, the participants indicated 
that the major barrier to the implementation of IPP was the lack of understanding of the role of 
healthcare professionals (knowledge competencies). The other barrier was the strong sense of 
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superiority of certain healthcare professionals which may lead to communication barriers in the 
provision of healthcare services.  
 
The expansion of the role of pharmacists in patient care to ensure the safe use of medication though 
IPE/IPP is feasible for a number of reasons. Firstly, support from the Indonesian Government with the 
establishment of joint accreditation in health education, one of the outcomes of the HPEQ project, 
should pave the way to foster collaborative practice for future healthcare professionals. Secondly, 
participants in the qualitative study were supportive towards expanding the role of pharmacists in 
patient care given the perceived benefits, such as ensuring medication safety, educating the patients 
and providing drug information to healthcare professionals. Lastly, pharmacist conducted clinical 
pharmacy service activities were able to identify and prevent medication errors. 
 
Although participants support expanding the role of pharmacists, barriers in the education and 
practice settings must be addressed. In the education setting, in order to reduce the strong sense of 
professional identity in medical students and to recognise more of the role of other healthcare 
professionals, it is recommended to implement IPE early and continuously in the students’ 
curriculum and to involve professionals other than medical practitioners as medical academics. 
Healthcare academics should role model collaboration, acknowledging the role of, and showing 
respect to and trust for other healthcare professionals. Support from health institutions in terms of 
facilities, human resources, and funds from the university are essential in the implementation of IPE 
at the study university.  
 
Pharmacy curriculum redesign in the area of experiential learning and the involvement of members 
of the Indonesian pharmacy organisation (IAI) who have practised patient care would facilitate 
pharmacy graduates gaining experiential learning as care providers. Further, pharmacy education in 
collaboration with the IAI should design and provide a supportive environment to foster competent 
pharmacists as care providers in the future. The IAI also needs to clearly explain the role of 
pharmacists in patient care to ensure the safe use of medication. Once the role is clear, the IAI with 
the support from Indonesian Government should introduce fees for the pharmacists’ services to 
patients. Further, a postgraduate degree may be required if pharmacists are to expand their roles in 
patient care.  
 
At the practice setting, the sense of superiority amongst medical practitioners may have led to a lack 
of understanding of the role of other healthcare professionals in the present study. This would hinder 
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communication amongst healthcare professionals. This in turn may explain the low level of 
collaboration identified at the study hospital which correlates to Level 1 (Potential Collaboration) in 
the D’Amour et al model of collaboration. This finding indicates that the implementation of IPP at the 
study hospital is essential. In addition, the high rate of medication errors identified in the present 
study also indicated the need to improve the medication management system in the study hospital. 
The Indonesian Government should enact legislation on teamwork and recruit sufficient qualified 
staff if pharmacists are to be involved in IPP in improving the safe use of medication  
 
In order to enhance the understanding of the role of the pharmacist in medication safety, support 
from clinical leaders is essential because these leaders can use their influence to shape the role 
pharmacists play in patient care. The support from clinical leaders will be ensured if the pharmacists 
establish good rapport with clinical leaders, and the leaders gain benefits from pharmacists’ 
involvement in patient care to ensure medication safety. All in all, the expansion of the role of 
pharmacists in patient care to ensure medication safety through IPE requires support from the health 
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Appendix 5 Semi structured questions of interviews and focus group discussions (FGDs) 
Semi-structure questions asked during interviews with heads at the study university 
1. What do you think about healthcare professional working in a team to ensure the safe use of 
medication in the current healthcare service? 
2. What do you think are required to implement interprofessional practice (IPP)?  
3. In your opinion, will healthcare providers ready to work with other healthcare professional in 
IPP in the study hospital to ensure the safe use of medication? Why? 
4. What do you think the barriers and drivers for IPP in ensuring medication safety in the current 
healthcare service? 
5. What do you think about adopting interprofessional education (IPE) involving medical, nursing 
and pharmacy students in the current health curricula?  
6. What do you think drivers and barriers to IPE implementation in the current health curricula in 
the study university?  
7. When do you think IPE should be adopted in the health curricula? Why? 
8. In your opinion, does pharmacist have role in patient care? What do you think pharmacists’ 
role in ensuring the safe use of medication?  
9. Do you agree if pharmacist involved in IPP in ensuring the safe use of medication in the study 
hospital? What do you think could be done to expand pharmacist role in patient care in current 
healthcare service?  
10. What do you think barriers and drivers of pharmacists’ engagement in patient care to ensure 
the safe use of medication?  
11. Do you think the current pharmacy curricula had supported pharmacists’ roles in patient care? 
Particularly in ensuring the safe use of medication? (this question was asked of Head of 
Pharmacy Department) 
 
Semi structured questions asked during interviews with stakeholders at the study hospital and 
FGDs 
1. What do you think about healthcare professional working in a team to ensure the safe use of 
medication? 
2. What are required to implement IPP?  
3. In your opinion, will healthcare providers ready to work with other healthcare professional in 
the current hospital to ensure the safe use of medication? Why?  
4. What do you think drivers and barriers to IPP in ensuring medication safety in the current 
healthcare service? 
5. What do you think drivers and barriers to IPE implementation in the current health curricula in 
the study university? When do you think IPE should be adopted in the health curricula? Why? 
(this question was asked of stakeholders at the hospital) 
6. In your opinion, does pharmacist have role in patient care? What do you think pharmacists’ 
role in ensuring the safe use of medication?  
7. Do you agree if pharmacist involved in IPP in ensuring the safe use of medication in the study 
hospital? What do you think could be done to expand pharmacist role in patient care in the 
study hospital?  
8. Are you prepared as care providers in the current healthcare service? Why? (this question was 
asked during FGD with Pharmacist Group and pharmacy interns) 
9. What do you think drivers and barriers to pharmacists’ engagement in patient care to ensure 
the safe use of medication in the study hospital? 
10. Why the majority of pharmacy interns reported to have lack of attributes from the pharmacy 
graduates questionnaire? (this question was asked during FGD with pharmacy interns) 
11. What were attributes (other than the lists provided in the pharmacy graduates questionnaire) 
gained when you undertook pharmacy degree at the study university? (this question was 
asked during FGD with pharmacy interns)  
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Appendix 7a The Readiness for Interprofessional Education Learning Scale (RIPLS) questionnaire for 









Appendix 7b The Readiness for Interprofessional Education Learning Scale (RIPLS) questionnaire 






























Appendix 9a The Readiness for Interprofessional Education Learning Scale (RIPLS) questionnaire for 









Appendix 9b The Readiness for Interprofessional Education Learning Scale (RIPLS) questionnaire 








Appendix 10a Participation information sheet in IPP and case vignettes survey for healthcare 






Appendix 10b Participation information sheet in IPP and case vignettes survey for healthcare 


















































Appendix 13a The Readiness for Interprofessional Learning Scale (RIPLS) pre-workshop 











Appendix 13b The Readiness for Interprofessional Learning Scale (RIPLS) pre-workshop 









Appendix 13c The Readiness for Interprofessional Learning Scale (RIPLS) post-workshop 









Appendix 13d The Readiness for Interprofessional Learning Scale (RIPLS) post-workshop 





























Appendix 14e IPL workshop module  
 
INTERPROFESSIONAL LEARNING WORKSHOP 
 
ON 
    
 
                                       
 
 
Medication Safety and Root Cause Analysis 
 
Materials are adopted from Curtin University Interprofessional Learning Workshop on Medication 





HANDOUT OF INTERPROFESSIONAL LEARNING WORKSHOP 
MEDICATION SAFETY AND ROOT CAUSE ANALYSIS 
AIMS OF THE WORKSHOP 
- To allow medical, nursing, and pharmacy students to learn together as a team to improve 
quality in healthcare 
- To promote patient safety through interprofessional education on root cause analysis 
ATTENDANCE 
- 72 of Fourth year undergraduate students of medical, nursing, and pharmacy programes 
- Academic staffs 
LEARNING OUTCOMES 
At the end of the workshop, participants should be able to: 
- Work within an interdisciplinary team to contribute to the high quality of healthcare 
- Determine the cause of an adverse healthcare events 
- Assess and monitor an adverse healthcare events 
- Promote the safe use of medications as part of an interdisciplinary health team 
- Construct an action plan to prevent medical mishaps and improve the quality of healthcare 
LEARNING METHODS 
- There will be 12 groups (6 students/ group) which have been allocated, indicated by numbers 
on the students/participants list. The small group will work together in 1 large group during 
parts of the course 
- Investigator will deliver the 6 case studies on medication errors. Thus, 2 groups will discuss the 
same case study. 
- Each group will consist of 2 students from different disciplines (nursing, medical doctor, and 
pharmacy) 
- Each small group will be given 1 case outlining medication errors 
- A facilitator will be assigned to the group to guide the activities and facilitate the process of 
identifying problems, discussing the case, formulating a response and developing an action 
plan 
- Each small group is required to product a brief report (1page) to be handed in at the end of the 
workshop outlining from the case: 
1. The problem (root cause) 
2. What should be done to prevent a similar event occurring 
3. How success in preventing this event occurring again could be measured 
One group will present for each case at the final session to the assembled participants and 
facilitators from the School of Medicine, Nursing, and Pharmacy. These groups will be chosen 
randomly. After each presentation members of other groups with the same case will be asked 





Time Activity Group Size PIC 
Day 1    
08.30 – 08.50 Registration and pre-
workshop survey 
Large  
08.50 – 09.00 Welcoming address Large Head of School of 
Medicine 
09.00 – 09.45 Lecture 1. Quality and 
Safety in Healthcare 
Large Ni Nyoman Ayuningsih  
09.45 – 10.00  Break   
10.00 – 10.45 Lecture 2. Introduction 
to Root Cause Analysis 
Large Prof Jeff Hughes 
10.45 – 11.30 Lecture 3. Medication 
Safety 
Large Yulia Trisna 
11.30 – 12.00 Q and A Large  
12.00 – 13.00 Lunch   
13.00 – 13.45 Lecture 4. What 
Happened? Errors vs 
Violations 
Large Yulia Trisna 
13.45 – 14.30 Lecture 5. Developing 
Interventions 
Large Prof Jeff Hughes 
14.30 – 15.00 Q and A   
Day 2    
08.30 – 09.30 Activity 1.1 Safety 
Assessment code for 
vignettes and Select 
team members of 
discussion 
Small Facilitators 
09.30 – 10.30 Activity 2.1 Decide 
who to be interviewed. 
Decide what data and 
information to be 
collected.  
Small Facilitators 
10.30 – 10.45 Break   
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11.45 – 12.45 Activity 2.3 Identify 
root causes and 
Brainstorm 
intervention for each 
root cause. Develop 
action plan and 
outcome measure 
Small Facilitators 
12.45 – 13.30 Lunch   
13.30 – 15.30 Group Presentation Large  
15.30 – 15.45 Break   








 Title Learning Outcomes (At the end 
of the session, students should 
be able to) 
Content Outline 










 Apply knowledge of current 
healthcare policies to patient 
care both currently and the 
future 
 Explain two approaches to the 
problem of human fallibility: the 
person and the system 
approaches 
 Overview of healthcare in 
Indonesia 
 Government Policies in Patient 
Safety 
 Fatigue and performance, no 
blame culture 
 Person and System approaches 
 Activity 1. 
Classifying an 
event 
   Ice breakers 
 Classify event using safety 
assessment matrix 
 Review event flow chart 
 Select investigation team members 











 Determine root cause of an 
adverse event using an 
appropriate RCA technique  
 Differentiate medication errors 
from adverse drug reactions in 
an adverse healthcare event 





 Medication errors, ADR 
 Swiss cheese model 





  Decide who to be interviewed 
 Decide what data and information 
to be collected 
 Identify contributing factors 










 Determine the difference 
between error and violation in an 
adverse healthcare event 
 
 Errors vs Violations 




 Create an intervention plan and 
determine appropriate clinical 
outcome measures for 
measuring its impact 
 Practicality of action plans 
 Measuring outcomes and 
endpoints of RCA 
 Activity 3. List 
of root causes 
and develop an 
intervention 
plan 
  Identify root cause 
 Brainstorm interventions for each 
root cause 






CASE STUDY 1 
A 78 year old man complained about having pain on his joints. He went to the nearest pharmacy and 
the pharmacist gave tablet which contains 200 mg of ibuprofen and 500 mg of paracetamol tablet 
three times daily. After taking the medication for 2 days, the symptom remained, then, he went to a 
general practitioner, and the physician prescribed 200 mg of celecoxib once daily. The patient took 
ibuprofen tablet and celecoxib for few days. After three days, the patient complaining on having 
gastrointestinal discomfort.  
 
CASE STUDY 2 
A 5 year old boy (16 kg) was suffered from cold and cough since 5 days earlier. He also had yellowish 
sputum and fever in the last two days. Then, he was admitted to hospital. The physician diagnosed 
the patient suffered from an acute upper respiratory tract infection. The physician prescribed 2.5 mL 
of Bactrim® Syrup (40 mg of trimethoprim and 200 mg of sulfamethoxazole) for this patient. A few 
hours after the administration of this medication the patient’s body temperature elevated 
significantly and he complained of sore throat and his mucous membranes were swollen.   
 
CASE STUDY 3 
A 75 year old woman was diagnosed with peptic ulcer disease.  On admission, she looked pale and 
was hypotensive. The physician prescribed 40 mg of Losec® (omeprazole) OD, 500 mg of Amoxil® 
(amoxicillin) TID, 500 mg of Abbotic® (clarithromycin) BD, Mylanta Forte® (antacid) one tablet QID. 
The nurse ordered the medications through the pharmacy department. At the pharmacy 
department, it was a busy day and there were only two pharmacists on duty.  The pharmacist 
dispensed 40 mg of Lasix®, 500mg of Amoxil®, and 500 mg of Abbotic®. When the medications 
arrived in the ward, the nurse found out the patient received wrong medication. 
 
CASE STUDY 4 
A 80 year old man received prescription containing 5 mg of Amlodipine once daily. At pharmacy 
department, the pharmacist dispensed 10 mg of Amlodipine. At the ward, the nurse administered 
the 10 mg of Amlodipine tablet. The patient experiencing headache and hypotension after receiving 
the medication.  
 
CASE STUDY 5 
An 83 year old woman was hospitalized due to immobilization. She has a history of diabetes, 
pneumonia, and peptic ulcer. She was on Actrapid® drip 1 IU per hour, plus Lantus® 6 IU OD, 40 mg 
of omeprazole intravenously OD, 1 g of sucralfate BD, 500 mg of ciprofloxacin orally BD, and 1 g of 
cefotaxime intravenously TID. The nurse administered the medication as the following: omeprazole 
once daily in the evening, while cefotaxime was administered three times at 8 hourly intervals, 
sucralfate and ciprofloxacin were administered twice daily concurrently.  
 
CASE STUDY 6 
A 75 year old woman was diagnosed with gastritis acute. The physican prescribed one spoon of 
Antacida Syrup three times daily, 400 mg of cimetidine tablet twice daily. The Antacida syrup did not 
come with its spoon when arrived at the ward. Thus, the nurse gave the Antacida Syrup using spoon 
which was available in the ward which was a tea spoon. The patient complained the gastritis 





Activity 1.1 Classify the incident using a safety assessment matrix 
Safety assessment code for vignettes 
TABLE 1. RISK ASSESSMENT CODE (RAC) 
OUTCOMES/CONSEQUENCES: Use this table to determine the “MOST LIKELY WORST CASE 
REASONABLE SCENARIO”. Remember to consider all risk categories (see over for 
likelihood/probability categories). All incidents or identified gaps must be assessed for ACTUAL 
and/or POTENTIAL outcome/consequence. 
Risk 
Category 




unrelated to the 
natural course of 
the illness and 
differing from the 
immediate 
expected outcome 
of the patient 
management OR 




patient or body 
part 
 Completed suicide 






 Intravascular gas 
embolism resulting 
in death or 
neurological 
damage 
 Haemolytic blood 
transfusion 
 Medication error 
leading to death 
 Maternal death or 
serious morbidity 
associated with 
labour or delivery 
 Infant abduction or 
discharge to wrong 
family 
 Escape of forensic 
patient  at risk to 
Patients/client with 
major permanent 




unrelated to the 
natural course of the 
illness and differing 
from the expected 
outcome of patient 
management OR any 
of the following: 
 Disfigurement 
 Surgical intervention 
required 
 Physical abuse, 
aggression, assault 
of staff, patient or 
visitor 
 Absconding of an 
involuntary patient 
at risk to self or 
others 
 Serious of self-harm 




Hospitalisation of 1 
or 2 visitors 
Patients/client with 
permanent lessening 




unrelated to the 
natural course of the 
illness and differing 
from the expected 
outcome of patient 
management OR any 
of the following: 
 Increased length of 
stay 
 Occasion of service 
or 
 Additional operation 
or procedure 




 Physical abuse, 
aggression or assault 
of staff, patient or 
visitor (threatening, 




expenses incurred or 
treatment of 1 or 2 











 Referral to 
another 
clinician 


















with no injury or 
increased level of 
care or length of 











Visitors: death of 
visitor or 
hospitalization of 3 
or more visitors 
STAFF 
RISK 
Staff: Death of staff 
member or 
hospitalization of 3 
or more staff 
Staff: any of the 
following permanent 
injury to staff 
member, 
hospitalization of 




anticipated in excess 
of 20 working days 
Staff: any of the 
following: medical 
expenses, lost time 
or restricted duties 
or injury/illness for 1 
or 2 staff anticipated 
to be between 1-20 
working days 
Staff: any of the 
following: first 
aid treatment 
and or GP 
consultation. 
Lost time or 
restricted 
duties less than 
1 working day 







































suspension of work. 
Additional resources 





















of legal action 
Services: Medium 
term temporary 
suspension of work. 
Backlog requires 











































































TABLE 2. PROBABILITY/LIKELIHOOD 
Frequent (almost certain) It is expected to occur either immediately or within a 
short period of time (to occur most weeks or months) 
Probable (likely) Will probably occur in most circumstances (several 
times a year) 
Occasional (possible) Probably will recur – might occur at some time (may 
happen every 1-2 year) 
Uncommon (unlikely) Possibly will recur – could occur at some time in 2-5 
years 
Remote (rare) Unlikely to recur – may occur only in exceptional 
circumstances – may happen every 5 – 30 years) 
 
TABLE 3. RISK ASSESSMENT CODE –Select the outcome/consequence column and move down the 










Frequent (almost certain) 1 1 2 3 3 
Probable (likely) 1 1 2 3 3 
Occasional (possible) 1 2 2 3 4 
Uncommon (unlikely) 1 2 3 4 4 





TABLE 4. RESPONSIBILITIES AND TIMELINES 
All incidents/risks require immediate 
management at site at time of 
occurrence 




Extreme Risk 1 Immediate report 
to operations and 





eq OSH/AIMS etc 
Timelines for action 
plan and executive 
endorsement agreed 




director and HSM at 
least monthly until 
risk reduced to 3 or 
below 
High Risk 2 
Medium Risk 3 
Within 3 days 
reporting process 
as above 
Action plan and 
relevant director 
endorsement within 
6 weeks of incidence 
Monthly to relevant 
site/area committee 









ACTIVITY 1.2 Select team members of investigation 
Select the people for the investigation team 
Bring together people who have an intimate knowledge of the ‘normal process.’ 
What Expertise do I need?            Who fits this role?                                 Selected 
   
   
   
   
   
   





ACTIVITY 2.1 Decide who to be interviewed. Decide what data and 
information to be collected 
DATA OR INFORMATION SOURCES INFORMATION AVAILABLE FORM EACH 
SOURCES 















Organisational policies and procedures or 


















ACTIVITY 2.2 IDENTIFY CONTRIBUTORY FACTORS 
1 CONTRIBUTING FACTORS AND ROOT CAUSES 
1.1  Where appropriate policies/procedures or guidelines – 
or lack/misunderstanding or a misuse thereof – a factor 




If Yes, tick appropriate box or boxes AND describe how it appeared to 
contribute 
Behavioural assessment                  Coordination of Care                           
 
Patient observation process              Identification process                   
 
Clinical guidelines  
 
 





If Yes, tick appropriate box or boxes AND describe how it appeared to 
contribute 
Staff allocation                  Staff training                       Staff supervision 
 
Recruitment                    Staff appraisals              
 
 
1.3 Was communication a factor in this event? Yes  
 
No 
If yes, tick appropriate box or boxed AND describe the perceived deficiency 
Communication  between staff 
 




1.5  What equipment (or the use of lack of use of 




If Yes, tick appropriate box or boxes AND describe how it appeared to 
contribute 
Faulty equipment                            Lack of equipment 
 




1.6 Was the physical environment of the health service or 
suitability of the environment to support the function it 








1.7 Were external factors an issue in this event? E.q service 
provision from an external organisation/lack of beds at 




If yes, describe the external factors that may have contributed 
1.8 Other factors Yes  
 
No 
If yes, describe the other factors that may have contributed 
376 
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Appendix 17 Medication errors identified during clinical pharmacy services (Phase 3) 









































PE1 Incomplete drug history 8 2             1 3           1   1       
PE2 Duplication 4             1 1   1         1           
PE3 Wrong drug 3       2                               1 
PE4 Unclear indication 8     1     1         4   1     1         
PE5 Wrong dose 15   1 2 1     1   2           3 2 1   2   
PE6 Wrong time 1     1                                   
PE7 Wrong dosage form 2                 1             1         
PE8 Unclear duration of antibiotics 8           1     1 1   1 2     1   1     
PE9 Contraindication 2                           2             
PE10 
Drug not given although it was 
indicated/omission 
7   2           2 1     2                 
PE11 
Drug given although it was not 
indicated 
1   1                                     
PE12 
Drug prescribed beyond 
hospital formulary 
0                                         
PE13 Illegible hand writing 4                         1     1 1     1 
PE14 
Drug not written on patient's 
progress notes 
37     4 5 3   2 3       3     1 1 3 2 6 4 
PE15 Others 1     1                                   
  TOTAL PRESCRIBING ERRORS 101                                         
TE1 Wrong dose 43 5   2 4 1 1 1 2 3 3 5     5 2 4 1 2 2   
TE1 - AE4 
wrong dose transcribed led to 
wrong dose administered 
9 2                 1   2 1 1 1 1         
TE2 Wrong time 5 1               2                 2     













































TE4 Drug needed not transcribed 72   5   1 1 5 2 4 5 4 4 4 7 6 3 2 1 5 10 3 
TE4 - AE10 
Drug needed not transcribed 
caused drug omission 
7     1                 1           4 1   
TE4 - AE11 
Drug needed not transcribed 
caused drug administered late 
2                 1                   1   
TE5 Illegible hand writing 0                                         
TE6 Drug not needed transcribed 10   1           1     2   2   3 1         
TE7 
Drug ceased has not been 
transcribed 
35         1     1 6 2 1   3   2 1 4 4 7 3 
TE7 - AE8 
Drug ceased has not been 
transcribed; the patient was 
given the drug 
29 1     1 5 4 2 1 4 1 2   1         1 3 3 
TE8 Wrong drug 8         1   1   1 1     1       1 1   1 
TE9 Wrong dosage form 2           1 1                           




230                                         
DE1 Wrong patient 1                               1         
DE2 Duplication 13           5 4       2       1         1 
DE3 Wrong drug 10 2           1 2 2 1 1   1               
DE4 Wrong dose 17   1   2     1 1 3 1 2       1 1 4       
DE5 Near miss 24 2 1 2 2   1 1 5 4 1       1 1   2   1   
DE6 Labelling 41 1 2 3 6   2 2 6 7 1 2 1     2 3   2 1   
DE7 Wrong dosage form 4                   1 1 1     1           
DE8 Wrong number of drug 21     3 1         2 1 1 7 1   2 3         
DE9 
Drug dispensed although it was 
not ordered 













































DE10 Drug omission in dispensing 26   2     1   2   3   2 5 1 1   3 2   4   
DE10 - AE10 
Dispensing omission causing 
drug omission in administration 
57     1 3   2     1 1 3 10 15   4 8 1 2 5 1 
DE10 - AE11 
Dispensing omission causing 
drug administered late 
6                     1 1       2     2   
  TOTAL DISPENSING ERRORS 225                                         
AE1 Wrong patient 0                                         
AE2 Duplication 3             1                   1 1     
AE3 Wrong drug 8     1 1         1       2 1         2   
AE4 Wrong dose 37 4   2       1   6   6 1     8 3 2 3 1   
AE5 Near miss 8     1             1       1     1 1 2 1 
AE6 Documentation 0                                         
Doc1 
Medication given not 
documented 
513   13 23 31 22 23 48 10 44 28 21 23 27 47 44 20 15 19 29 26 
Doc2 
Medication not given but 
documented 
80       1     4 1 6 14 3 16 6 1 5 2 5 9 4 3 
  
Medication not given and not 
documented (added to AE10) 
56   1 1 1 6 1   1 3   16 3 3 7 3 5 1   4   
AE7 Wrong dosage form 2         1 1                             
AE8 Drug given not indicated 10       1 2 2   1                   3   1 
AE9 Wrong drug instruction 19   1     2 1 1 1     1 1 2   2 2   4   1 
AE10 Drug omission 98     3 2 3 2 5 6 11 5 7 7 10 17 10 2 2 2   4 
AE10a 
Drug omission because of the 
patient refused 
35           16           4 5 1 1     4   4 
AE10b 
Drug omission because of 
medical examination 
23       8       2       5             7 1 
















































927                                         
ME Monitoring errors 2                   1                 1   
SE1 Drug Distribution System 52 1   1 4 1 1 3 1 4 2 2 2 12 2 8 3 1 2 2   
SE1 - AE10 
Drug distribution system led 
drug omission in administration 
3                             1     1   1 
SE2 Health insurance System 13     5             1         3   1   3   
SE2 - AE10 
Health insurance System led 
drug omission in administration 
5                                 1 2   2 
SE3 Technical problems 5   4                           1         
TOTAL ERRORS 
 


































































































49   3 6 7 3 3 1 1   1 6 1 1 3 2 3 3 2 1 2 
Intervention 
Not Accepted  





38     4   5   8 5 4 1 2 1 3 1 1 2       1 
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